
<html lang="en"     class="pb-page"  data-request-id="dabee1a5-4161-42ab-93c3-1cee51054694"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm040159c;website:website:acspubs;issue:issue:10.1021/jmcmar.2005.48.issue-4;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity" /></meta><meta name="dc.Creator" content="Hwei-Ru  Tsou,*,†" /></meta><meta name="dc.Creator" content="Elsebe G.  Overbeek-Klumpers,†" /></meta><meta name="dc.Creator" content="William A.  Hallett,†" /></meta><meta name="dc.Creator" content="Marvin F.  Reich,†" /></meta><meta name="dc.Creator" content="M. Brawner  Floyd,†" /></meta><meta name="dc.Creator" content="Bernard D.  Johnson,†" /></meta><meta name="dc.Creator" content="Ronald S.  Michalak,‡" /></meta><meta name="dc.Creator" content="Ramaswamy  Nilakantan,†" /></meta><meta name="dc.Creator" content="Carolyn  Discafani,§" /></meta><meta name="dc.Creator" content="Jonathan  Golas,§" /></meta><meta name="dc.Creator" content="Sridhar K.  Rabindran,§" /></meta><meta name="dc.Creator" content="Ru  Shen,§" /></meta><meta name="dc.Creator" content="Xiaoqing  Shi,§" /></meta><meta name="dc.Creator" content="Yu-Fen  Wang,§" /></meta><meta name="dc.Creator" content="Janis  Upeslacis,† and" /></meta><meta name="dc.Creator" content="Allan  Wissner†" /></meta><meta name="dc.Description" content="A series of new 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitrile derivatives that function as irreversible inhibitors of human epidermal growth factor receptor-2 (HER-2) and epidermal growth..." /></meta><meta name="Description" content="A series of new 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitrile derivatives that function as irreversible inhibitors of human epidermal growth factor receptor-2 (HER-2) and epidermal growth..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="January 27, 2005" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm040159c" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-48-4-1107" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(04)00159-1" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2005 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm040159c" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm040159c" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm040159c" /></link>
        
    
    

<title>Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm040159c" /></meta><meta property="og:title" content="Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cn00001.jpeg" /></meta><meta property="og:description" content=" A series of new 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitrile derivatives that function as irreversible inhibitors of human epidermal growth factor receptor-2 (HER-2) and epidermal growth factor receptor (EGFR) kinases have been prepared. These compounds demonstrated enhanced activities for inhibiting HER-2 kinase and the growth of HER-2 positive cells compared to our EGFR kinase inhibitor 86 (EKB-569). Three synthetic routes were used to prepare these compounds. They were prepared mostly by acylation of 6-amino-4-(arylamino)quinoline-3-carbonitriles with unsaturated acid chlorides or by amination of 4-chloro-6-(crotonamido)quinoline-3-carbonitriles with monocyclic or bicyclic anilines. The third route was developed to prepare a key intermediate, 6-acetamido-4-chloroquinoline-3-carbonitrile, that involved a safer cyclization step. We show that attaching a large lipophilic group at the para position of the 4-(arylamino) ring results in improved potency for inhibiting HER-2 kinase. We also show the importance of a basic dialkylamino group at the end of the Michael acceptor for activity, due to intramolecular catalysis of the Michael addition. This, along with improved water solubility, resulted in compounds with enhanced biological properties. We present molecular modeling results consistent with the proposed mechanism of inhibition. Binding studies of one compound, 25o (C-14 radiolabeled), showed that it binds irreversibly to HER-2 protein in BT474 cells. Furthermore, it demonstrated excellent oral activity, especially in HER-2 overexpressing xenografts. Compound 25o (HKI-272) was selected for further studies and is currently in phase I clinical trials for the treatment of cancer.  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm040159c"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm040159c">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm040159c&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm040159c&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm040159c&amp;href=/doi/10.1021/jm040159c" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2005</span><span class="cit-fg-volume">, 48</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1107-1131</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/48/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm049165z" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm049223g" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hwei-Ru++Tsou">Hwei-Ru Tsou</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elsebe+G.++Overbeek-Klumpers">Elsebe G. Overbeek-Klumpers</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+A.++Hallett">William A. Hallett</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marvin+F.++Reich">Marvin F. Reich</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=M.+Brawner++Floyd">M. Brawner Floyd</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bernard+D.++Johnson">Bernard D. Johnson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronald+S.++Michalak">Ronald S. Michalak</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramaswamy++Nilakantan">Ramaswamy Nilakantan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carolyn++Discafani">Carolyn Discafani</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan++Golas">Jonathan Golas</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sridhar+K.++Rabindran">Sridhar K. Rabindran</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ru++Shen">Ru Shen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoqing++Shi">Xiaoqing Shi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yu-Fen++Wang">Yu-Fen Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Janis++Upeslacis">Janis Upeslacis</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allan++Wissner">Allan Wissner</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm040159c&amp;href=/doi/10.1021%2Fjm040159c" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2005</span></span><span class="cit-volume">, 48</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1107–1131</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 27, 2005</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 August 2004</li><li><span class="item_label"><b>Published</b> online</span>27 January 2005</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 February 2005</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm040159c" title="DOI URL">https://doi.org/10.1021/jm040159c</a></div><div class="article_header-article-copyright"><strong>Copyright © 2005 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1107%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHwei-Ru%2BTsou%252C%2BElsebe%2BG.%2BOverbeek-Klumpers%252C%2BWilliam%2BA.%2BHallett%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D48%26issueNum%3D4%26contentID%3Djm040159c%26title%3DOptimization%2Bof%2B6%252C7-Disubstituted-4-%2528arylamino%2529quinoline-3-carbonitriles%2Bas%2BOrally%2BActive%252C%2BIrreversible%2BInhibitors%2Bof%2BHuman%2BEpidermal%2BGrowth%2BFactor%2BReceptor-2%2BKinase%2BActivity%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1131%26publicationDate%3DFebruary%2B2005">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm040159c"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5155</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">211</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm040159c" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hwei-Ru&quot;,&quot;last_name&quot;:&quot;Tsou&quot;},{&quot;first_name&quot;:&quot;Elsebe&quot;,&quot;last_name&quot;:&quot;G. Overbeek-Klumpers&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;A. Hallett&quot;},{&quot;first_name&quot;:&quot;Marvin&quot;,&quot;last_name&quot;:&quot;F. Reich&quot;},{&quot;first_name&quot;:&quot;M.&quot;,&quot;last_name&quot;:&quot;Brawner Floyd&quot;},{&quot;first_name&quot;:&quot;Bernard&quot;,&quot;last_name&quot;:&quot;D. Johnson&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;S. Michalak&quot;},{&quot;first_name&quot;:&quot;Ramaswamy&quot;,&quot;last_name&quot;:&quot;Nilakantan&quot;},{&quot;first_name&quot;:&quot;Carolyn&quot;,&quot;last_name&quot;:&quot;Discafani&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;Golas&quot;},{&quot;first_name&quot;:&quot;Sridhar&quot;,&quot;last_name&quot;:&quot;K. Rabindran&quot;},{&quot;first_name&quot;:&quot;Ru&quot;,&quot;last_name&quot;:&quot;Shen&quot;},{&quot;first_name&quot;:&quot;Xiaoqing&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Yu-Fen&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Janis&quot;,&quot;last_name&quot;:&quot;Upeslacis&quot;},{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;Wissner&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2005&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;48&quot;,&quot;pages&quot;:&quot;1107-1131&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm040159c&quot;},&quot;abstract&quot;:&quot;A series of new 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitrile derivatives that function as irreversible inhibitors of human epidermal growth factor receptor-2 (HER-2) and epidermal growth factor receptor (EGFR) kinases have been prepared. These compounds demonstrated enhanced activities for inhibiting HER-2 kinase and the growth of HER-2 positive cells compared to our EGFR kinase inhibitor 86 (EKB-569). Three synthetic routes were used to prepare these compounds. They were prepared mostly by acylation of 6-amino-4-(arylamino)quinoline-3-carbonitriles with unsaturated acid chlorides or by amination of 4-chloro-6-(crotonamido)quinoline-3-carbonitriles with monocyclic or bicyclic anilines. The third route was developed to prepare a key intermediate, 6-acetamido-4-chloroquinoline-3-carbonitrile, that involved a safer cyclization step. We show that attaching a large lipophilic group at the para position of the 4-(arylamino) ring results in improved potency for inhibiting HER-2 kinase. We also show the im&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm040159c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm040159c" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm040159c&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm040159c" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm040159c&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm040159c" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm040159c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm040159c&amp;href=/doi/10.1021/jm040159c" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm040159c" /></input><a href="/doi/pdf/10.1021/jm040159c" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (480 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm040159c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm040159c%26sid%3Dliteratum%253Aachs%26pmid%3D15715478%26genre%3Darticle%26aulast%3DTsou%26date%3D2005%26atitle%3DOptimization%2Bof%2B6%252C7-Disubstituted-4-%2528arylamino%2529quinoline-3-carbonitriles%2Bas%2BOrally%2BActive%252C%2BIrreversible%2BInhibitors%2Bof%2BHuman%2BEpidermal%2BGrowth%2BFactor%2BReceptor-2%2BKinase%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D48%26issue%3D4%26spage%3D1107%26epage%3D1131%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/48/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of new 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitrile derivatives that function as irreversible inhibitors of human epidermal growth factor receptor-2 (HER-2) and epidermal growth factor receptor (EGFR) kinases have been prepared. These compounds demonstrated enhanced activities for inhibiting HER-2 kinase and the growth of HER-2 positive cells compared to our EGFR kinase inhibitor <b>86</b> (EKB-569). Three synthetic routes were used to prepare these compounds. They were prepared mostly by acylation of 6-amino-4-(arylamino)quinoline-3-carbonitriles with unsaturated acid chlorides or by amination of 4-chloro-6-(crotonamido)quinoline-3-carbonitriles with monocyclic or bicyclic anilines. The third route was developed to prepare a key intermediate, 6-acetamido-4-chloroquinoline-3-carbonitrile, that involved a safer cyclization step. We show that attaching a large lipophilic group at the para position of the 4-(arylamino) ring results in improved potency for inhibiting HER-2 kinase. We also show the importance of a basic dialkylamino group at the end of the Michael acceptor for activity, due to intramolecular catalysis of the Michael addition. This, along with improved water solubility, resulted in compounds with enhanced biological properties. We present molecular modeling results consistent with the proposed mechanism of inhibition. Binding studies of one compound, <b>25o</b> (C-14 radiolabeled), showed that it binds irreversibly to HER-2 protein in BT474 cells. Furthermore, it demonstrated excellent oral activity, especially in HER-2 overexpressing xenografts. Compound <b>25o </b>(HKI-272) was selected for further studies and is currently in phase I clinical trials for the treatment of cancer. </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm040159cAF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  To whom correspondence should be addressed. Phone:  (845) 602-4712. Fax:  (845) 602-5561. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="691d1a061c01291e100c1d01470a060447">[email protected]</a></p></span></div><div class="fnGroupItem" id="jm040159cAF2"><span><h4><span class="NLM_fn-symbol">†</span></h4></span><span><p class="last">  Chemical and Screening Sciences.</p></span></div><div class="fnGroupItem" id="jm040159cAF3"><span><h4><span class="NLM_fn-symbol">‡</span></h4></span><span><p class="last">  Chemical Development.</p></span></div><div class="fnGroupItem" id="jm040159cAF4"><span><h4><span class="NLM_fn-symbol">§</span></h4></span><span><p class="last">  Oncology.</p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13462" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13462" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein tyrosine kinases play a key role in signal transduction pathways that regulate numerous cellular functions including proliferation, differentiation, migration, and angiogenesis. A large number of receptor and nonreceptor tyrosine kinases have been identified. Among them, the epidermal growth factor receptor (EGFR) tyrosine kinase (known as EGFR, HER-1, or ErbB-1) and human epidermal growth factor receptor-2 (known as HER-2, ErbB-2 or neu) have been widely studied as drug discovery targets. They are two of the four members of the EGF receptor family that also includes HER-3 (ErbB-3) and HER-4 (ErbB-4). These four closely related proteins share common structural elements such as an extracellular ligand binding domain and an intracellular tyrosine kinase domain. At least 12 different ligands that bind to the EGFR, HER-3, and HER-4 receptors have been identified. However, there is no known ligand for HER-2. Upon ligand binding, these receptors dimerize with themselves or with other family members and undergo autophosphorylation of tyrosine residues within the C-terminal cytoplasmic domain. These phosphorylated residues serve as docking sites for recruitment of downstream signaling proteins, leading to subsequent signal transduction cascades.<sup><a onclick="showRef(event, 'jm040159cb00001'); return false;" href="javascript:void(0);" class="ref jm040159cb00001">1</a></sup></div><div class="NLM_p">Hyperactivation of the EGFR family of receptors leading to uncontrolled cell proliferation is seen in a variety of cancers.<sup><a onclick="showRef(event, 'jm040159cb00002'); return false;" href="javascript:void(0);" class="ref jm040159cb00002">2</a></sup> Activation of EGFR may be due to overexpression of the receptors (head and neck, lung, breast, bladder, prostate, and kidney tumors), mutations resulting in constitutive activation (brain tumors), or overexpression of the ligands (EGF or TGFα in pancreatic, prostate, lung, ovary, and colon cancers).<sup><a onclick="showRef(event, 'jm040159cb00003 jm040159cb00004'); return false;" href="javascript:void(0);" class="ref jm040159cb00003 jm040159cb00004">3,4</a></sup> In contrast, activation of HER-2 occurs mainly via overexpression in breast, ovarian, lung, prostate, gastric, and oral cancers<sup><a onclick="showRef(event, 'jm040159cb00005'); return false;" href="javascript:void(0);" class="ref jm040159cb00005">2,5</a></sup> leading to spontaneous homodimerization and activation of downstream signaling events in a ligand-independent manner. In particular, overexpression of HER-2 was found in 25−30% of breast cancer cases and has been correlated with poor prognosis in patients.<sup><a onclick="showRef(event, 'jm040159cb00006'); return false;" href="javascript:void(0);" class="ref jm040159cb00006">6</a></sup></div><div class="NLM_p">Since deregulation of the EGFR and HER-2 tyrosine kinases has been associated with a variety of cancers, small-molecule inhibitors that could control the tyrosine phosphorylation event could be of therapeutic value as potential antitumor agents. Indeed, there are several ATP-competitive EGFR tyrosine kinase inhibitors currently in clinical trials for the treatment of cancer.<sup><a onclick="showRef(event, 'jm040159cb00007 jm040159cb00008'); return false;" href="javascript:void(0);" class="ref jm040159cb00007 jm040159cb00008">7,8</a></sup> Among them, a 6,7-disubstituted 4-anilinoquinoline-3-<a name="jm004800401108" id="jm004800401108"></a> carbonitrile <b>86</b> (EKB-569), developed by us,<sup><a onclick="showRef(event, 'jm040159cb00009 jm040159cb00010'); return false;" href="javascript:void(0);" class="ref jm040159cb00009 jm040159cb00010">9,10</a></sup> is an orally active, irreversible inhibitor of the EGFR kinase. This compound carries a Michael acceptor at the 6-position, which forms a covalent bond to Cys 773 located in the ATP binding pocket of the EGFR enzyme. The water-solubilizing dimethylamino group at the end of the Michael acceptor serves as an intramolecular base catalyst operating via a cyclic five-membered ring mechanism to catalyze the Michael addition process.<sup>9</sup> This enhanced reactivity with the EGFR enzyme along with improved bioavailability resulted in <b>86</b> displaying potent antitumor activity in EGFR-dependent tumor models. However, since <b>86</b> shows less efficacy in HER-2 dependent tumor models, we continued with our efforts to develop irreversible inhibitors with improved activity toward HER-2 expressing tumors. These efforts are the subject of this communication. </div><div class="NLM_p last">EGFR and HER-2 share an 82% sequence identity in the kinase domains; the identity is even higher in the active site.<sup><a onclick="showRef(event, 'jm040159cb00011'); return false;" href="javascript:void(0);" class="ref jm040159cb00011">11</a></sup> We constructed a homology model of HER-2 kinase for this study using the crystal structure of EGFR kinase in complex with erlotinib, a quinazoline-based inhibitor (also known as Tarceva, or CP-358774).<sup><a onclick="showRef(event, 'jm040159cb00012'); return false;" href="javascript:void(0);" class="ref jm040159cb00012">12</a></sup> Since Cys 773 in EGFR is conserved as Cys 805 in HER-2, the development of an irreversible inhibitor of the latter kinase appeared to be feasible. The most notable difference in the ATP binding region between these kinases is a single amino acid residue, i.e., Ser 783 in HER-2 vs Cys 775 in EGFR. The high level of identity between the ATP binding regions of these two enzymes suggested that it would be difficult to design molecules that would be selective for one over the other. Designing an inhibitor that showed improved efficacy in HER-2 models (compared to <b>86</b>) appeared to be a more realistic undertaking. The binding models of our inhibitors indicated that the aniline portion fits into a long lipophilic pocket. Since this is the region of the binding pocket with the most difference between the two kinases and since there is room to introduce large lipophilic groups at the para position of the aniline, we explored various modifications to the 4-arylamino portion of the inhibitors in an empirical search to identify molecules with improved HER-2 activity. Interestingly, several other groups<sup><a onclick="showRef(event, 'jm040159cb00013 jm040159cb00014 jm040159cb00015'); return false;" href="javascript:void(0);" class="ref jm040159cb00013 jm040159cb00014 jm040159cb00015">13-15</a></sup> have independently discovered, for quinazoline-based inhibitors, that large lipophilic substituents lead to improved HER-2 activity and, in some cases, improved dual HER-2/EGFR activity.<sup><a onclick="showRef(event, 'jm040159cb00016 jm040159cb00017'); return false;" href="javascript:void(0);" class="ref jm040159cb00016 jm040159cb00017">16,17</a></sup> Here, we describe the synthesis and SAR of a series of 6,7-disubstituted 4-(arylamino)quinoline-3-carbonitriles modified with a variety of lipophilic substituents on the arylamino ring. Compared to our EGFR kinase inhibitor <b>86</b>, several of these compounds, as exemplified by <b>25o</b> (Figure 1<a data-tab="pane-pcw-Figures" href="#jm040159cf00001" id="" class=" internalNav"></a>), show improved activity toward HER-2 kinase while retaining good potency for EGFR kinase. Most importantly, this dual HER-2 and EGFR inhibitor, <b>25o</b>, also demonstrated improved in vivo efficacy in HER-2 dependent tumor models. <div id="_i4"><figure id="jm040159cf00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cf00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00001.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159cf00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Most of the 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles (<b>7</b>, <b>8</b>, <b>21</b>, <b>25</b>) described here were prepared by one of the three methods shown in Schemes <a data-tab="pane-pcw-Figures" href="#jm040159ch00001a" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm040159ch00001" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm040159ch00002" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm040159ch00003" id="" class=" internalNav"></a>1−3. In Scheme 1, 4-chloro-6-nitroquinoline-3-carbonitriles <b>1a</b>,<b>b</b><sup>9</sup> were reacted with a substituted aniline <b>2</b> (including 5-amino-1-benzylindole and 5-amino-1-benzylindazole) and then reduced with iron and aqueous ammonium chloride to yield the corresponding 6-amino-4-anilinoquinoline-3-carbonitriles <b>4</b>, which were converted to the final products by two methods. In method 1A, the amines <b>4</b> were reacted with 4-bromocrotonyl chloride <b>5</b> and then the bromo group was displaced with secondary amines to yield the final compounds <b>7</b>. In method 1B, the final compounds <b>8</b> were prepared in one step by reacting the amines <b>4</b> with 4-(<i>N,N</i>-disubstituted amino)crotonyl chlorides <b>6</b>. Both methods shown in Scheme 1 were used successfully in our early work<sup>9</sup> to prepare <b>86 </b>and similar 4-anilinoquinoline-3-carbonitriles as inhibitors of EGFR kinase. Our original preparation of <b>1a</b>,<b>b</b> involved a high-temperature cyclization of a nitro-containing intermediate.<sup>9</sup> Although we never experienced any difficulty with this cyclization, we did have some concerns about performing the cyclization on a large scale. Therefore, we developed an alternative synthesis where the cyclization was carried out on an acetoamido intermediate <b>14</b> as shown in Scheme 2 (method 2). The commercially available 2-amino-5-nitrophenol <b>9</b> was protected as acetamide <b>10</b>. It was then ethylated and reduced to yield 4-acetamido-3-ethoxyaniline <b>12</b>, which upon condensation with ethyl (ethoxymethylene)cyano acetate <b>13</b> yielded the acetamido intermediate <b>14</b>. Cyclization of <b>14 </b>was carried out in Dowtherm at 250−255 °C to yield 6-acetamido-4-hydroxyquinoline-3-carbonitrile <b>15</b>. Chlorination of <b>15</b> generated the 4-chloro intermediate <b>16</b>. The subsequent reactions are similar to those already described (Scheme 1) with the addition that the acetamido group of <b>18</b> was deacetylated to amine <b>19</b> before reacting with the desired crotonyl chloride <b>20</b> to yield the final compounds <b>21</b>. <div id="_i7"><figure id="jm040159ch00001a" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00001a.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00001a.jpeg" id="_i8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Scheme 1.  Methods 1A and 1B<i><sup>a</sup></i><sup></sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00001a.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00001a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm040159ch00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00001.jpeg" id="_i9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1.  (Continued) </p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) <i>i</i>-PrOH, pyridine hydrochloride, reflux; (ii) Fe, NH<sub>4</sub>Cl, MeOH, H<sub>2</sub>O, reflux; (iii) THF, Hunig base, 4-bromocrotonyl chloride, 0 °C; (iv) DMF, NaI, R‘ ‘R‘NH, room temperature; (v) <i>N</i>-methyl-2-pyrrolidinone or DMF, from 0 °C to room temperature.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm040159ch00002" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00002.jpeg" id="_i10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2.  Method 2<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Ac<sub>2</sub>O, HOAc, 60 °C; (ii) EtBr, DMF, K<sub>2</sub>CO<sub>3</sub>, 60 °C; (iii) H<sub>2</sub>, Pd/C, THF; (iv) toluene, 90 °C; (v) Dowtherm, 250 °C; (vi) POCl<sub>3</sub>, diglyme, 100 °C; (vii) pyridine hydrochloride, <i>i</i>-PrOH or methoxyethanol, reflux; (viii) aqueous HCl, reflux; (xi) CH<sub>3</sub>CN, <i>N</i>-methyl-2-pyrrolidinone or DMF, from 0 °C to room temperature.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm040159ch00003" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00003.jpeg" id="_i11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3.  Method 3<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Fe, HOAc, NaOAc, MeOH, reflux; (ii) Me<sub>2</sub>NCH<sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCOCl in CH<sub>3</sub>CN, <i>N</i>-methyl-2-pyrrolidinone or DMF, from 0 °C to room temperature; (iii) pyridine hydrochloride, methoxyethanol, or <i>i</i>-PrOH, reflux.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">A third synthetic method was developed where the 6-crotonamide side chain was first attached to the quinoline-3-carbonitrile ring, followed by introduction of the anilines at the C-4 position, as shown in Scheme 3 (method 3). 4-Chloro-6-nitro compound <b>1b</b> was reduced to the 4-chloro-6-amino compound <b>22</b>, which was then condensed with 4-(<i>N,N</i>-dimethylamino)crotonyl chloride to yield <b>23</b>. This was then converted to the final products <b>25</b> by heating with a variety of anilines <b>24 </b>in methoxyethanol or 2-propanol using a catalytic amount of pyridine hydrochloride. This method was proved <a name="jm004800401110" id="jm004800401110"></a> useful when optimizing the 4-anilino groups for HER-2 activity while keeping the 6-crotonamide side chain constant. </div><div class="NLM_p">For some compounds (<b>31</b>, <b>32</b>, <b>36</b><b>−</b><b>38</b>) where the 4-aniline ring bears nitrogen-containing para substituents, the synthetic pathways are shown in Schemes <a data-tab="pane-pcw-Figures" href="#jm040159ch00004" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm040159cf00002" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm040159cf00003" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm040159ch00005" id="" class=" internalNav"></a>4 and 5. The amino group of <b>26</b> was first protected with BOC anhydride, the nitro group was reduced to yield the aniline <b>28</b>, and this was condensed with chloride <b>23 </b>followed by deprotection of the BOC group to yield <b>29</b>. Reductive amination of the amino group of <b>29</b> with aldehydes <b>30</b> using sodium triacetoxyborohydride in acetic acid gave <b>31</b> and <b>32</b>. An alternative approach was used to prepare the 7-methoxy intermediate <b>35</b> as shown in Scheme 5. The 4-chloro compound <b>1a</b> was first condensed with aniline <b>28</b>, then the nitro group was reduced followed by the reaction of <b>34</b> with 4-(<i>N,N</i>-dimethylamino)crotonyl chloride in a manner similar to that shown in Scheme 1 (method 1B). After deprotection of the BOC group with TFA, the key intermediate <b>35</b> was obtained. Condensing <b>35</b> with acid anhydride, acid chloride, or phenyl isocyanate yielded amides <b>36 </b>and <b>37</b> or urea <b>38</b>. <div id="_i12"><figure id="jm040159ch00004" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00004.jpeg" id="_i13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) (Boc)<sub>2</sub>O, DMAP, THF, 0 °C to room temperature; (ii) Fe, HOAc, MeOH, reflux; (iii) pyridine hydrochloride, methoxyethanol, reflux, then CH<sub>2</sub>Cl<sub>2</sub>, TFA, from 0 to 25 °C; (iv) NaBH(OAc)<sub>3</sub>, dichloroethane, HOAc, room temperature.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm040159cf00002" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cf00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00002.jpeg" id="_i14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Model of the HER-2−<b>25o</b> complex. The H-bond between the quinoline N1 and Met 801 is shown. Also shown are distances between the sulfur of Cys 805 and the Michael acceptor β-carbon, and the sulfhydryl hydrogen and the nitrogen of the dimethylamino group, the suggested intramolecular catalyst.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159cf00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm040159cf00003" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cf00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00003.jpeg" id="_i15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Scatter plot comparing the activities of compounds against the EGFR and HER-2 kinase enzymes. Note that mean values of log IC<sub>50</sub> are plotted. The error bars (horizontal for EGFR, vertical for HER-2) represent the standard error of the respective mean values. Note that the number of observations for each compound varies from 1 to 30. The single-point observations show no error bars. The least-squares regression line is also shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159cf00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm040159ch00005" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00005.jpeg" id="_i16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) <i>i</i>-PrOH, reflux; (ii) Fe, HOAc, MeOH, reflux; (iii) Me<sub>2</sub>NCH<sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCOCl in CH<sub>3</sub>CN, <i>N</i>-methyl-2-pyrrolidinone or DMF, from 0 °C to room temperature; (iv) CH<sub>2</sub>Cl<sub>2</sub>, TFA; (v) (PhCO)<sub>2</sub>O, DMA, 60 °C for <b>36</b>, nicotinyl chloride hydrochloride, (<i>i</i>-Pr)<sub>2</sub>NEt, DMA, 25 °C for <b>37</b>; (vi) Ph-N<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>O, DMA, 25 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The preparations of the substituted anilines that were needed to prepare some of the inhibitors are shown in Schemes <a data-tab="pane-pcw-Figures" href="#jm040159ch00006" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm040159ch00007" id="" class=" internalNav"></a>6 and 7. 3-Chloro-4-fluoronitrobenzene was reacted with 5-phenylthiazole-2-thiol under basic conditions to yield <b>39</b>, which was then reduced with iron and acetic acid in methanol to yield the aniline <b>40</b>. A similar synthetic sequence was used in the reaction of 3-chloro-4-fluoronitrobenzene with phenols, alcohols, and amines. 4-(1<i>H</i>-Imidazole-1-ylmethyl)-3-chloroaniline <b>42</b> was prepared by alkylation of imidazole with 2-chloro-4-nitrobenzyl bromide to yield <b>41</b>, followed by reduction of the nitro group. The 4-benzyoxyaniline <b>44</b> was readily prepared by reacting phenol <b>43</b> with benzyl bromide under basic conditions, followed by reduction of the nitro group as shown. The synthesis of 3-chloro-4-(4-phenylthiazol-2-ylmethyl)phenylamine, <b>51</b>, where the thiazole group is attached via a carbon atom instead of a heteroatom, is shown in Scheme 7. The toluene derivative <b>45</b> was heated with <i>tert</i>-butoxy-<i>N,N,N</i><i>‘</i><i>,N</i><i>‘</i>-tetramethylmethanediamine, <b>46</b>, to yield the enamine <b>47</b>,<sup><a onclick="showRef(event, 'jm040159cb00018'); return false;" href="javascript:void(0);" class="ref jm040159cb00018">18</a></sup> which was then converted to the phenylacetonitrile <b>48</b> by reacting with hydroxylamine-<i>O</i>-sulfonic acid in warm water.<sup><a onclick="showRef(event, 'jm040159cb00019'); return false;" href="javascript:void(0);" class="ref jm040159cb00019">19</a></sup> Heating the nitrile <b>48</b> with H<sub>2</sub>S in triethylamine and DMF in a steel bomb gave the thioacetamide <b>49</b>, which was then condensed with phenacyl bromide <b>50</b> to yield the desired aniline <b>51</b>. Scheme 8<a data-tab="pane-pcw-Figures" href="#jm040159ch00008" id="" class=" internalNav"></a> shows the synthesis of several bicyclic anilines. 5-Amino-1-benzylindole <b>54</b> was prepared by benzylation of the 5-nitro-1<i>H</i>-indole <b>52</b>, followed by reduction of the nitro group to the amine. 5-Amino-1-benzylindazole <b>55</b> and 5-amino-2,3-dihydro-1-benzylindole <b>57</b> were prepared in a similar manner. 5-Amino-1-phenylsulfonylindole <b>59</b> was synthesized similarly except that phenylsulfonyl chloride was used. <div id="_i17"><figure id="jm040159ch00006" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00006.jpeg" id="_i18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) NaH, DMF, room temperature, or NaOMe, DMF; (ii) Fe, NH<sub>4</sub>Cl, MeOH, H<sub>2</sub>O, reflux, or Fe, HOAc, MeOH, reflux; (iii) THF, reflux; (iv) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 25 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm040159ch00007" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00007.jpeg" id="_i19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 7 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Heat and distill at 160 °C; (ii) H<sub>2</sub>NOSO<sub>3</sub>H, hot H<sub>2</sub>O, 55 °C; (iii) Et<sub>3</sub>N, DMF, H<sub>2</sub>S, heat at 80 °C in a steel bomb; (iv) EtOH, reflux.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm040159ch00008" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00008.jpeg" id="_i20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 8 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) K<sub>2</sub>CO<sub>3</sub>, DMF, heat; (ii) Fe, HOAc, MeOH, H<sub>2</sub>O, reflux; (iii) NaH,benzene; (iv) Raney Ni, hydrazine, EtOH.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00008"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Preparations of some representative Michael acceptor side chains are shown in Schemes <a data-tab="pane-pcw-Figures" href="#jm040159ch00009" id="" class=" internalNav"></a>9 and 10. <i>tert</i>-Butyl 4-bromocrotonamide <b>60</b><sup><a onclick="showRef(event, 'jm040159cb00020'); return false;" href="javascript:void(0);" class="ref jm040159cb00020">20</a></sup> was converted into the corresponding iodide <b>61</b> by refluxing with sodium iodide in acetone. The iodide <b>61</b> was reacted with a variety of secondary amines such as pyrrolidine at 0 °C to yield amino ester <b>62</b>. After removal of the <i>tert</i>-butyl group <a name="jm004800401111" id="jm004800401111"></a> under acidic conditions, a suspension of amino acid HCl salt <b>63</b> in CH<sub>3</sub>CN containing a catalytic amount of <i>N</i>-methyl-2-pyrrolidinone (or DMF) was heated with oxalyl chloride to afford the acid chloride <b>64</b> as a hydrochloride salt, which was used immediately in subsequent reactions. 4-(1<i>H</i>-Imidazol-4-yl)-but-2-enoic acid hydrochloride, <b>67</b>, was prepared by reacting 1-trityl-1<i>H</i>-imidazole-4-acetate <b>65</b><sup><a onclick="showRef(event, 'jm040159cb00021'); return false;" href="javascript:void(0);" class="ref jm040159cb00021">21</a></sup> with triethyl phosphonoacetate and <i>n</i>-BuLi in THF at −78 °C and then with DIBAL<sup><a onclick="showRef(event, 'jm040159cb00022'); return false;" href="javascript:void(0);" class="ref jm040159cb00022">22</a></sup> to yield <b>66</b> (Scheme 10). Ester hydrolysis and removal of the trityl group from <b>66</b> were followed by acid chloride formation to give <b>68</b>. 3-(2-Dimethylaminophenyl)acrylic acid <b>70</b> was prepared by heating 2-(dimethylamino)benzaldehyde <b>69</b><sup><a onclick="showRef(event, 'jm040159cb00023'); return false;" href="javascript:void(0);" class="ref jm040159cb00023">23</a></sup> in pyridine with malonic acid using a catalytic amount of piperidine. Acid <b>70</b> was then converted to acid chloride HCl salt <b>71 </b>using oxalyl chloride. Acid chlorides <b>73</b> and <b>74</b> were prepared in a similar manner (Scheme 11). <div id="_i21"><figure id="jm040159ch00009" data-index="13" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00009.jpeg" id="_i22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 9 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) NaI, acetone, reflux; (ii) THF, 0 °C; (iii) 1 N HCl, reflux; (iv) CH<sub>3</sub>CN, (COCl)<sub>2</sub>, <i>N</i>-methyl-2-pyrrolidinone or DMF (cat.), 55 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00009"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">Compounds with other types of Michael acceptors (<b>82</b><b>−</b><b>85) </b>were prepared as shown in Scheme 12. The 6-amino derivative <b>72</b> was treated with 2-chloro-1-ethanesulfonyl chloride <b>78</b> in triethylamine at 0 °C, resulting in the vinylsulfonamide <b>82</b>. Preparation of acid chlorides <b>79</b> and <b>80</b> were reported earlier;<sup><a onclick="showRef(event, 'jm040159cb00024'); return false;" href="javascript:void(0);" class="ref jm040159cb00024">24</a></sup> these were reacted with <b>72</b> to yield <b>83</b> and <b>84</b>, respectively. Finally, commercially available 2-(bromomethyl)acrylic acid <b>81</b> was reacted with <b>72</b> to afford <b>85</b>. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Molecular Modeling</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73617" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73617" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A homology model for the catalytic domain of HER-2 kinase was built as follows. The crystal structure of the highly homologous EGFR kinase in complex with erlotinib<sup>12</sup> was used as the template. Appropriate side chain substitutions were made, a large sphere of water molecules were added, and the whole structure was minimized using Quanta/CHARMm.<sup><a onclick="showRef(event, 'jm040159cb00025'); return false;" href="javascript:void(0);" class="ref jm040159cb00025">25</a></sup></div><div class="NLM_p">By use of this model, ligands were hand-docked in accordance with our previous studies of compounds in the quinazoline/cyanoquinoline class,<sup>9,10,26</sup><a onclick="showRef(event, 'jm040159cb00026'); return false;" href="javascript:void(0);" class="ref jm040159cb00026"></a> and the EGFR−erlotinib complex.<sup>12</sup> The complex was again optimized using Quanta/CHARMm. Because EGFR and HER-2 are closely related in sequence, the construction of the homology model presented no significant challenges. </div><div class="NLM_p">In the final model of the HER-2−<b>25o</b> complex (see Figure 2), the N1 atom of the quinoline is hydrogen-bonded to the backbone NH of Met 801 at a distance of 3.32 Å. The cyano nitrogen is 2.76 Å from the OH of Ser 783. The chloroaniline portion of the inhibitor is surrounded by residues Thr 798, Lys 753, Leu 133, Thr 143, and Asp 144, while the pyridylmethoxy group lies in a pocket surrounded by Val 773, Met 774, Arg 784, Ser 783, Val 777, Phe 864, and Thr 862. </div><div class="NLM_p">The sulfur of Cys 805 is 3.43 Å from the reactive Michael acceptor carbon. The dimethylamino group, which we have shown earlier<sup>9</sup> can function as an intramolecular catalyst for Michael additions, is also close to the sulfhydryl hydrogen of Cys 805. </div><div class="NLM_p last">A paper describing a study of the binding modes of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles to the closely related EGFR kinase appeared recently.<sup><a onclick="showRef(event, 'jm040159cb00027'); return false;" href="javascript:void(0);" class="ref jm040159cb00027">27</a></sup> In it, the authors contend that they were unable to <a name="jm004800401112" id="jm004800401112"></a> reproduce a binding mode such as ours where the headpiece is buried deep into the ATP binding pocket and the Michael acceptor is positioned suitably to interact with Cys 773 (analogous to Cys 805 of HER-2 kinase). They reported a distance of 5.97 Å between the β-carbon and the sulfur of Cys 773 in their model. We point out that the ligand and the protein have considerable flexibility even when complexed. Thermal motion of the protein and ligand atoms should, in our opinion, be adequate to bring the β-carbon and the sulfur of Cys 773 close enough to form a covalent interaction. A close examination of the EGFR−erlotinib crystal structure<sup>12</sup> leads us to the same conclusion. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>Kinase and Cellular Inhibitory Activities.</b> The compounds shown in Tables 1−5 were evaluated for their ability to inhibit HER-2 and EGFR kinases. While some other researchers may determine IC<sub>50</sub> values of inhibitors in soluble formats using the entire HER-2 and EGFR enzymes along with exogenous peptide substrates, we use a solid-phase ELISA-based assay consisting of the purified cytoplasmic domain of HER-2 (amino acids 676−1255) or EGFR (amino acids 645−1186). Concentrations of compounds to inhibit autophosphorylation of these proteins by 50% were measured to generate the IC<sub>50</sub> values. As we indicated in our earlier publications, the IC<sub>50</sub> values generated by our method are routinely higher than the IC<sub>50</sub> values produced by other researchers using the full-length enzymes and exogenous peptide substrates, but the relative potencies remain consistent. </div><div class="NLM_p">In an earlier report, we showed that <b>86</b> functions as an irreversible inhibitor of EGFR kinase.<sup><a onclick="showRef(event, 'jm040159cb00028'); return false;" href="javascript:void(0);" class="ref jm040159cb00028">28</a></sup> We will show herein that compounds, as exemplified by <b>25o</b>, bind irreversibly to HER-2 kinase. As we have cautioned in our earlier publications,<sup>9,24</sup> care should be taken in interpreting the IC<sub>50</sub> values of compounds that function as irreversible inhibitors. The IC<sub>50</sub> values for such inhibitors should depend on the extent to which the covalent interaction has occurred. In addition, we have suggested, and it has been recapitulated by others,<sup>27</sup> that the IC<sub>50</sub> values could arise from two components, one reflecting reversible binding and another reflecting <a name="jm004800401113" id="jm004800401113"></a> the subsequent covalent binding. One would therefore expect that the IC<sub>50</sub> values would be time-dependent insofar as an inhibitor that reacts more slowly with the enzyme, or does not react at all, would be expected to have a higher IC<sub>50</sub> value. However, an absolute dependence of the IC<sub>50</sub> value with reactivity of the inhibitors cannot be counted on because of the component of the IC<sub>50</sub> that reflects reversible (noncovalent) binding. </div><div class="NLM_p">The compounds were also evaluated for their ability to inhibit the growth of several cell lines with varying levels of expression of HER-2 and/or EGFR (Tables 1−5). Three human carcinoma cell lines were used:  A431 (epidermoid), which overexpresses EGFR; SKBR3 (breast), which overexpresses HER-2 and, to a lesser extent, EGFR; SW620 (colon), which serves as a control line not expressing either EGFR or HER-2 to a significant extent. </div><div class="NLM_p">To get a global view of these data (Tables 1−5), a matrix of correlation coefficients was constructed and is shown in Table 6. It is evident that there is a reasonable correlation between the EGFR and HER-2 inhibitory activities. This is shown in detail in the scatter plot of the HER-2 and EGFR activities (Figure 3). This correlation is expected in view of the high sequence homology of the catalytic domains of these two kinases. In addition, we find a good correlation between the activities of the compounds in inhibiting the growth of the A431 and SKBR3 cell lines. Again, this is expected given that both these cell lines are known to express, to a large degree, and to depend on these growth factor receptors. The correlation between the A431 and SKBR3 cell lines data is significantly higher than the correlation between either of these data and the SW620 cell line results. </div><div class="NLM_p">On the other hand, we see a low correlation between the kinase activities and the ability of these compounds to inhibit the growth of the A431 and SKBR3 cell lines. Since factors other than the ability of a compound to inhibit an enzyme, such as the degree of cell permeability, play a role here, this might be expected. Likewise, the kinase data do not correlate well with the SW620 cell activities. </div><div class="NLM_p">As mentioned in the Introduction, we adopted the same chemical scaffold used with our irreversible EGFR inhibitor <b>86</b> and focused our synthetic efforts on introducing large lipophilic groups at the para position of the 3-chloroaniline ring because this portion of the molecule, when bound, resides in the region where the enzymes are most different. Since our efforts were directed <a name="jm004800401114" id="jm004800401114"></a> toward finding compounds with improved HER-2 activity relative to <b>86 </b>(EKB-569), we discuss the data using this compound as a reference. </div><div class="NLM_p">The compounds listed in Table 1 represent our initial exploration into the effects of placing large lipophilic groups at the para position of the 4-anilino substituent. It is evident that <b>7d</b>, bearing a 2-thiazolsulfanyl substituent, is 15-fold more potent than <b>86</b> in inhibiting the HER-2 kinase while retaining similar potency as <b>86</b> for EGFR kinase. The compound also demonstrated better activity for the HER-2 overexpressing cell line SKBR3. To further increase lipophilicity and steric bulk, a phenyl group was introduced at the C-5 (<b>8d</b>) and C-4 (<b>8e</b>) positions of the thiazole ring. While <b>8d</b> is a significantly less potent inhibitor of HER-2 kinase compared to <b>7d</b>, the regioisomer <b>8e</b> is 6-fold more potent than <b>7d</b> in the HER-2 assay. Also, when the thioether linkage of <b>8e</b> was replaced with a methylene bridge, the resulting compound <b>8f</b> remained as potent as <b>8e</b>. In addition, other compounds with large lipophilic substituents were prepared showing enhanced activity toward HER-2 kinase compared to <b>86</b>. It is evident that for HER-2 inhibition, the benzyloxy compound <b>8b</b> and the phenoxy compound <b>25a</b> are significantly more <a name="jm004800401115" id="jm004800401115"></a> potentthan <b>86</b> (16-fold and 7-fold, respectively) while the corresponding 4-(pyridinyl)oxy compound <b>7b </b>is significantly less potent. Furthermore, <b>8b</b> has about the same potency as <b>86</b> against the EGFR kinase. These results are similar to those found by other researchers in the quinazoline-based series, where enhancement of HER-2<a data-tab="pane-pcw-Figures" href="#jm040159ch00010" id="" class=" internalNav"></a> activity was observed for compounds bearing bulky substituents on the 4-aniline ring.<sup>14,16,17</sup><div id="_i25"><figure id="jm040159ch00010" data-index="14" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00010.jpeg" id="_i26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 10 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Triethyl phosphonoacetate, <i>n</i>-BuLi, THF, then DIBAL, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to room temperature; (ii) MeOH, NaOH, then HCl; (iii) CH<sub>2</sub>Cl<sub>2</sub>, (COCl)<sub>2</sub>, cat. DMF, reflux; (iv) malonic acid, pyridine, piperidine (cat.), 110 °C; (v) CH<sub>2</sub>Cl<sub>2</sub>, (COCl)<sub>2</sub>, DMF (cat.), reflux. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00010"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">We also looked at several compounds that have bicyclic aniline substituents such as <b>21b</b>, <b>21c</b>, <b>8</b><b>g</b><b>, </b>and<b> 8h</b> in Table 2. These compounds are significantly more potent than <b>86</b> in inhibiting HER-2 kinase, and they show good activity in inhibiting the growth of the SKBR3 cell line. </div><div class="NLM_p">Throughout this work, we used either a methoxy or ethoxy substituent at the 7-position. There is no clear advantage of either substituent with respect to potency (for example, compare <b>8b</b> with <b>8i</b> and compare <b>25a</b> with <b>8j </b>in Table 3). However, from our early work, we found that a number of the inhibitors that have a 7-methoxy<a data-tab="pane-pcw-Figures" href="#jm040159ch00011" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm040159ch00012" id="" class=" internalNav"></a> substituent showed a very weak positive response in an Ames test after microsomal incubation while the <a name="jm004800401116" id="jm004800401116"></a> corresponding ethoxy derivatives did not. Because of this observation, the majority of the compounds prepared possessed the 7-ethoxy substituent. <div id="_i27"><figure id="jm040159ch00011" data-index="15" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00011.jpeg" id="_i28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 11 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) <i>N</i>-Methyl-2-pyrrolidinone, from 0 °C to room temperature. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00011"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm040159ch00012" data-index="16" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00012.jpeg" id="_i29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 12 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) THF, Et<sub>3</sub>N, 0 °C; (ii) <i>N</i>-methyl-2-pyrrolidinone, from −15 °C to room temperature; (iii) <i>N</i>-methyl-2-pyrrolidinone, from 0 °C to room temperature; (iv) CH<sub>3</sub>CN, Hunig's base, reflux.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00012"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Preliminary in vivo experiments indicated that of the compounds we initially evaluated (Tables 1 and 2), the benzyl-substituted derivative <b>8b</b> looked the most promising for further modifications. Replacement of the benzyloxy group of <b>8b</b> with the slightly longer phenylethoxy group results in a compound, <b>25c</b>, that is slightly less potent in both kinase and cell proliferation assays (Table 3). By comparision of the activity of <b>25a</b>, <b>8b</b>, and <b>25c</b>, it is clear that the chain length of the para substituent contributes to potency in inhibiting HER-2 kinase in the order of benzyloxy > phenoxy > phenylethoxy. The position of the benzyloxy substituent is also important for activity, with a preference for the 4-position of the 3-chloroaniline ring. Switching the benzyloxy substitutent from the 4- to the 3-position by replacing the 3-chloro group gives <b>8r</b>, which is clearly an inferior inhibitor of both HER-2 and EGFR kinases. </div><div class="NLM_p">It is interesting to note the difference in the kinase<a class="ref showTableEvent internalNav" data-ID="jm040159ct00001" href="#jm040159ct00001"></a><a class="ref showTableEvent internalNav" data-ID="jm040159ct00002" href="#jm040159ct00002"></a><a class="ref showTableEvent internalNav" data-ID="jm040159ct00003" href="#jm040159ct00003"></a> activities between the pair of isomers where a methyl group was introduced at the methylene bridge of the benzyloxy group. While the <i>R</i> isomer (<b>25v</b>) showed potent kinase activity, the corresponding <i>S</i> isomer (<b>25w</b>) was 340-fold less potent for the HER-2 enzyme, suggesting a space requirement in the lipophilic pocket. Conformationally restricting the benzyloxy group by using 2,3-dihydro-1<i>H</i>-inden-1-yloxy substituents having<a class="ref showTableEvent internalNav" data-ID="jm040159ct00004" href="#jm040159ct00004"></a><a class="ref showTableEvent internalNav" data-ID="jm040159ct00005" href="#jm040159ct00005"></a><a class="ref showTableEvent internalNav" data-ID="jm040159ct00006" href="#jm040159ct00006"></a> both <i>R</i> and <i>S</i> isomer configurations (<b>8p</b> and <b>8q</b>, respectively) results in inhibitors with poor HER-2 kinase and to a lesser extent for EGFR activity relative to <b>8b</b>. Additional analogues of <b>8b</b> were prepared wherein the benzyloxy group was replaced with benzylamine (<b>31</b>), <i>N</i>-methylbenzylamine (<b>8s</b>), and 1-naphthylmethylamine (<b>32</b>). The benzylamine analogue <b>31</b> is as potent as <b>8b</b>, whereas <b>8s</b> shows much reduced activity. Poor activity was also observed for compounds where the benzylamine group in <b>31</b> was replaced with benzamide (<b>36</b>), nicotinamide (<b>37</b>), and phenylurea (<b>38</b>). <div class="NLM_table-wrap" id="jm040159ct00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  Initial Exploration of the Para Substituents for HER-2 Activity<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cu00001a.gif" alt="" id="_i30" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">kinase assays IC<sub>50</sub> (μM)</td><td class="colsep2 rowsep2" colspan="3">cell proliferation assays IC<sub>50</sub> (μM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">R</td><td class="colsep2 rowsep2">Y</td><td class="colsep2 rowsep2">synthetic  method</td><td class="colsep2 rowsep2">HER-2<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">EGFR<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">A431<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">SKBR3<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">SW620<i><sup>c</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7a</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">1-imidazolyl </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.80 </td><td class="colsep2 rowsep2">0.77 </td><td class="colsep2 rowsep2">1.2 </td><td class="colsep2 rowsep2">0.40 </td><td class="colsep2 rowsep2">2.7 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7b</b></td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2"><i>O</i>-(4-pyridinyl) </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">8.1 </td><td class="colsep2 rowsep2">0.65 </td><td class="colsep2 rowsep2">6.0 </td><td class="colsep2 rowsep2">2.8 </td><td class="colsep2 rowsep2">>9 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7c</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2"><i>S</i>-[2-(3-methylimidazolyl)] </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.155 </td><td class="colsep2 rowsep2">0.041 </td><td class="colsep2 rowsep2">0.132 </td><td class="colsep2 rowsep2">0.0013 </td><td class="colsep2 rowsep2">1.093 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7d</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2"><i>S</i>-(2-thiazolyl) </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.083 </td><td class="colsep2 rowsep2">0.042 </td><td class="colsep2 rowsep2">0.516 </td><td class="colsep2 rowsep2">0.0015 </td><td class="colsep2 rowsep2">1.592 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7e</b></td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">CH<sub>2</sub>-(1-imidazolyl) </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">1.055 </td><td class="colsep2 rowsep2">0.519 </td><td class="colsep2 rowsep2">2.839 </td><td class="colsep2 rowsep2">0.1094 </td><td class="colsep2 rowsep2">5.48 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8a</b></td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">4-morpholinyl </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">2.6 </td><td class="colsep2 rowsep2">12.7 </td><td class="colsep2 rowsep2">0.43 </td><td class="colsep2 rowsep2">1.2 </td><td class="colsep2 rowsep2">2.1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8b</b></td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">OCH<sub>2</sub>Ph </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.076 </td><td class="colsep2 rowsep2">0.053 </td><td class="colsep2 rowsep2">0.108 </td><td class="colsep2 rowsep2">0.0027 </td><td class="colsep2 rowsep2">0.486 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8c</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2"><i>S</i>-(2-pyrimidyl) </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.348 </td><td class="colsep2 rowsep2">0.403 </td><td class="colsep2 rowsep2">0.209 </td><td class="colsep2 rowsep2">0.0156 </td><td class="colsep2 rowsep2">1.300 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8d</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2"><i>S</i>-[2-(5-phenylthiazolyl)] </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">1.007 </td><td class="colsep2 rowsep2">0.032 </td><td class="colsep2 rowsep2">0.574 </td><td class="colsep2 rowsep2">0.0462 </td><td class="colsep2 rowsep2">0.961 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8e</b></td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2"><i>S</i>-[2-(4-phenylthiazolyl)] </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.013 </td><td class="colsep2 rowsep2">0.125 </td><td class="colsep2 rowsep2">0.374 </td><td class="colsep2 rowsep2">0.0094 </td><td class="colsep2 rowsep2">0.842 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8f</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">CH<sub>2</sub>-[2-(4-phenylthiazolyl)] </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.074 </td><td class="colsep2 rowsep2">0.214 </td><td class="colsep2 rowsep2">0.082 </td><td class="colsep2 rowsep2">0.0049 </td><td class="colsep2 rowsep2">0.328 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>21a</b></td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2"><i>O</i>-CH<sub>2</sub>-[2-(3-methylimidazolyl)] </td><td class="colsep2 rowsep2">2 </td><td class="colsep2 rowsep2">0.625 </td><td class="colsep2 rowsep2">0.500 </td><td class="colsep2 rowsep2">0.129 </td><td class="colsep2 rowsep2">0.0021 </td><td class="colsep2 rowsep2">0.993 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25a</b></td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2"><i>O</i>-Ph </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.184 </td><td class="colsep2 rowsep2">0.445 </td><td class="colsep2 rowsep2">0.052 </td><td class="colsep2 rowsep2">0.0039 </td><td class="colsep2 rowsep2">0.683 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>86</b></td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">1.23 </td><td class="colsep2 rowsep2">0.08 </td><td class="colsep2 rowsep2">0.08 </td><td class="colsep2 rowsep2">0.01 </td><td class="colsep2 rowsep2">0.68</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of HER-2 by 50% as determined from the dose−response curve.<i><sup>b</sup></i><sup></sup> Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of EGFR by 50% as determined from the dose−response curve.<i><sup>c</sup></i><sup></sup> Dose−response curves were determined at five concentrations. The IC<sub>50</sub> (μM) values are the concentrations needed to inhibit cell growth by 50% as determined from these curves.</p></div></div><div class="NLM_table-wrap" id="jm040159ct00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  2,3-Dihydro-1<i>H</i>-indole, 1-<i>H</i>-indole, and 1<i>H</i>-Indazole Inhibitors<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cu00002a.gif" alt="" id="_i31" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">kinase assays IC<sub>50</sub> (μM)</td><td class="colsep2 rowsep2" colspan="3">cell proliferation assays IC<sub>50</sub> (μM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">series</td><td class="colsep2 rowsep2">R</td><td class="colsep2 rowsep2">X</td><td class="colsep2 rowsep2">synthetic  method</td><td class="colsep2 rowsep2">HER-2<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">EGFR<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">A431<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">SKBR3<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">SW620<i><sup>c</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8</b><b>g</b></td><td class="colsep2 rowsep2">II </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">CH<sub>2</sub>Ph </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.015 </td><td class="colsep2 rowsep2">0.10 </td><td class="colsep2 rowsep2">0.084 </td><td class="colsep2 rowsep2">0.0014 </td><td class="colsep2 rowsep2">0.74 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8h</b></td><td class="colsep2 rowsep2">III </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">CH<sub>2</sub>Ph </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.075 </td><td class="colsep2 rowsep2">0.13 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.0034 </td><td class="colsep2 rowsep2">0.87 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>21b</b></td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">CH<sub>2</sub>Ph </td><td class="colsep2 rowsep2">2 </td><td class="colsep2 rowsep2">0.23 </td><td class="colsep2 rowsep2">0.34 </td><td class="colsep2 rowsep2">0.23 </td><td class="colsep2 rowsep2">0.028 </td><td class="colsep2 rowsep2">2.1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>21c</b></td><td class="colsep2 rowsep2">II </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">SO<sub>2</sub>Ph </td><td class="colsep2 rowsep2">2 </td><td class="colsep2 rowsep2">0.025 </td><td class="colsep2 rowsep2">0.082 </td><td class="colsep2 rowsep2">0.17 </td><td class="colsep2 rowsep2">0.015 </td><td class="colsep2 rowsep2">1.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of HER-2 by 50% as determined from the dose−response curve.<i><sup>b</sup></i><sup></sup> Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of EGFR by 50% as determined from the dose−response curve.<i><sup>c</sup></i><sup></sup> Dose−response curves were determined at five concentrations. The IC<sub>50</sub> (μM) values are the concentrations needed to inhibit cell growth by 50% as determined from these curves.</p></div></div><div class="NLM_table-wrap" id="jm040159ct00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  Optimization of the Aniline Substituents for HER-2 Activity<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cu00003a.gif" alt="" id="_i32" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">kinase assays IC<sub>50</sub> (μM)</td><td class="colsep2 rowsep2" colspan="3">cell proliferation assays IC<sub>50</sub> (μM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">series</td><td class="colsep2 rowsep2">R</td><td class="colsep2 rowsep2">X</td><td class="colsep2 rowsep2">Y</td><td class="colsep2 rowsep2">A</td><td class="colsep2 rowsep2">Z</td><td class="colsep2 rowsep2">synthetic method</td><td class="colsep2 rowsep2">HER-2<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">EGFR<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">A431<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">SKBR3<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">SW620<i><sup>c</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7f</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">3-F-Ph </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.033 </td><td class="colsep2 rowsep2">0.034 </td><td class="colsep2 rowsep2">0.120 </td><td class="colsep2 rowsep2">0.0025 </td><td class="colsep2 rowsep2">0.511 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8b</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">Ph </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.076 </td><td class="colsep2 rowsep2">0.053 </td><td class="colsep2 rowsep2">0.108 </td><td class="colsep2 rowsep2">0.0027 </td><td class="colsep2 rowsep2">0.486 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8i</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">Ph </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.039 </td><td class="colsep2 rowsep2">0.024 </td><td class="colsep2 rowsep2">0.083 </td><td class="colsep2 rowsep2">0.0038 </td><td class="colsep2 rowsep2">1.120 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8j</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">Ph </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.363 </td><td class="colsep2 rowsep2">0.185 </td><td class="colsep2 rowsep2">0.108 </td><td class="colsep2 rowsep2">0.0098 </td><td class="colsep2 rowsep2">1.019 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8k</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">2,4-di-F-Ph </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.081 </td><td class="colsep2 rowsep2">0.110 </td><td class="colsep2 rowsep2">0.211 </td><td class="colsep2 rowsep2">0.0033 </td><td class="colsep2 rowsep2">0.549 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8l</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">3-Cl-Ph </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.008 </td><td class="colsep2 rowsep2">0.007 </td><td class="colsep2 rowsep2">0.148 </td><td class="colsep2 rowsep2">0.0012 </td><td class="colsep2 rowsep2">0.965 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8m</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">2-OMe-Ph </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.044 </td><td class="colsep2 rowsep2">0.031 </td><td class="colsep2 rowsep2">0.307 </td><td class="colsep2 rowsep2">0.0022 </td><td class="colsep2 rowsep2">0.580 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8n</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">4-(OCH<sub>2</sub>Ph)Ph </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">3.775 </td><td class="colsep2 rowsep2">0.574 </td><td class="colsep2 rowsep2">0.680 </td><td class="colsep2 rowsep2">0.0800 </td><td class="colsep2 rowsep2">1.404 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8o</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">2-thienyl </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.131 </td><td class="colsep2 rowsep2">0.277 </td><td class="colsep2 rowsep2">0.077 </td><td class="colsep2 rowsep2">0.0033 </td><td class="colsep2 rowsep2">0.307 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8p</b></td><td class="colsep2 rowsep2">V </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">(1<i>R</i>)-2,3-dihydro-1<i>H</i>-inden-1-yloxy </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">2.1 </td><td class="colsep2 rowsep2">0.38 </td><td class="colsep2 rowsep2">0.069 </td><td class="colsep2 rowsep2">0.0023 </td><td class="colsep2 rowsep2">0.29 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8q</b></td><td class="colsep2 rowsep2">V </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">(1<i>S</i>)-2,3-dihydro-1<i>H</i>-inden-1-yloxy </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">9.8 </td><td class="colsep2 rowsep2">0.40 </td><td class="colsep2 rowsep2">0.11 </td><td class="colsep2 rowsep2">0.0063 </td><td class="colsep2 rowsep2">0.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8r</b></td><td class="colsep2 rowsep2">V </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">OCH<sub>2</sub>Ph </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">13.2 </td><td class="colsep2 rowsep2">13 </td><td class="colsep2 rowsep2">0.53 </td><td class="colsep2 rowsep2">0.04 </td><td class="colsep2 rowsep2">1.43 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8s</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">NMe </td><td class="colsep2 rowsep2">Ph </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">2.1 </td><td class="colsep2 rowsep2">0.25 </td><td class="colsep2 rowsep2">0.37 </td><td class="colsep2 rowsep2">0.034 </td><td class="colsep2 rowsep2">- </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>21d</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">2-Cl-Ph </td><td class="colsep2 rowsep2">2 </td><td class="colsep2 rowsep2">0.010 </td><td class="colsep2 rowsep2">0.011 </td><td class="colsep2 rowsep2">0.120 </td><td class="colsep2 rowsep2">0.0029 </td><td class="colsep2 rowsep2">0.948 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25a</b></td><td class="colsep2 rowsep2">V </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">OPh </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.184 </td><td class="colsep2 rowsep2">0.445 </td><td class="colsep2 rowsep2">0.052 </td><td class="colsep2 rowsep2">0.0039 </td><td class="colsep2 rowsep2">0.683 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25b</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">Ph </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.498 </td><td class="colsep2 rowsep2">0.345 </td><td class="colsep2 rowsep2">0.136 </td><td class="colsep2 rowsep2">0.0016 </td><td class="colsep2 rowsep2">0.924 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25c</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">CH<sub>2</sub>Ph </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.281 </td><td class="colsep2 rowsep2">0.165 </td><td class="colsep2 rowsep2">0.254 </td><td class="colsep2 rowsep2">0.0319 </td><td class="colsep2 rowsep2">0.500 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25d</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">Ph </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.406 </td><td class="colsep2 rowsep2">0.163 </td><td class="colsep2 rowsep2">0.423 </td><td class="colsep2 rowsep2">0.0110 </td><td class="colsep2 rowsep2">1.219 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25e</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CN </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">Ph </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">1.134 </td><td class="colsep2 rowsep2">0.768 </td><td class="colsep2 rowsep2">0.342 </td><td class="colsep2 rowsep2">0.0059 </td><td class="colsep2 rowsep2">0.540 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25f</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">2-F-Ph </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.732 </td><td class="colsep2 rowsep2">0.401 </td><td class="colsep2 rowsep2">0.285 </td><td class="colsep2 rowsep2">0.0028 </td><td class="colsep2 rowsep2">1.472 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25</b><b>g</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">4-F-Ph </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.078 </td><td class="colsep2 rowsep2">0.064 </td><td class="colsep2 rowsep2">0.102 </td><td class="colsep2 rowsep2">0.0082 </td><td class="colsep2 rowsep2">0.584 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25h</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">3-F-Ph </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">1.331 </td><td class="colsep2 rowsep2">0.362 </td><td class="colsep2 rowsep2">0.970 </td><td class="colsep2 rowsep2">0.0378 </td><td class="colsep2 rowsep2">1.200 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25i</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">3,5-di-F-Ph </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.388 </td><td class="colsep2 rowsep2">0.140 </td><td class="colsep2 rowsep2">0.262 </td><td class="colsep2 rowsep2">0.0033 </td><td class="colsep2 rowsep2">1.073 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25j</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">4-Cl-Ph </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.024 </td><td class="colsep2 rowsep2">0.051 </td><td class="colsep2 rowsep2">0.069 </td><td class="colsep2 rowsep2">0.0093 </td><td class="colsep2 rowsep2">0.593 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25k</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">3-CN-Ph </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.161 </td><td class="colsep2 rowsep2">0.195 </td><td class="colsep2 rowsep2">0.071 </td><td class="colsep2 rowsep2">0.0019 </td><td class="colsep2 rowsep2">2.220 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25l</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub></td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">1.477 </td><td class="colsep2 rowsep2">0.894 </td><td class="colsep2 rowsep2">0.114 </td><td class="colsep2 rowsep2">0.0078 </td><td class="colsep2 rowsep2">0.410 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25m</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">3-Me-Ph </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.132 </td><td class="colsep2 rowsep2">0.111 </td><td class="colsep2 rowsep2">0.052 </td><td class="colsep2 rowsep2">0.0127 </td><td class="colsep2 rowsep2">0.357 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25n</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">cyclohexyl </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.028 </td><td class="colsep2 rowsep2">0.285 </td><td class="colsep2 rowsep2">0.151 </td><td class="colsep2 rowsep2">0.0011 </td><td class="colsep2 rowsep2">0.551 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25o</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">2-pyridinyl (HKI-272) </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.059 </td><td class="colsep2 rowsep2">0.092 </td><td class="colsep2 rowsep2">0.086 </td><td class="colsep2 rowsep2">0.0018 </td><td class="colsep2 rowsep2">0.730 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25p</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">3-pyridinyl </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.269 </td><td class="colsep2 rowsep2">0.341 </td><td class="colsep2 rowsep2">0.056 </td><td class="colsep2 rowsep2">0.0004 </td><td class="colsep2 rowsep2">0.197 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25q</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">2-furyl </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.062 </td><td class="colsep2 rowsep2">0.023 </td><td class="colsep2 rowsep2">0.089 </td><td class="colsep2 rowsep2">0.0037 </td><td class="colsep2 rowsep2">0.366 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25r</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">2-benzothiazolyl </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.064 </td><td class="colsep2 rowsep2">0.188 </td><td class="colsep2 rowsep2">0.864 </td><td class="colsep2 rowsep2">0.0110 </td><td class="colsep2 rowsep2">2.147 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25s</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">4-quinolinyl </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">1.184 </td><td class="colsep2 rowsep2">0.238 </td><td class="colsep2 rowsep2">0.708 </td><td class="colsep2 rowsep2">0.0631 </td><td class="colsep2 rowsep2">3.261 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25t</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">1-naphthyl </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.020 </td><td class="colsep2 rowsep2">0.010 </td><td class="colsep2 rowsep2">0.564 </td><td class="colsep2 rowsep2">0.0127 </td><td class="colsep2 rowsep2">0.973 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25u</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">2-naphthyl </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.018 </td><td class="colsep2 rowsep2">0.015 </td><td class="colsep2 rowsep2">0.569 </td><td class="colsep2 rowsep2">0.0280 </td><td class="colsep2 rowsep2">0.775 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25v</b></td><td class="colsep2 rowsep2">V </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">[(1<i>R</i>)-1-phenylethyl]oxy </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">0.076 </td><td class="colsep2 rowsep2">0.10 </td><td class="colsep2 rowsep2">0.053 </td><td class="colsep2 rowsep2">0.0013 </td><td class="colsep2 rowsep2">0.14 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25w</b></td><td class="colsep2 rowsep2">V </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">[(1<i>S</i>)-1-phenylethyl]oxy </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">26 </td><td class="colsep2 rowsep2">0.77 </td><td class="colsep2 rowsep2">0.15 </td><td class="colsep2 rowsep2">0.013 </td><td class="colsep2 rowsep2">0.193.8 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>31</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">Ph </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">0.103 </td><td class="colsep2 rowsep2">0.045 </td><td class="colsep2 rowsep2">0.048 </td><td class="colsep2 rowsep2">0.0020 </td><td class="colsep2 rowsep2">0.578 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>32</b></td><td class="colsep2 rowsep2">IV </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">1-naphthyl </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">0.083 </td><td class="colsep2 rowsep2">0.034 </td><td class="colsep2 rowsep2">0.17 </td><td class="colsep2 rowsep2">0.023 </td><td class="colsep2 rowsep2">0.93 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>36</b></td><td class="colsep2 rowsep2">VI </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">Ph </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">13 </td><td class="colsep2 rowsep2">0.40 </td><td class="colsep2 rowsep2">0.81 </td><td class="colsep2 rowsep2">>5 </td><td class="colsep2 rowsep2">0.62 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>37</b></td><td class="colsep2 rowsep2">VI </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">3-pyridyl </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">3.9 </td><td class="colsep2 rowsep2">0.072 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.086 </td><td class="colsep2 rowsep2">2.7 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>38</b></td><td class="colsep2 rowsep2">VI </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">NHPh </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">1.1 </td><td class="colsep2 rowsep2">0.21 </td><td class="colsep2 rowsep2">2.6 </td><td class="colsep2 rowsep2">0.50 </td><td class="colsep2 rowsep2">>5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of HER-2 by 50% as determined from the dose−response curve.<i><sup>b</sup></i><sup></sup> Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of EGFR by 50% as determined from the dose−response curve.<i><sup>c</sup></i><sup></sup> Dose−response curves were determined at five concentrations. The IC<sub>50</sub> (μM) values are the concentrations needed to inhibit cell growth by 50% as determined from these curves.</p></div></div><div class="NLM_table-wrap" id="jm040159ct00004"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 4.  Optimization of the C-6 Crotonamide Side Chain<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cu00004a.gif" alt="" id="_i33" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">kinase assays IC<sub>50</sub> (μM)</td><td class="colsep2 rowsep2" colspan="3">cell proliferation assays IC<sub>50</sub> (μM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">R</td><td class="colsep2 rowsep2">synthetic  method</td><td class="colsep2 rowsep2">HER-2<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">EGFR<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">A431<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">SKBR3<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">SW620<i><sup>c</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7</b><b>g</b></td><td class="colsep2 rowsep2">N(Me)(CH<sub>2</sub>)<sub>2</sub>OMe </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.183 </td><td class="colsep2 rowsep2">0.068 </td><td class="colsep2 rowsep2">0.043 </td><td class="colsep2 rowsep2">0.0057 </td><td class="colsep2 rowsep2">0.817 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7h</b></td><td class="colsep2 rowsep2">N(Me)(CH<sub>2</sub>)<sub>2</sub>OH </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.027 </td><td class="colsep2 rowsep2">0.020 </td><td class="colsep2 rowsep2">0.072 </td><td class="colsep2 rowsep2">0.0048 </td><td class="colsep2 rowsep2">0.648 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7i</b></td><td class="colsep2 rowsep2">N(Me)-<span class="smallcaps smallerCapital">d</span>-glucamine </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.966 </td><td class="colsep2 rowsep2">0.719 </td><td class="colsep2 rowsep2">3.115 </td><td class="colsep2 rowsep2">0.1161 </td><td class="colsep2 rowsep2">21.099 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7j</b></td><td class="colsep2 rowsep2">N(<i>i</i>-Pr)<sub>2</sub></td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.028 </td><td class="colsep2 rowsep2">0.030 </td><td class="colsep2 rowsep2">0.258 </td><td class="colsep2 rowsep2">0.0043 </td><td class="colsep2 rowsep2">0.461 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7k</b></td><td class="colsep2 rowsep2">N[CH<sub>2</sub>CH(OH)CH<sub>3</sub>]<sub>2</sub></td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.104 </td><td class="colsep2 rowsep2">0.098 </td><td class="colsep2 rowsep2">0.156 </td><td class="colsep2 rowsep2">0.0027 </td><td class="colsep2 rowsep2">1.638 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7l</b></td><td class="colsep2 rowsep2">2-methoxymethyl-1-pyrrolidinyl </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.171 </td><td class="colsep2 rowsep2">0.151 </td><td class="colsep2 rowsep2">0.167 </td><td class="colsep2 rowsep2">0.0034 </td><td class="colsep2 rowsep2">0.807 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7m</b></td><td class="colsep2 rowsep2"><i>N</i>-piperidinyl </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.025 </td><td class="colsep2 rowsep2">0.031 </td><td class="colsep2 rowsep2">0.244 </td><td class="colsep2 rowsep2">0.0042 </td><td class="colsep2 rowsep2">0.397 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7n</b></td><td class="colsep2 rowsep2">4-OH-1-piperidinyl </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.169 </td><td class="colsep2 rowsep2">0.221 </td><td class="colsep2 rowsep2">0.092 </td><td class="colsep2 rowsep2">0.0017 </td><td class="colsep2 rowsep2">0.792 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7o</b></td><td class="colsep2 rowsep2">4,4-dihydroxy-1-piperidinyl </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.058 </td><td class="colsep2 rowsep2">0.282 </td><td class="colsep2 rowsep2">0.063 </td><td class="colsep2 rowsep2">0.0032 </td><td class="colsep2 rowsep2">4.107 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7p</b></td><td class="colsep2 rowsep2">2,6-dimethyl-1-piperidinyl </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.412 </td><td class="colsep2 rowsep2">0.247 </td><td class="colsep2 rowsep2">0.737 </td><td class="colsep2 rowsep2">0.0200 </td><td class="colsep2 rowsep2">0.657 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7q</b></td><td class="colsep2 rowsep2"><i>N-</i>morpholinyl </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.059 </td><td class="colsep2 rowsep2">0.020 </td><td class="colsep2 rowsep2">0.037 </td><td class="colsep2 rowsep2">0.0099 </td><td class="colsep2 rowsep2">2.842 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7r</b></td><td class="colsep2 rowsep2"><i>N-</i>thiomorpholinyl </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.029 </td><td class="colsep2 rowsep2">0.016 </td><td class="colsep2 rowsep2">0.127 </td><td class="colsep2 rowsep2">0.0456 </td><td class="colsep2 rowsep2">5.862 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7s</b></td><td class="colsep2 rowsep2"><i>N</i>-(4-methylpiperazinyl) </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.540 </td><td class="colsep2 rowsep2">0.360 </td><td class="colsep2 rowsep2">0.085 </td><td class="colsep2 rowsep2">0.0327 </td><td class="colsep2 rowsep2">1.162 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7t</b></td><td class="colsep2 rowsep2"><i>N</i>-azetidinyl </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.040 </td><td class="colsep2 rowsep2">0.026 </td><td class="colsep2 rowsep2">0.158 </td><td class="colsep2 rowsep2">0.0157 </td><td class="colsep2 rowsep2">0.951 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7u</b></td><td class="colsep2 rowsep2">2-carbomethoxy-1-aziridinyl </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.196 </td><td class="colsep2 rowsep2">0.343 </td><td class="colsep2 rowsep2">0.229 </td><td class="colsep2 rowsep2">0.0196 </td><td class="colsep2 rowsep2">2.451 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7v</b></td><td class="colsep2 rowsep2">1-aza-12-crown-4 </td><td class="colsep2 rowsep2">1A </td><td class="colsep2 rowsep2">0.603 </td><td class="colsep2 rowsep2">0.321 </td><td class="colsep2 rowsep2">0.132 </td><td class="colsep2 rowsep2">0.0032 </td><td class="colsep2 rowsep2">0.306 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8b</b></td><td class="colsep2 rowsep2">NMe<sub>2</sub></td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.076 </td><td class="colsep2 rowsep2">0.053 </td><td class="colsep2 rowsep2">0.108 </td><td class="colsep2 rowsep2">0.0027 </td><td class="colsep2 rowsep2">0.486 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8t</b></td><td class="colsep2 rowsep2"><i>N</i>-pyrrolidinyl </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.059 </td><td class="colsep2 rowsep2">0.078 </td><td class="colsep2 rowsep2">0.125 </td><td class="colsep2 rowsep2">0.0053 </td><td class="colsep2 rowsep2">0.309 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8u</b></td><td class="colsep2 rowsep2">4-imidazolyl </td><td class="colsep2 rowsep2">1B </td><td class="colsep2 rowsep2">0.069 </td><td class="colsep2 rowsep2">0.024 </td><td class="colsep2 rowsep2">0.829 </td><td class="colsep2 rowsep2">0.1485 </td><td class="colsep2 rowsep2">1.727</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of HER-2 by 50% as determined from the dose−response curve.<i><sup>b</sup></i><sup></sup> Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of EGFR by 50% as determined from the dose−response curve.<i><sup>c</sup></i><sup></sup> Dose−response curves were determined at five concentrations. The IC<sub>50</sub> (μM) values are the concentrations needed to inhibit cell growth by 50% as determined from these curves.</p></div></div><div class="NLM_table-wrap" id="jm040159ct00005"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 5.  Inhibitors Bearing C-6 Michael Acceptor Groups Other Than Crotonamide<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cu00005a.gif" alt="" id="_i34" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">kinase assays IC<sub>50</sub> (μM)</td><td class="colsep2 rowsep2" colspan="3">cell proliferation assays IC<sub>50</sub> (μM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">series</td><td class="colsep2 rowsep2">R</td><td class="colsep2 rowsep2">HER-2<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">EGFR<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">A431<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">SKBR3<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">SW620<i><sup>c</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>75</b></td><td class="colsep2 rowsep2">VII </td><td class="colsep2 rowsep2">8-quinolinyl </td><td class="colsep2 rowsep2">1.134 </td><td class="colsep2 rowsep2">0.990 </td><td class="colsep2 rowsep2">13.576 </td><td class="colsep2 rowsep2">4.1526 </td><td class="colsep2 rowsep2">28.749 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>76</b></td><td class="colsep2 rowsep2">VII </td><td class="colsep2 rowsep2">(2-NMe<sub>2</sub>)Ph </td><td class="colsep2 rowsep2">1.391 </td><td class="colsep2 rowsep2">1.569 </td><td class="colsep2 rowsep2">14.398 </td><td class="colsep2 rowsep2">7.6035 </td><td class="colsep2 rowsep2">32.841 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>77</b></td><td class="colsep2 rowsep2">VII </td><td class="colsep2 rowsep2">4-imidazolyl </td><td class="colsep2 rowsep2">0.227 </td><td class="colsep2 rowsep2">0.255 </td><td class="colsep2 rowsep2">>8.85 </td><td class="colsep2 rowsep2">0.6371 </td><td class="colsep2 rowsep2">>8.85 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>82</b></td><td class="colsep2 rowsep2">VIII </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">0.061 </td><td class="colsep2 rowsep2">0.045 </td><td class="colsep2 rowsep2">0.617 </td><td class="colsep2 rowsep2">0.0673 </td><td class="colsep2 rowsep2">1.495 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>83</b></td><td class="colsep2 rowsep2">XI </td><td class="colsep2 rowsep2">NMe<sub>2</sub></td><td class="colsep2 rowsep2">0.246 </td><td class="colsep2 rowsep2">0.223 </td><td class="colsep2 rowsep2">0.360 </td><td class="colsep2 rowsep2">0.1295 </td><td class="colsep2 rowsep2">0.360 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>84</b></td><td class="colsep2 rowsep2">XI </td><td class="colsep2 rowsep2">morpholinyl </td><td class="colsep2 rowsep2">0.089 </td><td class="colsep2 rowsep2">0.075 </td><td class="colsep2 rowsep2">0.150 </td><td class="colsep2 rowsep2">0.0069 </td><td class="colsep2 rowsep2">0.401 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>85</b></td><td class="colsep2 rowsep2">X </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">3.781 </td><td class="colsep2 rowsep2">1.191 </td><td class="colsep2 rowsep2">6.522 </td><td class="colsep2 rowsep2">2.2685 </td><td class="colsep2 rowsep2">15.501</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of HER-2 by 50% as determined from the dose−response curve.<i><sup>b</sup></i><sup></sup> Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of EGFR by 50% as determined from the dose−response curve.<i><sup>c</sup></i><sup></sup> Dose−response curves were determined at five concentrations. The IC<sub>50</sub> (μM) values are the concentrations needed to inhibit cell growth by 50% as determined from these curves.  </p></div></div><div class="NLM_table-wrap" id="jm040159ct00006"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 6.  Correlations between log(IC<sub>50</sub>) in EGFR and HER-2 Kinase Assays and Cell Proliferation Assays on Cell Lines A431, SKBR3, and SW620<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="5">log IC<sub>50</sub></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">EGFR</td><td class="colsep2 rowsep2">HER-2</td><td class="colsep2 rowsep2">A431</td><td class="colsep2 rowsep2">SKBR3</td><td class="colsep2 rowsep2">SW620 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">EGFR (log IC<sub>50</sub>) </td><td class="colsep2 rowsep2">1.000 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">HER-2 (log IC<sub>50</sub>) </td><td class="colsep2 rowsep2">0.815 </td><td class="colsep2 rowsep2">1.000 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">A431 (log IC<sub>50</sub>) </td><td class="colsep2 rowsep2">0.365 </td><td class="colsep2 rowsep2">0.281 </td><td class="colsep2 rowsep2">1.000 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">SKBR3 (log IC<sub>50</sub>) </td><td class="colsep2 rowsep2">0.335 </td><td class="colsep2 rowsep2">0.255 </td><td class="colsep2 rowsep2">0.934 </td><td class="colsep2 rowsep2">1.000 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">SW620 (log IC<sub>50</sub>) </td><td class="colsep2 rowsep2">0.489 </td><td class="colsep2 rowsep2">0.370 </td><td class="colsep2 rowsep2">0.478 </td><td class="colsep2 rowsep2">0.411 </td><td class="colsep2 rowsep2">1.000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> The Pearson product moment correlation coefficients are tabulated and are calculated using the formula</p></div></div></div><div class="NLM_p"><a name="jm004800401117" id="jm004800401117"></a>In our early work on the EGFR kinase inhibitors, we found that a small lipophilic substituent (such as Cl) in the 3-position of the aniline ring was important for EGFR inhibitory activity. A similar observation was made in this work; namely, the 3-chloroaniline compounds (<b>8b</b>, <b>8i</b>) are more potent than the corresponding <i>des</i>-chloroaniline derivatives (<b>25b</b>, <b>8j</b>) in kinase assays, but this is not evident in the cell proliferation assays. However, the benefit of the 3-chloro group was abolished when an additional chloro substituent was introduced at the 5-position, namely, a 3,5-dichloro-4-benzyloxyaniline derivative (<b>25d</b> vs <b>8b</b>;<b> 25h </b>vs <b>7f</b>). Replacement of the 3-chloro group of the aniline in <b>8b</b> with a 3-nitrile resulted in a much less potent compound <b>25e</b> in the kinase assays, but this effect is not as evident in the cell proliferation assays. </div><div class="NLM_p">With respect to the substituent on the benzyloxy ring of <b>8b</b>, the 3-chloro (<b>8l</b>) and 2-chloro (<b>21d</b>) derivatives are more potent than <b>8b</b> in the kinase assays; however, their cellular activities remained similar to that of <b>8b</b>. This effect on the kinase and cellular activities parallels that seen with <b>7f</b>, where a fluoro atom is at the 3-position. What was not expected is that, unlike the potent 2-chloro analogue <b>21d</b>, the 2-fluoro counterpart <b>25f</b> was much less active in the kinase assays but remained potent in the cell proliferation assays. While the 3-fluoro derivative <b>7f </b>showed good activity, the corresponding 3,5-difluoro compound <b>25i</b> was a less effective inhibitor of both the HER-2 and EGFR enzymes. Compounds bearing 3-cyano (<b>25k</b>) or 3-methyl (<b>25m</b>) are inferior to the corresponding 3-fluoro (<b>7f</b>) and 3-chloro (<b>8l</b>) compounds. Introduction of a 4-benzyloxy <a name="jm004800401118" id="jm004800401118"></a> substituent on the benzyloxy ring of <b>8b</b> (as shown in <b>8n</b>) is detrimental to activity. </div><div class="NLM_p">We then replaced the phenyl ring of the benzyloxy group of <b>8b </b>with cylcohexyl (<b>25n</b>), bicyclic, or heterocyclic groups. The cyclohexyl derivative <b>25n</b> was as potent an inhibitor as <b>8b</b> for HER-2 kinase but showed 10-fold less activity against EGFR kinase. The 1-naphthyl compound (<b>25t</b>) and 2-naphthyl compound (<b>25u</b>) were slightly more potent in the kinase assays but less potent in cell proliferation assays. In the heterocyclic series, the 2-pyridinyl (<b>25o</b>), 2-furyl (<b>25q</b>), and 2-thienyl (<b>8o</b>) analogues each showed similar activities compared to <b>8b</b>. </div><div class="NLM_p">In our earlier work,<sup>9</sup> we found that adding a basic dialkyamino group to the terminus of the crotonamide side chain at the 6-position of 4-anilinoquinoline-3-carbonitrile significantly increased the activity in both kinase and cell proliferation assays. On the basis of our binding model of <b>25o</b> complexed with HER-2, the water-solubilizing dimethylamino group points out of the ATP <a name="jm004800401119" id="jm004800401119"></a> binding pocket toward the aqueous environment. Also, the β-carbon of the crotonamide group is 3.43 Å away from the sulfur atom of Cys 805, and the dimethylamino moiety is situated 4.46 Å from the hydrogen of the sulfhydryl group. We have proposed that the dialkylamino group of compounds such as <b>25o</b> could serve as an intramolecular base catalyst for Michael additions by extracting the proton from the nucleophilic sulfhydryl group (Cys 805 for HER-2 and Cys 773 for EGFR) through a cyclic five-membered ring mechanism. </div><div class="NLM_p">Table 4 shows compounds where the terminal dialkylamino group of the crotonamide Michael acceptor was varied. With a few exceptions, it is evident that for most of these analogues, the kinase and cellular activities are minimally affected by the choice of the dialkylamino group. One exception is compound <b>7p</b>, which carries a 2,6-dimethyl-1-piperidinyl group. It is much less active than the corresponding compound <b>7m</b> carrying an <i>N</i>-piperidinyl group, suggesting that the steric bulk around the basic nitrogen may hinder the intramolecular base catalysis of the Michael addition of Cys 805 to form a covalent adduct. Likewise, the loss of kinase potency of <b>7v</b> may be due to the steric bulk of 1-aza-12-crown-4. However, <b>7v</b> was as potent as <b>8b</b> in the cell proliferation assays. A highly water-soluble analogue <b>7i</b> carrying an <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-glucamine group was also less active in the kinase and cell proliferation assays. Compound <b>77</b>, where the Michael acceptor is terminated with an imidazole ring, showed reduced activity in both kinase and cell proliferation assays (Table 5) compared to compounds with the terminal dimethylamino group. This loss of activity is likely due to the reduced basicity of the imidazole ring of <b>77</b> compared to the imidazole in <b>8u</b>. Also, the proposed intramolecular base catalysis of the Michael addition would not be expected to occur with <b>77</b> but could occur with <b>8u</b>. Similarly, quinolino and dimethylaminophenyl substituted derivatives <b>75</b> and <b>76,</b> respectively, show reduced activities most likely due to reduced basicity. There is no major difference in activities between compounds in the crotonamide series such as <b>8b</b> and <b>7q</b> compared to the coreresponding compounds <b>83</b> and <b>84</b> in the methacrylamide series. As expected, compound <b>85</b>, lacking a basic amino substituent but carrying a carboxylic group, is a poor inhibitor of both HER-2 and EGFR. Finally, compound <b>82</b> with an ethylenesulfonamide group is as potent as <b>8b</b>. From these in vitro studies, it is clear that among the best dual inhibitors of HER-2 and EGFR kinases are <b>7f</b>, <b>7m</b>, <b>8b</b>, <b>8o</b>, <b>8t</b>, and<b> 25o</b>. These compounds were selected for further in vivo studies.<a data-tab="pane-pcw-Figures" href="#jm040159cf00004" id="" class=" internalNav"></a><a class="ref showTableEvent internalNav" data-ID="jm040159ct00007" href="#jm040159ct00007"></a><div id="_i35"><figure id="jm040159cf00004" data-index="17" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cf00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00004.jpeg" id="_i36" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Inhibition of HER-2 phosphorylation in the 3T3/neu tumor model and BT474 xenograft. 3T3/neu (A) and BT474 (B) tumor-bearing mice were treated with vehicle or a single dose of compound (three to five animals per group). Tumors from control and treated mice were dissected at various times after compound administration. Protein extracts from each time point were pooled and analyzed by SDS−PAGE and immunoblotting. Extracts from individual tumors were also analyzed to determine the variability between animals. Phosphorylation of HER-2 was detected using phosphotyrosine antibodies and normalized to HER-2 levels, detected with anti HER-2 antibodies. Blots were quantified by scanning densitometry. Data for <b>25o</b> in part B are from ref 29.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159cf00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm040159ct00007"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 7.  Comparison of in Vivo Effects (% <i>T</i>/<i>C</i>) of HER-2 Inhibitor Leads and EKB-569 (<b>86</b>) in Tumor Models Sensitive to HER-2 or EGFR<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="7">% <i>T</i>/<i>C</i> (<i>p</i> value)</td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">3T3/<i>neu</i></td><td class="colsep2 rowsep2" colspan="2">BT474</td></tr></tbody></table><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">80 mg/kg</td><td class="colsep2 rowsep2">40 mg/kg</td><td class="colsep2 rowsep2">40 mg/kg</td><td class="colsep2 rowsep2">10 mg/kg</td><td class="colsep2 rowsep2">SKOV3 40 mg/kg</td><td class="colsep2 rowsep2">SUM190 40 mg/kg</td><td class="colsep2 rowsep2">A431 40 mg/kg </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7f</b></td><td class="colsep2 rowsep2">1 (<0.01) </td><td class="colsep2 rowsep2">3 (<0.01) </td><td class="colsep2 rowsep2">4 (<0.01) </td><td class="colsep2 rowsep2">41 (0.06) </td><td class="colsep2 rowsep2">12 (<0.01) </td><td class="colsep2 rowsep2">6 (<0.01) </td><td class="colsep2 rowsep2">34 (0.01) </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7m</b></td><td class="colsep2 rowsep2">27 (<0.01) </td><td class="colsep2 rowsep2">44 (<0.01) </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8b</b></td><td class="colsep2 rowsep2">3 (<0.01) </td><td class="colsep2 rowsep2">13 (<0.01) </td><td class="colsep2 rowsep2">13 (<0.01) </td><td class="colsep2 rowsep2">27 (<0.01) </td><td class="colsep2 rowsep2">26 (<0.01) </td><td class="colsep2 rowsep2">29 (0.06) </td><td class="colsep2 rowsep2">47 (0.07) </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8o</b></td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">46 (<0.01) </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8t</b></td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">36 (<0.01) </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25o</b></td><td class="colsep2 rowsep2">2 (<0.01) </td><td class="colsep2 rowsep2">5 (<0.01) </td><td class="colsep2 rowsep2">12 (<0.01) </td><td class="colsep2 rowsep2">34 (<0.01) </td><td class="colsep2 rowsep2">14 (<0.01) </td><td class="colsep2 rowsep2">20 (0.01) </td><td class="colsep2 rowsep2">56 (0.09) </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>86</b></td><td class="colsep2 rowsep2">5 (<0.01) </td><td class="colsep2 rowsep2">44 (<0.01) </td><td class="colsep2 rowsep2">18 (<0.01) </td><td class="colsep2 rowsep2">70 (0.16) </td><td class="colsep2 rowsep2">24 (<0.01) </td><td class="colsep2 rowsep2">32 (0.11) </td><td class="colsep2 rowsep2">6 (<0.01)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Tumor cells (3T3/neu, SKOV3, SUM-190, A431) or tumor fragments (BT474) were implanted subcutaneously in female athymic (nude) mice. For hormone-dependent tumors (BT474, SKOV3), estrogen pellets were implanted 1 week prior to tumor implantation. When tumors reached a size of 90−200 mg, they were randomly assigned to treatment groups (5−10 animals per group) (staging, day 0). Compounds were formulated in 0.5% methylcellulose and 2.0% polysorbate-80 (Tween-80) and adminstered orally once daily for 20 days (10 days for 3T3/neu and A431 xenograft). For 3T3/neu tumors, dosing was started the day after tumor cell implantation (day 0) because of rapid growth. Growth of tumors was determined once a week. Tumor mass was estimated using the formula (length)(width<sup>2</sup>)/2 and was expressed as relative tumor growth (RTG), the ratio of the tumor mass to the mass on the staging day (except 3T3/neu). The effect of the compounds on tumor growth is shown as % <i>T</i>/<i>C</i>, the RTG or mean tumor weight of treated group/RTG or mean tumor weight of placebo group, expressed as a percentage. Data were analyzed using a one-tailed Student's <i>t</i>-test (equal variance) after log transformation of the data. A <i>p</i> value of <0.05 indicates statistical significance of tumor inhibition. The data shown are from day 21 (3T3/neu, BT474, and A431 xenografts), day 28 (SUM-190 xenograft), and day 35 (SKOV3 xenograft), with the <i>p</i> value in parentheses. No compound-related adverse effects (death, weight loss) were observed in these studies.</p></div></div></div><div class="NLM_p"><b>Selectivity and Irreversible Binding to HER-2.</b> Compound <b>25o</b> was evaluated in two additional tyrosine kinases assays, namely, KDR and Src. The IC<sub>50</sub> values (0.8 μM for KDR and 1.4 μM for Src) were 14- and 24-fold greater for these kinases compared to HER-2. Compound <b>25o</b> was also evaluated against a number of serine−threonine kinases among which were Akt, cyclin D1/CDK4, cyclin E/CDK2, cyclin B1/CDK1, IKK-2, MK-2, PDK1, c-Raf, and Tpl-2, and no significant inhibitory activity was observed.<sup><a onclick="showRef(event, 'jm040159cb00029'); return false;" href="javascript:void(0);" class="ref jm040159cb00029">29</a></sup> It is clear that <b>25o</b> is a selective inhibitor of members of the ErbB family of kinases. </div><div class="NLM_p">In our earlier work,<sup>9</sup> EGFR kinase inhibitor <b>86</b> was shown to form a covalent adduct with EGFR kinase. We proposed that this is the result of a covalent interaction between the Michael acceptor group of <b>86</b> with Cys 773 located within the ATP binding pocket of EGFR. Since <b>25o</b> and <b>86</b> have identical Michael acceptor functionality and since the target cysteine residue is conserved in HER-2 (Cys 805), it is expected that <b>25o</b> will <a name="jm004800401120" id="jm004800401120"></a> irreversibly bind to HER-2. Washout experiments were designed to determine if <b>25o </b>functions as an irreversible binding inhibitor in intact BT474 cells by measuring the ability of the compound to inhibit the autophosphorylation of the receptor after removal of <b>25o</b> from the media. We found that after preincubation of cells with <b>25o</b> (5 h) followed by extensive washing to remove free drug from the media, autophosphorylation of HER-2 was still inhibited.<sup>29</sup></div><div class="NLM_p">A more direct indication of a covalent interaction with the enzyme was obtained using C-14 labeled <b>25o.</b><sup>29</sup> Labeled compound was incubated with the purified cytoplasmic domain of HER-2. After denaturation, the sample was analyzed by SDS−PAGE and fluorography. A single ∼95 kDa labeled band, corresponding to the HER-2 cytoplasmic domain, was observed. This radiolabeled signal was greatly diminished if the protein was preincubated with unlabeled <b>25o</b> prior to addition of radiolabeled <b>25o</b>. Similar experiments were performed by incubating C-14 labeled <b>25o</b> with intact BT474 cells. A prominent band corresponding to ∼185 kDa incorporated labeled drug. Additionally, incorporation of labeled drug could be inhibited when the cells were pretreated with a 5-fold excess of cold compound prior to exposure to the labeled drug. Finally, the labeled protein could be immunoprecipitated with an anti-HER-2 antibody suggesting that the ∼185 kDa species is in fact HER-2. These data strongly support our claim that <b>25o</b> functions as an irreversible binding inhibitor of HER-2 in solution and in intact cells. </div><div class="NLM_p"><b>HER-2 Phosphorylation in </b><b>in Vivo</b><b> Tumor Models.</b> To determine whether inhibition of tumor growth in vivo was associated with a block in the target receptor function, the phosphorylation of HER-2 was evaluated in xenografts after a single oral dose of 40 mg/kg of <b>7f</b> or <b>25o</b> (Figure 4). Compound <b>7f</b> reduced HER-2 phosphorylation in 3T3/neu tumor model by 30% within 3 h as shown in Figure 4A. Inhibition reached a maximum of 71% at 6 h and was partially reversed by 24 h (59%). In BT474 xenografts, <b>7f</b> reduced HER-2 phosphorylation by 52% in 3 h as shown in Figure 4B. Maximum inhibition was observed at 6 h (87%), which was sustained at 24 h (79%) and partially reversed by 48 h (58%). Similar effects were observed with <b>25o</b>,<sup>29</sup> although substantial reduction of phosphorylation (84% inhibition) was observed earlier, within 1 h of compound dosing, and was partly reversed (57% inhibition) by 24 h. The sustained inhibition of phosporylation of HER-2 seen in the in vivo studies of both the 3T3/neu tumor model and BT474 xenograft is consistent with irreversible inhibition of the target enzyme HER-2. </div><div class="NLM_p last"><b>In Vivo Efficacy.</b> The best compounds <b>7f</b>, <b>7m</b>, <b>8b</b>, <b>8o</b>, <b>8t</b>, and<b> 25o</b> based on the in vitro assays were evaluated in a number of tumor models in nude mice (Table 7). Our EGFR clinical lead <b>86</b> was also included in the testing for comparison. One model used for this evaluation involved murine fibroblast 3T3 cells transfected with HER-2/neu. Treatment was initiated the day after cell implantation in this model because of the rapid growth of the transplant. The compounds were dosed orally once a day for 10 days. After day 10, dosing was discontinued. It is evident that compounds <b>7f</b>, <b>8b</b>, and <b>25o</b> are more effective in reducing tumor growth than <b>86</b> when administered orally at 40 mg/kg. This correlates well with the higher potency of <b>7f</b>, <b>8b</b>, and <b>25o</b> against HER-2 enzyme compared to <b>86</b>. However, at a higher dose of 80 mg/kg, similar efficacy (95−99% inhibition) was observed for most of these analogues. Compounds were evaluated in three traditional tumor models that overexpress HER-2; among these were xenografts of BT-474, SKOV3, and SUM190 cells. In BT474 and SUM190 tumor models, <b>7f</b>, <b>8b</b>, and <b>25o</b> showed better efficacy and activity than <b>86</b>. For example, <b>86</b> inhibited the growth of BT474 tumors by 30% at a 10 mg/kg dose, whereas <b>7f</b>, <b>8b</b>, and <b>25o</b> showed higher inhibition (59%, 73%, and 66%, respectively) at the same dose. Since <b>7f</b>, <b>8b</b>, and <b>25o</b> inhibit EGFR kinase and proliferation of EGFR-overexpressing cells in vitro, the effect of these compounds in A431 xenografts was evaluated. Although all these compounds suppressed the growth of A431 tumor (44−66% inhibition), they were less potent than <b>86</b> (94% inhibition) in this tumor model. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last"><a name="jm004800401121" id="jm004800401121"></a>We have described three different synthetic routes and resultant SAR of a series of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. These compounds function as irreversible binding inhibitors of HER-2 and EGFR kinases consistent with our binding models for these compounds. Significantly, some of these compounds showed better activity in HER-2 kinase and HER-2 overexpressing cell proliferation assays compared to our EGFR kinase inhibitor <b>86</b>. They also demonstrated improved potency and efficacy in HER-2 dependent in vivo models compared to <b>86</b>. On the basis of the results described herein and on extensive pharmokinetic and toxicological studies, one member of this series, <b>25o</b>, has entered clinical trials for further development as an antitumor agent in breast and other HER-2 dependent cancers. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>Biology.</b> The preparation of the enzymes, the details of our kinase autophosphorylation assays, the cell proliferation assays, and the in vivo studies have been described in detail in our earlier publications.<sup>24,29</sup></div><div class="NLM_p"><b>HER-2 Phosphorylation in Xenografts.</b> Athymic female nude mice (Charles River Laboratories, Wilmington, MA; five animals/group) were implanted subcutaneously with 2 × 10<sup>6</sup> 3T3/neu cells or a single BT474 tumor fragment (∼30 mm<sup>3</sup>). When tumors reached 200−300 mg in size, animals were given a single oral dose (40 mg/kg) of <b>25o</b> or <b>7f</b>. Tumors from control and treated animals were excised at various times up to 48 h and minced. Tumor fragments were suspended in 10 mM Tris, pH 7.5, 5 mM EDTA, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 1 mM PMSF, 10 μg/mL pepstatin, 10 μg/mL leupeptin, 10 μg/mL aprotinin, 2 mM sodium vanadate, and 100 mM sodium fluoride (all chemical reagents were obtained from Sigma-Aldrich, St Louis, MO) and lysed by homogenization on ice with a polytron. After clarification by centrifugation, protein concentration in lysates was estimated using the BioRad <sub>DC</sub> protein assay (BioRad, Hercules, CA). An amount of 60 μg of lysate pooled from each group was analyzed by SDS−PAGE and immunoblotting with phosphotyrosine-specific antibodies (BD Biosciences PharMingen, San Diego, CA). HER-2 specific antibodies were used as controls for protein loading. Blots were quantified by scanning densitometry (FluorS MultiImage analyzer, BioRad). Extracts from individual tumors were analyzed to determine variability between animals. </div><div class="NLM_p"><b>Chemistry. </b><sup>1</sup>H NMR spectra were determined with a NT-300 WB spectrometer at 300 MHz. Chemical shifts (δ) are expressed in parts per million relative to the internal standard tetramethylsilane. Electrospray mass spectra were recorded in positive mode on a Micromass Platform spectrometer. Electron impact and high-resolution mass spectra were obtained on a Finnigan MAT-90 spectrometer. Some high-resolution electrospray mass spectra with higher precision were obtained on a Brucker 9.4T FTMS spectrometer. Chromatographic purifications were by flash chromatography using Baker 40 μm silica gel. Melting points were determined in open capillary tubes on a Meltemp melting point apparatus and are uncorrected. </div><div class="NLM_p"><b>Preparation of Substituted Anilines.</b><b>2-(2-Chloro-4-nitrophenylsulfanyl)-5-phenyl-1,3-thiazole (39). </b>A solution of 2.2 g (11.4 mmol) of 2-mercapto-5-phenyl-1,3-thiazole<sup><a onclick="showRef(event, 'jm040159cb00030'); return false;" href="javascript:void(0);" class="ref jm040159cb00030">30</a></sup> in 35 mL of DMF was added dropwise to a stirring mixture of 546 mg (13.6 mmol) of 60% sodium hydride in oil suspended in 7 mL of DMF, under nitrogen. After 30 min, a solution of 2 g (11.4 mmol) of 3-chloro-4-fluorobenzene in 14 mL of DMF was added dropwise. This was stirred for 16 h at room temperature. The DMF was evaporated, and the brown residue was stirred with 100 mL of hexane and filtered. The residue was washed with three portions of water and ether and crystallized from ethyl acetate to give 3.3 g (84%) of light-yellow crystals (<b>39)</b>:  mp = 126−128 °C; HRMS (ESI) <i>m</i>/<i>z</i> 348.986 43 (M + H)<sup>+1</sup>, Δ = −0.25 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.52 (s, 1H), 8.43 (d, 1H, <i>J</i> = 2.4 Hz), 8.17 (dd, 1H, <i>J</i> = 8.7, 2.4 Hz), 7.72 (d, 2H, <i>J</i> = 5.2 Hz), 7.52−7.40 (m, 4H). Anal. (C<sub>15</sub>H<sub>9</sub>ClN<sub>2</sub>O<sub>2</sub>S) C, H, N, Cl, S. </div><div class="NLM_p"><b>3-Chloro-4-(5-phenylthiazol-2-ylsulfanyl)phenylamine (40).</b> A mixture of 3.13 g (8.97 mmol) of 2-(2-chloro-4-nitrophenylsulfanyl)-5-phenyl-1,3-thiazol <b>39</b> and 3.5 g (62.6 mmol) of iron powder in 37 mL of MeOH and 3.1 mL of HOAc was mechanically stirred and refluxed for 2.5 h. The hot reaction mixture was filtered, and the solvents were evaporated in vacuo. The residue was partitioned between saturated NaHCO<sub>3</sub> and EtOAc. The organic layer was separated and dried to a solid. After it was washed with ether, 2.3 g (80%) of the product (<b>40</b>) as a light-gray solid was obtained:  mp = 121−123 °C; HRMS (ESI) <i>m</i>/<i>z</i> 319.012 51 (M + H)<sup>+1</sup>, Δ = −0.02 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.05 (s, 1H), 7.53−7.48 (m, 3H), 7.40−7.27 (m, 3H), 6.85 (d, 1H, <i>J</i> = 1.9 Hz), 6.62 (dd, 1H, <i>J</i> = 8.5, 1.9 Hz), 6.11 (bs, 2H). Anal. (C<sub>15</sub>H<sub>11</sub>ClN<sub>2</sub>S<sub>2</sub>) C, H, N, S, Cl. </div><div class="NLM_p"><b>2-(2-Chloro-4-nitrophenoxymethyl)-1-methyl-1</b><b><i>H</i></b><b>-imidazole.</b> The title compound was prepared from 4.60 g (0.0410 mol) of 1-methyl-1<i>H</i>-imidazol-2-yl)methanol,<sup><a onclick="showRef(event, 'jm040159cb00031'); return false;" href="javascript:void(0);" class="ref jm040159cb00031">31</a></sup> 7.92 g (0.0454 mol) of 3-chloro-4-fluoronitrobenzene, and 1.64 g (0.0410 mol) of 60% sodium hydride in oil using the method described above for <b>39</b> to yield 7.98 g (72%) of the title compound:  mp = 182−184 °C; MS (ES+) <i>m</i>/<i>z</i> 268.0 (M + H)<sup>+1</sup>. </div><div class="NLM_p"><b>2-(2-Chloro-4-nitrophenylsulfanyl)thiazole.</b> The title compound was prepared from 10.01 g (85.45 mmol) of thiazole-2-thiol and 15 g (85.45 mmol) of 2-chloro-1-fluoro-4-nitrobenzene using the method described above for <b>39</b> to yield 22 g (95%) of the title compound as a yellow solid:  MS (ESI) <i>m</i>/<i>z</i> 273.0 (M + H)<sup>+1</sup>. </div><div class="NLM_p"><b>2-(2-Chloro-4-nitrophenylsulfanyl)-4-phenylthiazole.</b> To a mixture of 5.8 g (0.03 mol) of 2-mercapto-4-phenylthiazole and 1.78 g (0.033 mol) of NaOMe in 50 mL of DMF was added 5.79 g (0.033 mol) of 3-chloro-4-fluoronitrobenzene. The reaction mixture was stirred at room temperature for about 5 h. Then it was poured into about 100 mL of ice−water. The resulting solid was filtered and recrystallized from 95% EtOH to give 7.64 g (73%) of the title compound as a light-yellow solid:  mp = 120−124 °C; MS (ESI) <i>m</i>/<i>z</i> 349.3 (M + H)<sup>+</sup>. </div><div class="NLM_p"><b>1-(4-Amino-2-chlorobenzyl)-1</b><b><i>H</i></b><b>-imidazole (42). </b>A solution of 10 g (39.9 mmol) of 2-chloro-4-nitrobenzyl bromide<sup><a onclick="showRef(event, 'jm040159cb00032'); return false;" href="javascript:void(0);" class="ref jm040159cb00032">32</a></sup> and 5.4 g (79.8 mmol) of imidazole in 125 mL of THF was refluxed for 45 min. The solvent was removed, and the residue was dissolved in EtOAc. The solution was washed with H<sub>2</sub>O and dried with MgSO<sub>4</sub>. The solvent was removed, and the residue was extracted with ether. The ether solution was diluted with 2 volumes of hexane. The resulting precipitate was collected, giving 4.3 g of 1-(2-chloro-4-nitrobenzyl)-1<i>H</i>-imidazole (<b>41</b>) as a white solid. This material was mechanically stirred at reflux in 180 mL of MeOH and 52 mL of H<sub>2</sub>O containing 8.1 g of NH<sub>4</sub>Cl and 6.6 g of iron powder for 2 h. The mixture was filtered, and solvent was removed. The residue was dissolved in EtOAc and washed with saturated NaHCO<sub>3</sub> solution. The solution was treated with activated charcoal and dried with MgSO<sub>4</sub>. Solvent was removed, giving 3.9 g of the product <b>42</b> as an oil that was used without additional purification. </div><div class="NLM_p"><b>2-(Benzyloxy)-1,3-dichloro-5-nitrobenzene. </b>A solution of 2.74 g (13.17 mmol) of 2,6-dichloro-4-nitrobenzene, 2.35 mL (3.38 g, 19.76 mmol) of benzyl bromide, and 10.73 g (32.92 mmol) of cesium carbonate in 67 mL of DMF was stirred at room temperature overnight. After the solvent was removed by rotary evaporation, the residue was partitioned between EtOAc and water. The organic layer was dried (MgSO<sub>4</sub>) and evaporated to give a brown semisolid, which was recrystallized from EtOAc to give 1.088 g (28%) of the starting material as bright-yellow crystals:  mp = 164−166 °C. The mother liquor was evaporated, and the residue was recrystallized from ether to give 2.06 g (52%) of the title compound as beige crystals:  mp = 78−80 °C; HRMS (ESI+) <i>m</i>/<i>z</i> 298.0026, ▵ = 1.1 mmu. </div><div class="NLM_p"><a name="jm004800401122" id="jm004800401122"></a><b>4-Benzyloxy-3,5-dichlorophenylamine (44). </b>A mixture of 1.77 g (5.94 mmol) of 2-(benzyloxy)-1,3-dichloro-5-nitrobenzene, 2.33 g of iron powder, 2.2 mL of HOAc, and 92 mL of MeOH was refluxed for 3 h. After filtration, the filtrate was evaporated to a residue that was partitioned between EtOAc and saturated KHCO<sub>3</sub> solution. The organic layer was evaporated to give a light-brown oil, which was triturated with ether−hexane (1:1) to give 1.41 g (88%) of the titile compound as a beige solid:  mp = 75−77 °C; HRMS (ESI+) <i>m</i>/<i>z</i> 268.628 45, ▵ = −0.62 mmu. </div><div class="NLM_p"><b>2-(4-Amino-2-chlorophenyl)ethanethioamide (49). </b>A solution of 15 g (76.3 mmol) of (2-chloro-4-nitrophenyl)acetonitrile (<b>48</b>)<sup>19</sup> in 100 mL of DMF was stirred at −78 °C as H<sub>2</sub>S was introduced to saturation. To the solution was added 7.7 g (76.3 mmol) of Et<sub>3</sub>N. The cooled mixture was placed in a steel bomb that was maintained at 80 °C for 16 h. The bomb was cooled and vented. The solution was treated with activated charcoal and filtered. The residue was diluted with ice/water, and the solid was collected and washed with H<sub>2</sub>O and hexane. The solid was air-dried and dissolved in 150 mL of MeOH. Elemental sulfur was removed by filtration. The solvent was removed, and the product was recrystallized from EtOAc−hexane to give 8.5 g (56%) of the title compound as tan crystals:  MS (ESI+) <i>m</i>/<i>z</i> 201.0 (M + H)<sup>+1</sup>. </div><div class="NLM_p"><b>3-Chloro-4-[(4-phenyl-1,3-thiazol-2-yl)methyl]aniline (51). </b>A solution of 4.56 g (22.92 mmol) of phenacyl bromide (<b>50</b>) and 4.6 g (22.92 mmol) of 2-(4-amino-2-chlorophenyl)ethanethioamide (<b>49</b>) in 47 mL of EtOH was refluxed for 3 h. The mixture was poured into saturated NaHCO<sub>3</sub> and extracted with ether. The solution was dried (MgSO<sub>4</sub>). Solvent was removed and the residue was chromatographed on silica gel, eluting with CH<sub>2</sub>Cl<sub>2</sub>−ether mixtures to yield 8.3 g (95%) of the HBr salt of the titile compound as a light-tan solid:  MS (ES+) <i>m</i>/<i>z</i> 301.1 (M + H)<sup>+1</sup>. </div><div class="NLM_p"><b>1-Benzyl-1</b><b><i>H</i></b><b>-indazol-5-amine (55).</b> A mixture of 5 g (30.65 mmol) of 5-nitroindazole (<b>53</b>), 5.76 g (33.68 mmol) of benzyl bromide, and 4.66 g (33.72 mmol) of K<sub>2</sub>CO<sub>3</sub> in 50 mL of DMF was heated at 75 °C for 4 h. After cooling, the reaction mixture was poured into 50 mL of H<sub>2</sub>O. The solid was collected and washed with H<sub>2</sub>O to give a mixture of two isomers:  1-<i>N</i>-benzyl-5-nitro-1<i>H</i>-indazole (major) and 2-<i>N</i>-benzyl-5-nitro-1<i>H</i>-indazole (minor). The crude mixture was dissolved in 35 mL of acetone. After filtration, 10.8 mL of H<sub>2</sub>O was added slowly to the filtrate with stirring. After 1 h, 2.9 g (37%) 1-<i>N</i>-benzyl-5-nitro-1<i>H</i>-indazole was collected as yellow crystals. A mixture of 1-<i>N</i>-benzyl-5-nitro-1<i>H</i>-indazole (1.4 g, 5.53 mmol) and iron powder (2.25 g) in 84 mL of MeOH and 33 mL of HOAc was refluxed for 2 h. The hot reaction mixture was filtered, and the filtrate was concentrated. The residue was partitioned between EtOAc and NaHCO<sub>3</sub> solution. The organic layer was concentrated to give 1.3 g (100%) of the title compound as orange crystals (<b>55)</b>:  HRMS (EI) <i>m</i>/<i>z</i> 223.1094, ▵ = 1.6 mmu. </div><div class="NLM_p"><b>1-Benzyl-2,3-dihydro-1</b><b><i>H</i></b><b>-indol-5-ylamine (57).</b> A solution of 3.11 g (0.0184 mmol) of 5-nitroindoline (<b>56</b>) and 2.48 mL (3.56 g, 0.0208 mol) of benzyl bromide in 35 mL of CH<sub>3</sub>CN was refluxed for 2 h. The solvent was removed in vacuo, and the solid was stirred with saturated aqueous NaHCO<sub>3</sub>. The resulting solid was chromatographed on silica gel and eluted with 1:9 EtOAc−hexanes to yield 2.83 g (58%) of 1-benzyl-5-nitro-2,3-dihydro-1<i>H</i>-indole:  mp = 87−88 °C; MS (ES+) <i>m</i>/<i>z</i> 255.0 (M + H)<sup>+1</sup>. A mixture of 2.54 g (0.01 mol) of 1-benzyl-5-nitro-2,3-dihydro-1<i>H</i>-indole, 2.23 g (0.04 mol) of iron powder, and 2.14 g (0.04 mol) of NH<sub>4</sub>Cl in 65 mL of EtOH and 10 mL of H<sub>2</sub>O was vigorously stirred and refluxed for 3 h. The reaction mixture was filtered through Celite; then the solvents were removed from the filtrate in vacuo. The residue was extracted with CH<sub>2</sub>Cl<sub>2</sub>, and these extracts were passed through Magnesol. The CH<sub>2</sub>Cl<sub>2</sub> was removed in vacuo to give 2.04 g (91%) of <b>57</b> as an oil. </div><div class="NLM_p"><b>Preparation of the Michael Acceptor Groups.</b><b>(</b><b><i>E</i></b><b>)-4-Iodobut-2-enoic Acid </b><b><i>tert</i></b><b>-Butyl Ester </b><b>(61).</b> A mixture of 4.42 g (20 mmol) of (<i>E</i>)-<i>tert</i>-butyl 4-bromobut-2-enoate (<b>60)</b>, 6.0 g (40 mmol) of NaI, and 40 mL of acetone was refluxed for 1 h. The cooled mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and H<sub>2</sub>O. The organic layer was washed successively with aqueous NaHSO<sub>3</sub>, H<sub>2</sub>O, aqueous NaHCO<sub>3</sub>, and H<sub>2</sub>O, dried, and concentrated to give an amber liquid:  <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 6.90 (dt, 1H, <i>J</i> = 8.3, 14.8 Hz), 5.86 (d, 1H, <i>J</i> = 14.8 Hz), 3.91 (d, 2H, <i>J</i> = 8.3 Hz), 1.48 (s, 9H). </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-4-(Pyrrolidin-1-yl)but-2-enoic Acid </b><b><i>tert</i></b><b>-Butyl Ester (62). </b>To a stirred solution of 2.08 g (7.75 mmol) of (<i>E</i>)-4-iodobut-2-enoic acid <i>tert</i>-butyl ester (<b>61</b>) in 15.5 mL of THF at 0 °C was added 1.29 mL (15.5 mmol) of pyrrolidine. The solution was warmed to 25 °C, stirred 15 min, and partitioned between toluene and aqueous KHCO<sub>3</sub>. The organic layer was washed with water, dried, and concentrated to give 1.50 g (92%) of amber oil:  MS (ES+) <i>m</i>/<i>z</i> 212.0 (M + H)<sup>+1</sup>. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-4-(Pyrrolidin-1-yl)but-2-enoic Acid Hydrochloride (63).</b> A solution of 1.49 g (7.05 mmol) of (<i>E</i>)-4-(pyrrolidin-1-yl)but-2-enoic acid <i>tert</i>-butyl ester (<b>62</b>) in 14.1 mL of 1 N HCl was refluxed for 15 min, diluted with toluene, and concentrated to give an amber solid:  MS (ES+) <i>m</i>/<i>z</i> 155.8 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.7 (bs, 1H), 11.4 (bs, 1H), 6.83 (dt, 1H, <i>J</i> = 6.8, 14.4 Hz), 6.18 (d, 1H, <i>J</i> = 14.4 Hz), 3.95 (d, 2H, <i>J</i> = 6.8 Hz), 3.05 (m, 2H), 1.92 (m, 6H). </div><div class="NLM_p"><b>4-(1</b><b><i>H</i></b><b>-Imidazol-4-yl)-but-2-enoic Acid Hydrochloride (67). </b>1<i>H</i>-Imidazole-4-acetic acid, 1-(triphenylmethyl) methyl ester (<b>65</b>)<sup>21</sup> was converted to the title compound using the method reported by Takacs.<sup>22</sup> A solution of 6.45 g (28.8 mmol) of triethyl phosphonoacetate in 100 mL of THF was cooled to −78 °C with stirring under an inert atmosphere. A solution of 12 mL of <i>n</i>-BuLi in hexanes (2.5 M, 30 mmol) was added dropwise. After 10 min, a solution of 1<i>H</i>-imidazole-4-acetic acid, 1-(triphenylmethyl) methyl ester in 60 mL of THF was added. After the mixture was stirred for 20 min, a solution of 27.5 mL of DIBAL in CH<sub>2</sub>Cl<sub>2</sub> (1 M, 27.5 mmol) was added. The mixture was stirred for 1.5 h and then allowed to slowly warm to room temperature over 2 h. Solid Na<sub>2</sub>SO<sub>4</sub>(H<sub>2</sub>O)<sub>10</sub> was added followed by 3 mL of H<sub>2</sub>O. The mixture was filtered, and the solvent was removed. The residue was dissolved in ethyl acetate, washed with saturated Na<sub>2</sub>CO<sub>3</sub>, and dried (MgSO<sub>4</sub>). The product, which is a mixture of cis and trans isomers, was treated with NaOCH<sub>3</sub> in CH<sub>3</sub>OH to convert most of the material to the trans isomer, which was purified by silica gel chromatography giving 5.9 g of intermediate (<b>66</b>). A 4.77 g portion of this ester (<b>66</b>) was hydrolyzed by dissolving it in 48 mL of CH<sub>3</sub>OH containing 9 mL of 5 M NaOH. After being stirred for 2 h, the mixture was neutralized to pH 4−5 and extracted with ethyl acetate. The solution was dried (MgSO<sub>4</sub>), and the solvent was removed. The trityl group was removed by refluxing this material in a mixture of 40 mL of H<sub>2</sub>O, 40 mL of EtOH, and 5 mL of concentrated HCl for 1.5 h. The mixture was cooled, and solid trityl alcohol was filtered off. Solvent was removed from the filtrate and the remaining H<sub>2</sub>O was coevaporated with toluene several times, resulting in 1.3 g of crude product HCl salt (<b>67</b>), which was used in the next step without additional purification. </div><div class="NLM_p"><b>3-(2-Dimethylaminophenyl)acrylic Acid (70). </b>A solution of 18 g (120.7 mmol) of 2-(dimethylamino)benzaldehyde (<b>69</b>),<sup>23</sup> 12.6 g (120.7 mmol) of malonic acid, and 6 drops of piperidine in 107 mL of pyridine was heated to 110 °C for 3 h. The mixture was diluted with 600 mL of H<sub>2</sub>O, and 30 mL of 5 N NaOH was added. The solution was washed twice with ether (washing discarded). The solution was acidified to pH 5−6, saturated with NaCl, and extracted with ethyl acetate. The extract was dried (MgSO<sub>4</sub>), and the solvents were removed. The solid was dissolved in ether, activated charcoal was added, and the mixture was filtered. The solution was concentrated, and 5.8 g (25%) of solid <b>70 </b>was obtained by filtration. MS (ES+) <i>m</i>/<i>z</i> 192.1 (M + H)<sup>+1</sup>. Anal. (C<sub>11</sub>H<sub>13</sub>NO<sub>2</sub>) C, H, N. </div><div class="NLM_p"><b>Preparation of Representative Intermediates.</b><b>4-(4-Benzyloxy-3-chlorophenylamino)-7-ethoxy-6-nitroquinoline-3-carbonitrile </b><b>Hydrochloride (3</b><b>g</b><b>).</b> A suspension of 2.60 g (11.15 mmol) of 4-benzyloxy-3-chloroaniline, 3.1 g (11.15 mmol) of 4-chloro-7-methoxy-6-nitroquinoline-3-carbonitrile,<sup>9</sup> and 0.3 g of pyridine hydrochloride in 180 mL of <i>i</i>-PrOH under nitrogen was refluxed with stirring for 8 h. When the mixture was coooled, a yellow solid was obtained, which was washed <a name="jm004800401123" id="jm004800401123"></a> with <i>i</i>-PrOH and ether to give 4.9 g (85%) of yellow solid:  mp = 251−255 °C; HRMS (ESI) <i>m</i>/<i>z</i> 475.113 95 (M + H)<sup>+1</sup>, Δ = −2.81 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.98 (bs, 1H), 9.33 (s, 1H), 8.88 (s, 1H), 7.67 (s, 1H), 7.58 (d, 1H, <i>J</i> = 2.0 Hz), 7.51−7.35 (m, 7H), 5.27 (s, 2H), 4.36 (q, 2H, <i>J</i> = 6.8 Hz), 1.43 (t, 3H, <i>J</i> = 6.8 Hz). Anal. (C<sub>25</sub>H<sub>19</sub>N<sub>4</sub>O<sub>4</sub>Cl·0.5HCl) H, N. C:  calcd, 60.89; found, 59.38. </div><div class="NLM_p"><b>6-Amino-4-(4-benzyloxy-3-chlorophenylamino)-7-ethoxyquinoline-3-carbonitrile (4</b><b>g</b><b>).</b> A 4.6 g (9 mmol) sample of <b>3g</b> in 138 mL of methanol was brought to reflux with stirring. To this was added 3.52 g of iron powder suspended in 55 mL of acetic acid, and reflux was continued for 2 h. The reaction mixture was filtered hot and left to crystallize, producing 4.9 g of yellow solid as the acetate salt. This was suspended into 700 mL of ethyl acetate and 300 mL of saturated KHCO<sub>3</sub> and stirred overnight. The aqueous phase was extracted twice with 500 mL portions of ethyl acetate, and the organic phases were combined, dried, and evaporated to a volume of about 100 mL. This yielded 2.73 g (68%) of product in three crops as off-white crystals:  mp = 237−239 °C; HRMS (ESI) <i>m</i>/<i>z</i> 445.141 15 (M + H)<sup>+1</sup>, Δ = −1.43 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.10 (s, 1H), 8.30 (s, 1H), 7.52−7.48 (m, 2H), 7.46−7.32 (m, 3H), 7.28−7.19 (m, 4H), 5.44 (bs, 2H), 5.19 (s, 2H), 4.23 (q, 2H, <i>J</i> = 6.9 Hz), 1.45 (t, 3H, <i>J</i> = 6.9 Hz). Anal. (C<sub>25</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub>Cl) C, H, N. </div><div class="NLM_p"><b>Synthesis Using Method 1A.</b><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-[(2-hydroxyethy</b><b>l)(methyl)amino]-2-butenamide (7h).</b> To a suspension of 6-amino-4-(4-benzyloxy-3-chlorophenylamino)-7-methoxyquinoline-3-carbonitrile (1 g, 2.25 mmol) (<b>4</b>) in 12 mL of THF at 0 °C, was added Hunig's base (0.78 mL, 4.5 mmol), followed by dropwise addition of 4-bromocrotonyl chloride (0.33 mL, 2.9 mmol) in 35 min. After the mixture was stirred for 2 h at 0 °C, the solvent was evaporated. The residue was partitioned between EtOAc and saturated sodium bicarbonate solution. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated. The crude product was purified by column chromatography using a gradient of ethyl acetate in methylene chloride to yield 0.79 g (62% yield) of a yellow solid as a 1:1 mixture of (<i>E</i>)-<i>N</i>-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-bromo-2-butenamide and (<i>E</i>)-<i>N</i>-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-chloro-2-butenamide. MS (ES+) <i>m</i>/<i>z</i> 593 (M + H)<sup>+1</sup>, 547 (M + 2H)<sup>+1</sup>. </div><div class="NLM_p">A 0.18 g (0.316 mmol) portion of the bromo/chloro mixture prepared above was dissolved in 1.8 mL of DMF and cooled to 0 °C. Sodium iodide (24 mg, 0.158 mmol) was added, follwed by methoxyethylmethylamine (0.28 mL, 3.16 mmol). The reaction mixture was stirred overnight at room temperature. The reaction solution was evaporated, and the residue was partitioned between EtOAc and saturated NaHCO<sub>3</sub>. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to an oil. Chromatography of the crude residue on a short column, eluting with EtOAc, then 5% MeOH/EtOAc, 10% MeOH/EtOAc, and 15% MeOH/EtOAc yielded 135 mg (71%) of yellow solid:  mp = 55−70 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.62 (bs, 1H), 9.49 (s, 1H), 8.96 (s, 1H), 8.47 (s, 1H), 7.49 (d, 2H, <i>J</i> = 6.9 Hz), 7.44−7.32 (m, 5H), 7.27−7.18 (m, 2H), 6.8−6.73 (m, 1H), 6.58 (d, 1H, <i>J</i> = 15.4 Hz), 5.21 (s, 2H), 4.31 (q, 2H, <i>J</i> = 6.9 Hz), 3.43 (t, 2H, <i>J</i> = 5.8 Hz), 3.33 (s, 2H), 3.23 (s, 3H), 3.19 (d, 2H, <i>J</i> = 5.5 Hz), 2.2 (s, 3H), 1.46 (t, 3H, <i>J</i> = 6.9 Hz). Anal. (C<sub>33</sub> H<sub>34</sub>ClN<sub>5</sub>O<sub>4</sub>·0.3H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(4-pyridinyloxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethyla</b><b>mino)-2-butenamide (7b).</b> The title compound was prepared using the method described above for <b>7h</b>:  MS (ES+) <i>m</i>/<i>z</i> 543.4 (M + H)<sup>+1</sup>, 272.2 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.08 (s, 1H), 9.77 (s, 1H), 8.95 (s, 1H), 8.76 (s, 1H), 7.66 (m, 2H), 7.51 (m, 2H), 7.40 (d, 1H, <i>J</i> = 2.1 Hz), 7.22 (dd, 1H, <i>J</i> = 8.4 Hz, 2.1 Hz), 6.84 (m, 2H), 6.23 (m, 2H), 4.36 (q, 2H, <i>J</i> = 6.9 Hz), 3.85 (m, 2H), 2.52 (s, 6H), 1.44 (t, 3H, <i>J</i> = 6.9 Hz). Anal. C<sub>29</sub>H<sub>27</sub>ClN<sub>6</sub>O<sub>3</sub>·4H<sub>2</sub>O) C, N. H:  calcd, 5.74; found, 5.20. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-(4-{[3-Chloro-4-(1,3-thiazol-2-ylsulfanyl)phenyl]amino}-3-cyano-7-methoxy-6-quinol</b><b>inyl)-4-(dimethylamino)-2-butenamide (7d). </b>The title compound was prepared using the method described above for <b>7h</b>:  MS (ES+) <i>m</i>/<i>z</i> 551.1 (M + H)<sup>+1</sup>, 276.2 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δδ 9.97 (s, 1H), 9.83 (s, 1H), 9.04 (s, 1H), 8.76 (s, 1H), 7.71 (m, 3H), 7.53 (s, 1H), 7.40 (s, 1H), 7.16 (d, 1H, <i>J</i> = 8.4 Hz), 6.76 (m, 2H), 4.07 (s, 3H), 3.49 (m, 2H), 2.47 (s, 6H). Anal. (C<sub>26</sub>H<sub>23</sub>ClN<sub>6</sub>O<sub>2</sub>S<sub>2</sub>·1.4H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(3-fluorobenzyloxy)-phenylamino]-3-cyano-7-ethoxy-6-quinolinyl}-(di</b><b>methylamino)-2-butenamide (7f). </b>The title compound was prepared using the method described above for <b>7h </b>to yield the product (29%) as a yellow glass after silica gel chromatography:  HRMS (ESI) <i>m</i>/<i>z</i> 574.199 79 (M + H)<sup>+1</sup>, Δ = −1.79 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.62 (s, 1H), 9.50 (s, 1H), 8.97 (s, 1H), 8.47 (s, 1H), 7.51−7.43 (m, 1H), 7.39−7.30 (m, 4H), 7.26−7.16 (m, 3H), 6.82−6.73 (m, 1H), 6.62−6.57 (m, 1H), 5.25 (s, 2H), 4.31 (q, 2H, <i>J</i> = 7.0 Hz), 3.07 (d, 2H, <i>J</i> = 5.6 Hz), 2.18 (s, 6H), 1.47 (t, 3H, <i>J</i> = 7.0 Hz). Anal. (C<sub>31</sub>H<sub>29</sub>ClFN<sub>5</sub>O<sub>3</sub>·1H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-[methyl(2,3,4,5,</b><b>6-pentahydroxyhexyl)amino]-2-butenamide (7i).</b> The title compound was prepared using the method described above for <b>7h</b>. The crude product was purified by preparative TLC developed with EtOAc−MeOH−NH<sub>4</sub>OH = 40:4:2. The resulting material was dissolved in acetone and filtered through Celite to obtained 125 mg (20%) of light-yellow solid:  mp = 72 °C; HRMS (ESI) <i>m</i>/<i>z</i> 705.256 68 (M + H)<sup>+1</sup>, Δ = −0.28 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.59 (s, 1H), 9.53 (s, 1H), 8.84 (s, 1H), 8.46 (s, 1H), 7.49 (d, 2H, <i>J</i> = 6.9 Hz), 7.44−7.35 (m, 7H), 7.27−7.19 (m, 2H), 5.21 (s, 2H), 4.45 (s, 1H), 4.29 (q, 4H, <i>J</i> = 6.9 Hz), 4.0 (m, 2H), 3.84 (bs, 1H), 3.56 (m, 2H) 3.48 (bs, 1H), 3.25 (d, 2H, <i>J</i> = 7.4 Hz), 3.11 (m, 1H), 2.77 (m, 2H), 2.34 (s, 1H), 2.13 (s, 3H), 1.46 (t, 3H, <i>J</i> = 6.8 Hz). Anal. (C<sub>36</sub>H<sub>40</sub>ClN<sub>5</sub>O<sub>8</sub>·2.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(1-piperidinyl)-</b><b>2-butenamide (7m)</b>. The title compound was prepared using the method described above for <b>7h </b>except NaI was replaced by 0.153 mL (0.88 mmol) of Hunig's base. Chromatography of the crude residue on a short column, eluting with 10% MeOH/EtOAc, yielded 273 mg (52%) of yellow glass:  mp = 105−107°C; HRMS (ESI) <i>m</i>/<i>z</i> 595.235 15 (M + H)<sup>+1</sup>, Δ = −0.54 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.61 (s, 1H), 9.51 (s, 1H), 8.94 (s, 1H), 8.47 (s, 1H), 7.49 (d, 2H, <i>J</i> = 6.9 Hz), 7.44−7.35 (m, 5H), 7.27−7.18 (m, 2H), 6.8−6.73 (m, 1H), 6.58 (d, 1H, <i>J</i> = 15.3 Hz), 5.21 (s, 2H), 4.31 (q, 2H, <i>J</i> = 6.9 Hz), 3.11 (bs, 2H), 2.36 (bs, 4H), 1.51 (d, 4H, <i>J</i> = 5 Hz), 1.46 (t, 3H, <i>J</i> = 6.9 Hz), 1.40 (bs, 2H). Anal. (C<sub>34</sub>H<sub>34</sub>ClN<sub>5</sub>O<sub>3</sub>·2.3H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-[(2</b><b><i>R</i></b><b>,6</b><b><i>S</i></b><b>)-2,6-di</b><b>methylpiperidinyl]-2-butenamide (7p).</b> The title compound was prepared using the method described above for <b>7h </b>except NaI was replaced by Hunig's base. Chromatography of the crude residue was done on a short column, eluting with EtOAc, 5% MeOH/EtOAc,EtOAc/MeOH/NH<sub>4</sub>OH = 40:4:1. The resulting material was purified in preparative plates, developing in EtOAc/MeOH/NH<sub>4</sub>OH = 40:4:1 to yield a light-yellow solid (43% yield):  mp = 98−99 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.61 (s, 1H), 9.49 (s, 1H), 8.93 (s, 1H), 8.47 (s, 1H), 7.49 (d, 2H, <i>J</i> = 6.9 Hz), 7.44−7.35 (m, 5H), 7.27−7.18 (m, 2H), 6.98−6.91 (m, 1H), 6.61 (d, 1H, <i>J</i> = 15.3 Hz), 5.21 (s, 2H), 4.31 (q, 2H, <i>J</i> = 6.9 Hz), 3.45 (d, 2H, <i>J</i> = 5.8 Hz), 2.41 (bs, 2H), 1.54 (m, 3H), 1.46 (t, 3H, <i>J</i> = 6.9 Hz), 1.28−1.14 (m, 3H), 1.05 (d, 6H, <i>J</i> = 6.1 Hz). Anal. (C<sub>36</sub>H<sub>38</sub>ClN<sub>5</sub>O<sub>3</sub>·1.05H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(4-morpholinyl)</b><b>-2-butenamide (7q).</b> The title compound was prepared using the method described above for <b>7h. </b>Chromatography of the crude residue on a short column, eluting with EtOAc and then 5% MeOH/EtOAc and 10% MeOH/EtOAc, yielded a yellow solid (75% yield):  HRMS (ESI) <i>m</i>/<i>z</i> 597.2144 (M + H)<sup>+1</sup>, Δ = −0.95 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.61 (bs, 1H), 9.52 (s, 1H), 8.95 (s, 1H), 8.47 (s, 1H), 7.49 (d, 2H, <i>J</i> = 6.9 Hz), 7.44−7.32 (m, 5H), 7.24−7.18 (m, 2H), 6.79−6.72 (m, 1H), 6.59 (d, 1H, <i>J</i> = 15.4 Hz), 5.21 (s, 2H), 4.32 (q, 2H, <i>J</i> = 6.9 Hz), 3.59 (t, 4H, <i>J</i> = 4.4 Hz), 3.14 (d, <a name="jm004800401124" id="jm004800401124"></a> 2H, <i>J</i> = 5.5 Hz), 2.38 (s, 4H), 1.46 (t, 3H, <i>J</i> = 6.9 Hz). Anal. (C<sub>33</sub> H<sub>32</sub>ClN<sub>5</sub>O<sub>4</sub>·0.35H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(1,4,7-trioxa-10-</b><b>azacyclododecan-10-yl)-2-butenamide (7v).</b> The title compound was prepared using the method described above for <b>7h </b>except NaI was replaced by Hunig's base. Chromatography of the crude residue on a short column, eluting with 5% MeOH/EtOAc, 10% MeOH/EtOAc, EtOAc/MeOH/NH<sub>4</sub>OH = 40:4:1, yielded a yellow glass (82% yield):  mp = 82−83 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.62 (s, 1H), 9.38 (s, 1H), 8.98 (s, 1H), 8.46 (s, 1H), 7.49 (d, 2H, <i>J</i> = 6.9 Hz), 7.44−7.32 (m, 5H), 7.27−7.18 (m, 2H), 6.82−6.75 (m, 1H), 6.66 (d, 1H, <i>J</i> = 15.3 Hz), 5.21 (s, 2H), 4.31 (q, 2H, <i>J</i> = 6.9 Hz), 3.56 (t, 12H, <i>J</i> = 4.2 Hz), 3.28 (d, 2H, <i>J</i> = 5.3 Hz), 2.65 (t, 4H, <i>J</i> = 4.5 Hz), 1.46 (t, 3H, <i>J</i> = 6.9 Hz). Anal. (C<sub>37</sub>H<sub>40</sub>ClN<sub>5</sub>O<sub>6</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>Synthesis Using Method 1B.</b><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(5-phenylthiazol-2-ylsulfanyl)phenylamino]-3-cyano-7-methoxy-6-qui</b><b>nolinyl}-4-(dimethylamino)-2-butenamide (8d).</b> A 0.044 mL (0.505 mmol) portion of oxalyl chloride was added to 93 mg (0.562 mmol) of 4-(dimethylamino)-1-ylbut-2-enoic acid hydrochloride in 1.2 mL of CH<sub>3</sub>CN. This was followed by the addition of a trace amount of DMF. This solution was heated in an oil bath at 60 °C for 30 min after gas evolution began. Then the orange reaction solution was concentrated to about <sup>1</sup>/<sub>4</sub> of its volume in vacuo without the application of heat. This solution was then cooled in an ice bath, and 145 mg (0.281 mmol) of 6-amino-4-[3-chloro-4-(5-phenylthiazol-2-ylsulfanyl)phenylamino]-7-methoxyquinoline-3-carbonitrile in 1.2 mL of <i>N</i>-methylpyrrolidinone was added dropwise. Cooling and stirring were continued for 2 h, then the reaction mixture was poured into saturated aqueous NaHCO<sub>3</sub> solution. The resulting brown precipitate was collected and chromatographed on silica gel. The column was eluted with a gradient of EtOAc to 1:9:0.2 MeOH−CH<sub>2</sub>Cl<sub>2</sub>−Et<sub>3</sub>N. The product was washed with ether to give 88 mg (50%) of <b>8d</b>:  HRMS (ESI) <i>m</i>/<i>z</i> 627.138 10 (M + H)<sup>+1</sup>, Δ = −2.74 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.99 (bs, 1H), 9.72 (s, 1H), 9.09 (s, 1H), 8.75 (s, 1H), 8.15 (s, 1H), 7.78 (d, 1H, <i>J</i> = 8.5 Hz), 7.57−7.52 (m, 3H), 7.44−7.30 (m, 4H), 7.20 (dd, 1H, <i>J</i> = 8.5 Hz, <i>J</i> = 2.3 Hz), 6.83−6.62 (m, 2H), 4.07 (s, 3H), 3.07 (d, 2H, <i>J</i> = 5.5 Hz), 2.19 (s, 6H). Anal. (C<sub>32</sub>H<sub>27</sub>ClN<sub>6</sub>O<sub>2</sub>S<sub>2</sub>·3.2H<sub>2</sub>O·0.5EtOAc) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(4-Benzyloxy-3-chlorophenylamino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethyla</b><b>mino)-2-butenamide (8b).</b> The title compound was prepared using the method described above for <b>8d</b>:  pale-yellow crystals (62% yield); mp = 108−112 °C; HRMS (ESI) <i>m</i>/<i>z</i> 1111.414 43 (2M + H)<sup>+1</sup>, Δ = −0.29 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.61 (s, 1H), 9.49 (s, 1H), 8.97 (s, 1H), 8.47 (s, 1H), 7.53−7.48 (m, 2H), 7.45−7.35 (m, 5H), 7.27−7.18 (m, 2H), 6.81−6.57 (m, 2H), 5.22 (s, 2H), 4.31 (q, 2H, <i>J</i> = 5.2 Hz), 3.07 (d, 2H, <i>J</i> = 3.7 Hz), 2.18 (s, 6H), 1.47 (t, 3H, <i>J</i> = 5.2 Hz). Anal. (C<sub>31</sub>H<sub>30</sub>ClN<sub>5</sub>O<sub>3</sub>·1.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-(4-{3-Chloro-4-[(4-phenyl-1,3-thiazol-2-yl)sulfanyl]anilino}-3-cyano-7-ethoxy-6-quin</b><b>olinyl)-4-(dimethylamino)-2-butenamide (8e).</b> The title compound was prepared using the method described above for <b>8d</b>:  55% yield:  MS (ES+) <i>m</i>/<i>z</i> 641.3 (M + H)<sup>+1</sup>, 321.2 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.98 (s, 1H), 9.51 (s, 1H), 9.06 (s, 1H), 8.75 (s, 1H), 8.00 (s, 1H), 7.92 (s, 1H), 7.89 (s, 1H), 7.79 (d, 1H), 7.46 (m, 3H), 7.36 (d, 2H, <i>J</i> = 7.23 Hz), 7.18 (dd, 1H, <i>J</i> = 8.52 Hz, <i>J </i>= 2.31 Hz), 6.80 (dt, 1H, <i>J</i> = 15.33 Hz, <i>J</i> = 5.79 Hz), 6.64 (d, 1H, <i>J</i> = 15.45 Hz), 4.36 (q, 2H, <i>J</i> = 6.93 Hz), 3.09 (d, 2H, <i>J</i> = 5.55 Hz), 2.19 (s, 6H), 1.49 (t, 3H, <i>J</i> = 6.93 Hz). Anal. (C<sub>33</sub>H<sub>29</sub>ClN<sub>6</sub>O<sub>2</sub>S<sub>2</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-(4-{3-Chloro-4-[(4-phenyl-1,3-thiazol-2-yl)methyl]anilino}-3-cyano-7-methoxy-6-quin</b><b>olinyl)-4-(dimethylamino)-2-butenamide</b><b>(8f).</b> The title compound was prepared using the method described above for <b>8d</b>:  MS (ES+) <i>m</i>/<i>z</i> 609.2 (M + H)<sup>+1</sup>, 305.2 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.75 (s, 1H), 9.69 (s, 1H), 9.03 (s, 1H), 8.63 (s, 1H), 7.94 (m, 3H), 7.49 (m, 4H), 7.35 (m, 2H), 7.19 (dd, 1H, <i>J</i> = 2.2 Hz, <i>J</i> = 8.3 Hz), 6.79 (m, 1H), 6.63 (d, 1H, <i>J</i> = 15.4 Hz), 4.49 (s, 2H), 4.01 (s, 3H), 2.20 (s, 6H), 3.10 (d, 2H, <i>J</i> = 5.6 Hz). Anal. (C<sub>33</sub>H<sub>29</sub>ClN<sub>6</sub>O<sub>2</sub>S·1.25 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[(1-Benzyl-1</b><b><i>H</i></b><b>-indol-5-yl)amino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamin</b><b>o)-2-butenamide (8</b><b>g</b><b>). </b>The titile compound was prepared using the method described above for <b>8d</b>. The crude product was chromatographed on silica gel. The column was eluted with 1:49 MeOH−CH<sub>2</sub>Cl<sub>2</sub> to give 175 mg (23%) of <b>8g</b>:  mp = 209−212 °C; MS (ES+) <i>m</i>/<i>z</i> 545.0 (M + H)<sup>+1</sup>, 272.9, 273.2 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.65 (s, 1H), 9.50 (s, 1H), 8.97 (s, 1H), 8.35 (s, 1H) 7,49 (m, 3H), 7.28 (m, 4H), 7.18 (m, 2H), 7.04 (dd, 1H, <i>J</i> = 1.83 Hz, <i>J</i> = 8.67 Hz), 6.77 (dt, 1H, <i>J</i> = 5.91 Hz, <i>J</i> = 15.36 Hz), 6.54 (m, 2H), 5.45 (s, 2H), 4.29 (q, 2H, <i>J</i> = 6.9), 3.08 (d, 2H, <i>J</i> = 5.5 Hz), 2.18 (s, 6H), 1.46 (t, 3H, <i>J</i> = 6.9 Hz). Anal. (C<sub>33</sub>H<sub>32</sub>N<sub>6</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[(1-Benzyl-1</b><b><i>H</i></b><b>-indazol-5-yl)amino]-3-cyano-7-methoxy-6-quinolinyl}-4-(dimethyla</b><b>mino)-2-butenamide (8h).</b> The title compound was prepared using the method described above for <b>8d</b>:  MS (ES+) <i>m</i>/<i>z</i> 532.1 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.75 (s, 1H), 9.70 (s, 1H), 9.5 (s, 1H), 8.45 (s, 1H), 8.1 (s, 1H), 7.7 (m, 2H), 7.4 (s, 1H), 7.3 (m, 4H), 7.2 (m, 2H), 6.6 (m, 2H), 5.7 (s, 2H), 4.02 (s, 3H), 3.08 (d, 2H, <i>J</i> = 5.0 Hz), 2.18 (s, 6H), 2.2 (s, 6H). Anal. (C<sub>31</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>·1.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(4-Benzyloxy)anilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butena</b><b>mide (8i).</b> The title compound was prepared using the method described above for <b>8d</b>. The crude product was recrystallized from EtOAc−1% MeOH to produce 587 mg (54%) of beige crystals:  mp = 131−133 °C; HRMS (EI) <i>m</i>/<i>z</i> 541.1891, Δ = −1.0 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.64 (bs, 2H), 8.97 (s, 1H), 8.45 (s, 1H), 7.51−7.44 (m, 2H), 7.42−7.32 (m, 5H), 7.26−7.16 (m, 2H), 6.8−6.56 (m, 2H), 5.21 (s, 2H), 4.02 (s, 3H), 3.06 (d, 2H<i>, </i><i>J</i> = 5.4 Hz), 2.17 (s, 6H). Anal. (C<sub>30</sub>H<sub>28</sub>ClN<sub>5</sub>O<sub>3</sub>·3H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)anilino]-3-cyano-7-methoxy-6-quinolinyl}-4-(dimethylamino)-2-but</b><b>enamide (8j).</b> The title compound was prepared using the method described above for <b>8d</b>. Chromatography of the crude residue on a column, eluting with 10% MeOH−EtOAc, 15% MeOH−EtOAc, and EtOAc−MeOH−Et<sub>3</sub>N = 40:4:1 yielded a yellow solid (38% yield):  mp = 193−195 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.64 (bs, 1H), 9.56 (s, 1H), 8.95 (s, 1H), 8.41 (s, 1H), 7.49 (d, 2H, <i>J</i> = 6.8 Hz), 7.43−7.33 (m, 4H), 7.21 (d, 2H, <i>J</i> = 6.9 Hz), 7.04 (dd, 2H, <i>J</i> = 2.1 Hz, <i>J</i> = 6.8 Hz), 6.8−6.71 (m, 1H), 6.57 (d, 1H, <i>J</i> = 15.4 Hz), 5.11 (s, 2H), 4.01 (s, 3H), 3.04 (d, 2H, <i>J</i> = 7.4 Hz), 2.17 (s, 6 H); HRMS (ESI) <i>m</i>/<i>z</i> 508.234 32 (M + H)<sup>+1</sup>, Δ = −0.33 mmu. Anal. (C<sub>30</sub>H<sub>29</sub>N<sub>5</sub>O<sub>3</sub>·1.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(3-chlorobenzyloxy)phenylamino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(</b><b>dimethylamino)-2-butenamide (8l).</b> The title compound was prepared using the method described above for <b>8d.</b> The crude product was chromatographed to yield a yellow glassy solid:  HRMS (ESI) <i>m</i>/<i>z</i> 590.169 20 (M + H)<sup>+1</sup>, Δ = −2.83 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.62 (s, 1H), 9.50 (s, 1H), 8.97 (s, 1H), 8.47 (s, 1H), 7.56 (s, 1H), 7.47−7.39 (m, 5H), 7.26−7.17 (m, 2H), 6.82−6.57 (m, 2H), 5.24 (s, 2H), 4.31 (q, 2H, <i>J</i> = 5.8 Hz), 3.08 (d, 2H, <i>J</i> = 3.6 Hz), 2.18 (s, 6H), 1.47 (t, 3H, <i>J</i> = 7.0 Hz). Anal. (C<sub>31</sub>H<sub>29</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>3</sub>·2H<sub>2</sub>O·0.1EtOAc) C, H, N. </div><div class="NLM_p">(<b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(4-{[4-(Benzyloxy)benzyl]oxy}-3-chloroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(</b><b>dimethylamino)-2-butenamide (8n).</b> This compound was prepared as a light-yellow solid (61%) using the method described for <b>8d</b>:  MS (ES+) <i>m</i>/<i>z</i> 661.8 (M + H)<sup>+1</sup>, 331.5 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.60 (s,1H), 9.51 (s,1H), 8.96 (s,1H), 8.47 (s,1H), 7.48−7.33 (m, 9H), 7.27−7.18 (m, 2H), 7.05 (d, 2H, <i>J</i> = 8.7 Hz), 6.82−6.73 (m, 1H), 6.59 (d, 1H, <i>J</i> = 14.7 Hz), 5.12 (s, 4H), 4.30 (q, 2H, <i>J</i> = 6.9 Hz), 3.07 (d, 2H, <i>J</i> = 6 Hz), 2.18 (s, 6H), 1.46 (t, 3H, <i>J</i> = 6 Hz). Anal. (C<sub>38</sub>H<sub>36</sub>ClN<sub>5</sub>O<sub>4</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(2-thienylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimet</b><b>hylamino)-2-butenamide (8o).</b> This compound was prepared using the method described for <b>8d</b>. Chromatography of the crude material on a silica gel pack, eluting with 5% MeOH−CHCl<sub>3</sub>, yielded a tan foam (51% yield):  HRMS (ESI) <i>m</i>/<i>z</i> 561.160 24 (M + H)<sup>+1</sup>, Δ <a name="jm004800401125" id="jm004800401125"></a> = −0.54 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.61 (bs, 1H), 9.49 (s, 1H), 8.97 (s, 1H), 8.47 (s, 1H), 7.58 (dd, 1H, <i>J</i> = 1.1 Hz, <i>J</i> = 5 Hz), 7.37 (d, 2H, <i>J</i> = 10 Hz), 7.29 (d, 1H, <i>J</i> = 8.8 Hz), 7.24−7.17 (m, 2H), 7.06−7.04 (m, 1H), 6.81−6.74 (m, 1H), 6.59 (d, 1H, <i>J</i> = 15.4 Hz), 5.38 (s, 2H), 4.30 (q, 2H, <i>J</i> = 6.9 Hz), 3.07 (d, 2H, <i>J</i> = 5.1 Hz), 2.17 (s, 6H), 1.47 (t, 3H, <i>J</i> = 6.9 Hz). Anal. (C<sub>29</sub> H<sub>28</sub>ClN<sub>5</sub>O<sub>3</sub> S) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-(4-{3-Chloro-4-[(1</b><b><i>R</i></b><b>)-2,3-dihydro-1</b><b><i>H</i></b><b>-inden-1-yloxy]anilino}-3-cyano-7-ethoxy-6-quin</b><b>olinyl)-4-(dimethylamino)-2-butenamide (8p). </b>This compound was prepared using the method described for<b> 8d</b>: MS (ES+) <i>m</i>/<i>z</i> 581.9 (M + H)<sup>+1</sup>, 291.5 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.64 (s, 1H), 9.50 (s, 1H), 8.99 (s, 1H), 8.49 (s, 1H), 7.43−7.35 (m, 6H), 7.25 (m, 2H), 6.79 (m, 1H), 6.60 (d, 1H, <i>J</i> = 14.5 Hz), 5.92 (m, 1H), 4.31 (q, 2H, <i>J</i> = 5.2 Hz), 3.11 (m, 1H), 3.08 (d, 2H, <i>J</i> = 6 Hz), 2.86 (m, 1H), 2.54 (m, 1H), 2.18 (s, 6H), 2.09 (m, 1H), 1.47 (t, 3H, <i>J</i> = 5.2 Hz). Anal. (C<sub>33</sub>H<sub>32</sub>ClN<sub>5</sub>O<sub>3</sub>·1.2H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-(4-{3-Chloro-4-[(1</b><b><i>S</i></b><b>)-2,3-dihydro-1</b><b><i>H</i></b><b>-inden-1-yloxy]anilino}-3-cyano-7-ethoxy-6-quin</b><b>olinyl)-4-(dimethylamino)-2-butenamide (8q). </b>This compound was prepared using the method described for<b> 8d</b>: MS (ES+) <i>m</i>/<i>z</i> 581.9 (M + H)<sup>+1</sup>, 291.5 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.64 (s, 1H), 9.50 (s, 1H), 8.98 (s, 1H), 8.49 (s, 1H), 7.35 (m, 6H), 7.25 (m, 2H), 6.79 (m, 1H), 6.60 (d, 1H, <i>J</i> = 14.5 Hz), 5.92 (m, 1H), 4.31 (q, 2H, <i>J</i> = 5.2 Hz), 3.11 (m, 1H), 3.08 (d, 2H, <i>J</i> = 6.9 Hz), 2.86 (m, 1H), 2.54 (m, 1H), 2.18 (s, 6H), 2.09 (m, 1H), 1.47 (t, 3H, <i>J</i> = 5.2 Hz). Anal. (C<sub>33</sub>H<sub>32</sub>ClN<sub>5</sub>O<sub>3</sub>·1.2H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-(Benzyloxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-buten</b><b>amide (8r). </b>This compound was prepared using the method described for<b> 8d</b>: MS (ES+) <i>m</i>/<i>z</i> 522.1 (M + H)<sup>+1</sup>, 261.8 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.60 (s, 1H), 9.80 (s, 1H), 9.00 (s, 1H), 8.45 (s, 1H), 7.41(m, 6H), 7.30 (t, 1H, <i>J</i> = 4.7 Hz), 6.82 (m, 4H), 6.60 (d, 1H, <i>J</i> = 15.5 Hz), 5.10 (s, 2H), 4.34 (q, 2H, <i>J</i> = 6.8 Hz), 2.17 (s, 6H), 3.12 (d, 2H, <i>J</i> = 6.8 Hz), 1.47 (t, 3H, <i>J</i> = 6.8 Hz). Anal. (C<sub>31</sub>H<sub>31</sub>N<sub>5</sub>O<sub>3</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-(4-{4-[Benzyl(methyl)amino]-3-chloroanilino}-3-cyano-7-ethoxy-6-quinolinyl)-4-(dim</b><b>ethylamino)-2-butenamide (8s).</b> This compound was prepared using the method described for <b>8d</b>:  MS (ES+) <i>m</i>/<i>z</i> 569.1 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.35−11.19 (m, 2H), 10.0 (s, 1H), 9.17 (s, 1H), 9.05 (s, 1H), 7.67 (s, 1H), 7.60 (s, 1H), 7.35−7.25 (m, 6H), 7.18 (d, 1H, <i>J</i> = 7.8 Hz), 6.96−6.87 (m, 1H), 6.8 (d, 1H, <i>J</i> = 16.5 Hz), 4.33 (q, 2H, <i>J</i> = 7.5 Hz), 4.26 (s, 1H), 3.95 (t, 2H, <i>J</i> = 3.9 Hz), 2.74 (s, 6H), 2.65 (s, 3H), 1.50 (t, 3H, <i>J</i> = 3.9 Hz). Anal. (C<sub>32</sub>H<sub>33</sub>ClN<sub>6</sub>O<sub>2</sub>·3HCl·1.3H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(pyrrolidin-1-yl</b><b>)-2-butenamide (8t). </b>To a stirred suspension of 1.20 g (6.26 mmol) of (<i>E</i>)-4-(pyrrolidin-1-yl)but-2-enoic acid hydrochloride (<b>63</b>) in 14 mL of MeCN at 25 °C was added 0.01 mL of <i>N</i>-methyl-2-pyrrolidinone (NMP, catalyst) followed by 0.55 mL (∼6.26 mmol) of oxalyl chloride. The resulting mixture was stirred at 55 °C for 10 min, concentrated to a volume of ∼5 mL at <15 °C, and cooled at 0 °C as 7.0 mL of NMP was added. To this solution was added a solution of 1.56 g (3.5 mmol) of <b>4g</b> in 7.0 mL of NMP. The solution was warmed to 25 °C, stirred for 1 h, and treated with aqueous K<sub>2</sub>CO<sub>3</sub>. The resulting precipitate was filtered, washed with H<sub>2</sub>O, and dried. The product was purified by short column chromatography on silica gel with final elution by 25:25:2:1 CH<sub>2</sub>Cl<sub>2</sub>−EtOAc−MeOH−Et<sub>3</sub>N to give 1.63 g (80%) of amber glass:  MS (ES+) <i>m</i>/<i>z</i> 582.2, 584.2 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.62 (s, 1H), 9.52 (s, 1H), 8.96 (s, 1H), 8.47 (s, 1H), 7.51 (d, 1H, <i>J</i> = 1.6 Hz), 7.49 (s, 1H), 7.45−7.15(m, 7H), 6.83 (dt, 1H, <i>J</i> = 5.6, <i>J</i> = 15.6 Hz), 6.62 (d, 1H, <i>J</i> = 15.6 Hz), 5.22 (s, 2H), 4.31 (q, 2H, <i>J</i> = 7.0 Hz), 3.33 (d, 2H, <i>J</i> = 5.6 Hz), 2.56 (m, 4H), 1.74 (m, 4H), 1.47 (t, 3H, <i>J</i> = 7.0 Hz). Anal. (C<sub>33</sub>H<sub>32</sub>ClN<sub>5</sub>O<sub>3</sub>·0.75MeOH) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(1</b><b><i>H</i></b><b>-imidazol-4-</b><b>yl)-2-butenamide (8u).</b> This compound was prepared by the method described above for <b>8d</b> using 4-(1<i>H</i>-imidazol-4-yl)but-2-enoic acid hydrochloride (<b>67</b>):  MS (ES+) <i>m</i>/<i>z</i> 579.3 (M + H)<sup>+1</sup>, 296.2 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.06 (bs, 1H), 9.61 (s, 1H), 9.45 (s, 1H), 8.87 (s, 1H), 8.46 (s, 1H), 7.60 (s, 1H), 7.50−7.32 (m, 8H), 7.23 (m, 2H), 7.04 (s, 1H), 6.48 (d, 1H, <i>J</i> = 15.8 Hz), 5.21 (s, 2H), 4.27 (q, 2H, <i>J</i> = 5.7 Hz), 3.36 (s, 2H), 1.39 (t, 3H, <i>J</i> = 5.7). Anal. (C<sub>32</sub>H<sub>27</sub>ClN<sub>6</sub>O<sub>3</sub>·1.4H<sub>2</sub>O) C, H. N:  calcd, 13.91; found, 12.78. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-3-(8-quinolinyl)-2</b><b>-propenamide (75).</b> The acid chloride hydrochloride salt of 3-quinolin-8-ylacrylic acid<sup><a onclick="showRef(event, 'jm040159cb00033'); return false;" href="javascript:void(0);" class="ref jm040159cb00033">33</a></sup> was prepared by refluxing 1.61 g (8.09 mmol) of the acid in 20.6 mL of SOCl<sub>2</sub>. After removal of the excess reagent, the resulting solid was washed several times with dry ether. This material was then used to prepare the title compound by the method described above for <b>8d</b>:  MS (ES+) <i>m</i>/<i>z</i> 627.40 (M + H)<sup>+1</sup>, 313.7 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.67 (s, 1H), 9.66 (s, 1H), 9.09 (s, 1H), 9.00 (m, 1H), 8.49 (s, 1H), 8.44 (dd, 1H, <i>J</i> = 1.7 Hz, <i>J</i> = 8.3 Hz), 8.20 (d, 1H, <i>J</i> = 7.20 Hz), 8.08 (d, 1H, <i>J</i> = 7.2 Hz), 7.73 (t, 1H, <i>J</i> = 7.7 Hz), 7.64 (m, 1H), 7.50−7.22 (m, 11H), 5.23 (s, 2H), 4.36 (q, 2H, <i>J</i> = 5.7 Hz), 1.51 (t, 3H, <i>J</i> = 5.7 Hz). Anal. (C<sub>37</sub>H<sub>28</sub>ClN<sub>5</sub>O<sub>3</sub>·0.66H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-3-[2-(dimethylami</b><b>no)phenyl]-2-propenamide (76). </b>The acid chloride of 3-[2-(dimethylamino)phenyl]acrylic acid (<b>70</b>) was prepared using (COCl)<sub>2</sub> as described above and was utilized by the method described above for <b>8d</b> to prepare the title compound:  MS (ES+) <i>m</i>/<i>z</i> 618.0 (M + H)<sup>+1</sup>, 309.6 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.64 (s, 1H), 9.53 (s, 1H), 9.12 (s, 1H), 8.48 (s, 1H), 7.93 (d, 1H, <i>J</i> = 15.8 Hz), 7. 61 (m, 1H), 7.52−7.08 (m, 13H), 5.22 (s, 2H), 4.35 (q, 2H, <i>J</i> = 6.9 Hz), 2.69 (s, 6H), 1.50 (t, 3H, <i>J</i> = 6.9 Hz). Anal. (C<sub>36</sub>H<sub>32</sub>ClN<sub>5</sub>O<sub>3</sub>·5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-3-(1</b><b><i>H</i></b><b>-4-imidazoly</b><b>l)acrylamide (77). </b>This was prepared from 0.44 g (1.0 mmol) of 6-amino-4-[4-(benzyloxy)-3-chlorophenylamino]-7-ethoxyquinoline-3-carbonitrile (<b>4g</b>) and 3-(1<i>H</i>-imidazol-4-yl)acryloyl chloride hydrochloride as described above for <b>8d</b>. The acid chloride was prepared from 0.235 g (1.7 mmol) of the corresponding acid and 8.5 mL of SOCl<sub>2</sub> at reflux temperature followed by evaporation. The crude product was triturated with hot MeOH to give 376 mg (67%) of light-yellow solid:  mp = 196−201 °C (dec); MS (ES+) <i>m</i>/<i>z</i> 283.1, 284.1 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.3 (bs, 1H), 9.62 (bs, 1H), 9.50 (s, 1H), 9.02 (s, 1H), 8.47 (s, 1H), 7.76 (s, 1H), 7.45−7.30 (m, 10H), 7.23 (m, 1H), 7.08 (d, 1H, <i>J</i> = 15.1 Hz), 5.22 (s, 2H), 4.31 (q, 2H, <i>J</i> = 6.8 Hz), 1.49 (t, 3H, <i>J</i> = 6.8 Hz). Anal. (C<sub>31</sub>H<sub>25</sub>ClN<sub>6</sub>O<sub>3</sub>·2H<sub>2</sub>O·H<sub>2</sub>CO<sub>3</sub>) C, H, N. </div><div class="NLM_p"><b>Synthesis Using Method 2.</b><b>2-Acetamido-5-nitrophenol (10).</b> To a stirred suspension of 400 g (2.6 mol) of 2-amino-5-nitrophenol (<b>9</b>) in 1.6 L of HOAc at 60 °C was added 368 mL (3.9 mol) of Ac<sub>2</sub>O over 1.5 h. The reaction mixture was stirred at 60 °C for 2 h. More Ac<sub>2</sub>O was added until less than 1% of 2-amino-5-nitrophenol (<b>9</b>) was present, as determined by HPLC. An amount of 2 L of H<sub>2</sub>O was added to the reaction mixture after it was cooled to 25 °C. The suspension was stirred in H<sub>2</sub>O for 1 h, filtered, washed with 2 × 640 mL of H<sub>2</sub>O, washed with 2 × 640 mL of heptane, and dried in an oven to yield 486.7 g (96%) product (<b>10</b>):  mp > 205 °C. </div><div class="NLM_p"><b>4-Acetamido-3-ethoxynitrobenzene (11).</b> To a stirred suspension of 400 g (2.04 mol) of 2-acetamido-5-nitrophenol (<b>10</b>) and 790 g (5.72 mol) of K<sub>2</sub>CO<sub>3</sub> in 2.0 L of DMF at 60−62 °C was added 294 g (2.70 mol) of EtBr over 1 h. The reaction mixture was stirred at 60 °C for 2 h. More EtBr was added until less than 1% of 2- acetamido-5-nitrophenol (<b>10</b>) was present, as determined by TLC. An amount of 4 L of H<sub>2</sub>O was added to the reaction mixture after it was cooled to 25 °C. The suspension was stirred in H<sub>2</sub>O for 30 min, filtered, washed with 4 × 1 L of warm (50 °C) H<sub>2</sub>O (maintain pH < 8) and 1 L of heptane, and dried at 60−65 °C in an oven to yield 447.8 g (98%) of product <b>11</b>:  mp = 164−165 °C. </div><div class="NLM_p"><b>3-(4-Acetamido-3-ethoxyaniline)-2-cyanopropenoic Acid Ethyl Ester (14). </b>An amount of 410 g (1.83 mol) of 4-acetamido-3-ethoxynitrobenzene (<b>11</b>) in 4.2 L THF was reduced to 3-(4-acetamido-3-ethoxyaniline)-2-cyanopropenoic acid ethyl ester under hydrogenation (at 28−30 °C, 50 psi) with 35 g of <a name="jm004800401126" id="jm004800401126"></a> 10% Pd−C for 3 h. The reaction mixture was filtered through a 0.2 μm cartridge and rinsed with THF. The filtrate was concentrated to give the aniline, which was stirred in 1.3 L of toluene containing 50 g of anhydrous Na<sub>2</sub>SO<sub>4</sub> at 25 °C for 20 min. The suspension was filtered, and the cake was washed with 200 mL of toluene. To the filtrate containing <b>12</b> in 1.5 L of toluene was added 475 g (2.8 mol) of ethyl (ethoxymethylene)cyanoacetate <b>13</b> and 3.5 L of toluene. The suspension was stirred and refluxed at 90 °C for 16 h. The reaction mixture was cooled to room temperature over 1 h and stirred at room temperature for 30 min. The light-yellow solid was filtered, washed with toluene (2 × 400 mL), and dried in a vacuum oven at 60−65 °C for 24 h to give 524 g (90.3%) of <b>14</b> as a mixture of <i>E</i> and <i>Z</i> isomers. </div><div class="NLM_p"><b>3-Cyano-7-ethoxy-4-hydroxy-6-</b><b><i>N</i></b><b>-acetylquinoline (15).</b> An amount of 210 g (0.664 mol) of <b>14 </b>was stirred in 12 L of Dowtherm A at 250−255 °C for 20 h. After the mixture was cooled to room temperature, the solid was filtered and washed with toluene (4 × 210 mL). The solid crude material was stirred in THF at reflux temperature (66 °C) for 30 min and cooled. The dark-brown solid was filtered, washed with THF (4 × 100 mL), and dried in a 60−65 °C vacuum oven to yield 75.3 g (42%) of <b>15</b>:  mp > 250 °C. </div><div class="NLM_p"><b>4-Chloro-3-cyano-7-ethoxy-6-</b><b><i>N</i></b><b>-acetylquinoline (16). </b>To a dark-brown suspension of 80.0 g (0.296 mol) of <b>15</b> in 1.6 L of diethylene glycol dimethyl ether was added 96.0 mL (1.04 mol) of phosphorus oxychloride in one portion. The reaction mixture was stirred at 100−102 °C for 45 min. The reaction mixture was cooled to 80−85 °C, and 25 g of Celite was added. The reaction mixture was filtered through a Celite pad with 3 × 100 mL and 1 × 50 mL of diethylene glycol dimethyl ether. The filtrate was concentrated to a volume of 875 mL and stirred in an aqueous solution of 75.0 g (0.543 mol) of K<sub>2</sub>CO<sub>3</sub> (maintaining temperature less than 50 °C). The yellow solid was filtered, washed with 3 × 100 g of warm H<sub>2</sub>O and 200 mL of toluene, then dried at 60−65 °C in an oven to yield 55.45 g (65%) of <b>16</b>:  mp = 250 °C. </div><div class="NLM_p"><b><i>N</i></b><b>-{4-[3-Chloro-4-(1-methyl-1</b><b><i>H</i></b><b>-imidazol-2-ylmethoxy)phenylamino]-3-cyano-7-ethoxyquin</b><b>olin-6-yl}acetamide Hydrochloride (18a).</b> A mixture of 6.10 g (0.0211 mol) of <i>N</i>-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide (<b>16</b>), 4.55 g (0.0191 mol) of 3-chloro-4-(1-methyl-1<i>H</i>-imidazol-2-ylmethoxy)phenylamine (<b>17a</b>), and 2.21 g (0.0191 mol) of pyridine hydrochloride in 50 mL of <i>i</i>-PrOH was refluxed for 16 h. The solid was filtered and washed with H<sub>2</sub>O and ether to give 2.86 g of <b>18a</b>:  mp = 251−252 °C; MS (ES+) <i>m</i>/<i>z</i> 491.1 (M + H)<sup>+1</sup>. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-(1-Benzenesulfonyl-1</b><b><i>H</i></b><b>-indol-5-ylamino)-3-cyano-7-ethoxyquinolin-6-yl]acetamide </b><b>(18c). </b>A solution of 3.29 g (0.0113 mol) of <i>N</i>-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide (<b>16</b>), 3.09 g (0.0113 mol) of 1-benzenesulfonyl-1<i>H</i>-indol-5-ylamine (<b>17c)</b>,<sup><a onclick="showRef(event, 'jm040159cb00034'); return false;" href="javascript:void(0);" class="ref jm040159cb00034">34</a></sup> and 1.31 g (0.0113 mol) of pyridine hydrochloride in 50 mL of 2-methoxyethanol was refluxed for 2 h. The reaction mixture was poured into H<sub>2</sub>O. The resulting mixture was extracted with 3 × 250 mL portions of EtOAc. The combined extracts were concentrated in vacuo until a solid formed. This was filtered to give 3.04 g (51%) of the product (<b>18c</b>):  mp = 255−257 °C; MS (ES+) <i>m</i>/<i>z</i> 526.0 (M + H)<sup>+1</sup>. </div><div class="NLM_p"><b>6-Amino-4-[3-chloro-4-(1-methyl-1</b><b><i>H</i></b><b>-imidazol-2-ylmethoxy)phenylamino]-7-ethoxyquinoli</b><b>ne-3-carbonitrile (19a).</b> A mixture of 3.27 g of <i>N</i>-{4-[3-chloro-4-(1-methyl-1<i>H</i>-imidazol-2-ylmethoxy)phenylamino]-3-cyano-7-ethoxyquinolin-6-yl}acetamide hydrochloride (<b>18a</b>) in 10 mL of H<sub>2</sub>O and 20 mL of 12 N HCl was stirred and heated in a oil bath for 2 h. The solvents were evaporated in vacuo<i>,</i> and the solid was treated with 50 mL of saturated aqueous NaHCO<sub>3</sub>, and then filtered. This solid was taken up in EtOAc and passed through Magnesol. This filtrate was evaporated to a solid in vacuo and digested with EtOAc to give 1.77 g (59%) of product (<b>19a</b>):  mp = 222−225 °C; MS (ES+) <i>m</i>/<i>z</i> 449.0 (M + H)<sup>+1</sup>. </div><div class="NLM_p"><b>6-Amino-4-(1-benzenesulfonyl-1</b><b><i>H</i></b><b>-indol-5-ylamino)-7-ethoxyquinoline-3-carbonitrile (19c). </b>A mixture of 2.82 g (5.27 mmol) of <i>N</i>-[4-(1-benzenesulfonyl-1<i>H</i>-indol-5-ylamino)-3-cyano-7-ethoxyquinolin-6-yl]acetamide (<b>18c</b>) in 20 mL of 12 N HCl and 10 mL of H<sub>2</sub>O was stirred and heated in an oil bath at 133 °C for 1 h. When the mixture was cooled, a solid formed. This was filtered and stirred with 100 mL of saturated aqueous NaHCO<sub>3</sub>. The solid was filtered to give 2.45 g (94%) of the product (<b>19c</b>):  mp = 263−267 °C; MS (ES+) <i>m</i>/<i>z</i> 641.3 (M + H)<sup>+1</sup>. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-(4-{3-Chloro-4-[(1-methyl-1</b><b><i>H</i></b><b>-imidazol-2-yl)methoxy]anilino}-3-cyano-7-ethoxy-6-qu</b><b>inolinyl)-4-(dimethylamino)-2-butenamide (21a). </b>The title compound was prepared from 1.18 g (7.13 mmol) of 4-(dimethylamino)-1-yl-but-2-enoic acid, 0.56 mL (820 mg, 6.46 mmol) of oxalyl chloride, and 1.6 g (3.56 mmol) of 6-amino-4-[3-chloro-4-(1-methyl-1<i>H</i>-imidazol-2-ylmethoxy)phenylamino]-7-ethoxyquinoline-3-carbonitrile (<b>19a</b>) using the method described above for <b>8d</b> to yield 1.031 g (52%) of <b>21a</b> as a yellow solid:  mp = 203−206 °C; MS (ES+) <i>m</i>/<i>z</i> 560.1 (M + H)<sup>+1</sup>, 281.3 (M + H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.61 (s, 1H,), 9.49 (s, 1H), 8.97 (s, 1H), 8.48 (s, 1H), 7.37 (m, 3H), 7.21 (m, 2H), 6.89 (s, 1H), 6.78 (dt, 1H, <i>J</i> = 15.4 Hz, <i>J</i> = 5.9 Hz), 6.38 (d, 1H, <i>J</i> = 15.4 Hz), 5.24 (s, 2H), 4.31 (q, 2H, <i>J</i> = 6.96 Hz), 3.73 (s, 3H), 3.08 (d, 2H, <i>J</i> = 5.58 Hz), 2.18 (s, 6H), 1.47 (t, 3H, <i>J</i> = 6.96 Hz). Anal. (C<sub>29</sub>H<sub>30</sub>ClN<sub>7</sub>O<sub>3</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(2</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[(1-Benzyl-2,3-dihydro-1</b><b><i>H</i></b><b>-indol-5-yl)amino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(</b><b>dimethylamino)-2-butenamide (21b). </b>The title compound was prepared from 662 mg (4.25 mmol) of 4-(dimethylamino)-1-yl-but-2-enoic acid, 0.35 mL (508 mg, 4.0 mmol) of oxalyl chloride, and 871 mg (2.83 mmol) of 6-amino-4-(1-benzyl-2,3-dihydro-1<i>H</i>-indol-5-ylamino)-7-ethoxyquinoline-3-carbonitrile (<b>19b</b>) using the method described above for <b>8d</b> to yield 585 mg (53%) of a tan solid (<b>21b</b>):  mp = 199−201 °C; MS (ES+) <i>m</i>/<i>z</i> 546.9 (M + H)<sup>+1</sup>, 274.0 (M + 2H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.49 (s, 1Η), 9.46 (s, 1Η), 9.19 (s, 1H), 9.46 (s, 1H), 8.91 (s, 1H), 8.35 (s, 1H), 7.32 (m, 7H), 6.97 (s, 1H), 6.92 (dd, 1H, <i>J</i> = 8.28 Hz, <i>J</i> = 1.88 Hz), 6.77 (dt, 1H, <i>J</i> = 5.96 Hz, <i>J</i> = 15.36 Hz), 6.58 (m, 2H), 4.48, (s, 1H), 4.28 (q, 2H, <i>J</i> = 7.04 Hz), 3.29, (t, 2H, <i>J</i> = 6.04 Hz), 2.92 (t, 2H, <i>J</i> = 8.20 Hz) 2.18 (s, 6H), 1.46 (t, 3H, <i>J</i> = 6.92 Hz). Anal. (C<sub>33</sub>H<sub>34</sub>N<sub>6</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-(3-Cyano-7-ethoxy-4-{[1-(phenylsulfonyl)-1</b><b><i>H</i></b><b>-indol-5-yl]amino}-6-quinolinyl)-4-(dim</b><b>ethylamino)-2-butenamide (21c). </b>The title compound was prepared from 662 mg (4 mmol) of 4-(dimethylamino)-1-yl-but-2-enoic acid, 0.31 mL (457 mg, 3.6 mmol) of oxalyl chloride, and 1.971 g (2 mmol) of 6-amino-4-(1-benzenesulfonyl-1<i>H</i>-indol-5-ylamino)-7-ethoxyquinoline-3-carbonitrile (<b>19c</b>) using the method described above for <b>8d </b>to yield 517 mg (43%) of a tan solid (<b>21c</b>):  mp = 243−245 °C; MS (ES+) <i>m</i>/<i>z</i> 595.0 (M + H)<sup>+1</sup>, 298.2 (M + H)<sup>+2</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.69 (s, 1H), 9.48 (s, 1H), 8.98 (s, 1H), 8.45 (s, 1H), 7.95 (m, 3H), 7.76 (d, 1H, <i>J</i> = 3.66 Hz), 7.69 (m, 1H), 7.58 (m, 2H), 7.45 (d, 1H, <i>J</i> = 1.92 Hz), 7.39 (s, 1H), 7.27 (dd, 1H, <i>J</i> = 8.85 Hz, <i>J</i> = 2.04 Hz), 6.84 (d, 1H, <i>J</i> = 3.66 Hz), 6.75 (dt, 1H, <i>J</i> = 15.39 Hz, <i>J</i> = 5.88 Hz), 6.29 (m, 1H), 4.31 (q, 2H, <i>J</i> = 6.84 Hz), 3.07, d, 2H, <i>J</i> = 5.61 Hz), 2.17 (s, 6H), 1.47 (t, 3H, <i>J</i> = 6.93 Hz). Anal. (C<sub>32</sub>H<sub>30</sub>N<sub>6</sub>O<sub>4</sub>S·0.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(2-chlorobenzyloxy)-phenylamino]-3-cyano-7-ethoxy-6-quinolinyl}-4-</b><b>(dimethylamino)-2-butenamide (21d).</b> A 958 mg (2 mmol) sample of <b>19d</b> was reacted with 4-(dimethylamino)-but-2-enoic acid chloride (<b>20</b>) as described above for <b>8d</b> to yield 780 mg (66%) of product as a yellow glass after silica gel chromatography:  HRMS (ESI) <i>m</i>/<i>z</i> 590.171 17 (M + H)<sup>+1</sup>, Δ = −0.86 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.62 (s, 1H), 9.49 (s, 1H), 8.97 (s, 1H), 8.48 (s, 1H), 7.68−7.65 (m, 1H), 7.55−7.53 (m, 1H), 7.44−7.38 (m, 4H), 7.30−7.27 (m, 1H), 7.22 (dd, 1H, <i>J</i> = 6.6, 1.9 Hz), 6.81−6.74 (m, 1H), 6.61−6.57 (m, 1H), 5.27 (s, 2H), 4.31 (q, 2H, <i>J</i> = 5.2 Hz), 3.07 (d, 2H, <i>J</i> = 3.8 Hz), 2.18 (s, 6H), 1.47 (t, 3H, <i>J</i> = 5.2 Hz). Anal. (C<sub>31</sub>H<sub>29</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>3</sub>·1H<sub>2</sub>O) C, H, N, Cl. </div><div class="NLM_p"><b>Synthesis Using Method 3.</b><b>4-Chloro-6-(5</b><b>-(dimethylamino)-</b><b>2-oxopent-3-enyl)-7-ethoxyquinoline-3-carbonitrile (23).</b> A solution of 4-dimethylaminocrotonyl chloride freshly prepared from 9 g (54.3 mmol) of 4-dimethylaminocrotonic acid hydrochloride was slurried in 20 mL of acetonitrile, and 6.69 g (27 mmol) of 6-amino-4-chloro-7-ethoxyquinoline-3-carbonitrile (<b>22</b>) as a slurry in 150 mL of 1-methyl-2-pyrrolidinone was added under nitrogen. This was cooled in <a name="jm004800401127" id="jm004800401127"></a> an ice bath and stirred for 2.5 h. The solution was poured into 1.3 L of a 1:1 mixture of saturated KHCO<sub>3</sub> and water and was stirred for 20 min, and the precipitate was filtered off, washed with water, and dried. Crystallization from acetonitrile yielded 7.97 g (82%) of brown solid in two crops, ESMS <i>m</i>/<i>z</i> 358.8 (M + H)<sup>+1</sup>. The product was used without further purification. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-(4-{Chloro-4-[(4-fluorobenzyl)oxy]anilino}-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimeth</b><b>ylamino)-2-buteneamide (25</b><b>g</b><b>). </b>A mixture of 0.350 g (0.975 mmol) of (<i>E</i>)-<i>N</i>-(4-chloro-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide (<b>23</b>), 0.295 g (1.17 mmol) of 3-chloro-4-(4-fluorobenzyloxy)aniline, and 0.226 g (1.95 mmol) of pyridine hydrochloride in 20 mL of <i>i-</i>PrOH was refluxed under N<sub>2</sub> for 10.5 h. The cooled reaction mixture was poured into 100 mL of H<sub>2</sub>O and basified with K<sub>2</sub>CO<sub>3</sub>. Addition of EtOAc caused the gummy mixture to solidify, and this material was collected, washed with EtOAc, and dried. A 0.545 g sample of crude product was purified by flash chromatography (silica, 8% MeOH in CHCl<sub>3</sub>) to give 0.510 g (53%) of yellow-orange foam:  HRMS (ESI) <i>m</i>/<i>z</i> 574.199 63 (M + H)<sup>+1</sup>, Δ = −0.69 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.61 (s, 1H), 9.49 (s, 1H), 8.97 (s, 1H), 8.47 (s, 1H), 7.54 (m, 2H), 7.37 (s, 2H), 7.25 (m, 4H), 6.78 (m, 1H), 6.59 (m, 1H), 5.20 (s, 2H), 4.30 (q, 2H, <i>J</i> = 6.96 Hz), 3.07 (d, 2H, <i>J</i> = 5.52 Hz), 2.18 (s, 6H), 1.47 (t, 3H, <i>J</i> = 6.96 Hz). Anal. (C<sub>31</sub>H<sub>29</sub>ClFN<sub>5</sub>O<sub>3</sub>·0.4H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(3-Chloro-4-phenoxyanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2</b><b>-butenamid (25a).</b> This compound was prepared as a yellow solid (0.57 g, 75%) by method 3 described for the preparation of <b>25g </b>using <b>23 </b>and 0.366 g (3.62 mmol) of 3-chloro-4-phenoxyphenylamine:  HRMS (ES+) <i>m</i>/<i>z</i> 542.195 57 (M + H)<sup>+1</sup>, Δ = 0.22 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.78 (s, 1H), 9.51 (s, 1H), 9.02 (s, 1H), 8.55 (s, 1H), 7.46 (s, 1H), 7.42 (s, 1H), 7.35 (t, 2H, <i>J</i> = 6.3 Hz), 7.24 (d, 1H, <i>J</i> = 3.3 Hz), 7.18 (d, 1H, <i>J</i> = 6.6 Hz), 7.09 (t, 1H, <i>J</i> = 6.6 Hz), 6.96 (d, 2H, <i>J</i> = 6.6 Hz), 6.82−6.76 (m, 1H), 6.62 (d, 1H, <i>J</i> = 9.9 Hz), 4.32 (q, 2H, <i>J</i> = 6.6 Hz), 3.08 (d, 2H, <i>J</i> = 3 Hz), 2.17 (s, 6H), 1.47 (t, 3H, <i>J</i> = 3 Hz). Anal. (C<sub>30</sub>H<sub>28</sub>ClN<sub>5</sub>O<sub>3</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-buten</b><b>amide (25b). </b>The product was prepared by method 3 described for the preparation of <b>25g</b> using 0.36 g (1.0 mmol) of <b>23</b>, 0.28 g (1.2 mmol) of 4-benzyloxyaniline hydrochloride, 92 mg (0.8 mmol) of pyridine hydrochloride, and 3.0 mL of methoxyethanol at reflux for 30 min. The product was purified by short column chromatography on silica gel with 25:25:2:1 CH<sub>2</sub>Cl<sub>2</sub>−EtOAc−MeOH−Et<sub>3</sub>N to give 487 mg (94%) of amber glass:  MS (ES+) <i>m</i>/<i>z</i> 521.9 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.56 (s, 1H), 9.49 (s, 1H), 8.96 (s, 1H), 8.41 (s, 1H), 7.48 (m, 2H), 7.38 (m, 3H,), 7.22 (d, 2H, <i>J</i> = 6.9 Hz), 7.05 (d, 2H, <i>J</i> = 6.9 Hz), 6.77 (dt, 1H, <i>J</i> = 5.3, <i>J</i> = 15.4 Hz), 6.58 (d, <i>J</i> = 15.4 Hz), 5.12 (s, 2H), 4.29 (q, 2H, <i>J</i> = 6.9 Hz), 3.08 (d, 2H, <i>J</i> = 5.3 Hz), 2.18 (s, 6H), 1.46 (t, 3H, <i>J</i> = 6.9 Hz). Anal. (C<sub>31</sub>H<sub>31</sub>N<sub>5</sub>O<sub>3</sub>·MeOH) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(2-phenylethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethyl</b><b>amino)-2-butenamide (25c).</b><b>25c</b> was prepared from a mixture of 0.250 g (0.696 mmol) of <b>23</b>, 0.207 g (0.835 mmol) of 3-chloro-4-phenylethoxyaniline, and 0.161 g (1.39 mmol) of pyridine hydrochloride in 12 mL of <i>i</i>-PrOH using the same procedure described for <b>25g</b>. A 1.00 g sample of crude product was purified by flash chromatography (silica gel, 8% MeOH in CHCl<sub>3</sub>) to give 0.700 g (74%) of tan foam:  <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.59 (s, 1H), 9.48 (s, 1H), 8.97 (s, 1H), 8.45 (s, 1H), 7.28 (m, 10H), 6.78 (m, 1H), 6.58 (m, 1H), 4.28 (m, 4H), 3.09 (m, 4H), 2.17 (s, 6H), 1.47 (t, 3H, <i>J</i> = 6.96 Hz); HRMS (ESI) <i>m</i>/<i>z</i> 570.226 63 (M + H)<sup>+1</sup>, Δ = −0.17 mmu. Anal. (C<sub>32</sub>H<sub>32</sub>ClN<sub>5</sub>O<sub>3</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(4-Benzyloxy-3,5-dichlorophenylamino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimeth</b><b>ylamino)-butenamide (25d).</b> As described in the preparation of <b>25g</b>, 448 mg (1.25 mmol) of <b>23</b> and 402 mg (1.5 mmol) of 4-benzyloxy-3,5-dichloroaniline in 35 mL of <i>i</i>-PrOH were reacted to yield 203 mg (27%) of beige crystals in two crops from CH<sub>3</sub>CN:  mp = 106−109 °C; HRMS (ESI) <i>m</i>/<i>z</i> 590.171 37 (M + H)<sup>+1</sup>, Δ = −0.66 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.74 (bs, 1H), 9.50 (s, 1H), 9.00 (s, 1H), 8.62 (s, 1H), 7.55−7.52 (m, 2H), 7.48−7.33 (m, 6H), 6.81−6.60 (m, 2H), 5.01 (s, 2H), 4.33 (q, 2H, <i>J</i> = 5.2 Hz), 3.08 (d, 2H, <i>J</i> = 5.1 Hz), 2.17 (s, 6H), 1.48 (t, 3H, <i>J</i> = 5.2 Hz). Anal. (C<sub>31</sub>H<sub>29</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>3</sub>·0.5H<sub>2</sub>O·0.25EtOAc) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-cyanoanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)</b><b>-2-butenamide (25e).</b> The title compound was prepared from a mixture of 0.500 g (1.39 mmol) of <b>23</b>, 0.374 g (1.67 mmol) of 5-amino-2-(benzyloxy)benzonitrile, and 0.322 g (2.78 mmol) of pyridine hydrochloride in 35 mL of <i>i</i>-PrOH using the same procedure as described for <b>25g</b>. A 680 mg sample of crude product was purified by flash chromatography (silica gel, 7% MeOH in CHCl<sub>3</sub>) to give 0.560 g (74%) of off-white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.68 (s, 1H), 9.51 (s, 1H), 8.97 (s, 1H), 8.49 (s, 1H), 7.69 (m, 1H), 7.46 (m, 8H), 6.77 (m, 1H), 6.59 (m, 1H), 5.31 (s, 2H), 4.30 (q, 2H, <i>J</i> = 6.9 Hz), 3.07 (d, 2H, <i>J</i> = 5.55 Hz), 2.18 (s, 6H), 1.48 (t, 3H, <i>J</i> = 6.9 Hz); HRMS (ESI) <i>m</i>/<i>z</i> 547.244 18 (M + H)<sup>+1</sup>, Δ = −1.04 mmu. Anal. (C<sub>32</sub>H<sub>30</sub>N<sub>6</sub>O<sub>3</sub>·1.4H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(2-fluorobenzyloxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimeth</b><b>ylamino)-2-butenamide (25f).</b> The title compound was prepared from a mixture of 0.500 g (1.39 mmol) of <b>23</b>, 0.421 g (1.67 mmol) of 3-chloro-4-[(2-fluorobenzyl)oxy]aniline, and 0.322 g (2.78 mmol) of pyridine hydrochloride in 45 mL of <i>i</i>-PrOH using the same procedure described for <b>25g</b>. A 0.740 g sample of crude product was purified by flash chromatography (silica gel, 7% MeOH in CHCl<sub>3</sub>) to give 0.590 g (74%) of yellow solid; HRMS (ESI) <i>m</i>/<i>z</i> 574.20070 (M + H)<sup>+1</sup>, Δ = − 0.88 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.62 (s, 1H), 9.50 (s, 1H), 8.97 (s, 1H), 8.48 (s, 1H), 7.61 (m, 1H), 7.38 (m, 2H), 7.35 (m, 2H), 7.25 (m, 4H), 6.78 (m, 1H), 6.58 (m, 1H), 5.25 (s, 2H), 4.33 (m, 2H), 3.17 (d, 2H, <i>J</i> = 3.96 Hz), 3.07 (d, 2H, <i>J</i> = 3.84 Hz), 2.18 (s, 6H), 1.47 (t, 3H, <i>J</i> = 5.19 Hz). Anal. (C<sub>31</sub>H<sub>29</sub>ClFN<sub>5</sub>O<sub>3</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3,5-Dichloro-4-(3-fluorobenzyloxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(di</b><b>methylamino)-2-butenamide (25h).</b> A 720 mg (2 mmol) sample of <b>23</b> was reacted with 647 mg (2.4 mmol) of 3,5-dichloro-4-[(3-fluorobenzyl)oxy]aniline as described above for <b>25g</b> to yield 457 mg (38%) of beige crystals in two crops from CH<sub>3</sub>CN:  mp = 128−131 °C; HRMS (ESI) <i>m</i>/<i>z</i> 608.162 27 (M + H)<sup>+1</sup>, Δ = −0.33 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.75 (s, 1H), 9.50 (s, 1H), 8.99 (s, 1H), 8.62 (s, 1H), 7.50−7.41 (m, 2H), 7.38−7.31 (m, 4H), 7.25−7.19 (m, 1H), 6.81−6.74 (m, 1H), 6.64−6.59 (m, 1H), 5.04 (s, 2H), 4.33 (q, 2H, <i>J</i> = 5.1 Hz), 3.08 (bs, 2H), 2.17 (s, 6H), 1.48 (t, 3H, <i>J</i> = 5.1 Hz). Anal. (C<sub>31</sub>H<sub>28</sub>Cl<sub>2</sub>FN<sub>5</sub>O<sub>3</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(3,5-difluorobenzyloxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(di</b><b>methylamino)-2-butenamide (25i).</b> As described in the preparation of <b>25g</b>, 720 mg (2 mmol) of <b>23</b> and 644 mg (2.4 mmol) of 3-chloro-4-(3,5-difluorobenzyloxy)aniline were reacted to yield 432 mg (37%) of golden brown crystals from CH<sub>3</sub>CN:  mp = 101−104 °C; HRMS (CI) <i>m</i>/<i>z</i> 592.1913 (M + H)<sup>+1</sup>, Δ = 1.4 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.73 (s, 1H), 9.63 (s, 1H), 8.97 (s, 1H), 8.48 (s, 1H), 7.39−7.37 (m, 2H), 7.25−7.20 (m, 5H), 6.81−6.58 (m, 2H), 5.27 (s, 2H), 4.31 (q, 2H, <i>J</i> = 5.2 Hz), 3.08 (d, 2H, <i>J</i> = 3.9 Hz), 2.18 (s, 6H), 1.47 (t, 3H, <i>J</i> = 5.2 Hz). Anal. (C<sub>31</sub>H<sub>28</sub>ClF<sub>2</sub>N<sub>5</sub>O<sub>3</sub>·1.12H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(3-cyanobenzyloxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimeth</b><b>ylamino)-2-butenamide (25k).</b> The title compound was prepared from a mixture of 0.500 g (1.39 mmol) of <b>23</b>, 0.431 g (1.67 mmol) of 3-[(4-amino-2-chlorophenoxy)methyl]benzonitrile, and 0.322 g (2.78 mmol) of pyridine hydrochloride in 36 mL of <i>i</i>-PrOH using the same procedure described for <b>25g</b>. A 0.740 g sample of crude product was purified by flash chromatography (silica gel, 7% MeOH in CHCl<sub>3</sub>) to give 0.600 g (74%) of yellow solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.63 (s, 1H), 9.06 (s, 1H), 8.97 (s, 1H), 8.47 (s, 1H), 7.94 (s, 1H), 7.83 (m, 2H), 7.65 (m, 2H), 7.39 (s, 2H), 7.23 (m, 2H), 6.77 (m, 1H), 6.59 (m, 1H), 5.29 (s, 2H), 4.30 (q, 2H, <i>J</i> = 5.16 Hz), 3.07 (d, 2H, <i>J</i> = 3.9 Hz), 2.17 (s, <i>J</i><a name="jm004800401128" id="jm004800401128"></a> = 6 Hz), 1.47 (t, 3H, <i>J</i> = 5.16 Hz); HRMS (ESI) <i>m</i>/<i>z</i> 291.106 65 (M + 2H)<sup>+2</sup>, Δ = 0.68 mmu. Anal. (C<sub>32</sub>H<sub>29</sub>ClN<sub>6</sub>O<sub>3</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(3-methylbenzyloxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimet</b><b>hylamino)-2-butenamide (25m).</b> The title compound was prepared from a mixture of 0.500 g (1.39 mmol) of <b>23</b>, 0.414 g (1.67 mmol) of 3-chloro-4-(3-methylbenzyloxy)aniline, and 0.322 g (2.78 mmol) of pyridine hydrochloride in 25 mL of <i>i</i>-PrOH using the same procedure as for <b>25g</b>. A 0.700 g sample of crude product was purified by flash chromatography (silica, 5% MeOH in CHCl<sub>3</sub>) to give 430 mg (54%) of tan foam:  HRMS (ESI) <i>m</i>/<i>z</i> 570.225 10 (M + H)<sup>+1</sup>, Δ = −0.27 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.61 (s, 1H), 9.49 (s, 1H), 8.97 (s, 1H), 8.47 (s, 1H), 7.29 (m, 7H), 6.78 (m, 1H), 6.59 (M, 1H), 5.17 (s, 2H), 4.30 (q, 2H, <i>J </i>= 5.19 Hz), 3.07 (d, 2H, <i>J</i> = 3.99 Hz), 2.33 (s, 3H), 2.18 (s, 6H), 1.47 (t, 3H, <i>J</i> = 5.19 Hz). Anal. (C<sub>32</sub>H<sub>32</sub>ClN<sub>5</sub>O<sub>3</sub>·0.6H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(cyclohexylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimet</b><b>hylamino)-2-butenamide (25n).</b> The title compound was prepared from a mixture of 0.650 g (1.81 mmol) of <b>23</b>, 0.521 g (2.17 mmol) of 3-chloro-4-(cyclohexylmethoxy)aniline, and 0.420 g (3.62 mmol) of pyridine hydrochloride in 30 mL of <i>i</i>-PrOH using the same procedure as described for <b>25g</b>. A 1.00 g sample of crude product was purified by flash chromatography (silica gel, 7% MeOH in CHCl<sub>3</sub>) to give 0.860 g (84%) of yellow foam:  HRMS (ESI) <i>m</i>/<i>z</i> 281.632 08 (M + 2H)<sup>+2</sup>, Δ = −0.38 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub><i>) </i>δ 9.59 (s, 1H), 9.49 (s, 1H), 8.96 (s, 1H), 8.46 (s, 1H), 7.38 (s, 1H), 7.33 (d, 1H, <i>J</i> = 1.86 Hz), 7.17 (m, 2H), 6.78 (m, 1H), 5.59 (m, 1H), 4.33 (q, 2H, <i>J</i> = 3.84 Hz), 3.87 (d, 2H, <i>J</i> = 4.62 Hz), 3.07 (d, 2H, <i>J</i> = 3.87 Hz), 2.18 (s, 6H), 1.80 (m, 6H), 1.47 (t, 3H, <i>J</i> = 5.22 Hz), 1.16 (m, 5H). Anal. (C<sub>31</sub>H<sub>36</sub>ClN<sub>5</sub>O<sub>3</sub>·0.25H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dime</b><b>thylamino)-2-butenamide (25o).</b> This compound was prepared as a yellow solid (0.86 g, 85%) by the method described for <b>25g</b> using 0.65 g (1.81 mmol) of <b>23</b> and 0.42 g (3.62 mmol) of 3-chloro-4-(2-pyridinylmethoxy)aniline:  HRMS (ES+) <i>m</i>/<i>z</i> 557.205 89 (M + H)<sup>+1</sup>, Δ = −0.36 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.62 (s, 1H), 9.49 (s, 1H), 8.96 (s, 1H), 8.60 (d, 1H, <i>J</i> = 3.9 Hz), 8.47 (s, 1H), 7.88 (t, 1H, <i>J</i> = 3.9 Hz), 7.58 (d, 1H, <i>J</i> = 3.9 Hz), 7.39−7.35 (m, 3H), 7.26 (d, 1H, <i>J</i> = 7.8 Hz), 7.19 (d, 1H, <i>J</i> = 8.1 Hz), 6.81−6.73 (m, 1H), 6.59 (d, 1H, <i>J</i> = 7.8 Hz), 5.28 (s, 2H), 4.30 (q, 2H, <i>J</i> = 6.9 Hz), 3.07 (d, 2H, <i>J</i> = 3.9 Hz), 2.17 (s, 6H), 1.46 (t, 3H, <i>J</i> = 3.9 Hz). Anal. (C<sub>30</sub>H<sub>29</sub>ClN<sub>6</sub>O<sub>3</sub>·1.1H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(2-furylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethyl</b><b>amino)-2-butenamide (25q).</b> The title compound was prepared from a mixture of 0.500 g (1.39 mmol) of <b>23</b>, 0.374 g (1.67 mmol) of 3-chloro-4-(2-furylmethoxy)aniline, and 0.322 g (2.78 mmol) of pyridine hydrochloride in 25 mL of <i>i</i>-PrOH using the same procedure as for <b>25g</b>. A 0.600 g sample of the crude product was purified by flash chromatography (silica gel, 5% MeOH in CHCl<sub>3</sub>) to give 0.360 mg (47%) of brown foam:  HRMS (ESI) <i>m</i>/<i>z</i> 546.192 59 (M + H)<sup>+1</sup>, Δ = 2.33 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.61 (s, 1H), 9.49 (s, 1H), 8.97 (s, 1H), 8.47 (s, 1H), 7.73 (s, 1H), 7.34 (m, 3H), 7.21 (m, 1H), 6.77 (m, 1H), 6.62 (m, 2H), 6.49 (m, 1H), 5.16 (s, 2H), 4.30 (q, 2H, <i>J</i> = 5.19 Hz), 3.07 (d, 2H, <i>J</i> = 3.69 Hz), 2.18 (s, 6H), 1.47 (t, 3H, <i>J</i> = 5.19 Hz). Anal. (C<sub>29</sub>H<sub>28</sub>ClN<sub>5</sub>O<sub>4</sub>·0.3H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(1-naphthylmethoxy)anilino[-3-cyano-7-ethoxy-6-quinolinyl}-4-(dime</b><b>thylamino)-2-butenamide (25t).</b> The title compound was prepared from a mixture of 0.500 g (1.39 mmol) of <b>23</b>, 0.474 g (1.67 mmol) of 3-chloro-4-(1-naphthylmethoxy)aniline, and 0.322 g (2.78 mmol) of pyridine hydrochloride in 23 mL of <i>i</i>-PrOH using the same procedure as described for <b>25g</b>. The crude product was dissolved in CHCl<sub>3</sub>−MeOH, neutralized with concentrated NH<sub>4</sub>OH, and evaporated. A 0.960 mg sample of this material was purified by flash chromatography (silica gel, 7% MeOH in CHCl<sub>3</sub>) to give 0.720 mg (86%) of brown foam:  HRMS (ESI) <i>m</i>/<i>z</i> 606.226 84 (M + H)<sup>+1</sup>, Δ = 0.19 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.64 (s, 1H), 9.51 (s, 1H), 8.98 (s, 1H), 8.48 (s, 1H), 8.14 (d, 1H, <i>J</i> = 5.91 Hz), 7.98 (m, 2H), 7.74 (d, 1H, <i>J</i> = 5.01 Hz), 7.56 (m, 3H), 7.46 (d, 2H, <i>J</i> = 6.69 Hz), 7.38 (m, 2H), 7.25 (dd, 1H, <i>J</i> = 6.6 Hz, <i>J</i> = 1.89 Hz), 6.78 (m, 1H), 6.60 (m, 1H), 5.67 (s, 2H), 4.31 (q, 2H, <i>J</i> = 5.16 Hz), 3.07 (d, 2H <i>J</i> = 3.81 Hz), 2.17 (s, 6H), 1.47 (t, 3H, <i>J</i> = 5.16 Hz). Anal. (C<sub>35</sub>H<sub>32</sub>ClN<sub>5</sub>O<sub>3</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[3-Chloro-4-(2-naphthylmethoxy)anilino[-3-cyano-7-ethoxy-6-quinolinyl}-4-(dime</b><b>thylamino)-2-butenamide (25u).</b> The title compound was prepared from a mixture of 0.500 g (1.39 mmol) of <b>23</b>, 0.474 g (1.67 mmol) of 3-chloro-4-(2-naphthylmethoxy)aniline, and 0.322 g (2.78 mmol) of pyridine hydrochloride in 25 mL of <i>i</i>-PrOH using the same procedure as described for <b>25g</b>. A 0.900 g sample of crude product was purified by flash chromatography (silica gel, 7% MeOH in CHCl<sub>3</sub>) to give 0.590 g (70%) of yellow foam:  HRMS (ESI) <i>m</i>/<i>z</i> 606.225 88 (M + H)<sup>+1</sup>, Δ = −0.77 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.63 (s, 1H), 9.51 (s, 1H), 8.98 (s, 1H), 8.47 (s, 1H), 7.96 (m, 4H), 7.62 (d, 1H, <i>J</i> = 7.53 Hz), 7.54 (m, 2H), 7.39 (m, 2H), 7.30 (m, 1H), 7.23 (m, 1H), 6.78 (m, 1H), 6.59 (m, 1H), 5.39 (s, 2H), 4.30 (q, 2H, <i>J</i> = 5.19 Hz), 3.06 (d, 2H, <i>J</i> = 3.75 Hz), 2.17 (s, 6H), 1.47 (t, 3H, <i>J </i>= 5.19 Hz). Anal. (C<sub>35</sub>H<sub>32</sub>ClN<sub>5</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(3-Chloro-4-{[(1</b><b><i>R</i></b><b>)-1-phenylethyl]oxy}anilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(d</b><b>imethylamino)-2-butenamide (25v).</b> This compound was prepared as a yellow solid (0.6 g, 74%) by the same method for the preparation of <b>25g</b>, using 0.5 g (1.39 mmol) of <b>23 </b>and 0.414 g (1.67 mmol) of 3-chloro-4-{[(1<i>R</i>)-1-phenylethyl]oxy}aniline:  MS(ESI+) <i>m</i>/<i>z</i> 570.2 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.54 (s, 1H), 9.47 (s, 1H), 8.93 (s, 1H), 8.44 (s, 1H), 7.43 (d, 2H, <i>J</i> = 6 Hz), 7.36−7.33 (m, 4H), 7.27 (t, 1H, <i>J</i> = 5.1 Hz), 7.05 (t, 2H, <i>J</i> = 3.3 Hz), 6.78−6.72 (m, 1H), 6.58 (d, 1H, <i>J</i> = 9.3 Hz), 5.61 (q, 1H, <i>J</i> = 6 Hz), 4.29 (q, 2H, <i>J</i> = 6.3 Hz), 3.06 (d, 2H, <i>J</i> = 6.3 Hz), 2.16 (s, 6H), 1.58 (d, 3H, <i>J</i> = 3.3 Hz), 1.45 (t, 3H, <i>J</i> = 6.3 Hz). Anal. (C<sub>32</sub>H<sub>32</sub>ClN<sub>5</sub>O<sub>3</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(3-Chloro-4-{[(1</b><b><i>S</i></b><b>)-1-phenylethyl]oxy}anilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(d</b><b>imethylamino)-2-butenamide (25w).</b> This compound was prepared as a yellow solid (0.56 g, 70%) by the same method described for <b>25g</b> using 0.5 g (1.39 mmol) of <b>23 </b>and 0.414 g of (1.67 mmol) 3-chloro-4-{[(1<i>S</i>)-1-phenylethyl]oxy}aniline:  HRMS (ESI) <i>m</i>/<i>z</i> 570.225 71 (M + H)<sup>+1</sup>, Δ = −0.94 mmu; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.55 (s, 1H), 9.48 (s, 1H), 8.93 (s, 1H), 8.45 (s, 1H), 7.43 (d, 2H, <i>J</i> = 6.3 Hz), 7.38−7.24 (m, 5H), 7.06 (d, 2H, <i>J</i> = 1.5 Hz), 6.80−6.71 (m, 1H), 6.58 (d, 1H, <i>J</i> = 15.6 Hz), 5.61 (q, 1H, <i>J</i> = 6.3 Hz), 4.29 (q, 2H, <i>J</i> = 6.3 Hz), 3.06 (d, 2H, <i>J</i> = 6.3 Hz), 2.16 (s, 6H), 1.58 (d, 3H, <i>J</i> = 3.3 Hz), 1.45 (t, 3H, <i>J</i> = 6.3 Hz). Anal. (C<sub>32</sub>H<sub>32</sub>ClN<sub>5</sub>O<sub>3</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>,</b><b><i>N</i></b><b>-Bis(</b><b><i>tert</i></b><b>-butoxycarbonyl)-2-chloro-4-nitroaniline (27).</b> To a stirred solution of 8.63 g (50 mmol) of 2-chloro-4-nitroaniline and 0.30 g (2.5 mmol) of DMAP in 50 mL of THF at 0 °C was added 22.9 g (105 mmol) of (Boc)<sub>2</sub>O. The resulting purple solution was warmed to 25 °C, stirred for 3 h, and concentrated. The residue was partitioned between EtOAc and 1 M citric acid. The EtOAc layer was washed well with brine, dried, and concentrated to give 19.2 g (100%) of off-white solid:  mp = 103−110 °C. Anal. (C<sub>16</sub>H<sub>21</sub>ClN<sub>2</sub>O<sub>6</sub>) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b><sup>1</sup></b><sup></sup><b>,</b><b><i>N</i></b><b><sup>1</sup></b><sup></sup><b>-Bis(</b><b><i>tert</i></b><b>-butoxycarbonyl)-2-chloro-</b><b><i>p</i></b><b>-phenylenediamine (28).</b> A stirred mixture of 13.5 g (36.2 mmol) of <b>27</b>, 7.09 g (127 mg atom) of iron powder, 14.5 mL (253 mmol) of HOAc, and 181 mL of MeOH was refluxed for 30 min and concentrated to remove MeOH. The residue was stirred with EtOAc and H<sub>2</sub>O for 15 min and filtered. The EtOAc layer was washed with aqueous NaHCO<sub>3</sub> and H<sub>2</sub>O, dried, and concentrated to give 12.4 g (100%) of off-white solid:  <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 7.00 (d, 1H, <i>J</i> = 8.6 Hz), 6.77 (bs, 1H), 6.61 (d, 1H, <i>J</i> = 8.6 Hz), 4.46 (bs, 2H), 1.36 (s, 18H). </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(4-Amino-3-chloroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-b</b><b>utenamide (29).</b> A stirred mixture of 3.99 g (11.1 mmol) of<b> 23</b>, 4.56 g (13.3 mmol) of <b>28</b>, 2.56 g (22.2 mmol) of pyridine hydrochloride, and 67 mL of methoxyethanol was refluxed for 1 h. The cooled mixture was stirred with dilute aqueous K<sub>2</sub>CO<sub>3</sub> (pH ∼9). The resulting <a name="jm004800401129" id="jm004800401129"></a> precipitate was filtered, washed well with water, and dried to give 5.84 g brown solid. </div><div class="NLM_p">The solid was stirred with 111 mL of CH<sub>2</sub>Cl<sub>2</sub> at 0 °C and treated with 55 mL of TFA. The resulting solution was warmed to 25 °C, stirred for 15 min, diluted with toluene, and concentrated. The residue was partitioned between 20:1 EtOAc−MeOH and aqueous K<sub>2</sub>CO<sub>3</sub>. The organic layer was washed with brine, dried, and concentrated. Short column chromatography of the residue on silica gel with final elution by 25:5:1 EtOAc−MeOH−Et<sub>3</sub>N gave 3.05 g (60%) of amber solid:  mp = 222−232 °C (dec); MS (ES+) <i>m</i>/<i>z</i> 465.2, 467.2 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.49 (s, 1H), 9.47 (s, 1H), 8.91 (s, 1H), 8.38 (s, 1H), 7.33 (s, 1H), 7.14 (d, 1H, <i>J</i> = 2.3 Hz), 6.98 (dd, 1H, <i>J</i> = 2.3 Hz, <i>J</i> = 8.6 Hz), 6.80 (d, 1H, <i>J</i> = 8.6 Hz), 6.77 (dt, 1H, <i>J</i> = 5.6 Hz, <i>J</i> = 15.4 Hz), 6.57 (d, 1H, <i>J</i> = 15.4 Hz), 5.41 (bs, 2H), 4.28 (q, 2H, <i>J</i> = 7.0 Hz), 3.09 (d, 2H, <i>J</i> = 5.6 Hz), 2.19 (s, 6H), 1.46 (t, 3H, <i>J</i> = 7.0 Hz) Anal. (C<sub>24</sub>H<sub>25</sub>ClN<sub>6</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-{4-[4-(Benzylamino)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylami</b><b>no)-2-butenamide (31).</b> To a stirred suspension of 465 mg (1.0 mmol) of <b>29</b> in 4.0 mL of DCE were added successively 0.21 g (2.0 mmol) of benzaldehyde, 0.59 g (2.8 mmol) of NaBH(OAc)<sub>3</sub>, and 0.23 mL (4.0 mmol) of HOAc at 25 °C. After 18 h the reaction mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and aqueous NaHCO<sub>3</sub>. The organic layer was washed with water, dried, and concentrated. Short column chromatography of the residue on silica gel with final elution by 25:25:2:1 CH<sub>2</sub>Cl<sub>2</sub>−EtOAc−MeOH−Et<sub>3</sub>N gave 375 mg (68%) of an amber foam:  MS (ES+) <i>m</i>/<i>z</i> 555.1, 557.1 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.49 (s, 1H), 9.46 (s, 1H), 8.89 (s, 1H), 8.37 (s, 1H), 7.33 (s, 1H) 7.40−7.15 (m, 5H), 7.22 (d, 1H, <i>J</i> = 2.3 Hz), 6.98 (dd, 1H, <i>J</i> = 2.3, <i>J</i> = 8.7 Hz), 6.77 (dt, 1H, <i>J</i> = 5.6 Hz, <i>J</i> = 15.4 Hz), 6.59 (d, <i>J</i> = 15.4 Hz), 6.56 (d, 1H, <i>J</i> = 8.7 Hz), 6.16 (t, <i>J</i> = 6.0 Hz), 4.44 (d, 2H, <i>J</i> = 6.0 Hz), 4.30 (q, 2H, <i>J</i> = 6.9 Hz), 3.12 (d, 2H, <i>J</i> = 5.6 Hz), 2.21 (s, 6H), 1.45 (t, 3H, <i>J</i> = 6.9 Hz). Anal. (C<sub>31</sub>H<sub>31</sub>ClN<sub>6</sub>O<sub>2</sub>·0.5H<sub>2</sub>CO<sub>3</sub>·0.5MeOH) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-</b><b>(4-{3-Chloro-4-[(1-naphthylmethyl)amino]anilino}-3-cyano-7-ethoxy-6-quinolinyl)-4-</b><b>(dimethylamino)-2-butenamide (32).</b> The product was prepared from 465 mg (1.0 mmol) of <b>29</b> and 0.31 g (2.0 mmol) of 1-naphthaldehyde as described above for <b>31</b> to give 546 mg (91%) of yellow foam:  MS (ES+) <i>m</i>/<i>z</i> 604.8, 606.7 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.65 (s, 1H), 9.50 (s, 1H), 8.88 (s, 1H), 8.38 (s, 1H), 8.22 (d, 1H, <i>J</i> = 8.2 Hz), 7.97 (dd, 1H, <i>J</i> = 1.6 Hz, <i>J</i> = 8.2 Hz), 7.82 (m, 1H), 7.56 (m, 2H), 7.44 (d, 1H, <i>J</i> = 1.6 Hz), 7.42 (s, 1H), 7.35 (s, 1H), 7.27 (d, 1H, <i>J</i> = 2.4 Hz), 6.99 (dd, 1H, <i>J</i> = 2.4 Hz, <i>J</i> = 8.7 Hz), 6.78 (dt, 1H, <i>J</i> = 5.6 Hz, <i>J</i> = 15.3 Hz), 6.67 (d, 1H, <i>J</i> = 15.3 Hz), 6.58 (d, 1H, <i>J</i> = 8.7 Hz), 6.18 (t, 1H, <i>J</i> = 5.8 Hz), 4.92 (d, 2H, <i>J</i> = 5.8 Hz), 4.29 (q, 2H, <i>J</i> = 6.9 Hz), 3.08 (d, 2H, <i>J</i> = 5.6 Hz), 2.18 (s, 6H), 1.45 (t, 3H, <i>J</i> = 6.9 Hz). Anal. (C<sub>35</sub>H<sub>33</sub>ClN<sub>6</sub>O<sub>2</sub>·2.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>Di(</b><b><i>tert</i></b><b>-butyl)-2-chloro-4-[(3-cyano-7-methoxy-6-nitro-4-quinolinyl)amino]phenylimidodica</b><b>rbonate (33). </b>A stirred mixture of 5.27 g (20 mmol) of 4-chloro-7-methoxy-6-nitroquinoline-3-carbonitrile (<b>1a</b>), 8.22 g (24 mmol) of <b>28</b>, and 100 mL of <i>i</i>-PrOH was refluxed for 1 h, cooled, and partitioned between EtOAc and aqueous K<sub>2</sub>CO<sub>3</sub>. The organic layer was washed with water, dried, and concentrated. The crude product was recrystallized from EtOAc−hexane to give 10.3 g (90%) of yellow solid:  mp = 235−240 °C (dec); MS (ES+) <i>m</i>/<i>z</i> 570.1, 572.1 (M + H)<sup>+1</sup>. </div><div class="NLM_p"><b>Di(</b><b><i>tert</i></b><b>-butyl)4-[(6-amino-3-cyano-7-methoxy-4-quinolinyl)amino]-2-chlorophenylimidodica</b><b>rbonate (34). </b>A stirred mixture of 10.2 g (17.9 mmol) of<b> 33</b>, 3.5 g (62.6 mg atom) of iron powder, 7.2 mL (125 mmol) of HOAc, and 179 mL of MeOH was refluxed for 2 h, cooled, and concentrated to remove MeOH. The residue was stirred in EtOAc−H<sub>2</sub>O and filtered to remove iron salts. The organic layer was washed with H<sub>2</sub>O, NaHCO<sub>3</sub>, and H<sub>2</sub>O, dried, and concentrated to give 9.08 g of tan solid, which was sufficiently pure for the next step:  MS (ES+) <i>m</i>/<i>z</i> 540.1, 542.1 (M + H)<sup>+1</sup>. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-[4-(4-Amino-3-chloroanilino)-3-cyano-7-methoxy-6-quinolinyl]-4-(dimethylamino)-2-</b><b>butenamide (35).</b> The acylation of 7.99 g (14.8 mmol) of<b> 34</b> with 4.90 g (29.6 mmol) of 4-dimethylaminobut-2-enoic acid hydrochloride in 65 mL of MeCN was carried out using the same procedure described for the preparation of <b>23</b> to provide 9.06 g of the intermediate <i>N</i>,<i>N</i>-bis(<i>tert</i>-butoxycarbonyl) derivative. The crude product was subjected to short column chromatography on silica gel with final elution by 25:5:1 EtOAc−MeOH−Et<sub>3</sub>N to provide 7.30 g (75%) of amber solid, which was sufficiently pure for conversion to the title compound. </div><div class="NLM_p">The solid was stirred with 112 mL of CH<sub>2</sub>Cl<sub>2</sub> at 0 °C and treated with 56 mL of TFA. The resulting solution was warmed to 25 °C, stirred for 5 min, diluted with toluene, and concentrated. The residue was partitioned between 20:1 EtOAc−MeOH and aqueous K<sub>2</sub>CO<sub>3</sub>. The organic layer was washed with brine, dried, and concentrated to give 4.89 g (97%) of light-yellow solid that was sufficiently pure for further reactions. Short column chromatography of a portion of the product on SG with final elution by 25:5:1 EtOAc−MeOH−Et<sub>3</sub>N gave a yellow solid:  mp = 190−200 °C (dec); MS (ES+) <i>m</i>/<i>z</i> 451.2, 453.2 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.67 (s, 1H), 9.48 (s, 1H), 8.92 (s, 1H), 8.39 (s, 1H), 7.36 (s, 1H), 7.14 (d, 1H, <i>J</i> = 2.3 Hz), 6.98 (dd, 1H, <i>J</i> = 2.3 Hz, <i>J</i> = 8.6 Hz), 6.80 (d, 1H, <i>J</i> = 8.6 Hz), 6.75 (dt, 1H, <i>J</i> = 5.8 Hz, <i>J</i> = 15.4 Hz), 6.58 (d, 1H, <i>J</i> = 15.4 Hz), 5.41 (bs, 2H), 4.01 (s, 3H), 3.15 (d, 2H, <i>J</i> = 5.8 Hz), 2.24 (s, 6H). Anal. (C<sub>23</sub>H<sub>23</sub>ClN<sub>6</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-(4-{4-[(Benzoyl)amino]-3-chloroanilino}-3-cyano-7-methoxy-6-quinolinyl)-4-(dimeth</b><b>ylamino)-2-butenamide (36). </b>A stirred solution of 226 mg (0.50 mmol) of <b>35</b>, 0.34 g (1.5 mmol) of benzoic anhydride, and 1.5 mL of dimethylacetamide (DMA) was heated at 60 °C for 20 h. The reaction mixture was partitioned between 20:1 CH<sub>2</sub>Cl<sub>2</sub>−MeOH and aqueous K<sub>2</sub>CO<sub>3</sub>. The organic layer was washed with H<sub>2</sub>O, dried, and concentrated. Short column chromatography of the residue on silica gel with final elution by 25:5:1 EtOAc−MeOH−Et<sub>3</sub>N gave 0.20 g (72%) of amber solid:  mp = 170−180 °C; MS (ES+) <i>m</i>/<i>z</i> 555.3, 557.3 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.0 (s, 1H), 9.74 (s, 1H), 9.70 (s, 1H), 9.04 (s, 1H), 8.63 (s, 1H), 8.03 (s, 1H), 7.95 (m, 2H), 7.65−7.40 (m, 6H), 6.79 (dt, 1H, <i>J</i> = 5.7 Hz, <i>J</i> = 15.3 Hz), 6.63 (d, 1H, <i>J</i> = 15.3 Hz), 4.06 (s, 3H), 3.02 (d, 2H, <i>J</i> = 5.7 Hz), 2.20 (s, 6H). Anal. (C<sub>30</sub>H<sub>27</sub>ClN<sub>6</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-(4-{3-Chloro-4-[(nicotinoyl)amino]anilino}-3-cyano-7-methoxy-6-quinolinyl)-4-(dime</b><b>thylamino)-2-butenamide (37). </b>A solution of 226 mg (0.50 mmol) of <b>35</b> in 1.5 mL of DMA was treated with 164 mg (0.92 mmol) of nicotinyl chloride hydrochloride and 0.16 mL (0.92 mmol) of disopropylethylamine. The resulting mixture was stirred at 25 °C for 16 h and at 40 °C for 1 h, treated with aqueous K<sub>2</sub>CO<sub>3</sub> at 25 °C, stirred for 30 min, and filtered. The yellow solid was washed with a large volume of H<sub>2</sub>O and dried to give 0.26 g (94%) of product:  mp = 208−218 = °C (dec); MS (ES+) <i>m</i>/<i>z</i> 556.3,558.3 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i> d</i><sub>6</sub>) δ 10.3 (s, 3H), 9.76 (s, 1H), 9.70 (s, 1H), 9.16 (s, 1H), 9.05 (s, 1H), 8.78 (m, 1H), 8.63 (s, 1H), 8.34 (m, 1H), 7.60−7.10 (m, 5H), 6.79 (dt, 1H, <i>J</i> = 5.6, <i>J</i> = 15.6 Hz), 6.63 (d, 1H, <i>J</i> = 15.6 Hz), 4.05 (s, 3H), 3.07 (d, 2H, <i>J</i> = 5.6 Hz), 2.18 (s, 6H) Anal. (C<sub>29</sub>H<sub>26</sub>ClN<sub>7</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-</b><b><i>N</i></b><b>-(4-{4-[(Anilinocarbonyl)amino]-3-chloroanilino}-3-cyano-7-methoxy-6-quinolinyl)-4-</b><b>(dimethylamino)-2-butenamide (38). </b>A solution of 226 mg (0.50 mmol) of <b>35 </b>and 0.18 g (1.5 mmol) of phenyl isocyanate in 1.5 mL of DMA was stirred at 25 °C for 60 min, diluted with 20 mL of Et<sub>2</sub>O and a few drops of H<sub>2</sub>O, and stirred for 30 m. The resulting yellow solid was filtered off, washed with boiling Et<sub>2</sub>O, and dried to give 220 mg (77%) of product:  mp = 200−210 °C (dec); MS (ES+) <i>m</i>/<i>z</i> 570.2, 572.2 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.67 (s, 3H), 9.39 (s, 1H), 8.99 (s, 1H), 8.53 (s, 1H), 8.33 (s, 1H), 8.18 (d, 1H, <i>J</i> = 8.9 Hz), 7.50−7.15 (m, 7H), 6.78 (dt, 1H, <i>J</i> = 5.7 Hz, <i>J</i> = 15.3 Hz), 6.64 (d, 1H, <i>J</i> = 15.3 Hz), 4.04 (s, 3H), 3.08 (d, 2H, <i>J</i> = 5.7 Hz), 2.18 (s, 6H). Anal. (C<sub>30</sub>H<sub>28</sub>ClN<sub>7</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}ethylenesulfonamide</b><b>(82).</b> To a solution of 300 mg (0.68 mmol) of <b>72</b> and 0.34 mL (2.43 mmol) of <a name="jm004800401130" id="jm004800401130"></a> triethylamine in 34 mL of THF at 0 °C was added 0.212 mL (2.03 mmol) of 2-chloro-1-ethanesulfonyl chloride (<b>78</b>) over 10 min. The reaction mixture was stirred at 0 °C for 40 min. Solvent was evaporated. EtOAc, NaOH, and brine were added, and the solid was filtered. After the filtrate was evaporated, acetone was added to dissolve the product. It was filtered, and the acetone solution was evaporated to the crude product as a yellow gum. It was treated with EtOAc and filtered. The EtOAc layer was evaporated and the product was precipitated out with hexane and EtOAc to yield 109 mg (30%) of yellow glass:  mp = 96−97 °C; HRMS (ESI) <i>m</i>/<i>z</i> 534.119 23, Δ = 0.68 mmu (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.69 (s, 1H), 9.5 (bs, 1H), 8.48 (s, 1H), 8.24 (s, 1H), 7.49 (d, 2H, <i>J</i> = 7 Hz), 7.44−7.32 (m, 5H), 7.28−7.21 (m, 2H), 6.83 (dd, 1H, <i>J</i> = 9.9 Hz, <i>J</i> = 16.4 Hz), 6.01−5.91 (m, 2H), 5.22 (s, 2H), 4.23 (q, 2H, <i>J</i> = 6.9 Hz), 1.44 (t, 3H, <i>J</i> = 6.8 Hz). Anal. (C<sub>27</sub>H<sub>23</sub>ClN<sub>4</sub>O<sub>4</sub>S·1.2 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-2-[(dimethylamino)m</b><b>ethyl]acrylamide (83).</b> An amount of 400 mg (0.9 mmol) of <b>72</b> in 4 mL (0.22 mmol) of NMP was cooled to −15 °C. To a solution of 0.298 g (1.80 mmol) of 2-dimethylaminomethylacrylic acid hydrochloride<sup><a onclick="showRef(event, 'jm040159cb00035'); return false;" href="javascript:void(0);" class="ref jm040159cb00035">35</a></sup> in 15 mL of CH<sub>3</sub>CN at 60 °C was added 0.285 mL (3.24 mmol) of (COCl)<sub>2</sub> for 30 min. The resulting 2-dimethylaminomethylacrylic acid chloride solution was evaporated to a yellow oil. It was suspended in 15 mL of CH<sub>3</sub>CN and added dropwise to an NMP solution (4 mL) containing 400 mg (0.90 mmol) of <b>72</b> at −15 °C. The yellow suspension was stirred overnight from −15 °C to room temperature. The reaction mixture was poured into EtOAc−1 N NaOH solution and stirred for 30 min. The resulting yellow precipitate was collected and purified on preparative TLC plates, eluting with 10% MeOH−EtOAc in 1% HOAc to yield 50.5 mg (12%) of light-yellow solid:  mp = 110−111 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.9 (s, 1H), 9.61 (s, 1H), 9.25 (s, 1H), 8.47 (s, 1H), 7.49 (d, 2H, <i>J</i> = 7.1 Hz), 7.44−7.35 (m, 6H), 7.26−7.18 (m, 3H), 6.19 (s, 1H), 5.65 (s, 1H), 5.21 (s, 2H), 4.31 (q, 2H, <i>J</i> = 6.9 Hz), 2.3 (s, 6H), 1.48 (t, 3H, <i>J</i> = 6.9 Hz). Anal. (C<sub>31</sub>H<sub>30</sub>ClN<sub>5</sub>O<sub>3</sub>·1.3 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-{4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-2-(morpholinylmethyl</b><b>)acrylamide (84). </b>To a solution of 281 mg (1.35 mmol) of 2-(morpholin-4yl)methylacrylic acid hydrochloride<sup>35</sup> in 3 mL of CH<sub>3</sub>CN at 60 °C was added 0.106 mL (1.22 mmol) of (COCl)<sub>2</sub>. This was stirred at 60 °C for 15 min, evaporated, and cooled to 0 °C. It was added to a solution of 300 mg (0.68 mmol) of <b>72 </b>in 3 mL of NMP at 0 °C, and the mixture was stirred overnight from 0 °C to room temperature. The reaction mixture was stirred with saturated NaHCO<sub>3</sub>. The bright-yellow suspension was filtered and purified by preparative TLC plates developing with 5% MeOH−EtOAc to yield 119 mg (30%) of light-yellow solid:  mp = 95−97 °C; HRMS (ESI) <i>m</i>/<i>z</i> 597.2144, Δ = 1.37 mmu (M + H)<sup>+1</sup><sub>;</sub><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.1 (s, 1H), 9.63 (s, 1H), 9.17 (s, 1H), 9.06 (s, 1H), 8.48 (s, 1H), 7.5−7.35 (m, 7H), 7.26−7.17 (m, 2H), 6.24 (d, 1H, <i>J</i> = 1.7 Hz), 5.7 (s, 1H), 5.21 (s, 2H), 4.44 (q, 2H, <i>J</i> = 6.9 Hz), 3.69 (s, 4H), 3.38 (s, 2H), 2.49 (s, 4H), 1.43 (t, 3H, <i>J</i> = 6.9 Hz). Anal. (C<sub>33</sub> H<sub>32</sub>ClN<sub>5</sub>O<sub>4</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p last"><b>2-[({4-[4-(Benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}amino)methyl]acrylic </b><b>Acid (85)</b>. A 0.8 g (1.8 mmol) amount of <b>72</b> in 70 mL of CH<sub>3</sub>CN was heated until solids dissolved. To the stirred solution was added 0.37 g (2.2 mmol) of 3-bromo-2-oxopropionic acid and 0.28 g (2.2 mmol) of Hunig's base. The mixture was refluxed for 30 min. Then about 45 mL of the solvent was distilled off. The residue was stirring in H<sub>2</sub>O containing 1 mL of Et<sub>3</sub>N. The solution was made acidic with acetic acid. The resulting solid was collected and air-dried. The product was purified by chromatography on silica gel, eluting with EtOAc−MeOH (3:1). The product fractions were combined, dissolved in hot EtOH−MeOH, concentrated, and diluted with EtOAc. The product, 0.35 g (37%), was collected. MS (ES+) <i>m</i>/<i>z</i> 528.7 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.30 (s, 1H), 7.62 (s, 1H), 7.48 (d, 2H, <i>J</i> = 3 Hz), 7.41 (t, 2H, <i>J</i> = 6 Hz), 7.34 (m, 1H), 7.08 (d, 1H, <i>J</i> = 6.5 Hz), 6.85 (m, 2H), 6.69 (dd, 1H, <i>J</i> = 1.9 Hz, <i>J</i> = 6.5 Hz), 6.19 (s, 1H), 5.57 (s, 1H), 5.18 (s, 1H), 5.11 (s, 2H), 5.00 (s, 2H), 4.10 (q, 2H, <i>J</i> = 5.2 Hz), 3.33 (bs, 2H), 1.37 (t, 3H, <i>J</i> = 5.2 Hz). Anal. (C<sub>29</sub>H<sub>25</sub>ClN<sub>4</sub>O<sub>4</sub>·1.2H<sub>2</sub>O) C, H, N. </div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm040159c/suppl_file/jm040159c_s.pdf">jm040159c_s.pdf (624.63 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm040159c" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hwei-Ru Tsou</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elsebe G. Overbeek-Klumpers</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William A. Hallett</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marvin F. Reich</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">M. Brawner Floyd</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernard D. Johnson</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald S. Michalak</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramaswamy Nilakantan</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carolyn Discafani</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan Golas</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sridhar K. Rabindran</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ru Shen</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoqing Shi</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu-Fen Wang</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janis Upeslacis</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan Wissner</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, Chemical Development, and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965 </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Drs. Tarek Mansour, Philip Frost, and Semiramis Ayral-Kaloustian for their support and encouragement. We also thank members of the Wyeth Discovery Biology group for in vivo evaluations and members of the Wyeth Discovery Analytical Chemistry group for analytical and spectral determinations. </p></div><div class="refs-header-label"><a name="jm004800401131" id="jm004800401131"></a></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="jm040159cb00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm040159cb00001_1"><span><span class="NLM_string-ref">Traxler, P. Tyrosine kinases as targets in cancer therapysuccesses and failures. <i>  Expert Opin. Ther. Targets</i><b>2003</b>, <i>7</i> (2), 215−234.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2003&pages=234&issue=2&author=P+Traxler&title=Tyrosine+kinases+as+targets+in+cancer+therapysuccesses+and+failures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP%26atitle%3DTyrosine%2520kinases%2520as%2520targets%2520in%2520cancer%2520therapysuccesses%2520and%2520failures%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2003%26volume%3D7%26issue%3D2%26spage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm040159cb00002_1"><span><span class="NLM_string-ref">Yarden Y.; Sliwknowski, M. X. Untangling of the ErB signaling network. <i>  Nat. Rev. Mol. Cell Biol</i>. <b>2001</b>, <i>2</i>, 127−137.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=137&author=Y.+Yarden&author=M.+X+Sliwknowski&title=Untangling+of+the+ErB+signaling+network"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYarden%26aufirst%3DY.%26atitle%3DUntangling%2520of%2520the%2520ErB%2520signaling%2520network%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2001%26volume%3D2%26spage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm040159cb00003_1"><span><span class="NLM_string-ref">Dowsett, M.; Cooke, T.; Ellis, L.; Gullick, W. J.; Gusterson, B.; Mallon, E.; Walker, R. Assesment of HER2 status in breast cancer:  why, when and how? <i>Eur. J. Cancer </i><b>2000</b>, <i>36</i>, 170−176.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2000&pages=176&author=M.+Dowsett&author=T.+Cooke&author=L.+Ellis&author=W.+J.+Gullick&author=B.+Gusterson&author=E.+Mallon&author=R+Walker&title=Assesment+of+HER2+status+in+breast+cancer%3A%E2%80%89+why%2C+when+and+how"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDowsett%26aufirst%3DM.%26atitle%3DAssesment%2520of%2520HER2%2520status%2520in%2520breast%2520cancer%253A%25E2%2580%2589%2520why%252C%2520when%2520and%2520how%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2000%26volume%3D36%26spage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm040159cb00004_1"><span><span class="NLM_string-ref">Kim, H.; Muller, W. J. The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis. <i>  Exp. Cell Res. </i><b>1999</b>, <i>253</i>, 78−87.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1999&pages=87&author=H.+Kim&author=W.+J+Muller&title=The+role+of+the+epidermal+growth+factor+receptor+family+in+mammary+tumorigenesis+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26atitle%3DThe%2520role%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520family%2520in%2520mammary%2520tumorigenesis%2520and%2520metastasis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D253%26spage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm040159cb00005_1"><span><span class="NLM_string-ref">Koeppen, H. K. W.; Wright, B. D.; Burt, A. D.; Quirke, P.; McNicol, A. M.; Nybdal, N. O.; Sliwkowski, M. X.; Hillan, K. J. Overexpression of HER-2/neu in solid tumours:  an immunohistochemical survey. <i>  Histopathology</i><b>2001</b>, <i>38</i>, 96−104.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2001&pages=104&author=H.+K.+W.+Koeppen&author=B.+D.+Wright&author=A.+D.+Burt&author=P.+Quirke&author=A.+M.+McNicol&author=N.+O.+Nybdal&author=M.+X.+Sliwkowski&author=K.+J+Hillan&title=Overexpression+of+HER-2%2Fneu+in+solid+tumours%3A%E2%80%89+an+immunohistochemical+survey"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoeppen%26aufirst%3DH.%2BK.%2BW.%26atitle%3DOverexpression%2520of%2520HER-2%252Fneu%2520in%2520solid%2520tumours%253A%25E2%2580%2589%2520an%2520immunohistochemical%2520survey%26jtitle%3DHistopathology%26date%3D2001%26volume%3D38%26spage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm040159cb00006_1"><span><span class="NLM_string-ref">Nass, S. J.; Hahm, H. A.; Davidson, N. E. Breast cancer biology blossoms in the clinic. <i>  Nat. Med. </i><b>1998</b>,<i> 7, </i>761−762.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=762&author=S.+J.+Nass&author=H.+A.+Hahm&author=N.+E+Davidson&title=Breast+cancer+biology+blossoms+in+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNass%26aufirst%3DS.%2BJ.%26atitle%3DBreast%2520cancer%2520biology%2520blossoms%2520in%2520the%2520clinic%26jtitle%3DNat.%2520Med.%26date%3D1998%26volume%3D7%26spage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm040159cb00007_1"><span><span class="NLM_string-ref">Ciardiello, F.; De Vita, F.; Orditura, M.; De Placido, S.; Tortora, G. Epidermal growth factor receptor tyrosind kinase inhibitors in late stage trials. <i>  Expert Opin. Emerging Drugs</i><b>2003</b>, <i>8</i> (2), 501−514.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=514&issue=2&author=F.+Ciardiello&author=F.+De+Vita&author=M.+Orditura&author=S.+De+Placido&author=G+Tortora&title=Epidermal+growth+factor+receptor+tyrosind+kinase+inhibitors+in+late+stage+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiardiello%26aufirst%3DF.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520tyrosind%2520kinase%2520inhibitors%2520in%2520late%2520stage%2520trials%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2003%26volume%3D8%26issue%3D2%26spage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm040159cb00008_1"><span><span class="NLM_string-ref">Supuran, C. T.; Scozzafava, A. Protein tyrosine kinase inhibitors as anticancer agents. <i>  Expert Opin. Ther. Patents </i><b>2004</b>, <i>14</i> (1), 35−53.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=53&issue=1&author=C.+T.+Supuran&author=A+Scozzafava&title=Protein+tyrosine+kinase+inhibitors+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DProtein%2520tyrosine%2520kinase%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2004%26volume%3D14%26issue%3D1%26spage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm040159cb00009_1"><span><span class="NLM_string-ref">Wissner, A.; Overbeek, E.; Reich, M. F.; Floyd, M. B.; Johnson, B. D.; Mamuya, N.; Rosfjord, E. C.; Discafani, C.; Davis, R.; Shi, X.; Rabindran, S. K.; Gruber, B. C.; Ye, F.; Hallett, W. A.; Nilakantan, R.; Shen, R.; Wang, Y.-F.; Greenberger, L. M.; Tsou, H.-R. Synthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2). <i>  J. Med. Chem</i>. <b>2003</b>, <i>46 </i>(1), 49−63.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=63&issue=1&author=A.+Wissner&author=E.+Overbeek&author=M.+F.+Reich&author=M.+B.+Floyd&author=B.+D.+Johnson&author=N.+Mamuya&author=E.+C.+Rosfjord&author=C.+Discafani&author=R.+Davis&author=X.+Shi&author=S.+K.+Rabindran&author=B.+C.+Gruber&author=F.+Ye&author=W.+A.+Hallett&author=R.+Nilakantan&author=R.+Shen&author=Y.-F.+Wang&author=L.+M.+Greenberger&author=H.-R+Tsou&title=Synthesis+and+Structure%E2%88%92Activity+Relationships+of+6%2C7-Disubstituted+4-Anilinoquinoline-3-carbonitriles.+The+Design+of+an+Orally+Active%2C+Irreversible+Inhibitor+of+the+Tyrosine+Kinase+Activity+of+the+Epidermal+Growth+Factor+Receptor+%28EGFR%29+and+the+Human+Epidermal+Growth+Factor+Receptor-2+%28HER-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2588%2592Activity%2520Relationships%2520of%25206%252C7-Disubstituted%25204-Anilinoquinoline-3-carbonitriles.%2520The%2520Design%2520of%2520an%2520Orally%2520Active%252C%2520Irreversible%2520Inhibitor%2520of%2520the%2520Tyrosine%2520Kinase%2520Activity%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528EGFR%2529%2520and%2520the%2520Human%2520Epidermal%2520Growth%2520Factor%2520Receptor-2%2520%2528HER-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D1%26spage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00010"><div class="reference"><div class="NLM_citation" id="jm040159cb00010_1"><span><span class="NLM_string-ref">Wissner, A.; Floyd, M. B.; Rabindran, S. K.; Nilakantan, R.; Greenberger, L. M.; Shen, R.; Wang, Y.-F.; Tsou, H.-R. Syntheses and EGFR and HER-2 kinase inhibitory activities of 4-anilinoquinoline-3-carbonitriles:  analogues of three important 4-anilinoquinazolines currently undergoing clinical evaluation as therapeutic antitumor agents. <i>  Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12,</i> 2893−2897.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2897&author=A.+Wissner&author=M.+B.+Floyd&author=S.+K.+Rabindran&author=R.+Nilakantan&author=L.+M.+Greenberger&author=R.+Shen&author=Y.-F.+Wang&author=H.-R+Tsou&title=Syntheses+and+EGFR+and+HER-2+kinase+inhibitory+activities+of+4-anilinoquinoline-3-carbonitriles%3A%E2%80%89+analogues+of+three+important+4-anilinoquinazolines+currently+undergoing+clinical+evaluation+as+therapeutic+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DSyntheses%2520and%2520EGFR%2520and%2520HER-2%2520kinase%2520inhibitory%2520activities%2520of%25204-anilinoquinoline-3-carbonitriles%253A%25E2%2580%2589%2520analogues%2520of%2520three%2520important%25204-anilinoquinazolines%2520currently%2520undergoing%2520clinical%2520evaluation%2520as%2520therapeutic%2520antitumor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm040159cb00011_1"><span><span class="NLM_string-ref">Prigent, S. A.; Lemoine, N. R. The type 1 (EGFR-related) family of growth factor receptors and their ligands. <i>  Prog. Growth Factor Res. </i><b>1992</b>, <i>4</i>, 1−24.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1992&pages=24&author=S.+A.+Prigent&author=N.+R+Lemoine&title=The+type+1+%28EGFR-related%29+family+of+growth+factor+receptors+and+their+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrigent%26aufirst%3DS.%2BA.%26atitle%3DThe%2520type%25201%2520%2528EGFR-related%2529%2520family%2520of%2520growth%2520factor%2520receptors%2520and%2520their%2520ligands%26jtitle%3DProg.%2520Growth%2520Factor%2520Res.%26date%3D1992%26volume%3D4%26spage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm040159cb00012_1"><span><span class="NLM_string-ref">Stamos, J.; Sliwkowski, M. X.; Eigenbrot, C. Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor. <i>  J. Biol. Chem</i>. <b>2002</b>, <i>277</i>, 46265−46272.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46272&author=J.+Stamos&author=M.+X.+Sliwkowski&author=C+Eigenbrot&title=Structure+of+the+Epidermal+Growth+Factor+Receptor+Kinase+Domain+Alone+and+in+Complex+with+a+4-Anilinoquinazoline+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStamos%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520Kinase%2520Domain%2520Alone%2520and%2520in%2520Complex%2520with%2520a%25204-Anilinoquinazoline%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm040159cb00013_1"><span><span class="NLM_string-ref">Cockerill, S.; Stubberfield, C.; Stables, J.; Carter, M.; Guntrip, S.; Smith, K.; McKeown, S.; Shaw, R.; Topley, P.; Thomsen, L.; Affleck, K.; Jowett, A.; Hayes, D.; Willson, M.; Woollard, P.; Spalding, D. Indazolylamino Quinazolines and Pyridopyrimidines as Inhibitors of the EGFr and C-erbB-2. <i>  Bioorg. Med. Chem. Lett. </i><b>2001</b>, <i>11</i>, 1401−1405.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1405&author=S.+Cockerill&author=C.+Stubberfield&author=J.+Stables&author=M.+Carter&author=S.+Guntrip&author=K.+Smith&author=S.+McKeown&author=R.+Shaw&author=P.+Topley&author=L.+Thomsen&author=K.+Affleck&author=A.+Jowett&author=D.+Hayes&author=M.+Willson&author=P.+Woollard&author=D+Spalding&title=Indazolylamino+Quinazolines+and+Pyridopyrimidines+as+Inhibitors+of+the+EGFr+and+C-erbB-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCockerill%26aufirst%3DS.%26atitle%3DIndazolylamino%2520Quinazolines%2520and%2520Pyridopyrimidines%2520as%2520Inhibitors%2520of%2520the%2520EGFr%2520and%2520C-erbB-2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm040159cb00014_1"><span><span class="NLM_string-ref">Bhattacharya, S. K.; Cox, E. D.; Kath, J. C.; Mathiowetz, A. M.; Morris, J.; Moyer, J. D.; Pustilnik, L. R.; Rafidi, K.; Richter, D. T.; Su, C.; Wessel, M. D. Achieving selectivity between highly homologous tyrosine kinases:  a novel selective erbB2 inhibitor. <i>  Biochem. Biophys. Res. Commun</i>. <b>2003</b>, <i>307</i>, 267−273.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2003&pages=273&author=S.+K.+Bhattacharya&author=E.+D.+Cox&author=J.+C.+Kath&author=A.+M.+Mathiowetz&author=J.+Morris&author=J.+D.+Moyer&author=L.+R.+Pustilnik&author=K.+Rafidi&author=D.+T.+Richter&author=C.+Su&author=M.+D+Wessel&title=Achieving+selectivity+between+highly+homologous+tyrosine+kinases%3A%E2%80%89+a+novel+selective+erbB2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26atitle%3DAchieving%2520selectivity%2520between%2520highly%2520homologous%2520tyrosine%2520kinases%253A%25E2%2580%2589%2520a%2520novel%2520selective%2520erbB2%2520inhibitor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D307%26spage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm040159cb00015_1"><span><span class="NLM_string-ref">Barbacci, E. G.; Pustilnik, L. R.; Rossi, A. M. K.; Emerson, E.; Miller, P. E.; Boscoe, B. P.; Cox, E. D.; Iwata, K. K.; Jani, J. P.; Provoncha, K.; Kath, J. C.; Liu, Z.; Moyer, J. D. The Biological and Biochemical Effects of CP-654577, a Selective erbB2 Kinase Inhibitor, on Human Breast Cancer Cells. <i>  Cancer Res. </i><b>2003</b>, <i>63</i>, 4450−4459.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=4459&author=E.+G.+Barbacci&author=L.+R.+Pustilnik&author=A.+M.+K.+Rossi&author=E.+Emerson&author=P.+E.+Miller&author=B.+P.+Boscoe&author=E.+D.+Cox&author=K.+K.+Iwata&author=J.+P.+Jani&author=K.+Provoncha&author=J.+C.+Kath&author=Z.+Liu&author=J.+D+Moyer&title=The+Biological+and+Biochemical+Effects+of+CP-654577%2C+a+Selective+erbB2+Kinase+Inhibitor%2C+on+Human+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarbacci%26aufirst%3DE.%2BG.%26atitle%3DThe%2520Biological%2520and%2520Biochemical%2520Effects%2520of%2520CP-654577%252C%2520a%2520Selective%2520erbB2%2520Kinase%2520Inhibitor%252C%2520on%2520Human%2520Breast%2520Cancer%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D4459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm040159cb00016_1"><span><span class="NLM_string-ref">Gaul, M. D.; Guo, Y.; Affleck, K.; Cockerill, G. S.; Gilmer, T. M.; Griffin, R. J.; Guntrip, S.; Keith, B. R.; Knight, W. B.; Mullin, R. J.; Murray, D. M.; Rusnak, D. W.; Smith, K.; Tadepalli, S.; Wood, E. R.; Lackey, K. Discovery and Biological Evaluation of Potent Dual ErbB-2/EGFR Tyrosine Kinase Inhibitors:  6-Thiazolylquinazolines. <i>  Bioorg. Med. Chem. </i><i>Lett</i>. <b>2003</b>, <i>13</i>, 637−640.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=640&author=M.+D.+Gaul&author=Y.+Guo&author=K.+Affleck&author=G.+S.+Cockerill&author=T.+M.+Gilmer&author=R.+J.+Griffin&author=S.+Guntrip&author=B.+R.+Keith&author=W.+B.+Knight&author=R.+J.+Mullin&author=D.+M.+Murray&author=D.+W.+Rusnak&author=K.+Smith&author=S.+Tadepalli&author=E.+R.+Wood&author=K+Lackey&title=Discovery+and+Biological+Evaluation+of+Potent+Dual+ErbB-2%2FEGFR+Tyrosine+Kinase+Inhibitors%3A%E2%80%89+6-Thiazolylquinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaul%26aufirst%3DM.%2BD.%26atitle%3DDiscovery%2520and%2520Biological%2520Evaluation%2520of%2520Potent%2520Dual%2520ErbB-2%252FEGFR%2520Tyrosine%2520Kinase%2520Inhibitors%253A%25E2%2580%2589%25206-Thiazolylquinazolines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm040159cb00017_1"><span><span class="NLM_string-ref">Zhang, Y.-M.; Cockerill, S.; Guntrip, S. B.; Rusnak, D.; Smith, K.; Vanderwall, D.; Wood, E.; Lackey, K. Synthesis and SAR of potent EGFR/erbB2 dual inhibitors. <i>  Bioog. Med. Chem. Lett</i>. <b>2004</b>, <i>14</i>, 111−114.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=114&author=Y.-M.+Zhang&author=S.+Cockerill&author=S.+B.+Guntrip&author=D.+Rusnak&author=K.+Smith&author=D.+Vanderwall&author=E.+Wood&author=K+Lackey&title=Synthesis+and+SAR+of+potent+EGFR%2FerbB2+dual+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.-M.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520potent%2520EGFR%252FerbB2%2520dual%2520inhibitors%26jtitle%3DBioog.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm040159cb00018_1"><span><span class="NLM_string-ref">Bredereck, H.; Simchen, G.; Wahl, R. Orthoamide, VIII. Über die Umsetung aktivierter Methylgruppen an substituierten Toluolen und Heterocyclen mit Aminal-<i>tert</i>-butylester zu Enaminen (Orthoamides. VIII. Conversion of activated methyl groups on substituted toluenes and heterocycles to enamines by reaction with aminal <i>tert</i>-butyl ester). <i>  Chem. Ber</i>. <b>1968</b>, <i>101</i>, 4048−4056.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1968&pages=4056&author=H.+Bredereck&author=G.+Simchen&author=R.+Wahl&author=VIII+Orthoamide&title=%C3%9Cber+die+Umsetung+aktivierter+Methylgruppen+an+substituierten+Toluolen+und+Heterocyclen+mit+Aminal-tert-butylester+zu+Enaminen+%28Orthoamides.+VIII.+Conversion+of+activated+methyl+groups+on+substituted+toluenes+and+heterocycles+to+enamines+by+reaction+with+aminal+tert-butyl+ester%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBredereck%26aufirst%3DH.%26atitle%3D%25C3%259Cber%2520die%2520Umsetung%2520aktivierter%2520Methylgruppen%2520an%2520substituierten%2520Toluolen%2520und%2520Heterocyclen%2520mit%2520Aminal-tert-butylester%2520zu%2520Enaminen%2520%2528Orthoamides.%2520VIII.%2520Conversion%2520of%2520activated%2520methyl%2520groups%2520on%2520substituted%2520toluenes%2520and%2520heterocycles%2520to%2520enamines%2520by%2520reaction%2520with%2520aminal%2520tert-butyl%2520ester%2529%26jtitle%3DChem.%2520Ber.%26date%3D1968%26volume%3D101%26spage%3D4056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm040159cb00019_1"><span><span class="NLM_string-ref">Biere, H.; Russe, R. Eine einfache methode zur nitrilbildung unter kettenverlängerung von aktiven alkylgruppen (A simple method for nitrile formation with chain elongation of active alkyl groups). <i>  Tetrahedron Lett</i>. <b>1979</b>, <i>20</i> (16), 1361−1362.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1979&pages=1362&issue=16&author=H.+Biere&author=R+Russe&title=Eine+einfache+methode+zur+nitrilbildung+unter+kettenverl%C3%A4ngerung+von+aktiven+alkylgruppen+%28A+simple+method+for+nitrile+formation+with+chain+elongation+of+active+alkyl+groups%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiere%26aufirst%3DH.%26atitle%3DEine%2520einfache%2520methode%2520zur%2520nitrilbildung%2520unter%2520kettenverl%25C3%25A4ngerung%2520von%2520aktiven%2520alkylgruppen%2520%2528A%2520simple%2520method%2520for%2520nitrile%2520formation%2520with%2520chain%2520elongation%2520of%2520active%2520alkyl%2520groups%2529%26jtitle%3DTetrahedron%2520Lett.%26date%3D1979%26volume%3D20%26issue%3D16%26spage%3D1362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00020"><div class="reference"><div class="NLM_citation" id="jm040159cb00020_1"><span><span class="NLM_string-ref">Orsini, F.; Pelizzoni, F.; Ricca, G. Zinc(0)-mediated formation of carbon−carbon bond from γ-bromo crotonate. <i>  Synth.</i><i> Comm</i>. <b>1982</b>, <i>12</i> (14), 1147−1154.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1982&pages=1154&issue=14&author=F.+Orsini&author=F.+Pelizzoni&author=G.+Ricca&author=+Zinc&title=formation+of+carbon%E2%88%92carbon+bond+from+%CE%B3-bromo+crotonate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrsini%26aufirst%3DF.%26atitle%3Dformation%2520of%2520carbon%25E2%2588%2592carbon%2520bond%2520from%2520%25CE%25B3-bromo%2520crotonate%26jtitle%3DSynth.%2520Comm.%26date%3D1982%26volume%3D12%26issue%3D14%26spage%3D1154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00021"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00021'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="jm040159cb00021_1"><span><span class="NLM_string-ref">Anthony, N. J.; Gomez, R. P.; Schaber, M. D.; Mosser, S. D.; Hamilton, K. A.; O'Neil, T. J.; Koblan, K. S.; Graham, S. L.; Hartman, G. D.; Shah, D.; Rands, E.; Kohl, N. E.; Gibbs, J. B.; Oliff, A. I. Design and in Vivo Analysis of Potent Non-Thiol Inhibitors of Farnesyl Protein Transferase. <i>  J. </i><i>Med. Chem.</i><b>1999</b>, <i>42</i> (17), 3356−3368.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3368&issue=17&author=N.+J.+Anthony&author=R.+P.+Gomez&author=M.+D.+Schaber&author=S.+D.+Mosser&author=K.+A.+Hamilton&author=T.+J.+O%27Neil&author=K.+S.+Koblan&author=S.+L.+Graham&author=G.+D.+Hartman&author=D.+Shah&author=E.+Rands&author=N.+E.+Kohl&author=J.+B.+Gibbs&author=A.+I+Oliff&title=Design+and+in+Vivo+Analysis+of+Potent+Non-Thiol+Inhibitors+of+Farnesyl+Protein+Transferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26atitle%3DDesign%2520and%2520in%2520Vivo%2520Analysis%2520of%2520Potent%2520Non-Thiol%2520Inhibitors%2520of%2520Farnesyl%2520Protein%2520Transferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26issue%3D17%26spage%3D3368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00022"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00022'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="jm040159cb00022_1"><span><span class="NLM_string-ref">Takacs, J. M.; Helle, M. A.; Seely, F. L. An improved procedure for the two carbon homologation of esters to α,β-unsaturated esters. <i>  Tetrahedron Lett. </i><b>1986</b>, <i>27 </i>(11), 1257−1260.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1986&pages=1260&issue=11&author=J.+M.+Takacs&author=M.+A.+Helle&author=F.+L+Seely&title=An+improved+procedure+for+the+two+carbon+homologation+of+esters+to+%CE%B1%2C%CE%B2-unsaturated+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakacs%26aufirst%3DJ.%2BM.%26atitle%3DAn%2520improved%2520procedure%2520for%2520the%2520two%2520carbon%2520homologation%2520of%2520esters%2520to%2520%25CE%25B1%252C%25CE%25B2-unsaturated%2520esters%26jtitle%3DTetrahedron%2520Lett.%26date%3D1986%26volume%3D27%26issue%3D11%26spage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00023"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00023'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="jm040159cb00023_1"><span><span class="NLM_string-ref">Wulff, G.; Wolf, G. Zur Chemie von Haftgruppen, VI. Über die Eignung verschiedener Aldehyde und Ketone als Haftgruppen fur Monoalkohole (Chemistry of binding sites. VI. On the suitability of various aldehydes and ketones as binding sites for monoalcohols). <i>  Chem. Ber</i>. <b>1986</b>, <i>119</i> (6), 1876−1889.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1986&pages=1889&issue=6&author=G.+Wulff&author=G+Wolf&title=Zur+Chemie+von+Haftgruppen%2C+VI.+%C3%9Cber+die+Eignung+verschiedener+Aldehyde+und+Ketone+als+Haftgruppen+fur+Monoalkohole+%28Chemistry+of+binding+sites.+VI.+On+the+suitability+of+various+aldehydes+and+ketones+as+binding+sites+for+monoalcohols%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWulff%26aufirst%3DG.%26atitle%3DZur%2520Chemie%2520von%2520Haftgruppen%252C%2520VI.%2520%25C3%259Cber%2520die%2520Eignung%2520verschiedener%2520Aldehyde%2520und%2520Ketone%2520als%2520Haftgruppen%2520fur%2520Monoalkohole%2520%2528Chemistry%2520of%2520binding%2520sites.%2520VI.%2520On%2520the%2520suitability%2520of%2520various%2520aldehydes%2520and%2520ketones%2520as%2520binding%2520sites%2520for%2520monoalcohols%2529%26jtitle%3DChem.%2520Ber.%26date%3D1986%26volume%3D119%26issue%3D6%26spage%3D1889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00024"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00024'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="jm040159cb00024_1"><span><span class="NLM_string-ref">Tsou, H.-R.; Mamuya, N.; Johnson, B. D.; Reich, M. F.; Gruber, B. C.; Ye, F.; Nilakantan, R.; Shen, R.; Discafani, C.; DeBlanc, R.; Davis, R.; Koehn, F. E.; Greenberger, L. M.; Wang, Y.-F.; Wissner, A. 6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity. <i>  J. Med. Chem. </i><b>2001</b>, <i>44</i>, 2719−2734.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2734&author=H.-R.+Tsou&author=N.+Mamuya&author=B.+D.+Johnson&author=M.+F.+Reich&author=B.+C.+Gruber&author=F.+Ye&author=R.+Nilakantan&author=R.+Shen&author=C.+Discafani&author=R.+DeBlanc&author=R.+Davis&author=F.+E.+Koehn&author=L.+M.+Greenberger&author=Y.-F.+Wang&author=A.+Wissner&author=+Substituted&title=Inhibitors+of+the+Epidermal+Growth+Factor+Receptor+%28EGFR%29+and+Human+Epidermal+Growth+Factor+Receptor+%28HER-2%29+Tyrosine+Kinases+with+Enhanced+Antitumor+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26atitle%3DInhibitors%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528EGFR%2529%2520and%2520Human%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528HER-2%2529%2520Tyrosine%2520Kinases%2520with%2520Enhanced%2520Antitumor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00025"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00025'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="jm040159cb00025_1"><span><span class="NLM_string-ref">Quanta and CHARMm are products of Accelrys Inc., 9685 Scranton Road San Diego, CA 92121-3752.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Quanta+and+CHARMm+are+products+of+Accelrys+Inc.%2C+9685+Scranton+Road+San+Diego%2C+CA+92121-3752.+Quanta+and+CHARMm+are+products+of+Accelrys+Inc.%2C+9685+Scranton+Road+San+Diego%2C+CA+92121-3752."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dother%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00026"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00026'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="jm040159cb00026_1"><span><span class="NLM_string-ref">Wissner, A.; Hamann, P. R.; Nilakantan, R.; Greenberger, L. M.; Ye, F.; Rapuano, T. A.; Loganzo, F. Syntheses and EGFR kinase inhibitory activity of 6-substituted-4-anilino [1,7] and [1,8] naphthyridine-3-carbonitriles. <i>  Bioorg. Med. Chem. Lett. </i><b>2004</b>, <i>14</i> (6), 1411−1416.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1416&issue=6&author=A.+Wissner&author=P.+R.+Hamann&author=R.+Nilakantan&author=L.+M.+Greenberger&author=F.+Ye&author=T.+A.+Rapuano&author=F+Loganzo&title=Syntheses+and+EGFR+kinase+inhibitory+activity+of+6-substituted-4-anilino+%5B1%2C7%5D+and+%5B1%2C8%5D+naphthyridine-3-carbonitriles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DSyntheses%2520and%2520EGFR%2520kinase%2520inhibitory%2520activity%2520of%25206-substituted-4-anilino%2520%255B1%252C7%255D%2520and%2520%255B1%252C8%255D%2520naphthyridine-3-carbonitriles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D6%26spage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00027"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00027'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="jm040159cb00027_1"><span><span class="NLM_string-ref">Akula, N.; Bhalla, J.; Sridhar, J.; Pattabiraman, N. Binding modes of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles to EGFR. <i>  Bioorg. Med. </i><i>Chem. Lett. </i><b>2004</b>, <i>14</i>, 3397−3400.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3400&author=N.+Akula&author=J.+Bhalla&author=J.+Sridhar&author=N+Pattabiraman&title=Binding+modes+of+6%2C7-disubstituted+4-anilinoquinoline-3-carbonitriles+to+EGFR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkula%26aufirst%3DN.%26atitle%3DBinding%2520modes%2520of%25206%252C7-disubstituted%25204-anilinoquinoline-3-carbonitriles%2520to%2520EGFR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00028"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00028'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="jm040159cb00028_1"><span><span class="NLM_string-ref">Torrance, C. J.; Jackson, P. E.; Montgomery, E.; Kinzler, K. W.; Vogelstein, B.; Wissner, A.; Nunes, M.; Frost, P.; Discafani, C. M. Combinatorial chemoprevention of intestinal neoplasia. <i>  Nat. Med</i>. <b>2000</b>, <i>6</i>, 1024−1028.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1028&author=C.+J.+Torrance&author=P.+E.+Jackson&author=E.+Montgomery&author=K.+W.+Kinzler&author=B.+Vogelstein&author=A.+Wissner&author=M.+Nunes&author=P.+Frost&author=C.+M+Discafani&title=Combinatorial+chemoprevention+of+intestinal+neoplasia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorrance%26aufirst%3DC.%2BJ.%26atitle%3DCombinatorial%2520chemoprevention%2520of%2520intestinal%2520neoplasia%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26spage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00029"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00029'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="jm040159cb00029_1"><span><span class="NLM_string-ref">Rabindran, S. K.; Discafani, C. M.; Rosfjord, E. C.; Baxter, M.; Floyd, M. B.; Golas, J.; Hallett, W. A.; Johnson, S. D.; Nilakantan, R.; Overbeek, E.; Reich, M. F.; Shen, R.; Shi, A.; Tsou, H.-R.; Wang, Y.-F.; Wissner, A. Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase. Cancer Research. <i>  Cancer Res</i>. <b>2004</b>, <i>64</i>, 3958−3965.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=3965&author=S.+K.+Rabindran&author=C.+M.+Discafani&author=E.+C.+Rosfjord&author=M.+Baxter&author=M.+B.+Floyd&author=J.+Golas&author=W.+A.+Hallett&author=S.+D.+Johnson&author=R.+Nilakantan&author=E.+Overbeek&author=M.+F.+Reich&author=R.+Shen&author=A.+Shi&author=H.-R.+Tsou&author=Y.-F.+Wang&author=A+Wissner&title=Antitumor+activity+of+HKI-272%2C+an+orally+active%2C+irreversible+inhibitor+of+the+HER-2+tyrosine+kinase.+Cancer+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26atitle%3DAntitumor%2520activity%2520of%2520HKI-272%252C%2520an%2520orally%2520active%252C%2520irreversible%2520inhibitor%2520of%2520the%2520HER-2%2520tyrosine%2520kinase.%2520Cancer%2520Research%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D3965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00030"><div class="reference"><div class="NLM_citation" id="jm040159cb00030_1"><span><span class="NLM_string-ref">Jochims, J. C.; Abu-Taha, A. Über 5- und 4-Hydroxythiazolidin-2-thione (Studies on 5- and 4-hydroxythiazolidine-2-thiones). <i>  Chem Ber</i>. <b>1976</b>, <i>109</i> (1), 139−153.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Jochims%2C+J.+C.%3B+Abu-Taha%2C+A.+%C3%9Cber+5-+und+4-Hydroxythiazolidin-2-thione+%28Studies+on+5-+and+4-hydroxythiazolidine-2-thiones%29.+Chem+Ber.+1976%2C+109+%281%29%2C+139%E2%88%92153.+Jochims%2C+J.+C.%3B+Abu-Taha%2C+A.+%C3%9Cber+5-+und+4-Hydroxythiazolidin-2-thione+%28Studies+on+5-+and+4-hydroxythiazolidine-2-thiones%29.+Chem+Ber.+1976%2C+109+%281%29%2C+139%E2%88%92153."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJochims%26aufirst%3DJ.%2BC.%26jtitle%3DChem%2520Ber.%26date%3D1976%26volume%3D109%26issue%3D1%26spage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00031"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00031'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="jm040159cb00031_1"><span><span class="NLM_string-ref">Alcaldi, E.; Alemany, M.; Gisbert, M. A direct synthetic approach to novel quadrupolar [14] azolophanes. <i>  Tetrahedron</i><b>1996</b>, <i>52</i>, 15171−15188.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1996&pages=15188&author=E.+Alcaldi&author=M.+Alemany&author=M+Gisbert&title=A+direct+synthetic+approach+to+novel+quadrupolar+%5B14%5D+azolophanes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlcaldi%26aufirst%3DE.%26atitle%3DA%2520direct%2520synthetic%2520approach%2520to%2520novel%2520quadrupolar%2520%255B14%255D%2520azolophanes%26jtitle%3DTetrahedron%26date%3D1996%26volume%3D52%26spage%3D15188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00032"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00032'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="jm040159cb00032_1"><span><span class="NLM_string-ref">Shkodinskaya, E. N.; Kurdyukova, E. M.; Berlin, A. Y. Halogen substitution in the ring of sarcolysin derivatives. <i>  J. Gen. Chem. USSR (Engl. Transl.)</i><b>1961</b>, <i>31</i>, 3537−3540.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1961&pages=3540&author=E.+N.+Shkodinskaya&author=E.+M.+Kurdyukova&author=A.+Y+Berlin&title=Halogen+substitution+in+the+ring+of+sarcolysin+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShkodinskaya%26aufirst%3DE.%2BN.%26atitle%3DHalogen%2520substitution%2520in%2520the%2520ring%2520of%2520sarcolysin%2520derivatives%26jtitle%3DJ.%2520Gen.%2520Chem.%2520USSR%2520%2528Engl.%2520Transl.%2529%26date%3D1961%26volume%3D31%26spage%3D3540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00033"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00033'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="jm040159cb00033_1"><span><span class="NLM_string-ref">Gall, R.; Erlenmeyer, H. Über einige Derivate heterocyclischer Carbonsäuren IV. Metallionen und biologische Wirkung, 36. Mitteilung (Metal ions and biological action. XXXVI. Some derivatives of heterocyclic carboxylic acids. IV). <i>  Helv. Chim Acta</i><b>1955</b>, <i>38</i> (6), 1421−1423.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1955&pages=1423&issue=6&author=R.+Gall&author=H+Erlenmeyer&title=%C3%9Cber+einige+Derivate+heterocyclischer+Carbons%C3%A4uren+IV.+Metallionen+und+biologische+Wirkung%2C+36.+Mitteilung+%28Metal+ions+and+biological+action.+XXXVI.+Some+derivatives+of+heterocyclic+carboxylic+acids.+IV%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGall%26aufirst%3DR.%26atitle%3D%25C3%259Cber%2520einige%2520Derivate%2520heterocyclischer%2520Carbons%25C3%25A4uren%2520IV.%2520Metallionen%2520und%2520biologische%2520Wirkung%252C%252036.%2520Mitteilung%2520%2528Metal%2520ions%2520and%2520biological%2520action.%2520XXXVI.%2520Some%2520derivatives%2520of%2520heterocyclic%2520carboxylic%2520acids.%2520IV%2529%26jtitle%3DHelv.%2520Chim%2520Acta%26date%3D1955%26volume%3D38%26issue%3D6%26spage%3D1423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00034"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00034'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="jm040159cb00034_1"><span><span class="NLM_string-ref">Boger, D. L.; Zarrinmayeh, H. Regiocontrolled Nucleophilic Addition to Selectively Activated <i>p</i>-Quinone Diimines:  Alternative Preparation of a Key Intermediate Employed in the Preparation of the CC1065 Left-Hand Subunit. <i>  J. Org. Chem</i>. <b>1990</b>, <i>55</i>, 1379−1390.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=1390&author=D.+L.+Boger&author=H+Zarrinmayeh&title=Regiocontrolled+Nucleophilic+Addition+to+Selectively+Activated+p-Quinone+Diimines%3A%E2%80%89+Alternative+Preparation+of+a+Key+Intermediate+Employed+in+the+Preparation+of+the+CC1065+Left-Hand+Subunit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DRegiocontrolled%2520Nucleophilic%2520Addition%2520to%2520Selectively%2520Activated%2520p-Quinone%2520Diimines%253A%25E2%2580%2589%2520Alternative%2520Preparation%2520of%2520a%2520Key%2520Intermediate%2520Employed%2520in%2520the%2520Preparation%2520of%2520the%2520CC1065%2520Left-Hand%2520Subunit%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1990%26volume%3D55%26spage%3D1390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm040159cb00035"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm040159cb00035'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="jm040159cb00035_1"><span><span class="NLM_string-ref">Krawczul, H. The Mannich Reacion of Malonic Acid. An Efficient Route to Some α-Functionalized Acrylates. <i>  Synth. Commun. </i><b>1995</b>, <i>25</i>, 641−650.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=650&author=H+Krawczul&title=The+Mannich+Reacion+of+Malonic+Acid.+An+Efficient+Route+to+Some+%CE%B1-Functionalized+Acrylates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrawczul%26aufirst%3DH%26atitle%3DThe%2520Mannich%2520Reacion%2520of%2520Malonic%2520Acid.%2520An%2520Efficient%2520Route%2520to%2520Some%2520%25CE%25B1-Functionalized%2520Acrylates%26jtitle%3DSynth.%2520Commun.%26date%3D1995%26volume%3D25%26spage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm040159cb00001':['jm040159cb00001_1'],'jm040159cb00002':['jm040159cb00002_1'],'jm040159cb00003':['jm040159cb00003_1'],'jm040159cb00004':['jm040159cb00004_1'],'jm040159cb00005':['jm040159cb00005_1'],'jm040159cb00006':['jm040159cb00006_1'],'jm040159cb00007':['jm040159cb00007_1'],'jm040159cb00008':['jm040159cb00008_1'],'jm040159cb00009':['jm040159cb00009_1'],'jm040159cb00010':['jm040159cb00010_1'],'jm040159cb00011':['jm040159cb00011_1'],'jm040159cb00012':['jm040159cb00012_1'],'jm040159cb00013':['jm040159cb00013_1'],'jm040159cb00014':['jm040159cb00014_1'],'jm040159cb00015':['jm040159cb00015_1'],'jm040159cb00016':['jm040159cb00016_1'],'jm040159cb00017':['jm040159cb00017_1'],'jm040159cb00018':['jm040159cb00018_1'],'jm040159cb00019':['jm040159cb00019_1'],'jm040159cb00020':['jm040159cb00020_1'],'jm040159cb00021':['jm040159cb00021_1'],'jm040159cb00022':['jm040159cb00022_1'],'jm040159cb00023':['jm040159cb00023_1'],'jm040159cb00024':['jm040159cb00024_1'],'jm040159cb00025':['jm040159cb00025_1'],'jm040159cb00026':['jm040159cb00026_1'],'jm040159cb00027':['jm040159cb00027_1'],'jm040159cb00028':['jm040159cb00028_1'],'jm040159cb00029':['jm040159cb00029_1'],'jm040159cb00030':['jm040159cb00030_1'],'jm040159cb00031':['jm040159cb00031_1'],'jm040159cb00032':['jm040159cb00032_1'],'jm040159cb00033':['jm040159cb00033_1'],'jm040159cb00034':['jm040159cb00034_1'],'jm040159cb00035':['jm040159cb00035_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 211 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Adam Birkholz, David J. Kopecky, Laurie P. Volak, Michael D. Bartberger, Yuping Chen, Christopher M. Tegley, Tara Arvedson, John D. McCarter, Christopher Fotsch, <span class="NLM_string-name hlFld-ContribAuthor">Victor J. Cee</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic Study of the Glutathione Reactivity of N-Phenylacrylamides: 2. Effects of Acrylamide Substitution. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11602-11614. <a href="https://doi.org/10.1021/acs.jmedchem.0c00749" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00749%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSystematic%252BStudy%252Bof%252Bthe%252BGlutathione%252BReactivity%252Bof%252BN-Phenylacrylamides%25253A%252B2.%252BEffects%252Bof%252BAcrylamide%252BSubstitution%26aulast%3DBirkholz%26aufirst%3DAdam%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D04052020%26date%3D09102020%26date%3D23092020%26volume%3D63%26issue%3D20%26spage%3D11602%26epage%3D11614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jonas Lategahn, Julia Hardick, Tobias Grabe, Janina Niggenaber, Kirujan Jeyakumar, Marina Keul, Hannah L. Tumbrink, Christian Becker, Luke Hodson, Tonia Kirschner, Philip Klövekorn, Julia Ketzer, Matthias Baumann, Susanne Terheyden, Anke Unger, Jörn Weisner, Matthias P. Müller, Willem A. L. van Otterlo, Sebastian Bauer, <span class="NLM_string-name hlFld-ContribAuthor">Daniel Rauh</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Her2-insYVMA with Covalent Inhibitors—A Focused Compound Screening and Structure-Based Design Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11725-11755. <a href="https://doi.org/10.1021/acs.jmedchem.0c00870" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00870</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00870%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BHer2-insYVMA%252Bwith%252BCovalent%252BInhibitors%2525E2%252580%252594A%252BFocused%252BCompound%252BScreening%252Band%252BStructure-Based%252BDesign%252BApproach%26aulast%3DLategahn%26aufirst%3DJonas%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22052020%26date%3D30092020%26date%3D15092020%26volume%3D63%26issue%3D20%26spage%3D11725%26epage%3D11755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tonko Dražić, Sara Kopf, James Corridan, Mila M. Leuthold, Branimir Bertoša, <span class="NLM_string-name hlFld-ContribAuthor">Christian D. Klein</span>. </span><span class="cited-content_cbyCitation_article-title">Peptide-β-lactam Inhibitors of Dengue and West Nile Virus NS2B-NS3 Protease Display Two Distinct Binding Modes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (1)
                                     , 140-156. <a href="https://doi.org/10.1021/acs.jmedchem.9b00759" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00759</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00759%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPeptide-%2525CE%2525B2-lactam%252BInhibitors%252Bof%252BDengue%252Band%252BWest%252BNile%252BVirus%252BNS2B-NS3%252BProtease%252BDisplay%252BTwo%252BDistinct%252BBinding%252BModes%26aulast%3DDra%25C5%25BEi%25C4%2587%26aufirst%3DTonko%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D09052019%26date%3D24122019%26date%3D05122019%26volume%3D63%26issue%3D1%26spage%3D140%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Janina Niggenaber, Julia Hardick, Jonas Lategahn, <span class="NLM_string-name hlFld-ContribAuthor">Daniel Rauh</span>. </span><span class="cited-content_cbyCitation_article-title">Structure Defines Function: Clinically Relevant Mutations in ErbB Kinases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (1)
                                     , 40-51. <a href="https://doi.org/10.1021/acs.jmedchem.9b00964" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00964</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00964%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%252BDefines%252BFunction%25253A%252BClinically%252BRelevant%252BMutations%252Bin%252BErbB%252BKinases%26aulast%3DNiggenaber%26aufirst%3DJanina%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D17062019%26date%3D28082019%26date%3D15082019%26volume%3D63%26issue%3D1%26spage%3D40%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Andrew
C. Flick, Carolyn A. Leverett, Hong X. Ding, Emma McInturff, Sarah J. Fink, Christopher J. Helal, <span class="NLM_string-name hlFld-ContribAuthor">Christopher J. O’Donnell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Approaches to the New Drugs Approved During 2017. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (16)
                                     , 7340-7382. <a href="https://doi.org/10.1021/acs.jmedchem.9b00196" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00196%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252BApproaches%252Bto%252Bthe%252BNew%252BDrugs%252BApproved%252BDuring%252B2017%26aulast%3DFlick%26aufirst%3DAndrew%2BC.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30012019%26date%3D15042019%26date%3D02042019%26volume%3D62%26issue%3D16%26spage%3D7340%26epage%3D7382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yulan Wang, Yang Dai, Xiaowei Wu, Fei Li, Bo Liu, Chunpu Li, Qiufeng Liu, Yuanyang Zhou, Bao Wang, Mingrui Zhu, Rongrong Cui, Xiaoqin Tan, Zhaoping Xiong, Jia Liu, Minjia Tan, Yechun Xu, Meiyu Geng, Hualiang Jiang, Hong Liu, Jing Ai, <span class="NLM_string-name hlFld-ContribAuthor">Mingyue Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of a Series of Pyrazolo[3,4-d]pyridazinone Compounds as the Novel Covalent Fibroblast Growth Factor Receptor Inhibitors by the Rational Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (16)
                                     , 7473-7488. <a href="https://doi.org/10.1021/acs.jmedchem.9b00510" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00510%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252Ba%252BSeries%252Bof%252BPyrazolo%25255B3%25252C4-d%25255Dpyridazinone%252BCompounds%252Bas%252Bthe%252BNovel%252BCovalent%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252BInhibitors%252Bby%252Bthe%252BRational%252BDrug%252BDesign%26aulast%3DWang%26aufirst%3DYulan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D22032019%26date%3D09082019%26date%3D23072019%26volume%3D62%26issue%3D16%26spage%3D7473%26epage%3D7488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alexander M. Cryer, Cheuk Chan, Anastasia Eftychidou, Christy Maksoudian, Mohan Mahesh, Teresa D. Tetley, Alan C. Spivey, <span class="NLM_string-name hlFld-ContribAuthor">Andrew J. Thorley</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine Kinase Inhibitor Gold Nanoconjugates for the Treatment of Non-Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2019,</strong> <em>11 </em>
                                    (18)
                                     , 16336-16346. <a href="https://doi.org/10.1021/acsami.9b02986" title="DOI URL">https://doi.org/10.1021/acsami.9b02986</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.9b02986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.9b02986%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DTyrosine%252BKinase%252BInhibitor%252BGold%252BNanoconjugates%252Bfor%252Bthe%252BTreatment%252Bof%252BNon-Small%252BCell%252BLung%252BCancer%26aulast%3DCryer%26aufirst%3DAlexander%2BM.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D21022019%26date%3D15042019%26date%3D25042019%26date%3D15042019%26volume%3D11%26issue%3D18%26spage%3D16336%26epage%3D16346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yongjia Hao, Jiankun Lyu, Rong Qu, Yi Tong, Deheng Sun, Fang Feng, Linjiang Tong, Tingyuan Yang, Zhenjiang Zhao, Lili Zhu, Jian Ding, Yufang Xu, Hua Xie, <span class="NLM_string-name hlFld-ContribAuthor">Honglin Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (13)
                                     , 5609-5622. <a href="https://doi.org/10.1021/acs.jmedchem.8b00346" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00346</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00346%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BPyrimido%25255B4%25252C5-d%25255Dpyrimidine-2%25252C4%2525281H%25252C3H%252529-diones%252Bas%252BPotent%252Band%252BSelective%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BInhibitors%252Bagainst%252BL858R%25252FT790M%252BResistance%252BMutation%26aulast%3DHao%26aufirst%3DYongjia%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04032018%26date%3D25062018%26date%3D15062018%26volume%3D61%26issue%3D13%26spage%3D5609%26epage%3D5622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyung Hwan  Oh</span>, <span class="hlFld-ContribAuthor ">Jin Gyeong  Kim</span>, and <span class="hlFld-ContribAuthor ">Jin Kyoon  Park</span>  . </span><span class="cited-content_cbyCitation_article-title">A Modular Synthesis of 4-Aminoquinolines and [1,3] N-to-C Rearrangement to Quinolin-4-ylmethanesulfonamides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (15)
                                     , 3994-3997. <a href="https://doi.org/10.1021/acs.orglett.7b01701" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b01701</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b01701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b01701%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BModular%252BSynthesis%252Bof%252B4-Aminoquinolines%252Band%252B%25255B1%25252C3%25255D%252BN-to-C%252BRearrangement%252Bto%252BQuinolin-4-ylmethanesulfonamides%26aulast%3DOh%26aufirst%3DKyung%2BHwan%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D06062017%26date%3D20072017%26date%3D04082017%26volume%3D19%26issue%3D15%26spage%3D3994%26epage%3D3997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeff B.  Smaill</span>, <span class="hlFld-ContribAuthor ">Andrea J.  Gonzales</span>, <span class="hlFld-ContribAuthor ">Julie A.  Spicer</span>, <span class="hlFld-ContribAuthor ">Helen  Lee</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Reed</span>, <span class="hlFld-ContribAuthor ">Karen  Sexton</span>, <span class="hlFld-ContribAuthor ">Irene W.  Althaus</span>, <span class="hlFld-ContribAuthor ">Tong  Zhu</span>, <span class="hlFld-ContribAuthor ">Shannon L.  Black</span>, <span class="hlFld-ContribAuthor ">Adrian  Blaser</span>, <span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Paul A.  Ellis</span>, <span class="hlFld-ContribAuthor ">Stephen  Fakhoury</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Harvey</span>, <span class="hlFld-ContribAuthor ">Ken  Hook</span>, <span class="hlFld-ContribAuthor ">Florence O. J.  McCarthy</span>, <span class="hlFld-ContribAuthor ">Brian D.  Palmer</span>, <span class="hlFld-ContribAuthor ">Freddy  Rivault</span>, <span class="hlFld-ContribAuthor ">Kevin  Schlosser</span>, <span class="hlFld-ContribAuthor ">Teresa  Ellis</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Thompson</span>, <span class="hlFld-ContribAuthor ">Erin  Trachet</span>, <span class="hlFld-ContribAuthor ">R. Thomas  Winters</span>, <span class="hlFld-ContribAuthor ">Haile  Tecle</span>, and <span class="hlFld-ContribAuthor ">Alexander  Bridges</span>  . </span><span class="cited-content_cbyCitation_article-title">Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 8103-8124. <a href="https://doi.org/10.1021/acs.jmedchem.6b00883" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00883</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00883%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTyrosine%252BKinase%252BInhibitors.%252B20.%252BOptimization%252Bof%252BSubstituted%252BQuinazoline%252Band%252BPyrido%25255B3%25252C4-d%25255Dpyrimidine%252BDerivatives%252Bas%252BOrally%252BActive%25252C%252BIrreversible%252BInhibitors%252Bof%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BFamily%26aulast%3DSmaill%26aufirst%3DJeff%2BB.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D15062016%26date%3D22082016%26date%3D08092016%26date%3D04082016%26volume%3D59%26issue%3D17%26spage%3D8103%26epage%3D8124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gérald  Lelais</span>, <span class="hlFld-ContribAuthor ">Robert  Epple</span>, <span class="hlFld-ContribAuthor ">Thomas H.  Marsilje</span>, <span class="hlFld-ContribAuthor ">Yun O.  Long</span>, <span class="hlFld-ContribAuthor ">Matthew  McNeill</span>, <span class="hlFld-ContribAuthor ">Bei  Chen</span>, <span class="hlFld-ContribAuthor ">Wenshuo  Lu</span>, <span class="hlFld-ContribAuthor ">Jaganmohan  Anumolu</span>, <span class="hlFld-ContribAuthor ">Sangamesh  Badiger</span>, <span class="hlFld-ContribAuthor ">Badry  Bursulaya</span>, <span class="hlFld-ContribAuthor ">Michael  DiDonato</span>, <span class="hlFld-ContribAuthor ">Rina  Fong</span>, <span class="hlFld-ContribAuthor ">Jose  Juarez</span>, <span class="hlFld-ContribAuthor ">Jie  Li</span>, <span class="hlFld-ContribAuthor ">Mari  Manuia</span>, <span class="hlFld-ContribAuthor ">Daniel E.  Mason</span>, <span class="hlFld-ContribAuthor ">Perry  Gordon</span>, <span class="hlFld-ContribAuthor ">Todd  Groessl</span>, <span class="hlFld-ContribAuthor ">Kevin  Johnson</span>, <span class="hlFld-ContribAuthor ">Yong  Jia</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Chun  Li</span>, <span class="hlFld-ContribAuthor ">John  Isbell</span>, <span class="hlFld-ContribAuthor ">Glen  Spraggon</span>, <span class="hlFld-ContribAuthor ">Steven  Bender</span>, and <span class="hlFld-ContribAuthor ">Pierre-Yves  Michellys</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (14)
                                     , 6671-6689. <a href="https://doi.org/10.1021/acs.jmedchem.5b01985" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01985</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01985%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528R%25252CE%252529-N-%2525287-Chloro-1-%2525281-%25255B4-%252528dimethylamino%252529but-2-enoyl%25255Dazepan-3-yl%252529-1H-benzo%25255Bd%25255Dimidazol-2-yl%252529-2-methylisonicotinamide%252B%252528EGF816%252529%25252C%252Ba%252BNovel%25252C%252BPotent%25252C%252Band%252BWT%252BSparing%252BCovalent%252BInhibitor%252Bof%252BOncogenic%252B%252528L858R%25252C%252Bex19del%252529%252Band%252BResistant%252B%252528T790M%252529%252BEGFR%252BMutants%252Bfor%252Bthe%252BTreatment%252Bof%252BEGFR%252BMutant%252BNon-Small-Cell%252BLung%252BCancers%26aulast%3DLelais%26aufirst%3DG%25C3%25A9rald%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D22122015%26date%3D19072016%26date%3D28072016%26volume%3D59%26issue%3D14%26spage%3D6671%26epage%3D6689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Jessica E.    Reed </span><span class="hlFld-ContribAuthor "> Jeff B.    Smaill </span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of Dacomitinib, a Potent Irreversible EGFR Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 207-233. <a href="https://doi.org/10.1021/bk-2016-1239.ch008" title="DOI URL">https://doi.org/10.1021/bk-2016-1239.ch008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1239.ch008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1239.ch008%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Bof%252BDacomitinib%25252C%252Ba%252BPotent%252BIrreversible%252BEGFR%252BInhibitor%26aulast%3DReed%26aufirst%3DJessica%2BE.%26date%3D2016%26date%3D2016%26spage%3D207%26epage%3D233%26atitle%3DComprehensive%252BAccounts%252Bof%252BPharmaceutical%252BResearch%252Band%252BDevelopment%25253A%252BFrom%252BDiscovery%252Bto%252BLate-Stage%252BProcess%252BDevelopment%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2016%26date%3D2016%26volume%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xitao  Li</span>, <span class="hlFld-ContribAuthor ">Yingying  Zuo</span>, <span class="hlFld-ContribAuthor ">Guanghui  Tang</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Xueying  Wang</span>, <span class="hlFld-ContribAuthor ">Tianlin  Guo</span>, <span class="hlFld-ContribAuthor ">Mengying  Xia</span>, <span class="hlFld-ContribAuthor ">Ning  Ding</span>, and <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of 2,5-Diaminopyrimidine Covalent Irreversible Inhibitors of Bruton’s Tyrosine Kinase with in Vivo Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5112-5128. <a href="https://doi.org/10.1021/jm4017762" title="DOI URL">https://doi.org/10.1021/jm4017762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4017762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4017762%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252B2%25252C5-Diaminopyrimidine%252BCovalent%252BIrreversible%252BInhibitors%252Bof%252BBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%252Bwith%252Bin%252BVivo%252BAntitumor%252BActivity%26aulast%3DLi%26aufirst%3DXitao%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D16112013%26date%3D10062014%26date%3D26062014%26volume%3D57%26issue%3D12%26spage%3D5112%26epage%3D5128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Yanlong  Kang</span>, <span class="hlFld-ContribAuthor ">Hardik J.  Patel</span>, <span class="hlFld-ContribAuthor ">Maulik R.  Patel</span>, <span class="hlFld-ContribAuthor ">Pallav D.  Patel</span>, <span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Yogita  Patel</span>, <span class="hlFld-ContribAuthor ">Alexander  Gozman</span>, <span class="hlFld-ContribAuthor ">Ronnie  Maharaj</span>, <span class="hlFld-ContribAuthor ">Cristina C.  Clement</span>, <span class="hlFld-ContribAuthor ">Alvin  Lu</span>, <span class="hlFld-ContribAuthor ">Jason C.  Young</span>, and <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>  . </span><span class="cited-content_cbyCitation_article-title">Heat Shock Protein 70 Inhibitors. 2. 2,5′-Thiodipyrimidines, 5-(Phenylthio)pyrimidines, 2-(Pyridin-3-ylthio)pyrimidines, and 3-(Phenylthio)pyridines as Reversible Binders to an Allosteric Site on Heat Shock Protein 70. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (4)
                                     , 1208-1224. <a href="https://doi.org/10.1021/jm401552y" title="DOI URL">https://doi.org/10.1021/jm401552y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401552y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401552y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHeat%252BShock%252BProtein%252B70%252BInhibitors.%252B2.%252B2%25252C5%2525E2%252580%2525B2-Thiodipyrimidines%25252C%252B5-%252528Phenylthio%252529pyrimidines%25252C%252B2-%252528Pyridin-3-ylthio%252529pyrimidines%25252C%252Band%252B3-%252528Phenylthio%252529pyridines%252Bas%252BReversible%252BBinders%252Bto%252Ban%252BAllosteric%252BSite%252Bon%252BHeat%252BShock%252BProtein%252B70%26aulast%3DTaldone%26aufirst%3DTony%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D04102013%26date%3D18022014%26date%3D27022014%26volume%3D57%26issue%3D4%26spage%3D1208%26epage%3D1224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Lianwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Ku</span>, <span class="hlFld-ContribAuthor ">Fang  Bai</span>, <span class="hlFld-ContribAuthor ">Zhenjiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Yufang  Xu</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, and <span class="hlFld-ContribAuthor ">Honglin  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Pteridin-7(8H)-one-Based Irreversible Inhibitors Targeting the Epidermal Growth Factor Receptor (EGFR) Kinase T790M/L858R Mutant. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (20)
                                     , 7821-7837. <a href="https://doi.org/10.1021/jm401045n" title="DOI URL">https://doi.org/10.1021/jm401045n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401045n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401045n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPteridin-7%2525288H%252529-one-Based%252BIrreversible%252BInhibitors%252BTargeting%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BKinase%252BT790M%25252FL858R%252BMutant%26aulast%3DZhou%26aufirst%3DWei%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D03042013%26date%3D09102013%26date%3D24102013%26date%3D22092013%26volume%3D56%26issue%3D20%26spage%3D7821%26epage%3D7837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianwei  Wu</span>, <span class="hlFld-ContribAuthor ">Wenteng  Chen</span>, <span class="hlFld-ContribAuthor ">Guangxin  Xia</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiaan  Shao</span>, <span class="hlFld-ContribAuthor ">Biqin  Tan</span>, <span class="hlFld-ContribAuthor ">Chunchun  Zhang</span>, <span class="hlFld-ContribAuthor ">Wanwan  Yu</span>, <span class="hlFld-ContribAuthor ">Qinjie  Weng</span>, <span class="hlFld-ContribAuthor ">Haiyan  Liu</span>, <span class="hlFld-ContribAuthor ">Miao  Hu</span>, <span class="hlFld-ContribAuthor ">Hailin  Deng</span>, <span class="hlFld-ContribAuthor ">Yu  Hao</span>, <span class="hlFld-ContribAuthor ">Jingkang  Shen</span>, and <span class="hlFld-ContribAuthor ">Yongping  Yu</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting EGFR. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (10)
                                     , 974-978. <a href="https://doi.org/10.1021/ml4002437" title="DOI URL">https://doi.org/10.1021/ml4002437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml4002437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml4002437%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BConformationally%252BConstrained%252BInhibitors%252BTargeting%252BEGFR%26aulast%3DWu%26aufirst%3DJianwei%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D27062013%26date%3D06082013%26date%3D09082013%26date%3D10102013%26date%3D06082013%26volume%3D4%26issue%3D10%26spage%3D974%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Hui  Peng</span>, <span class="hlFld-ContribAuthor ">Hui-Yi  Shiao</span>, <span class="hlFld-ContribAuthor ">Chih-Hsiang  Tu</span>, <span class="hlFld-ContribAuthor ">Pang-Min  Liu</span>, <span class="hlFld-ContribAuthor ">John Tsu-An  Hsu</span>, <span class="hlFld-ContribAuthor ">Prashanth Kumar  Amancha</span>, <span class="hlFld-ContribAuthor ">Jian-Sung  Wu</span>, <span class="hlFld-ContribAuthor ">Mohane Selvaraj  Coumar</span>, <span class="hlFld-ContribAuthor ">Chun-Hwa  Chen</span>, <span class="hlFld-ContribAuthor ">Sing-Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-Hsing  Lin</span>, <span class="hlFld-ContribAuthor ">Hsu-Yi  Sun</span>, <span class="hlFld-ContribAuthor ">Yu-Sheng  Chao</span>, <span class="hlFld-ContribAuthor ">Ping-Chiang  Lyu</span>, <span class="hlFld-ContribAuthor ">Hsing-Pang  Hsieh</span>, and <span class="hlFld-ContribAuthor ">Su-Ying  Wu</span>  . </span><span class="cited-content_cbyCitation_article-title">Protein Kinase Inhibitor Design by Targeting the Asp-Phe-Gly (DFG) Motif: The Role of the DFG Motif in the Design of Epidermal Growth Factor Receptor Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (10)
                                     , 3889-3903. <a href="https://doi.org/10.1021/jm400072p" title="DOI URL">https://doi.org/10.1021/jm400072p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400072p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400072p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProtein%252BKinase%252BInhibitor%252BDesign%252Bby%252BTargeting%252Bthe%252BAsp-Phe-Gly%252B%252528DFG%252529%252BMotif%25253A%252BThe%252BRole%252Bof%252Bthe%252BDFG%252BMotif%252Bin%252Bthe%252BDesign%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BInhibitors%26aulast%3DPeng%26aufirst%3DYi-Hui%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D15012013%26date%3D10052013%26date%3D23052013%26date%3D23042013%26volume%3D56%26issue%3D10%26spage%3D3889%26epage%3D3903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongjun  Mao</span>, <span class="hlFld-ContribAuthor ">Zheng  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yang</span>, <span class="hlFld-ContribAuthor ">Xiangfei  Xia</span>, <span class="hlFld-ContribAuthor ">Rongxia  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Li</span>, <span class="hlFld-ContribAuthor ">Xiangrui  Jiang</span>, <span class="hlFld-ContribAuthor ">Kai  Xie</span>, <span class="hlFld-ContribAuthor ">Jin  Zheng</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Jin  Suo</span>, and <span class="hlFld-ContribAuthor ">Jingshan  Shen</span>  . </span><span class="cited-content_cbyCitation_article-title">A New and Improved Process for N-(4-Chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2012,</strong> <em>16 </em>
                                    (12)
                                     , 1970-1973. <a href="https://doi.org/10.1021/op300260m" title="DOI URL">https://doi.org/10.1021/op300260m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op300260m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop300260m%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DA%252BNew%252Band%252BImproved%252BProcess%252Bfor%252BN-%2525284-Chloro-3-cyano-7-ethoxyquinolin-6-yl%252529acetamide%26aulast%3DMao%26aufirst%3DYongjun%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D18092012%26date%3D16112012%26date%3D21122012%26date%3D08112012%26volume%3D16%26issue%3D12%26spage%3D1970%26epage%3D1973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tjeerd  Barf</span> and <span class="hlFld-ContribAuthor ">Allard  Kaptein</span>  . </span><span class="cited-content_cbyCitation_article-title">Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (14)
                                     , 6243-6262. <a href="https://doi.org/10.1021/jm3003203" title="DOI URL">https://doi.org/10.1021/jm3003203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3003203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3003203%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIrreversible%252BProtein%252BKinase%252BInhibitors%25253A%252BBalancing%252Bthe%252BBenefits%252Band%252BRisks%26aulast%3DBarf%26aufirst%3DTjeerd%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D07032012%26date%3D08062012%26date%3D26072012%26date%3D23052012%26volume%3D55%26issue%3D14%26spage%3D6243%26epage%3D6262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youichi  Kawakita</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Banno</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Ohashi</span>, <span class="hlFld-ContribAuthor ">Toshiya  Tamura</span>, <span class="hlFld-ContribAuthor ">Tadashi  Yusa</span>, <span class="hlFld-ContribAuthor ">Akiko  Nakayama</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Miki</span>, <span class="hlFld-ContribAuthor ">Hidehisa  Iwata</span>, <span class="hlFld-ContribAuthor ">Hidenori  Kamiguchi</span>, <span class="hlFld-ContribAuthor ">Toshimasa  Tanaka</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Habuka</span>, <span class="hlFld-ContribAuthor ">Satoshi  Sogabe</span>, <span class="hlFld-ContribAuthor ">Yoshikazu  Ohta</span>, and <span class="hlFld-ContribAuthor ">Tomoyasu  Ishikawa</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Pyrrolo[3,2-d]pyrimidine Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors: Exploration of Novel Back-Pocket Binders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (8)
                                     , 3975-3991. <a href="https://doi.org/10.1021/jm300185p" title="DOI URL">https://doi.org/10.1021/jm300185p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300185p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300185p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BPyrrolo%25255B3%25252C2-d%25255Dpyrimidine%252BHuman%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B2%252B%252528HER2%252529%25252FEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BDual%252BInhibitors%25253A%252BExploration%252Bof%252BNovel%252BBack-Pocket%252BBinders%26aulast%3DKawakita%26aufirst%3DYouichi%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D10022012%26date%3D10042012%26date%3D26042012%26date%3D22032012%26volume%3D55%26issue%3D8%26spage%3D3975%26epage%3D3991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaohua  Chang</span>, <span class="hlFld-ContribAuthor ">Lianwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Shilin  Xu</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, <span class="hlFld-ContribAuthor ">Tianfeng  Xu</span>, <span class="hlFld-ContribAuthor ">Yingxue  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaomei  Ren</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Duanqing  Pei</span>, and <span class="hlFld-ContribAuthor ">Ke  Ding</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting Epidermal Growth Factor Receptor Threonine790 → Methionine790 Mutant. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (6)
                                     , 2711-2723. <a href="https://doi.org/10.1021/jm201591k" title="DOI URL">https://doi.org/10.1021/jm201591k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201591k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201591k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BConformationally%252BConstrained%252BInhibitors%252BTargeting%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BThreonine790%252B%2525E2%252586%252592%252BMethionine790%252BMutant%26aulast%3DChang%26aufirst%3DShaohua%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D25112011%26date%3D01032012%26date%3D22032012%26date%3D16022012%26volume%3D55%26issue%3D6%26spage%3D2711%26epage%3D2723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mi Young  Cha</span>, <span class="hlFld-ContribAuthor ">Kwang-Ok  Lee</span>, <span class="hlFld-ContribAuthor ">Seok-Jong  Kang</span>, <span class="hlFld-ContribAuthor ">Young Hee  Jung</span>, <span class="hlFld-ContribAuthor ">Ji Yeon  Song</span>, <span class="hlFld-ContribAuthor ">Kyung Jin  Choi</span>, <span class="hlFld-ContribAuthor ">Joo Yun  Byun</span>, <span class="hlFld-ContribAuthor ">Han-Jae  Lee</span>, <span class="hlFld-ContribAuthor ">Gwan Sun  Lee</span>, <span class="hlFld-ContribAuthor ">Seung Bum  Park</span>, and <span class="hlFld-ContribAuthor ">Maeng Sup  Kim</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Pyrimidine-Based Dual Inhibitors of Human Epidermal Growth Factor Receptor 1 (HER-1) and HER-2 Tyrosine Kinases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (6)
                                     , 2846-2857. <a href="https://doi.org/10.1021/jm201758g" title="DOI URL">https://doi.org/10.1021/jm201758g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201758g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201758g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BPyrimidine-Based%252BDual%252BInhibitors%252Bof%252BHuman%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B1%252B%252528HER-1%252529%252Band%252BHER-2%252BTyrosine%252BKinases%26aulast%3DCha%26aufirst%3DMi%2BYoung%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D30122011%26date%3D09032012%26date%3D22032012%26date%3D28022012%26volume%3D55%26issue%3D6%26spage%3D2846%26epage%3D2857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caterina  Carmi</span>, <span class="hlFld-ContribAuthor ">Elena  Galvani</span>, <span class="hlFld-ContribAuthor ">Federica  Vacondio</span>, <span class="hlFld-ContribAuthor ">Silvia  Rivara</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Simonetta  Russo</span>, <span class="hlFld-ContribAuthor ">Stefania  Aiello</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Bordi</span>, <span class="hlFld-ContribAuthor ">Gabriele  Costantino</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavazzoni</span>, <span class="hlFld-ContribAuthor ">Roberta R.  Alfieri</span>, <span class="hlFld-ContribAuthor ">Andrea  Ardizzoni</span>, <span class="hlFld-ContribAuthor ">Pier Giorgio  Petronini</span>, and <span class="hlFld-ContribAuthor ">Marco  Mor</span>  . </span><span class="cited-content_cbyCitation_article-title">Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 2251-2264. <a href="https://doi.org/10.1021/jm201507x" title="DOI URL">https://doi.org/10.1021/jm201507x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201507x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201507x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIrreversible%252BInhibition%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BActivity%252Bby%252B3-Aminopropanamides%26aulast%3DCarmi%26aufirst%3DCaterina%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D08112011%26date%3D17022012%26date%3D08032012%26date%3D26012012%26volume%3D55%26issue%3D5%26spage%3D2251%26epage%3D2264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoyasu  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Masaki  Seto</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Banno</span>, <span class="hlFld-ContribAuthor ">Youichi  Kawakita</span>, <span class="hlFld-ContribAuthor ">Mami  Oorui</span>, <span class="hlFld-ContribAuthor ">Takahiko  Taniguchi</span>, <span class="hlFld-ContribAuthor ">Yoshikazu  Ohta</span>, <span class="hlFld-ContribAuthor ">Toshiya  Tamura</span>, <span class="hlFld-ContribAuthor ">Akiko  Nakayama</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Miki</span>, <span class="hlFld-ContribAuthor ">Hidenori  Kamiguchi</span>, <span class="hlFld-ContribAuthor ">Toshimasa  Tanaka</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Habuka</span>, <span class="hlFld-ContribAuthor ">Satoshi  Sogabe</span>, <span class="hlFld-ContribAuthor ">Jason  Yano</span>, <span class="hlFld-ContribAuthor ">Kathleen  Aertgeerts</span>, and <span class="hlFld-ContribAuthor ">Keiji  Kamiyama</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-d]pyrimidine Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (23)
                                     , 8030-8050. <a href="https://doi.org/10.1021/jm2008634" title="DOI URL">https://doi.org/10.1021/jm2008634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2008634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2008634%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNovel%252BHuman%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B2%252B%252528HER2%252529%25252FEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BDual%252BInhibitors%252BBearing%252Ba%252BPyrrolo%25255B3%25252C2-d%25255Dpyrimidine%252BScaffold%26aulast%3DIshikawa%26aufirst%3DTomoyasu%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D01072011%26date%3D04112011%26date%3D08122011%26date%3D17102011%26volume%3D54%26issue%3D23%26spage%3D8030%26epage%3D8050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takenori  Mitamura</span> and <span class="hlFld-ContribAuthor ">Akiya  Ogawa</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2,4-Diiodoquinolines via the Photochemical Cyclization of o-Alkynylaryl Isocyanides with Iodine. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>76 </em>
                                    (4)
                                     , 1163-1166. <a href="https://doi.org/10.1021/jo1021772" title="DOI URL">https://doi.org/10.1021/jo1021772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo1021772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo1021772%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2%25252C4-Diiodoquinolines%252Bvia%252Bthe%252BPhotochemical%252BCyclization%252Bof%252Bo-Alkynylaryl%252BIsocyanides%252Bwith%252BIodine%26aulast%3DMitamura%26aufirst%3DTakenori%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D01112010%26date%3D18012011%26date%3D18022011%26volume%3D76%26issue%3D4%26spage%3D1163%26epage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fraser F.  Fleming</span>, <span class="hlFld-ContribAuthor ">Lihua  Yao</span>, <span class="hlFld-ContribAuthor ">P. C.  Ravikumar</span>, <span class="hlFld-ContribAuthor ">Lee  Funk</span>, and <span class="hlFld-ContribAuthor ">Brian C.  Shook</span>  . </span><span class="cited-content_cbyCitation_article-title">Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (22)
                                     , 7902-7917. <a href="https://doi.org/10.1021/jm100762r" title="DOI URL">https://doi.org/10.1021/jm100762r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100762r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100762r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNitrile-Containing%252BPharmaceuticals%25253A%252BEfficacious%252BRoles%252Bof%252Bthe%252BNitrile%252BPharmacophore%26aulast%3DFleming%26aufirst%3DFraser%2BF.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D23062010%26date%3D30082010%26date%3D25112010%26volume%3D53%26issue%3D22%26spage%3D7902%26epage%3D7917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chia-Hsien  Wu</span>, <span class="hlFld-ContribAuthor ">Mohane Selvaraj  Coumar</span>, <span class="hlFld-ContribAuthor ">Chang-Ying  Chu</span>, <span class="hlFld-ContribAuthor ">Wen-Hsing  Lin</span>, <span class="hlFld-ContribAuthor ">Yi-Rong  Chen</span>, <span class="hlFld-ContribAuthor ">Chiung-Tong  Chen</span>, <span class="hlFld-ContribAuthor ">Hui-Yi  Shiao</span>, <span class="hlFld-ContribAuthor ">Shaik  Rafi</span>, <span class="hlFld-ContribAuthor ">Sing-Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Hui  Hsu</span>, <span class="hlFld-ContribAuthor ">Chun-Hwa  Chen</span>, <span class="hlFld-ContribAuthor ">Chun-Yu  Chang</span>, <span class="hlFld-ContribAuthor ">Teng-Yuan  Chang</span>, <span class="hlFld-ContribAuthor ">Tzu-Wen  Lien</span>, <span class="hlFld-ContribAuthor ">Ming-Yu  Fang</span>, <span class="hlFld-ContribAuthor ">Kai-Chia  Yeh</span>, <span class="hlFld-ContribAuthor ">Ching-Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Teng-Kuang  Yeh</span>, <span class="hlFld-ContribAuthor ">Su-Huei  Hsieh</span>, <span class="hlFld-ContribAuthor ">John T.-A.  Hsu</span>, <span class="hlFld-ContribAuthor ">Chun-Chen  Liao</span>, <span class="hlFld-ContribAuthor ">Yu-Sheng  Chao</span>, and <span class="hlFld-ContribAuthor ">Hsing-Pang  Hsieh</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Tetrahydropyridothieno[2,3-d]pyrimidine Scaffold Based Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors: The Role of Side Chain Chirality and Michael Acceptor Group for Maximal Potency. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (20)
                                     , 7316-7326. <a href="https://doi.org/10.1021/jm100607r" title="DOI URL">https://doi.org/10.1021/jm100607r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100607r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100607r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BTetrahydropyridothieno%25255B2%25252C3-d%25255Dpyrimidine%252BScaffold%252BBased%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BKinase%252BInhibitors%25253A%252BThe%252BRole%252Bof%252BSide%252BChain%252BChirality%252Band%252BMichael%252BAcceptor%252BGroup%252Bfor%252BMaximal%252BPotency%26aulast%3DWu%26aufirst%3DChia-Hsien%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D18052010%26date%3D23092010%26date%3D28102010%26volume%3D53%26issue%3D20%26spage%3D7316%26epage%3D7326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caterina  Carmi</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavazzoni</span>, <span class="hlFld-ContribAuthor ">Stefano  Vezzosi</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Bordi</span>, <span class="hlFld-ContribAuthor ">Federica  Vacondio</span>, <span class="hlFld-ContribAuthor ">Claudia  Silva</span>, <span class="hlFld-ContribAuthor ">Silvia  Rivara</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Roberta R.  Alfieri</span>, <span class="hlFld-ContribAuthor ">Silvia  La Monica</span>, <span class="hlFld-ContribAuthor ">Maricla  Galetti</span>, <span class="hlFld-ContribAuthor ">Andrea  Ardizzoni</span>, <span class="hlFld-ContribAuthor ">Pier Giorgio  Petronini</span> and <span class="hlFld-ContribAuthor ">Marco  Mor</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (5)
                                     , 2038-2050. <a href="https://doi.org/10.1021/jm901558p" title="DOI URL">https://doi.org/10.1021/jm901558p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901558p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901558p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BIrreversible%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BInhibitors%252Bby%252BChemical%252BModulation%252Bof%252Bthe%252BCysteine-Trap%252BPortion%26aulast%3DCarmi%26aufirst%3DCaterina%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D21102009%26date%3D12022010%26date%3D11032010%26volume%3D53%26issue%3D5%26spage%3D2038%26epage%3D2050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ratika  Krishnamurty</span> and <span class="hlFld-ContribAuthor ">Dustin J.  Maly</span>. </span><span class="cited-content_cbyCitation_article-title">Biochemical Mechanisms of Resistance to Small-Molecule Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2010,</strong> <em>5 </em>
                                    (1)
                                     , 121-138. <a href="https://doi.org/10.1021/cb9002656" title="DOI URL">https://doi.org/10.1021/cb9002656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb9002656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb9002656%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DBiochemical%252BMechanisms%252Bof%252BResistance%252Bto%252BSmall-Molecule%252BProtein%252BKinase%252BInhibitors%26aulast%3DKrishnamurty%26aufirst%3DRatika%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D03%252001%25202010%26date%3D27%252010%25202009%26date%3D03%252001%25202010%26date%3D15012010%26date%3D03012010%26volume%3D5%26issue%3D1%26spage%3D121%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mi Young  Cha</span>, <span class="hlFld-ContribAuthor ">Kwang-Ok  Lee</span>, <span class="hlFld-ContribAuthor ">Jong Woo  Kim</span>, <span class="hlFld-ContribAuthor ">Chang Gon  Lee</span>, <span class="hlFld-ContribAuthor ">Ji Yeon  Song</span>, <span class="hlFld-ContribAuthor ">Young Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Gwan Sun  Lee</span>, <span class="hlFld-ContribAuthor ">Seung Bum  Park</span> and <span class="hlFld-ContribAuthor ">Maeng Sup  Kim</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of A Novel Her-1/Her-2 Dual Tyrosine Kinase Inhibitor for the Treatment of Her-1 Selective Inhibitor-Resistant Non-small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (21)
                                     , 6880-6888. <a href="https://doi.org/10.1021/jm901146p" title="DOI URL">https://doi.org/10.1021/jm901146p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901146p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901146p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BA%252BNovel%252BHer-1%25252FHer-2%252BDual%252BTyrosine%252BKinase%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHer-1%252BSelective%252BInhibitor-Resistant%252BNon-small%252BCell%252BLung%252BCancer%26aulast%3DCha%26aufirst%3DMi%2BYoung%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D31072009%26date%3D15102009%26date%3D12112009%26volume%3D52%26issue%3D21%26spage%3D6880%26epage%3D6888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean P.  McClintock</span>, <span class="hlFld-ContribAuthor ">Nathan  Forster</span>, <span class="hlFld-ContribAuthor ">Rainer  Herges</span> and <span class="hlFld-ContribAuthor ">Michael M.  Haley</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of α-Ketoester- and α-Hydroxyester-Substituted Isoindazoles via the Thermodynamic Coarctate Cyclization of Ester-Terminated Azo-Ene-Yne Systems. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2009,</strong> <em>74 </em>
                                    (17)
                                     , 6631-6636. <a href="https://doi.org/10.1021/jo9011283" title="DOI URL">https://doi.org/10.1021/jo9011283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo9011283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo9011283%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B1-Ketoester-%252Band%252B%2525CE%2525B1-Hydroxyester-Substituted%252BIsoindazoles%252Bvia%252Bthe%252BThermodynamic%252BCoarctate%252BCyclization%252Bof%252BEster-Terminated%252BAzo-Ene-Yne%252BSystems%26aulast%3DMcClintock%26aufirst%3DSean%2BP.%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D27052009%26date%3D30072009%26date%3D04092009%26volume%3D74%26issue%3D17%26spage%3D6631%26epage%3D6636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michele H.  Potashman</span> and <span class="hlFld-ContribAuthor ">Mark E.  Duggan</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Modifiers: An Orthogonal Approach to Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (5)
                                     , 1231-1246. <a href="https://doi.org/10.1021/jm8008597" title="DOI URL">https://doi.org/10.1021/jm8008597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm8008597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm8008597%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252BModifiers%25253A%252BAn%252BOrthogonal%252BApproach%252Bto%252BDrug%252BDesign%26aulast%3DPotashman%26aufirst%3DMichele%2BH.%26date%3D2009%26date%3D2009%26date%3D2008%26date%3D12%252003%25202009%26date%3D09%252002%25202009%26date%3D11%252007%25202008%26volume%3D52%26issue%3D5%26spage%3D1231%26epage%3D1246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel M.  Aranha</span>, <span class="hlFld-ContribAuthor ">Amy M.  Bowser</span> and <span class="hlFld-ContribAuthor ">Jose S.  Madalengoitia</span>. </span><span class="cited-content_cbyCitation_article-title">Facile 1,3-diaza-Claisen Rearrangements of Tertiary Allylic Amines Bearing an Electron-Deficient Alkene. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2009,</strong> <em>11 </em>
                                    (3)
                                     , 575-578. <a href="https://doi.org/10.1021/ol802577z" title="DOI URL">https://doi.org/10.1021/ol802577z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol802577z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol802577z%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DFacile%252B1%25252C3-diaza-Claisen%252BRearrangements%252Bof%252BTertiary%252BAllylic%252BAmines%252BBearing%252Ban%252BElectron-Deficient%252BAlkene%26aulast%3DAranha%26aufirst%3DRachel%2BM.%26date%3D2009%26date%3D2009%26date%3D2008%26date%3D05%252002%25202009%26date%3D06%252001%25202009%26date%3D7%252011%25202008%26volume%3D11%26issue%3D3%26spage%3D575%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean P.  McClintock</span>, <span class="hlFld-ContribAuthor ">Laura D.  Shirtcliff</span>, <span class="hlFld-ContribAuthor ">Rainer  Herges</span> and <span class="hlFld-ContribAuthor ">Michael M.  Haley</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Analysis on the Dual Reactivity of Conjugated “Ene-Ene-Yne” Systems. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2008,</strong> <em>73 </em>
                                    (22)
                                     , 8755-8762. <a href="https://doi.org/10.1021/jo801390x" title="DOI URL">https://doi.org/10.1021/jo801390x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo801390x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo801390x%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DComputational%252BAnalysis%252Bon%252Bthe%252BDual%252BReactivity%252Bof%252BConjugated%252B%2525E2%252580%25259CEne-Ene-Yne%2525E2%252580%25259D%252BSystems%26aulast%3DMcClintock%26aufirst%3DSean%2BP.%26date%3D2008%26date%3D2008%26date%3D2008%26date%3D21%252011%25202008%26date%3D18%252010%25202008%26date%3D25%252006%25202008%26volume%3D73%26issue%3D22%26spage%3D8755%26epage%3D8762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rambabu  Gundla</span>, <span class="hlFld-ContribAuthor ">Roza  Kazemi</span>, <span class="hlFld-ContribAuthor ">Ramadevi  Sanam</span>, <span class="hlFld-ContribAuthor ">Ravikumar  Muttineni</span>, <span class="hlFld-ContribAuthor ">Jagarlapudi A. R. P.  Sarma</span>, <span class="hlFld-ContribAuthor ">Raveendra  Dayam</span> and <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Small-Molecule Inhibitors of Human Epidermal Growth Factor Receptor-2: Combined Ligand and Target-Based Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (12)
                                     , 3367-3377. <a href="https://doi.org/10.1021/jm7013875" title="DOI URL">https://doi.org/10.1021/jm7013875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm7013875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm7013875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BSmall-Molecule%252BInhibitors%252Bof%252BHuman%252BEpidermal%252BGrowth%252BFactor%252BReceptor-2%25253A%252BCombined%252BLigand%252Band%252BTarget-Based%252BApproach%26aulast%3DGundla%26aufirst%3DRambabu%26date%3D2008%26date%3D2008%26date%3D2007%26date%3D26%252006%25202008%26date%3D24%252005%25202008%26date%3D05%252011%25202007%26volume%3D51%26issue%3D12%26spage%3D3367%26epage%3D3377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haibin  Zhou</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Lu</span>, <span class="hlFld-ContribAuthor ">Krishnapriya  Chinnaswamy</span>, <span class="hlFld-ContribAuthor ">Jeanne A.  Stuckey</span>, <span class="hlFld-ContribAuthor ">Liu  Liu</span>, <span class="hlFld-ContribAuthor ">Donna  McEachern</span>, <span class="hlFld-ContribAuthor ">Chao-Yie  Yang</span>, <span class="hlFld-ContribAuthor ">Denzil  Bernard</span>, <span class="hlFld-ContribAuthor ">Hong  Shen</span>, <span class="hlFld-ContribAuthor ">Liangyou  Rui</span>, <span class="hlFld-ContribAuthor ">Yi  Sun</span>, <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-021-22924-4" title="DOI URL">https://doi.org/10.1038/s41467-021-22924-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-021-22924-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-021-22924-4%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DSelective%252Binhibition%252Bof%252Bcullin%252B3%252Bneddylation%252Bthrough%252Bcovalent%252Btargeting%252BDCN1%252Bprotects%252Bmice%252Bfrom%252Bacetaminophen-induced%252Bliver%252Btoxicity%26aulast%3DZhou%26aufirst%3DHaibin%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Camilo  Serrano-Sterling</span>, <span class="hlFld-ContribAuthor ">Diana  Becerra</span>, <span class="hlFld-ContribAuthor ">Jaime  Portilla</span>, <span class="hlFld-ContribAuthor ">Hugo  Rojas</span>, <span class="hlFld-ContribAuthor ">Mario  Macías</span>, <span class="hlFld-ContribAuthor ">Juan-Carlos  Castillo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and X-ray crystallographic analysis of novel (E)-2-cyano-3-(het)arylacrylamides as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1244 </em>, 130944. <a href="https://doi.org/10.1016/j.molstruc.2021.130944" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.130944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.130944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.130944%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252BX-ray%252Bcrystallographic%252Banalysis%252Bof%252Bnovel%252B%252528E%252529-2-cyano-3-%252528het%252529arylacrylamides%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DSerrano-Sterling%26aufirst%3DCamilo%26date%3D2021%26volume%3D1244%26spage%3D130944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxia  Liang</span>, <span class="hlFld-ContribAuthor ">Qian  Yang</span>, <span class="hlFld-ContribAuthor ">Pan  Wu</span>, <span class="hlFld-ContribAuthor ">Changliang  He</span>, <span class="hlFld-ContribAuthor ">Lizi  Yin</span>, <span class="hlFld-ContribAuthor ">Funeng  Xu</span>, <span class="hlFld-ContribAuthor ">Zhongqiong  Yin</span>, <span class="hlFld-ContribAuthor ">Guizhou  Yue</span>, <span class="hlFld-ContribAuthor ">Yuanfeng  Zou</span>, <span class="hlFld-ContribAuthor ">Lixia  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Song</span>, <span class="hlFld-ContribAuthor ">Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Jing</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015–2020. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>113 </em>, 105011. <a href="https://doi.org/10.1016/j.bioorg.2021.105011" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DThe%252Bsynthesis%252Breview%252Bof%252Bthe%252Bapproved%252Btyrosine%252Bkinase%252Binhibitors%252Bfor%252Banticancer%252Btherapy%252Bin%252B2015%2525E2%252580%2525932020%26aulast%3DLiang%26aufirst%3DXiaoxia%26date%3D2021%26volume%3D113%26spage%3D105011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxia  Liang</span>, <span class="hlFld-ContribAuthor ">Pan  Wu</span>, <span class="hlFld-ContribAuthor ">Qian  Yang</span>, <span class="hlFld-ContribAuthor ">Yunyu  Xie</span>, <span class="hlFld-ContribAuthor ">Changliang  He</span>, <span class="hlFld-ContribAuthor ">Lizi  Yin</span>, <span class="hlFld-ContribAuthor ">Zhongqiong  Yin</span>, <span class="hlFld-ContribAuthor ">Guizhou  Yue</span>, <span class="hlFld-ContribAuthor ">Yuanfeng  Zou</span>, <span class="hlFld-ContribAuthor ">Lixia  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Song</span>, <span class="hlFld-ContribAuthor ">Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Jing</span>. </span><span class="cited-content_cbyCitation_article-title">An update of new small-molecule anticancer drugs approved from 2015 to 2020. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113473. <a href="https://doi.org/10.1016/j.ejmech.2021.113473" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113473%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Bupdate%252Bof%252Bnew%252Bsmall-molecule%252Banticancer%252Bdrugs%252Bapproved%252Bfrom%252B2015%252Bto%252B2020%26aulast%3DLiang%26aufirst%3DXiaoxia%26date%3D2021%26volume%3D220%26spage%3D113473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mugada Sugunakara  Rao</span>, <span class="hlFld-ContribAuthor ">Sahid  Hussain</span>. </span><span class="cited-content_cbyCitation_article-title">DABCO-mediated decarboxylative cyclization of isatoic anhydride with aroyl/heteroaroyl/alkoylacetonitriles under microwave conditions: Strategy for the synthesis of substituted 4-quinolones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>76 </em>, 153187. <a href="https://doi.org/10.1016/j.tetlet.2021.153187" title="DOI URL">https://doi.org/10.1016/j.tetlet.2021.153187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2021.153187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2021.153187%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDABCO-mediated%252Bdecarboxylative%252Bcyclization%252Bof%252Bisatoic%252Banhydride%252Bwith%252Baroyl%25252Fheteroaroyl%25252Falkoylacetonitriles%252Bunder%252Bmicrowave%252Bconditions%25253A%252BStrategy%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bsubstituted%252B4-quinolones%26aulast%3DRao%26aufirst%3DMugada%2BSugunakara%26date%3D2021%26volume%3D76%26spage%3D153187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julie  Bolcaen</span>, <span class="hlFld-ContribAuthor ">Shankari  Nair</span>, <span class="hlFld-ContribAuthor ">Cathryn  Driver</span>, <span class="hlFld-ContribAuthor ">Tebatso  Boshomane</span>, <span class="hlFld-ContribAuthor ">Thomas  Ebenhan</span>, <span class="hlFld-ContribAuthor ">Charlot  Vandevoorde</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (7)
                                     , 626. <a href="https://doi.org/10.3390/ph14070626" title="DOI URL">https://doi.org/10.3390/ph14070626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14070626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14070626%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DNovel%252BReceptor%252BTyrosine%252BKinase%252BPathway%252BInhibitors%252Bfor%252BTargeted%252BRadionuclide%252BTherapy%252Bof%252BGlioblastoma%26aulast%3DBolcaen%26aufirst%3DJulie%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D7%26spage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shivananda  Kandagalla</span>, <span class="hlFld-ContribAuthor ">Hrvoje  Rimac</span>, <span class="hlFld-ContribAuthor ">Vladimir A  Potemkin</span>, <span class="hlFld-ContribAuthor ">Maria A  Grishina</span>. </span><span class="cited-content_cbyCitation_article-title">Complementarity principle in terms of electron density for the study of EGFR complexes. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (10)
                                     , 863-875. <a href="https://doi.org/10.4155/fmc-2020-0265" title="DOI URL">https://doi.org/10.4155/fmc-2020-0265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0265%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DComplementarity%252Bprinciple%252Bin%252Bterms%252Bof%252Belectron%252Bdensity%252Bfor%252Bthe%252Bstudy%252Bof%252BEGFR%252Bcomplexes%26aulast%3DKandagalla%26aufirst%3DShivananda%26date%3D2021%26volume%3D13%26issue%3D10%26spage%3D863%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shalini</span>, <span class="hlFld-ContribAuthor ">Vipan  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Have molecular hybrids delivered effective anti-cancer treatments and what should future drug discovery focus on?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>16 </em>
                                    (4)
                                     , 335-363. <a href="https://doi.org/10.1080/17460441.2021.1850686" title="DOI URL">https://doi.org/10.1080/17460441.2021.1850686</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1850686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1850686%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DHave%252Bmolecular%252Bhybrids%252Bdelivered%252Beffective%252Banti-cancer%252Btreatments%252Band%252Bwhat%252Bshould%252Bfuture%252Bdrug%252Bdiscovery%252Bfocus%252Bon%25253F%26aulast%3DShalini%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D4%26spage%3D335%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Zhao</span>, <span class="hlFld-ContribAuthor ">Stephen  Scott</span>, <span class="hlFld-ContribAuthor ">Kurt W.  Evans</span>, <span class="hlFld-ContribAuthor ">Erkan  Yuca</span>, <span class="hlFld-ContribAuthor ">Turcin  Saridogan</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Zheng</span>, <span class="hlFld-ContribAuthor ">Heping  Wang</span>, <span class="hlFld-ContribAuthor ">Anil  Korkut</span>, <span class="hlFld-ContribAuthor ">Christian X.  Cruz Pico</span>, <span class="hlFld-ContribAuthor ">Mehmet  Demirhan</span>, <span class="hlFld-ContribAuthor ">Bryce  Kirby</span>, <span class="hlFld-ContribAuthor ">Scott  Kopetz</span>, <span class="hlFld-ContribAuthor ">Irmina  Diala</span>, <span class="hlFld-ContribAuthor ">Alshad S.  Lalani</span>, <span class="hlFld-ContribAuthor ">Sarina  Piha-Paul</span>, <span class="hlFld-ContribAuthor ">Funda  Meric-Bernstam</span>. </span><span class="cited-content_cbyCitation_article-title">Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2021,</strong> <em>27 </em>
                                    (6)
                                     , 1681-1694. <a href="https://doi.org/10.1158/1078-0432.CCR-20-3017" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-20-3017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-20-3017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-20-3017%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DCombining%252BNeratinib%252Bwith%252BCDK4%25252F6%25252C%252BmTOR%25252C%252Band%252BMEK%252BInhibitors%252Bin%252BModels%252Bof%252BHER2-positive%252BCancer%26aulast%3DZhao%26aufirst%3DMing%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D6%26spage%3D1681%26epage%3D1694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs). </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>165 </em>, 105422. <a href="https://doi.org/10.1016/j.phrs.2021.105422" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105422</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105422%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DOrally%252Beffective%252BFDA-approved%252Bprotein%252Bkinase%252Btargeted%252Bcovalent%252Binhibitors%252B%252528TCIs%252529%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2021%26volume%3D165%26spage%3D105422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianbo  Sun</span>, <span class="hlFld-ContribAuthor ">Hui  Zhong</span>, <span class="hlFld-ContribAuthor ">Kun  Wang</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Gains from no real PAINS: Where ‘Fair Trial Strategy’ stands in the development of multi-target ligands. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>13 </em><a href="https://doi.org/10.1016/j.apsb.2021.02.023" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.02.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.02.023%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DGains%252Bfrom%252Bno%252Breal%252BPAINS%25253A%252BWhere%252B%2525E2%252580%252598Fair%252BTrial%252BStrategy%2525E2%252580%252599%252Bstands%252Bin%252Bthe%252Bdevelopment%252Bof%252Bmulti-target%252Bligands%26aulast%3DSun%26aufirst%3DJianbo%26date%3D2021%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanna  Mao</span>, <span class="hlFld-ContribAuthor ">Kunjal  Soni</span>, <span class="hlFld-ContribAuthor ">Chetan  Sangani</span>, <span class="hlFld-ContribAuthor ">Yongfang  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">An Overview of Privileged Scaffold: Quinolines and Isoquinolines in Medicinal Chemistry as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (28)
                                     , 2599-2633. <a href="https://doi.org/10.2174/1568026620999200917154225" title="DOI URL">https://doi.org/10.2174/1568026620999200917154225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620999200917154225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620999200917154225%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DAn%252BOverview%252Bof%252BPrivileged%252BScaffold%25253A%252BQuinolines%252Band%252BIsoquinolines%252Bin%252BMedicinal%252BChemistry%252Bas%252BAnticancer%252BAgents%26aulast%3DMao%26aufirst%3DYanna%26date%3D2020%26volume%3D20%26issue%3D28%26spage%3D2599%26epage%3D2633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacqueline A.  Carozza</span>, <span class="hlFld-ContribAuthor ">Jenifer A.  Brown</span>, <span class="hlFld-ContribAuthor ">Volker  Böhnert</span>, <span class="hlFld-ContribAuthor ">Daniel  Fernandez</span>, <span class="hlFld-ContribAuthor ">Yasmeen  AlSaif</span>, <span class="hlFld-ContribAuthor ">Rachel E.  Mardjuki</span>, <span class="hlFld-ContribAuthor ">Mark  Smith</span>, <span class="hlFld-ContribAuthor ">Lingyin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Aided Development of Small-Molecule Inhibitors of ENPP1, the Extracellular Phosphodiesterase of the Immunotransmitter cGAMP. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2020,</strong> <em>27 </em>
                                    (11)
                                     , 1347-1358.e5. <a href="https://doi.org/10.1016/j.chembiol.2020.07.007" title="DOI URL">https://doi.org/10.1016/j.chembiol.2020.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2020.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2020.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DStructure-Aided%252BDevelopment%252Bof%252BSmall-Molecule%252BInhibitors%252Bof%252BENPP1%25252C%252Bthe%252BExtracellular%252BPhosphodiesterase%252Bof%252Bthe%252BImmunotransmitter%252BcGAMP%26aulast%3DCarozza%26aufirst%3DJacqueline%2BA.%26date%3D2020%26volume%3D27%26issue%3D11%26spage%3D1347%26epage%3D1358.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annamaria  Martorana</span>, <span class="hlFld-ContribAuthor ">Gabriele  La Monica</span>, <span class="hlFld-ContribAuthor ">Antonino  Lauria</span>. </span><span class="cited-content_cbyCitation_article-title">Quinoline-Based Molecules Targeting c-Met, EGF, and VEGF Receptors and the Proteins Involved in Related Carcinogenic Pathways. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (18)
                                     , 4279. <a href="https://doi.org/10.3390/molecules25184279" title="DOI URL">https://doi.org/10.3390/molecules25184279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25184279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25184279%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DQuinoline-Based%252BMolecules%252BTargeting%252Bc-Met%25252C%252BEGF%25252C%252Band%252BVEGF%252BReceptors%252Band%252Bthe%252BProteins%252BInvolved%252Bin%252BRelated%252BCarcinogenic%252BPathways%26aulast%3DMartorana%26aufirst%3DAnnamaria%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D18%26spage%3D4279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yolanda  Jerez</span>, <span class="hlFld-ContribAuthor ">Blanca  Herrero</span>, <span class="hlFld-ContribAuthor ">Marta  Arregui</span>, <span class="hlFld-ContribAuthor ">Blanca  Morón</span>, <span class="hlFld-ContribAuthor ">Miguel  Martín</span>, <span class="hlFld-ContribAuthor ">Isabel  Echavarría</span>. </span><span class="cited-content_cbyCitation_article-title">Neratinib for the treatment of early-stage, hormone receptor-positive, HER2-overexpressed breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (17)
                                     , 1165-1177. <a href="https://doi.org/10.2217/fon-2020-0046" title="DOI URL">https://doi.org/10.2217/fon-2020-0046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon-2020-0046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon-2020-0046%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DNeratinib%252Bfor%252Bthe%252Btreatment%252Bof%252Bearly-stage%25252C%252Bhormone%252Breceptor-positive%25252C%252BHER2-overexpressed%252Bbreast%252Bcancer%26aulast%3DJerez%26aufirst%3DYolanda%26date%3D2020%26volume%3D16%26issue%3D17%26spage%3D1165%26epage%3D1177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan Martín  Cadena García</span>, <span class="hlFld-ContribAuthor ">Carlos Eduardo  Giraldo Murillo</span>, <span class="hlFld-ContribAuthor ">Manuela  Ramos Jaramillo</span>. </span><span class="cited-content_cbyCitation_article-title">EGFR and HER2 small molecules inhibitors as potential therapeutics in veterinary oncology. </span><span class="cited-content_cbyCitation_journal-name">Revista Colombiana de Ciencias Químico-Farmacéuticas</span><span> <strong>2020,</strong> <em>49 </em>
                                    (2)
                                     <a href="https://doi.org/10.15446/rcciquifa.v49n2.89898" title="DOI URL">https://doi.org/10.15446/rcciquifa.v49n2.89898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15446/rcciquifa.v49n2.89898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15446%2Frcciquifa.v49n2.89898%26sid%3Dliteratum%253Aachs%26jtitle%3DRevista%2520Colombiana%2520de%2520Ciencias%2520Qu%25C3%25ADmico-Farmac%25C3%25A9uticas%26atitle%3DEGFR%252Band%252BHER2%252Bsmall%252Bmolecules%252Binhibitors%252Bas%252Bpotential%252Btherapeutics%252Bin%252Bveterinary%252Boncology%26aulast%3DCadena%2BGarc%25C3%25ADa%26aufirst%3DJuan%2BMart%25C3%25ADn%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhupender S.  Chhikara</span>, <span class="hlFld-ContribAuthor ">Sajda  Ashraf</span>, <span class="hlFld-ContribAuthor ">Saghar  Mozaffari</span>, <span class="hlFld-ContribAuthor ">Nicole  St. Jeans</span>, <span class="hlFld-ContribAuthor ">Dindyal  Mandal</span>, <span class="hlFld-ContribAuthor ">Rakesh Kumar  Tiwari</span>, <span class="hlFld-ContribAuthor ">Zaheer  Ul-Haq</span>, <span class="hlFld-ContribAuthor ">Keykavous  Parang</span>. </span><span class="cited-content_cbyCitation_article-title">Phenylpyrazalopyrimidines as Tyrosine Kinase Inhibitors: Synthesis, Antiproliferative Activity, and Molecular Simulations. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (9)
                                     , 2135. <a href="https://doi.org/10.3390/molecules25092135" title="DOI URL">https://doi.org/10.3390/molecules25092135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25092135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25092135%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPhenylpyrazalopyrimidines%252Bas%252BTyrosine%252BKinase%252BInhibitors%25253A%252BSynthesis%25252C%252BAntiproliferative%252BActivity%25252C%252Band%252BMolecular%252BSimulations%26aulast%3DChhikara%26aufirst%3DBhupender%2BS.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D9%26spage%3D2135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Azadeh  Nasrazadani</span>, <span class="hlFld-ContribAuthor ">Adam  Brufsky</span>. </span><span class="cited-content_cbyCitation_article-title">Neratinib: the emergence of a new player in the management of HER2+ breast cancer brain metastasis. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (7)
                                     , 247-254. <a href="https://doi.org/10.2217/fon-2019-0719" title="DOI URL">https://doi.org/10.2217/fon-2019-0719</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon-2019-0719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon-2019-0719%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DNeratinib%25253A%252Bthe%252Bemergence%252Bof%252Ba%252Bnew%252Bplayer%252Bin%252Bthe%252Bmanagement%252Bof%252BHER2%25252B%252Bbreast%252Bcancer%252Bbrain%252Bmetastasis%26aulast%3DNasrazadani%26aufirst%3DAzadeh%26date%3D2020%26volume%3D16%26issue%3D7%26spage%3D247%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mani  Ramanathan</span>, <span class="hlFld-ContribAuthor ">Jing  Wan</span>, <span class="hlFld-ContribAuthor ">Yi-Hung  Liu</span>, <span class="hlFld-ContribAuthor ">Shie-Ming  Peng</span>, <span class="hlFld-ContribAuthor ">Shiuh-Tzung  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-arylamino-3-cyanoquinolines
              via
              a cascade reaction through a nitrilium intermediate. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (5)
                                     , 975-982. <a href="https://doi.org/10.1039/C9OB02427A" title="DOI URL">https://doi.org/10.1039/C9OB02427A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB02427A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB02427A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-arylamino-3-cyanoquinolines%252Bvia%252Ba%252Bcascade%252Breaction%252Bthrough%252Ba%252Bnitrilium%252Bintermediate%26aulast%3DRamanathan%26aufirst%3DMani%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D5%26spage%3D975%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Kinase Inhibitors: An Overview. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 43-94. <a href="https://doi.org/10.1007/7355_2020_103" title="DOI URL">https://doi.org/10.1007/7355_2020_103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2020_103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2020_103%26sid%3Dliteratum%253Aachs%26atitle%3DCovalent%252BKinase%252BInhibitors%25253A%252BAn%252BOverview%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2020%26date%3D2020%26spage%3D43%26epage%3D94%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DProteinkinase%252BInhibitors%26aulast%3DLaufer%26aufirst%3DStefan%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qizhang  Li</span>, <span class="hlFld-ContribAuthor ">Zhiying  Wang</span>, <span class="hlFld-ContribAuthor ">Qiang  Zheng</span>, <span class="hlFld-ContribAuthor ">Sen  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2020,</strong> <em>18 </em>, 2200-2208. <a href="https://doi.org/10.1016/j.csbj.2020.08.016" title="DOI URL">https://doi.org/10.1016/j.csbj.2020.08.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2020.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2020.08.016%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DPotential%252Bclinical%252Bdrugs%252Bas%252Bcovalent%252Binhibitors%252Bof%252Bthe%252Bpriming%252Bproteases%252Bof%252Bthe%252Bspike%252Bprotein%252Bof%252BSARS-CoV-2%26aulast%3DLi%26aufirst%3DQizhang%26date%3D2020%26volume%3D18%26spage%3D2200%26epage%3D2208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanlong  Yin</span>, <span class="hlFld-ContribAuthor ">Xiao  Yuan</span>, <span class="hlFld-ContribAuthor ">Huile  Gao</span>, <span class="hlFld-ContribAuthor ">Qian  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Nanoformulations of small molecule protein tyrosine kinases inhibitors potentiate targeted cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Pharmaceutics</span><span> <strong>2020,</strong> <em>573 </em>, 118785. <a href="https://doi.org/10.1016/j.ijpharm.2019.118785" title="DOI URL">https://doi.org/10.1016/j.ijpharm.2019.118785</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpharm.2019.118785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpharm.2019.118785%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Pharmaceutics%26atitle%3DNanoformulations%252Bof%252Bsmall%252Bmolecule%252Bprotein%252Btyrosine%252Bkinases%252Binhibitors%252Bpotentiate%252Btargeted%252Bcancer%252Btherapy%26aulast%3DYin%26aufirst%3DYanlong%26date%3D2020%26volume%3D573%26spage%3D118785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. A.  Seebacher</span>, <span class="hlFld-ContribAuthor ">A. E.  Stacy</span>, <span class="hlFld-ContribAuthor ">G. M.  Porter</span>, <span class="hlFld-ContribAuthor ">A. M.  Merlot</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical development of targeted and immune based anti-cancer therapies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2019,</strong> <em>38 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-019-1094-2" title="DOI URL">https://doi.org/10.1186/s13046-019-1094-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-019-1094-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-019-1094-2%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DClinical%252Bdevelopment%252Bof%252Btargeted%252Band%252Bimmune%252Bbased%252Banti-cancer%252Btherapies%26aulast%3DSeebacher%26aufirst%3DN.%2BA.%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Ma</span>, <span class="hlFld-ContribAuthor ">Quchang  Ouyang</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Zefei  Jiang</span>, <span class="hlFld-ContribAuthor ">Zhongsheng  Tong</span>, <span class="hlFld-ContribAuthor ">Yunjiang  Liu</span>, <span class="hlFld-ContribAuthor ">Huiping  Li</span>, <span class="hlFld-ContribAuthor ">Shiying  Yu</span>, <span class="hlFld-ContribAuthor ">Jifeng  Feng</span>, <span class="hlFld-ContribAuthor ">Shusen  Wang</span>, <span class="hlFld-ContribAuthor ">Xichun  Hu</span>, <span class="hlFld-ContribAuthor ">Jianjun  Zou</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Binghe  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrotinib or Lapatinib Combined With Capecitabine in HER2–Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Oncology</span><span> <strong>2019,</strong> <em>37 </em>
                                    (29)
                                     , 2610-2619. <a href="https://doi.org/10.1200/JCO.19.00108" title="DOI URL">https://doi.org/10.1200/JCO.19.00108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1200/JCO.19.00108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1200%2FJCO.19.00108%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Oncology%26atitle%3DPyrotinib%252Bor%252BLapatinib%252BCombined%252BWith%252BCapecitabine%252Bin%252BHER2%2525E2%252580%252593Positive%252BMetastatic%252BBreast%252BCancer%252BWith%252BPrior%252BTaxanes%25252C%252BAnthracyclines%25252C%252Band%25252For%252BTrastuzumab%25253A%252BA%252BRandomized%25252C%252BPhase%252BII%252BStudy%26aulast%3DMa%26aufirst%3DFei%26date%3D2019%26volume%3D37%26issue%3D29%26spage%3D2610%26epage%3D2619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunze  Li</span>, <span class="hlFld-ContribAuthor ">Min  Rao</span>, <span class="hlFld-ContribAuthor ">Zhenwei  Fan</span>, <span class="hlFld-ContribAuthor ">Baoyi  Nian</span>, <span class="hlFld-ContribAuthor ">Yaofeng  Yuan</span>, <span class="hlFld-ContribAuthor ">Jiajia  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">A visible-light-irradiated electron donor-acceptor complex-promoted radical reaction system for the C H perfluoroalkylation of quinolin-4-ols. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (38)
                                     , 151046. <a href="https://doi.org/10.1016/j.tetlet.2019.151046" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.151046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.151046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.151046%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bvisible-light-irradiated%252Belectron%252Bdonor-acceptor%252Bcomplex-promoted%252Bradical%252Breaction%252Bsystem%252Bfor%252Bthe%252BC%252BH%252Bperfluoroalkylation%252Bof%252Bquinolin-4-ols%26aulast%3DLi%26aufirst%3DYunze%26date%3D2019%26volume%3D60%26issue%3D38%26spage%3D151046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keriann M.  Backus</span>, <span class="hlFld-ContribAuthor ">Jian  Cao</span>, <span class="hlFld-ContribAuthor ">Sean M.  Maddox</span>. </span><span class="cited-content_cbyCitation_article-title">Opportunities and challenges for the development of covalent chemical immunomodulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (15)
                                     , 3421-3439. <a href="https://doi.org/10.1016/j.bmc.2019.05.050" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.05.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.05.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOpportunities%252Band%252Bchallenges%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bcovalent%252Bchemical%252Bimmunomodulators%26aulast%3DBackus%26aufirst%3DKeriann%2BM.%26date%3D2019%26volume%3D27%26issue%3D15%26spage%3D3421%26epage%3D3439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Mei  Huang</span>, <span class="hlFld-ContribAuthor ">Shi-Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Leng</span>, <span class="hlFld-ContribAuthor ">Balakrishna  Moku</span>, <span class="hlFld-ContribAuthor ">Chuang  Zhao</span>, <span class="hlFld-ContribAuthor ">Njud S.  Alharbi</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Converting (
              E
              )-(Hetero)arylethanesulfonyl Fluorides to (
              Z
              )-(Hetero)arylethanesulfonyl Fluorides Under Light Irradiation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (28)
                                     , 4597-4603. <a href="https://doi.org/10.1002/ejoc.201900799" title="DOI URL">https://doi.org/10.1002/ejoc.201900799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900799%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DConverting%252B%252528%252BE%252B%252529-%252528Hetero%252529arylethanesulfonyl%252BFluorides%252Bto%252B%252528%252BZ%252B%252529-%252528Hetero%252529arylethanesulfonyl%252BFluorides%252BUnder%252BLight%252BIrradiation%26aulast%3DHuang%26aufirst%3DYu-Mei%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D28%26spage%3D4597%26epage%3D4603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. N.  Vennila</span>, <span class="hlFld-ContribAuthor ">Kuppanagounder P.  Elango</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding the binding of quinoline amines with human serum albumin by spectroscopic and induced fit docking methods. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2019,</strong> <em>37 </em>
                                    (11)
                                     , 2753-2765. <a href="https://doi.org/10.1080/07391102.2018.1496141" title="DOI URL">https://doi.org/10.1080/07391102.2018.1496141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2018.1496141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2018.1496141%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DUnderstanding%252Bthe%252Bbinding%252Bof%252Bquinoline%252Bamines%252Bwith%252Bhuman%252Bserum%252Balbumin%252Bby%252Bspectroscopic%252Band%252Binduced%252Bfit%252Bdocking%252Bmethods%26aulast%3DVennila%26aufirst%3DK.%2BN.%26date%3D2019%26date%3D2018%26volume%3D37%26issue%3D11%26spage%3D2753%26epage%3D2765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramadan A.  Mekheimer</span>, <span class="hlFld-ContribAuthor ">Mariam A.  Al-Sheikh</span>, <span class="hlFld-ContribAuthor ">Hanadi Y.  Medrasi</span>, <span class="hlFld-ContribAuthor ">Ghayah A.  Bahatheg</span>, <span class="hlFld-ContribAuthor ">Kamal U.  Sadek</span>. </span><span class="cited-content_cbyCitation_article-title">Chloroquinoline-3-carbonitriles: Synthesis and Reactions. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2019,</strong> <em>23 </em>
                                    (7)
                                     , 823-851. <a href="https://doi.org/10.2174/1385272823666190516120946" title="DOI URL">https://doi.org/10.2174/1385272823666190516120946</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272823666190516120946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272823666190516120946%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DChloroquinoline-3-carbonitriles%25253A%252BSynthesis%252Band%252BReactions%26aulast%3DMekheimer%26aufirst%3DRamadan%2BA.%26date%3D2019%26volume%3D23%26issue%3D7%26spage%3D823%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra  Canonici</span>, <span class="hlFld-ContribAuthor ">Laura  Ivers</span>, <span class="hlFld-ContribAuthor ">Neil T.  Conlon</span>, <span class="hlFld-ContribAuthor ">Kasper  Pedersen</span>, <span class="hlFld-ContribAuthor ">Nicola  Gaynor</span>, <span class="hlFld-ContribAuthor ">Brigid C.  Browne</span>, <span class="hlFld-ContribAuthor ">Neil A.  O’Brien</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Gullo</span>, <span class="hlFld-ContribAuthor ">Denis M.  Collins</span>, <span class="hlFld-ContribAuthor ">Norma  O’Donovan</span>, <span class="hlFld-ContribAuthor ">John  Crown</span>. </span><span class="cited-content_cbyCitation_article-title">HER-targeted tyrosine kinase inhibitors enhance response to trastuzumab and pertuzumab in HER2-positive breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2019,</strong> <em>37 </em>
                                    (3)
                                     , 441-451. <a href="https://doi.org/10.1007/s10637-018-0649-y" title="DOI URL">https://doi.org/10.1007/s10637-018-0649-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-018-0649-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-018-0649-y%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DHER-targeted%252Btyrosine%252Bkinase%252Binhibitors%252Benhance%252Bresponse%252Bto%252Btrastuzumab%252Band%252Bpertuzumab%252Bin%252BHER2-positive%252Bbreast%252Bcancer%26aulast%3DCanonici%26aufirst%3DAlexandra%26date%3D2019%26date%3D2018%26volume%3D37%26issue%3D3%26spage%3D441%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuyu  Jin</span>, <span class="hlFld-ContribAuthor ">Xiuyun  Sun</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>, <span class="hlFld-ContribAuthor ">Hua  Xie</span>, <span class="hlFld-ContribAuthor ">Yu  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological study of potent and covalent HER-2 tyrosine kinase inhibitors with low cytotoxicity in vitro. </span><span class="cited-content_cbyCitation_journal-name">Chemical Papers</span><span> <strong>2019,</strong> <em>73 </em>
                                    (6)
                                     , 1333-1345. <a href="https://doi.org/10.1007/s11696-019-00686-0" title="DOI URL">https://doi.org/10.1007/s11696-019-00686-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11696-019-00686-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11696-019-00686-0%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Papers%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bstudy%252Bof%252Bpotent%252Band%252Bcovalent%252BHER-2%252Btyrosine%252Bkinase%252Binhibitors%252Bwith%252Blow%252Bcytotoxicity%252Bin%252Bvitro%26aulast%3DJin%26aufirst%3DShuyu%26date%3D2019%26date%3D2019%26volume%3D73%26issue%3D6%26spage%3D1333%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tarek S.  Mansour</span>, <span class="hlFld-ContribAuthor ">Vijay  Potluri</span>, <span class="hlFld-ContribAuthor ">Ranga R.  Pallepati</span>, <span class="hlFld-ContribAuthor ">Vishnu  Basetti</span>, <span class="hlFld-ContribAuthor ">Mallaiah  Keesara</span>, <span class="hlFld-ContribAuthor ">Ashok G.  Moghudula</span>, <span class="hlFld-ContribAuthor ">Pranab  Maiti</span>. </span><span class="cited-content_cbyCitation_article-title">Lead generation of 1,2-dithiolanes as exon 19 and exon 21 mutant EGFR tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (12)
                                     , 1435-1439. <a href="https://doi.org/10.1016/j.bmcl.2019.04.029" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.04.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.04.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.04.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLead%252Bgeneration%252Bof%252B1%25252C2-dithiolanes%252Bas%252Bexon%252B19%252Band%252Bexon%252B21%252Bmutant%252BEGFR%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DMansour%26aufirst%3DTarek%2BS.%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D1435%26epage%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Properties of FDA-approved small molecule protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>144 </em>, 19-50. <a href="https://doi.org/10.1016/j.phrs.2019.03.006" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DProperties%252Bof%252BFDA-approved%252Bsmall%252Bmolecule%252Bprotein%252Bkinase%252Binhibitors%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2019%26volume%3D144%26spage%3D19%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salomón  Assad</span>, <span class="hlFld-ContribAuthor ">Rocío  Sabala</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Jiménez</span>, <span class="hlFld-ContribAuthor ">Estibaliz  Sansinenea</span>, <span class="hlFld-ContribAuthor ">Aurelio  Ortiz</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective conjugate addition of organocuprates to N-[4-(Dibenzylaminobutenoyl)]oxazolidinone. Synthesis of chiral β-substituted γ-aminoacids. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (25)
                                     , 1646-1648. <a href="https://doi.org/10.1016/j.tetlet.2019.05.035" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.05.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.05.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.05.035%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDiastereoselective%252Bconjugate%252Baddition%252Bof%252Borganocuprates%252Bto%252BN-%25255B4-%252528Dibenzylaminobutenoyl%252529%25255Doxazolidinone.%252BSynthesis%252Bof%252Bchiral%252B%2525CE%2525B2-substituted%252B%2525CE%2525B3-aminoacids%26aulast%3DAssad%26aufirst%3DSalom%25C3%25B3n%26date%3D2019%26volume%3D60%26issue%3D25%26spage%3D1646%26epage%3D1648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rocío  Sabala</span>, <span class="hlFld-ContribAuthor ">Salomon  Assad</span>, <span class="hlFld-ContribAuthor ">Ángel  Mendoza</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Jiménez</span>, <span class="hlFld-ContribAuthor ">Estibaliz  Sansinenea</span>, <span class="hlFld-ContribAuthor ">Aurelio  Ortiz</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric synthesis of α,β-substituted γ-amino acids via conjugate addition. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (26)
                                     , 1741-1744. <a href="https://doi.org/10.1016/j.tetlet.2019.05.060" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.05.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.05.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.05.060%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAsymmetric%252Bsynthesis%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2-substituted%252B%2525CE%2525B3-amino%252Bacids%252Bvia%252Bconjugate%252Baddition%26aulast%3DSabala%26aufirst%3DRoc%25C3%25ADo%26date%3D2019%26volume%3D60%26issue%3D26%26spage%3D1741%26epage%3D1744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rutugandha  Paranjpe</span>, <span class="hlFld-ContribAuthor ">Dima  Basatneh</span>, <span class="hlFld-ContribAuthor ">Gabriel  Tao</span>, <span class="hlFld-ContribAuthor ">Carmine  De Angelis</span>, <span class="hlFld-ContribAuthor ">Sobia  Noormohammed</span>, <span class="hlFld-ContribAuthor ">Ekim  Ekinci</span>, <span class="hlFld-ContribAuthor ">Susan  Abughosh</span>, <span class="hlFld-ContribAuthor ">Romi  Ghose</span>, <span class="hlFld-ContribAuthor ">Meghana V.  Trivedi</span>. </span><span class="cited-content_cbyCitation_article-title">Neratinib in HER2-Positive Breast Cancer Patients. </span><span class="cited-content_cbyCitation_journal-name">Annals of Pharmacotherapy</span><span> <strong>2019,</strong> <em>53 </em>
                                    (6)
                                     , 612-620. <a href="https://doi.org/10.1177/1060028018824088" title="DOI URL">https://doi.org/10.1177/1060028018824088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1060028018824088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1060028018824088%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Pharmacotherapy%26atitle%3DNeratinib%252Bin%252BHER2-Positive%252BBreast%252BCancer%252BPatients%26aulast%3DParanjpe%26aufirst%3DRutugandha%26date%3D2019%26date%3D2019%26volume%3D53%26issue%3D6%26spage%3D612%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Denis M.  Collins</span>, <span class="hlFld-ContribAuthor ">Neil T.  Conlon</span>, <span class="hlFld-ContribAuthor ">Srinivasaraghavan  Kannan</span>, <span class="hlFld-ContribAuthor ">Chandra S.  Verma</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Eli</span>, <span class="hlFld-ContribAuthor ">Alshad S.  Lalani</span>, <span class="hlFld-ContribAuthor ">John  Crown</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (6)
                                     , 737. <a href="https://doi.org/10.3390/cancers11060737" title="DOI URL">https://doi.org/10.3390/cancers11060737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11060737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11060737%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DPreclinical%252BCharacteristics%252Bof%252Bthe%252BIrreversible%252BPan-HER%252BKinase%252BInhibitor%252BNeratinib%252BCompared%252Bwith%252BLapatinib%25253A%252BImplications%252Bfor%252Bthe%252BTreatment%252Bof%252BHER2-Positive%252Band%252BHER2-Mutated%252BBreast%252BCancer%26aulast%3DCollins%26aufirst%3DDenis%2BM.%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D6%26spage%3D737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eslam M.H.  Ali</span>, <span class="hlFld-ContribAuthor ">Mohammed S.  Abdel-Maksoud</span>, <span class="hlFld-ContribAuthor ">Chang-Hyun  Oh</span>. </span><span class="cited-content_cbyCitation_article-title">Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (7)
                                     , 1159-1194. <a href="https://doi.org/10.1016/j.bmc.2019.02.044" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.02.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.02.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.02.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThieno%25255B2%25252C3-d%25255Dpyrimidine%252Bas%252Ba%252Bpromising%252Bscaffold%252Bin%252Bmedicinal%252Bchemistry%25253A%252BRecent%252Badvances%26aulast%3DAli%26aufirst%3DEslam%2BM.H.%26date%3D2019%26volume%3D27%26issue%3D7%26spage%3D1159%26epage%3D1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>139 </em>, 395-411. <a href="https://doi.org/10.1016/j.phrs.2018.11.014" title="DOI URL">https://doi.org/10.1016/j.phrs.2018.11.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2018.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2018.11.014%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DSmall%252Bmolecule%252Binhibitors%252Btargeting%252Bthe%252BEGFR%25252FErbB%252Bfamily%252Bof%252Bprotein-tyrosine%252Bkinases%252Bin%252Bhuman%252Bcancers%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2019%26volume%3D139%26spage%3D395%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>, <span class="hlFld-ContribAuthor ">Marija R.  Popovic‐Nikolic</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>, <span class="hlFld-ContribAuthor ">Elisa  Uliassi</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">A perspective on multi‐target drug discovery and design for complex diseases. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Medicine</span><span> <strong>2018,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40169-017-0181-2" title="DOI URL">https://doi.org/10.1186/s40169-017-0181-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40169-017-0181-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40169-017-0181-2%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Medicine%26atitle%3DA%252Bperspective%252Bon%252Bmulti%2525E2%252580%252590target%252Bdrug%252Bdiscovery%252Band%252Bdesign%252Bfor%252Bcomplex%252Bdiseases%26aulast%3DRamsay%26aufirst%3DRona%2BR.%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarfaraj  Niazi</span>, <span class="hlFld-ContribAuthor ">Madhusudan  Purohit</span>, <span class="hlFld-ContribAuthor ">Archana  Sonawani</span>, <span class="hlFld-ContribAuthor ">Javed H.  Niazi</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing the molecular interactions of aptamers that specifically bind to the extracellular domain of HER2 cancer biomarker protein: An  in silico  assessment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2018,</strong> <em>83 </em>, 112-121. <a href="https://doi.org/10.1016/j.jmgm.2018.06.003" title="DOI URL">https://doi.org/10.1016/j.jmgm.2018.06.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2018.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2018.06.003%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DRevealing%252Bthe%252Bmolecular%252Binteractions%252Bof%252Baptamers%252Bthat%252Bspecifically%252Bbind%252Bto%252Bthe%252Bextracellular%252Bdomain%252Bof%252BHER2%252Bcancer%252Bbiomarker%252Bprotein%25253A%252BAn%252Bin%252Bsilico%252Bassessment%26aulast%3DNiazi%26aufirst%3DSarfaraj%26date%3D2018%26volume%3D83%26spage%3D112%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nan  Jiang</span>, <span class="hlFld-ContribAuthor ">Jing‑Jing  Lin</span>, <span class="hlFld-ContribAuthor ">Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Bei‑Ning  Zhang</span>, <span class="hlFld-ContribAuthor ">Ao  Li</span>, <span class="hlFld-ContribAuthor ">Zheng‑Yang  Chen</span>, <span class="hlFld-ContribAuthor ">Song  Guo</span>, <span class="hlFld-ContribAuthor ">Bin‑Bin  Li</span>, <span class="hlFld-ContribAuthor ">Yu‑Zhong  Duan</span>, <span class="hlFld-ContribAuthor ">Ru‑Yi  Yan</span>, <span class="hlFld-ContribAuthor ">Hong‑Feng  Yan</span>, <span class="hlFld-ContribAuthor ">Xiao‑Yan  Fu</span>, <span class="hlFld-ContribAuthor ">Jin‑Lian  Zhou</span>, <span class="hlFld-ContribAuthor ">He‑Ming  Yang</span>, <span class="hlFld-ContribAuthor ">Yan  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review). </span><span class="cited-content_cbyCitation_journal-name">Experimental and Therapeutic Medicine</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.3892/etm.2018.6459" title="DOI URL">https://doi.org/10.3892/etm.2018.6459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/etm.2018.6459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fetm.2018.6459%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520and%2520Therapeutic%2520Medicine%26atitle%3DNovel%252Btreatment%252Bstrategies%252Bfor%252Bpatients%252Bwith%252BHER2%2525E2%252580%252591positive%252Bbreast%252Bcancer%252Bwho%252Bdo%252Bnot%252Bbenefit%252Bfrom%252Bcurrent%252Btargeted%252Btherapy%252Bdrugs%252B%252528Review%252529%26aulast%3DJiang%26aufirst%3DNan%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renata  Duchnowska</span>, <span class="hlFld-ContribAuthor ">Sibylle  Loibl</span>, <span class="hlFld-ContribAuthor ">Jacek  Jassem</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine kinase inhibitors for brain metastases in HER2-positive breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Treatment Reviews</span><span> <strong>2018,</strong> <em>67 </em>, 71-77. <a href="https://doi.org/10.1016/j.ctrv.2018.05.004" title="DOI URL">https://doi.org/10.1016/j.ctrv.2018.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ctrv.2018.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ctrv.2018.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Treatment%2520Reviews%26atitle%3DTyrosine%252Bkinase%252Binhibitors%252Bfor%252Bbrain%252Bmetastases%252Bin%252BHER2-positive%252Bbreast%252Bcancer%26aulast%3DDuchnowska%26aufirst%3DRenata%26date%3D2018%26volume%3D67%26spage%3D71%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira  Makino</span>, <span class="hlFld-ContribAuthor ">Anna  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Ayaka  Tomoike</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Kimura</span>, <span class="hlFld-ContribAuthor ">Kenji  Arimitsu</span>, <span class="hlFld-ContribAuthor ">Masahiko  Hirata</span>, <span class="hlFld-ContribAuthor ">Yoshiro  Ohmomo</span>, <span class="hlFld-ContribAuthor ">Ryuichi  Nishii</span>, <span class="hlFld-ContribAuthor ">Hidehiko  Okazawa</span>, <span class="hlFld-ContribAuthor ">Yasushi  Kiyono</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>. </span><span class="cited-content_cbyCitation_article-title">PET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (8)
                                     , 1609-1613. <a href="https://doi.org/10.1016/j.bmc.2018.02.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPET%252Bprobe%252Bdetecting%252Bnon-small%252Bcell%252Blung%252Bcancer%252Bsusceptible%252Bto%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252Btyrosine%252Bkinase%252Binhibitor%252Btherapy%26aulast%3DMakino%26aufirst%3DAkira%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D1609%26epage%3D1613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Pierre  Koch</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">Das Cysteinom der Proteinkinasen als Zielstruktur in der Arzneistoffentwicklung. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (16)
                                     , 4456-4470. <a href="https://doi.org/10.1002/ange.201707875" title="DOI URL">https://doi.org/10.1002/ange.201707875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201707875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201707875%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDas%252BCysteinom%252Bder%252BProteinkinasen%252Bals%252BZielstruktur%252Bin%252Bder%252BArzneistoffentwicklung%26aulast%3DChaikuad%26aufirst%3DApirat%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D16%26spage%3D4456%26epage%3D4470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Pierre  Koch</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">The Cysteinome of Protein Kinases as a Target in Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (16)
                                     , 4372-4385. <a href="https://doi.org/10.1002/anie.201707875" title="DOI URL">https://doi.org/10.1002/anie.201707875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201707875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201707875%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DThe%252BCysteinome%252Bof%252BProtein%252BKinases%252Bas%252Ba%252BTarget%252Bin%252BDrug%252BDevelopment%26aulast%3DChaikuad%26aufirst%3DApirat%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D16%26spage%3D4372%26epage%3D4385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shubhandra  Tripathi</span>, <span class="hlFld-ContribAuthor ">Gaurava  Srivastava</span>, <span class="hlFld-ContribAuthor ">Ashok  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Design of Multi-Target Drugs Against Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 443-458. <a href="https://doi.org/10.1007/7653_2018_24" title="DOI URL">https://doi.org/10.1007/7653_2018_24</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7653_2018_24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7653_2018_24%26sid%3Dliteratum%253Aachs%26atitle%3DComputational%252BDesign%252Bof%252BMulti-Target%252BDrugs%252BAgainst%252BBreast%252BCancer%26aulast%3DTripathi%26aufirst%3DShubhandra%26date%3D2018%26date%3D2018%26spage%3D443%26epage%3D458%26pub%3DSpringer%2520New%2520York%26atitle%3DMulti-Target%252BDrug%252BDesign%252BUsing%252BChem-Bioinformatic%252BApproaches%26aulast%3DRoy%26aufirst%3DKunal%26date%3D2019%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra N.  Milik</span>, <span class="hlFld-ContribAuthor ">Deena S.  Lasheen</span>, <span class="hlFld-ContribAuthor ">Rabah A.T.  Serya</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 131-151. <a href="https://doi.org/10.1016/j.ejmech.2017.07.023" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.023%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHow%252Bto%252Btrain%252Byour%252Binhibitor%25253A%252BDesign%252Bstrategies%252Bto%252Bovercome%252Bresistance%252Bto%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252Binhibitors%26aulast%3DMilik%26aufirst%3DSandra%2BN.%26date%3D2017%26volume%3D142%26spage%3D131%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mansour S.  Alsaid</span>, <span class="hlFld-ContribAuthor ">Abdullah A.  Al-Mishari</span>, <span class="hlFld-ContribAuthor ">Aiten M.  Soliman</span>, <span class="hlFld-ContribAuthor ">Fatma A.  Ragab</span>, <span class="hlFld-ContribAuthor ">Mostafa M.  Ghorab</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>141 </em>, 84-91. <a href="https://doi.org/10.1016/j.ejmech.2017.09.061" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.09.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.09.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.09.061%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBenzo%25255Bg%25255Dquinazolin%252Bbenzenesulfonamide%252Bderivatives%252Bas%252Bdual%252BEGFR%25252FHER2%252Binhibitors%26aulast%3DAlsaid%26aufirst%3DMansour%2BS.%26date%3D2017%26volume%3D141%26spage%3D84%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cynthia X.  Ma</span>, <span class="hlFld-ContribAuthor ">Ron  Bose</span>, <span class="hlFld-ContribAuthor ">Feng  Gao</span>, <span class="hlFld-ContribAuthor ">Rachel A.  Freedman</span>, <span class="hlFld-ContribAuthor ">Melinda L.  Telli</span>, <span class="hlFld-ContribAuthor ">Gretchen  Kimmick</span>, <span class="hlFld-ContribAuthor ">Eric  Winer</span>, <span class="hlFld-ContribAuthor ">Michael  Naughton</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Goetz</span>, <span class="hlFld-ContribAuthor ">Christy  Russell</span>, <span class="hlFld-ContribAuthor ">Debu  Tripathy</span>, <span class="hlFld-ContribAuthor ">Melody  Cobleigh</span>, <span class="hlFld-ContribAuthor ">Andres  Forero</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Pluard</span>, <span class="hlFld-ContribAuthor ">Carey  Anders</span>, <span class="hlFld-ContribAuthor ">Polly Ann  Niravath</span>, <span class="hlFld-ContribAuthor ">Shana  Thomas</span>, <span class="hlFld-ContribAuthor ">Jill  Anderson</span>, <span class="hlFld-ContribAuthor ">Caroline  Bumb</span>, <span class="hlFld-ContribAuthor ">Kimberly C.  Banks</span>, <span class="hlFld-ContribAuthor ">Richard B.  Lanman</span>, <span class="hlFld-ContribAuthor ">Richard  Bryce</span>, <span class="hlFld-ContribAuthor ">Alshad S.  Lalani</span>, <span class="hlFld-ContribAuthor ">John  Pfeifer</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Hayes</span>, <span class="hlFld-ContribAuthor ">Mark  Pegram</span>, <span class="hlFld-ContribAuthor ">Kimberly  Blackwell</span>, <span class="hlFld-ContribAuthor ">Philippe L.  Bedard</span>, <span class="hlFld-ContribAuthor ">Hussam  Al-Kateb</span>, <span class="hlFld-ContribAuthor ">Matthew J.C.  Ellis</span>. </span><span class="cited-content_cbyCitation_article-title">Neratinib Efficacy and Circulating Tumor DNA Detection of
              HER2
              Mutations in
              HER2
              Nonamplified Metastatic Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2017,</strong> <em>23 </em>
                                    (19)
                                     , 5687-5695. <a href="https://doi.org/10.1158/1078-0432.CCR-17-0900" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-17-0900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-17-0900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-17-0900%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DNeratinib%252BEfficacy%252Band%252BCirculating%252BTumor%252BDNA%252BDetection%252Bof%252BHER2%252BMutations%252Bin%252BHER2%252BNonamplified%252BMetastatic%252BBreast%252BCancer%26aulast%3DMa%26aufirst%3DCynthia%2BX.%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D19%26spage%3D5687%26epage%3D5695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathew A  Cherian</span>, <span class="hlFld-ContribAuthor ">Cynthia X  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">The role of neratinib in HER2-driven breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2017,</strong> <em>13 </em>
                                    (22)
                                     , 1931-1943. <a href="https://doi.org/10.2217/fon-2017-0186" title="DOI URL">https://doi.org/10.2217/fon-2017-0186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon-2017-0186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon-2017-0186%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DThe%252Brole%252Bof%252Bneratinib%252Bin%252BHER2-driven%252Bbreast%252Bcancer%26aulast%3DCherian%26aufirst%3DMathew%2BA%26date%3D2017%26volume%3D13%26issue%3D22%26spage%3D1931%26epage%3D1943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabel  Echavarria</span>, <span class="hlFld-ContribAuthor ">Sara  López-Tarruella</span>, <span class="hlFld-ContribAuthor ">Iván  Márquez-Rodas</span>, <span class="hlFld-ContribAuthor ">Yolanda  Jerez</span>, <span class="hlFld-ContribAuthor ">Miguel  Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Neratinib for the treatment of HER2-positive early stage breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2017,</strong> <em>17 </em>
                                    (8)
                                     , 669-679. <a href="https://doi.org/10.1080/14737140.2017.1338954" title="DOI URL">https://doi.org/10.1080/14737140.2017.1338954</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737140.2017.1338954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737140.2017.1338954%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DNeratinib%252Bfor%252Bthe%252Btreatment%252Bof%252BHER2-positive%252Bearly%252Bstage%252Bbreast%252Bcancer%26aulast%3DEchavarria%26aufirst%3DIsabel%26date%3D2017%26date%3D2017%26volume%3D17%26issue%3D8%26spage%3D669%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramadan Ahmed  Mekheimer</span>, <span class="hlFld-ContribAuthor ">Mariam Abdullah  Al-Sheikh</span>, <span class="hlFld-ContribAuthor ">Hanadi Yousef  Medrasi</span>, <span class="hlFld-ContribAuthor ">Ghayah Ali Abdullah  Bahatheg</span>. </span><span class="cited-content_cbyCitation_article-title">Fused quinoline heterocycles X. First synthesis of new four heterocyclic ring systems 10-amino-6,9-disubstituted-[1,2,4]triazino[4′,3′:1,5]pyrazolo[4,3-
              c
              ]quinoline derivatives. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2017,</strong> <em>47 </em>
                                    (11)
                                     , 1052-1064. <a href="https://doi.org/10.1080/00397911.2017.1293110" title="DOI URL">https://doi.org/10.1080/00397911.2017.1293110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2017.1293110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2017.1293110%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DFused%252Bquinoline%252Bheterocycles%252BX.%252BFirst%252Bsynthesis%252Bof%252Bnew%252Bfour%252Bheterocyclic%252Bring%252Bsystems%252B10-amino-6%25252C9-disubstituted-%25255B1%25252C2%25252C4%25255Dtriazino%25255B4%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2%25253A1%25252C5%25255Dpyrazolo%25255B4%25252C3-%252Bc%252B%25255Dquinoline%252Bderivatives%26aulast%3DMekheimer%26aufirst%3DRamadan%2BAhmed%26date%3D2017%26date%3D2017%26volume%3D47%26issue%3D11%26spage%3D1052%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pankaj Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Novel EGFR (T790M)-cMET dual inhibitors: putative therapeutic agents for non-small-cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (5)
                                     , 469-483. <a href="https://doi.org/10.4155/fmc-2016-0234" title="DOI URL">https://doi.org/10.4155/fmc-2016-0234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0234%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BEGFR%252B%252528T790M%252529-cMET%252Bdual%252Binhibitors%25253A%252Bputative%252Btherapeutic%252Bagents%252Bfor%252Bnon-small-cell%252Blung%252Bcancer%26aulast%3DSingh%26aufirst%3DPankaj%2BKumar%26date%3D2017%26volume%3D9%26issue%3D5%26spage%3D469%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R.  Coxon</span>, <span class="hlFld-ContribAuthor ">Christopher  Wong</span>, <span class="hlFld-ContribAuthor ">Richard  Bayliss</span>, <span class="hlFld-ContribAuthor ">Kathy  Boxall</span>, <span class="hlFld-ContribAuthor ">Katherine H.  Carr</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Fry</span>, <span class="hlFld-ContribAuthor ">Ian R.  Hardcastle</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Matheson</span>, <span class="hlFld-ContribAuthor ">David R.  Newell</span>, <span class="hlFld-ContribAuthor ">Mangaleswaran  Sivaprakasam</span>, <span class="hlFld-ContribAuthor ">Huw  Thomas</span>, <span class="hlFld-ContribAuthor ">David  Turner</span>, <span class="hlFld-ContribAuthor ">Sharon  Yeoh</span>, <span class="hlFld-ContribAuthor ">Lan Z.  Wang</span>, <span class="hlFld-ContribAuthor ">Roger J.  Griffin</span>, <span class="hlFld-ContribAuthor ">Bernard T.  Golding</span>, <span class="hlFld-ContribAuthor ">Céline  Cano</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-guided design of purine-based probes for selective Nek2 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (12)
                                     , 19089-19124. <a href="https://doi.org/10.18632/oncotarget.13249" title="DOI URL">https://doi.org/10.18632/oncotarget.13249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.13249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.13249%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DStructure-guided%252Bdesign%252Bof%252Bpurine-based%252Bprobes%252Bfor%252Bselective%252BNek2%252Binhibition%26aulast%3DCoxon%26aufirst%3DChristopher%2BR.%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D12%26spage%3D19089%26epage%3D19124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. K.  Singh</span>, <span class="hlFld-ContribAuthor ">O.  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics and pharmacophore modelling studies of different subtype (ALK and EGFR (T790M)) inhibitors in NSCLC. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2017,</strong> <em>28 </em>
                                    (3)
                                     , 221-233. <a href="https://doi.org/10.1080/1062936X.2017.1300189" title="DOI URL">https://doi.org/10.1080/1062936X.2017.1300189</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2017.1300189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2017.1300189%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DMolecular%252Bdynamics%252Band%252Bpharmacophore%252Bmodelling%252Bstudies%252Bof%252Bdifferent%252Bsubtype%252B%252528ALK%252Band%252BEGFR%252B%252528T790M%252529%252529%252Binhibitors%252Bin%252BNSCLC%26aulast%3DSingh%26aufirst%3DP.%2BK.%26date%3D2017%26date%3D2017%26volume%3D28%26issue%3D3%26spage%3D221%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Xin  Xu</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Xing  Yan</span>, <span class="hlFld-ContribAuthor ">Chongzhao  Ran</span>, <span class="hlFld-ContribAuthor ">Xinliang  Mao</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, <span class="hlFld-ContribAuthor ">Chunhua  Qiao</span>. </span><span class="cited-content_cbyCitation_article-title">Novel conjugates of endoperoxide and 4-anilinoquinazoline as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 1341-1345. <a href="https://doi.org/10.1016/j.bmcl.2017.02.023" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.02.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.02.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bconjugates%252Bof%252Bendoperoxide%252Band%252B4-anilinoquinazoline%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DYang%26aufirst%3DJing%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D1341%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Qu</span>, <span class="hlFld-ContribAuthor ">A.  Yan</span>, <span class="hlFld-ContribAuthor ">J. S.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">SAR and QSAR study on the bioactivities of human epidermal growth factor receptor-2 (HER2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2017,</strong> <em>28 </em>
                                    (2)
                                     , 111-132. <a href="https://doi.org/10.1080/1062936X.2017.1284898" title="DOI URL">https://doi.org/10.1080/1062936X.2017.1284898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2017.1284898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2017.1284898%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DSAR%252Band%252BQSAR%252Bstudy%252Bon%252Bthe%252Bbioactivities%252Bof%252Bhuman%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor-2%252B%252528HER2%252529%252Binhibitors%26aulast%3DQu%26aufirst%3DD.%26date%3D2017%26date%3D2017%26volume%3D28%26issue%3D2%26spage%3D111%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dirk  Theile</span>, <span class="hlFld-ContribAuthor ">Gal  Lenz</span>, <span class="hlFld-ContribAuthor ">Jamil A.  Momand</span>, <span class="hlFld-ContribAuthor ">Susan E.  Kane</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance to HER2-Targeted Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 35-88. <a href="https://doi.org/10.1007/978-3-319-70142-4_2" title="DOI URL">https://doi.org/10.1007/978-3-319-70142-4_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-70142-4_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-70142-4_2%26sid%3Dliteratum%253Aachs%26atitle%3DResistance%252Bto%252BHER2-Targeted%252BTherapy%26aulast%3DTheile%26aufirst%3DDirk%26date%3D2017%26date%3D2017%26spage%3D35%26epage%3D88%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DResistance%252Bto%252BTargeted%252BTherapies%252Bin%252BBreast%252BCancer%26aulast%3DProsperi%26aufirst%3DJenifer%2BR.%26date%3D2017%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.A.  Mortlock</span>, <span class="hlFld-ContribAuthor ">D.M.  Wilson</span>, <span class="hlFld-ContribAuthor ">J.G.  Kettle</span>, <span class="hlFld-ContribAuthor ">F.W.  Goldberg</span>, <span class="hlFld-ContribAuthor ">K.M.  Foote</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Kinase Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 39-75. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12391-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12391-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12391-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12391-1%26sid%3Dliteratum%253Aachs%26atitle%3DSelective%252BKinase%252BInhibitors%252Bin%252BCancer%26aulast%3DMortlock%26aufirst%3DA.A.%26date%3D2017%26spage%3D39%26epage%3D75%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatima  Tufail</span>, <span class="hlFld-ContribAuthor ">Mohammad  Saquib</span>, <span class="hlFld-ContribAuthor ">Swastika  Singh</span>, <span class="hlFld-ContribAuthor ">Jyoti  Tiwari</span>, <span class="hlFld-ContribAuthor ">Mandavi  Singh</span>, <span class="hlFld-ContribAuthor ">Jaya  Singh</span>, <span class="hlFld-ContribAuthor ">Jagdamba  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Bioorganopromoted green Friedländer synthesis: a versatile new malic acid promoted solvent free approach to multisubstituted quinolines. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2017,</strong> <em>41 </em>
                                    (4)
                                     , 1618-1624. <a href="https://doi.org/10.1039/C6NJ03907C" title="DOI URL">https://doi.org/10.1039/C6NJ03907C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6NJ03907C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6NJ03907C%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DBioorganopromoted%252Bgreen%252BFriedl%2525C3%2525A4nder%252Bsynthesis%25253A%252Ba%252Bversatile%252Bnew%252Bmalic%252Bacid%252Bpromoted%252Bsolvent%252Bfree%252Bapproach%252Bto%252Bmultisubstituted%252Bquinolines%26aulast%3DTufail%26aufirst%3DFatima%26date%3D2017%26date%3D2017%26volume%3D41%26issue%3D4%26spage%3D1618%26epage%3D1624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Osamu  Yabe</span>, <span class="hlFld-ContribAuthor ">Akihiro  Suzuki</span>, <span class="hlFld-ContribAuthor ">Tomomi  Ikemoto</span>. </span><span class="cited-content_cbyCitation_article-title">A Convergent Scale-up Synthesis of A HER2/EGRF Dual Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2017,</strong> <em>94 </em>
                                    (4)
                                     , 702. <a href="https://doi.org/10.3987/COM-17-13663" title="DOI URL">https://doi.org/10.3987/COM-17-13663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-17-13663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-17-13663%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DA%252BConvergent%252BScale-up%252BSynthesis%252Bof%252BA%252BHER2%25252FEGRF%252BDual%252BKinase%252BInhibitor%26aulast%3DYabe%26aufirst%3DOsamu%26date%3D2017%26volume%3D94%26issue%3D4%26spage%3D702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhrubajyoti  Gogoi</span>, <span class="hlFld-ContribAuthor ">Vishwa Jyoti  Baruah</span>, <span class="hlFld-ContribAuthor ">Amrita Kashyap  Chaliha</span>, <span class="hlFld-ContribAuthor ">Bibhuti Bhushan  Kakoti</span>, <span class="hlFld-ContribAuthor ">Diganta  Sarma</span>, <span class="hlFld-ContribAuthor ">Alak Kumar  Buragohain</span>. </span><span class="cited-content_cbyCitation_article-title">3D pharmacophore-based virtual screening, docking and density functional theory approach towards the discovery of novel human epidermal growth factor receptor-2 (HER2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Theoretical Biology</span><span> <strong>2016,</strong> <em>411 </em>, 68-80. <a href="https://doi.org/10.1016/j.jtbi.2016.09.016" title="DOI URL">https://doi.org/10.1016/j.jtbi.2016.09.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtbi.2016.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtbi.2016.09.016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Theoretical%2520Biology%26atitle%3D3D%252Bpharmacophore-based%252Bvirtual%252Bscreening%25252C%252Bdocking%252Band%252Bdensity%252Bfunctional%252Btheory%252Bapproach%252Btowards%252Bthe%252Bdiscovery%252Bof%252Bnovel%252Bhuman%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor-2%252B%252528HER2%252529%252Binhibitors%26aulast%3DGogoi%26aufirst%3DDhrubajyoti%26date%3D2016%26volume%3D411%26spage%3D68%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annemie  Prové</span>, <span class="hlFld-ContribAuthor ">Luc  Dirix</span>. </span><span class="cited-content_cbyCitation_article-title">Neratinib for the treatment of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2016,</strong> <em>17 </em>
                                    (16)
                                     , 2243-2248. <a href="https://doi.org/10.1080/14656566.2016.1244528" title="DOI URL">https://doi.org/10.1080/14656566.2016.1244528</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2016.1244528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2016.1244528%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DNeratinib%252Bfor%252Bthe%252Btreatment%252Bof%252Bbreast%252Bcancer%26aulast%3DProv%25C3%25A9%26aufirst%3DAnnemie%26date%3D2016%26date%3D2016%26volume%3D17%26issue%3D16%26spage%3D2243%26epage%3D2248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hampig Raphael  Kourie</span>, <span class="hlFld-ContribAuthor ">Marie  Chaix</span>, <span class="hlFld-ContribAuthor ">Andrea  Gombos</span>, <span class="hlFld-ContribAuthor ">Phillippe  Aftimos</span>, <span class="hlFld-ContribAuthor ">Ahmad  Awada</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacodynamics, pharmacokinetics and clinical efficacy of neratinib in HER2-positive breast cancer and breast cancer with HER2 mutations. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Metabolism & Toxicology</span><span> <strong>2016,</strong> <em>12 </em>
                                    (8)
                                     , 947-957. <a href="https://doi.org/10.1080/17425255.2016.1198317" title="DOI URL">https://doi.org/10.1080/17425255.2016.1198317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17425255.2016.1198317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17425255.2016.1198317%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Metabolism%2520%2526%2520Toxicology%26atitle%3DPharmacodynamics%25252C%252Bpharmacokinetics%252Band%252Bclinical%252Befficacy%252Bof%252Bneratinib%252Bin%252BHER2-positive%252Bbreast%252Bcancer%252Band%252Bbreast%252Bcancer%252Bwith%252BHER2%252Bmutations%26aulast%3DKourie%26aufirst%3DHampig%2BRaphael%26date%3D2016%26date%3D2016%26volume%3D12%26issue%3D8%26spage%3D947%26epage%3D957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm040159c&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm040159c%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2005.48.issue-4%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=211&amp;pagesCount=3&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159cf00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cf00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00001.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159cf00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159ch00001a" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00001a.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00001a.jpeg" id="rightTab-_i8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Scheme 1.  Methods 1A and 1B<i><sup>a</sup></i><sup></sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00001a.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00001a"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159ch00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00001.jpeg" id="rightTab-_i9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1.  (Continued) </p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) <i>i</i>-PrOH, pyridine hydrochloride, reflux; (ii) Fe, NH<sub>4</sub>Cl, MeOH, H<sub>2</sub>O, reflux; (iii) THF, Hunig base, 4-bromocrotonyl chloride, 0 °C; (iv) DMF, NaI, R‘ ‘R‘NH, room temperature; (v) <i>N</i>-methyl-2-pyrrolidinone or DMF, from 0 °C to room temperature.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159ch00002" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00002.jpeg" id="rightTab-_i10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2.  Method 2<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Ac<sub>2</sub>O, HOAc, 60 °C; (ii) EtBr, DMF, K<sub>2</sub>CO<sub>3</sub>, 60 °C; (iii) H<sub>2</sub>, Pd/C, THF; (iv) toluene, 90 °C; (v) Dowtherm, 250 °C; (vi) POCl<sub>3</sub>, diglyme, 100 °C; (vii) pyridine hydrochloride, <i>i</i>-PrOH or methoxyethanol, reflux; (viii) aqueous HCl, reflux; (xi) CH<sub>3</sub>CN, <i>N</i>-methyl-2-pyrrolidinone or DMF, from 0 °C to room temperature.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159ch00003" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00003.jpeg" id="rightTab-_i11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3.  Method 3<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Fe, HOAc, NaOAc, MeOH, reflux; (ii) Me<sub>2</sub>NCH<sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCOCl in CH<sub>3</sub>CN, <i>N</i>-methyl-2-pyrrolidinone or DMF, from 0 °C to room temperature; (iii) pyridine hydrochloride, methoxyethanol, or <i>i</i>-PrOH, reflux.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159ch00004" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00004.jpeg" id="rightTab-_i13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) (Boc)<sub>2</sub>O, DMAP, THF, 0 °C to room temperature; (ii) Fe, HOAc, MeOH, reflux; (iii) pyridine hydrochloride, methoxyethanol, reflux, then CH<sub>2</sub>Cl<sub>2</sub>, TFA, from 0 to 25 °C; (iv) NaBH(OAc)<sub>3</sub>, dichloroethane, HOAc, room temperature.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159cf00002" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cf00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00002.jpeg" id="rightTab-_i14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Model of the HER-2−<b>25o</b> complex. The H-bond between the quinoline N1 and Met 801 is shown. Also shown are distances between the sulfur of Cys 805 and the Michael acceptor β-carbon, and the sulfhydryl hydrogen and the nitrogen of the dimethylamino group, the suggested intramolecular catalyst.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159cf00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159cf00003" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cf00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00003.jpeg" id="rightTab-_i15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Scatter plot comparing the activities of compounds against the EGFR and HER-2 kinase enzymes. Note that mean values of log IC<sub>50</sub> are plotted. The error bars (horizontal for EGFR, vertical for HER-2) represent the standard error of the respective mean values. Note that the number of observations for each compound varies from 1 to 30. The single-point observations show no error bars. The least-squares regression line is also shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159cf00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159ch00005" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00005.jpeg" id="rightTab-_i16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) <i>i</i>-PrOH, reflux; (ii) Fe, HOAc, MeOH, reflux; (iii) Me<sub>2</sub>NCH<sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCOCl in CH<sub>3</sub>CN, <i>N</i>-methyl-2-pyrrolidinone or DMF, from 0 °C to room temperature; (iv) CH<sub>2</sub>Cl<sub>2</sub>, TFA; (v) (PhCO)<sub>2</sub>O, DMA, 60 °C for <b>36</b>, nicotinyl chloride hydrochloride, (<i>i</i>-Pr)<sub>2</sub>NEt, DMA, 25 °C for <b>37</b>; (vi) Ph-N<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>C<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>O, DMA, 25 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159ch00006" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00006.jpeg" id="rightTab-_i18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) NaH, DMF, room temperature, or NaOMe, DMF; (ii) Fe, NH<sub>4</sub>Cl, MeOH, H<sub>2</sub>O, reflux, or Fe, HOAc, MeOH, reflux; (iii) THF, reflux; (iv) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 25 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159ch00007" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00007.jpeg" id="rightTab-_i19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 7 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Heat and distill at 160 °C; (ii) H<sub>2</sub>NOSO<sub>3</sub>H, hot H<sub>2</sub>O, 55 °C; (iii) Et<sub>3</sub>N, DMF, H<sub>2</sub>S, heat at 80 °C in a steel bomb; (iv) EtOH, reflux.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159ch00008" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00008.jpeg" id="rightTab-_i20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 8 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) K<sub>2</sub>CO<sub>3</sub>, DMF, heat; (ii) Fe, HOAc, MeOH, H<sub>2</sub>O, reflux; (iii) NaH,benzene; (iv) Raney Ni, hydrazine, EtOH.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00008"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159ch00009" data-index="13" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00009.jpeg" id="rightTab-_i22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 9 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) NaI, acetone, reflux; (ii) THF, 0 °C; (iii) 1 N HCl, reflux; (iv) CH<sub>3</sub>CN, (COCl)<sub>2</sub>, <i>N</i>-methyl-2-pyrrolidinone or DMF (cat.), 55 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00009"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159ch00010" data-index="14" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00010.jpeg" id="rightTab-_i26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 10 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Triethyl phosphonoacetate, <i>n</i>-BuLi, THF, then DIBAL, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to room temperature; (ii) MeOH, NaOH, then HCl; (iii) CH<sub>2</sub>Cl<sub>2</sub>, (COCl)<sub>2</sub>, cat. DMF, reflux; (iv) malonic acid, pyridine, piperidine (cat.), 110 °C; (v) CH<sub>2</sub>Cl<sub>2</sub>, (COCl)<sub>2</sub>, DMF (cat.), reflux. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00010"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159ch00011" data-index="15" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00011.jpeg" id="rightTab-_i28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 11 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) <i>N</i>-Methyl-2-pyrrolidinone, from 0 °C to room temperature. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00011"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159ch00012" data-index="16" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159ch00012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00012.jpeg" id="rightTab-_i29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 12 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) THF, Et<sub>3</sub>N, 0 °C; (ii) <i>N</i>-methyl-2-pyrrolidinone, from −15 °C to room temperature; (iii) <i>N</i>-methyl-2-pyrrolidinone, from 0 °C to room temperature; (iv) CH<sub>3</sub>CN, Hunig's base, reflux.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159ch00012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159ch00012"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm040159cf00004" data-index="17" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/medium/jm040159cf00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00004.jpeg" id="rightTab-_i36" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Inhibition of HER-2 phosphorylation in the 3T3/neu tumor model and BT474 xenograft. 3T3/neu (A) and BT474 (B) tumor-bearing mice were treated with vehicle or a single dose of compound (three to five animals per group). Tumors from control and treated mice were dissected at various times after compound administration. Protein extracts from each time point were pooled and analyzed by SDS−PAGE and immunoblotting. Extracts from individual tumors were also analyzed to determine the variability between animals. Phosphorylation of HER-2 was detected using phosphotyrosine antibodies and normalized to HER-2 levels, detected with anti HER-2 antibodies. Blots were quantified by scanning densitometry. Data for <b>25o</b> in part B are from ref 29.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-4/jm040159c/production/images/large/jm040159cf00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm040159c&amp;id=jm040159cf00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><a name="jm004800401131" id="jm004800401131"></a></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm040159cb00001"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00001_1"><span><span class="NLM_string-ref">Traxler, P. Tyrosine kinases as targets in cancer therapysuccesses and failures. <i>  Expert Opin. Ther. Targets</i><b>2003</b>, <i>7</i> (2), 215−234.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2003&pages=234&issue=2&author=P+Traxler&title=Tyrosine+kinases+as+targets+in+cancer+therapysuccesses+and+failures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP%26atitle%3DTyrosine%2520kinases%2520as%2520targets%2520in%2520cancer%2520therapysuccesses%2520and%2520failures%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2003%26volume%3D7%26issue%3D2%26spage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00002"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00002_1"><span><span class="NLM_string-ref">Yarden Y.; Sliwknowski, M. X. Untangling of the ErB signaling network. <i>  Nat. Rev. Mol. Cell Biol</i>. <b>2001</b>, <i>2</i>, 127−137.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=137&author=Y.+Yarden&author=M.+X+Sliwknowski&title=Untangling+of+the+ErB+signaling+network"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYarden%26aufirst%3DY.%26atitle%3DUntangling%2520of%2520the%2520ErB%2520signaling%2520network%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2001%26volume%3D2%26spage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00003"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00003_1"><span><span class="NLM_string-ref">Dowsett, M.; Cooke, T.; Ellis, L.; Gullick, W. J.; Gusterson, B.; Mallon, E.; Walker, R. Assesment of HER2 status in breast cancer:  why, when and how? <i>Eur. J. Cancer </i><b>2000</b>, <i>36</i>, 170−176.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2000&pages=176&author=M.+Dowsett&author=T.+Cooke&author=L.+Ellis&author=W.+J.+Gullick&author=B.+Gusterson&author=E.+Mallon&author=R+Walker&title=Assesment+of+HER2+status+in+breast+cancer%3A%E2%80%89+why%2C+when+and+how"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDowsett%26aufirst%3DM.%26atitle%3DAssesment%2520of%2520HER2%2520status%2520in%2520breast%2520cancer%253A%25E2%2580%2589%2520why%252C%2520when%2520and%2520how%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2000%26volume%3D36%26spage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00004"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00004_1"><span><span class="NLM_string-ref">Kim, H.; Muller, W. J. The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis. <i>  Exp. Cell Res. </i><b>1999</b>, <i>253</i>, 78−87.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1999&pages=87&author=H.+Kim&author=W.+J+Muller&title=The+role+of+the+epidermal+growth+factor+receptor+family+in+mammary+tumorigenesis+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26atitle%3DThe%2520role%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520family%2520in%2520mammary%2520tumorigenesis%2520and%2520metastasis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D253%26spage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00005"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00005_1"><span><span class="NLM_string-ref">Koeppen, H. K. W.; Wright, B. D.; Burt, A. D.; Quirke, P.; McNicol, A. M.; Nybdal, N. O.; Sliwkowski, M. X.; Hillan, K. J. Overexpression of HER-2/neu in solid tumours:  an immunohistochemical survey. <i>  Histopathology</i><b>2001</b>, <i>38</i>, 96−104.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2001&pages=104&author=H.+K.+W.+Koeppen&author=B.+D.+Wright&author=A.+D.+Burt&author=P.+Quirke&author=A.+M.+McNicol&author=N.+O.+Nybdal&author=M.+X.+Sliwkowski&author=K.+J+Hillan&title=Overexpression+of+HER-2%2Fneu+in+solid+tumours%3A%E2%80%89+an+immunohistochemical+survey"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoeppen%26aufirst%3DH.%2BK.%2BW.%26atitle%3DOverexpression%2520of%2520HER-2%252Fneu%2520in%2520solid%2520tumours%253A%25E2%2580%2589%2520an%2520immunohistochemical%2520survey%26jtitle%3DHistopathology%26date%3D2001%26volume%3D38%26spage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00006"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00006_1"><span><span class="NLM_string-ref">Nass, S. J.; Hahm, H. A.; Davidson, N. E. Breast cancer biology blossoms in the clinic. <i>  Nat. Med. </i><b>1998</b>,<i> 7, </i>761−762.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=762&author=S.+J.+Nass&author=H.+A.+Hahm&author=N.+E+Davidson&title=Breast+cancer+biology+blossoms+in+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNass%26aufirst%3DS.%2BJ.%26atitle%3DBreast%2520cancer%2520biology%2520blossoms%2520in%2520the%2520clinic%26jtitle%3DNat.%2520Med.%26date%3D1998%26volume%3D7%26spage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00007"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00007_1"><span><span class="NLM_string-ref">Ciardiello, F.; De Vita, F.; Orditura, M.; De Placido, S.; Tortora, G. Epidermal growth factor receptor tyrosind kinase inhibitors in late stage trials. <i>  Expert Opin. Emerging Drugs</i><b>2003</b>, <i>8</i> (2), 501−514.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=514&issue=2&author=F.+Ciardiello&author=F.+De+Vita&author=M.+Orditura&author=S.+De+Placido&author=G+Tortora&title=Epidermal+growth+factor+receptor+tyrosind+kinase+inhibitors+in+late+stage+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiardiello%26aufirst%3DF.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520tyrosind%2520kinase%2520inhibitors%2520in%2520late%2520stage%2520trials%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2003%26volume%3D8%26issue%3D2%26spage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00008"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00008_1"><span><span class="NLM_string-ref">Supuran, C. T.; Scozzafava, A. Protein tyrosine kinase inhibitors as anticancer agents. <i>  Expert Opin. Ther. Patents </i><b>2004</b>, <i>14</i> (1), 35−53.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=53&issue=1&author=C.+T.+Supuran&author=A+Scozzafava&title=Protein+tyrosine+kinase+inhibitors+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DProtein%2520tyrosine%2520kinase%2520inhibitors%2520as%2520anticancer%2520agents%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2004%26volume%3D14%26issue%3D1%26spage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00009"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00009_1"><span><span class="NLM_string-ref">Wissner, A.; Overbeek, E.; Reich, M. F.; Floyd, M. B.; Johnson, B. D.; Mamuya, N.; Rosfjord, E. C.; Discafani, C.; Davis, R.; Shi, X.; Rabindran, S. K.; Gruber, B. C.; Ye, F.; Hallett, W. A.; Nilakantan, R.; Shen, R.; Wang, Y.-F.; Greenberger, L. M.; Tsou, H.-R. Synthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2). <i>  J. Med. Chem</i>. <b>2003</b>, <i>46 </i>(1), 49−63.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=63&issue=1&author=A.+Wissner&author=E.+Overbeek&author=M.+F.+Reich&author=M.+B.+Floyd&author=B.+D.+Johnson&author=N.+Mamuya&author=E.+C.+Rosfjord&author=C.+Discafani&author=R.+Davis&author=X.+Shi&author=S.+K.+Rabindran&author=B.+C.+Gruber&author=F.+Ye&author=W.+A.+Hallett&author=R.+Nilakantan&author=R.+Shen&author=Y.-F.+Wang&author=L.+M.+Greenberger&author=H.-R+Tsou&title=Synthesis+and+Structure%E2%88%92Activity+Relationships+of+6%2C7-Disubstituted+4-Anilinoquinoline-3-carbonitriles.+The+Design+of+an+Orally+Active%2C+Irreversible+Inhibitor+of+the+Tyrosine+Kinase+Activity+of+the+Epidermal+Growth+Factor+Receptor+%28EGFR%29+and+the+Human+Epidermal+Growth+Factor+Receptor-2+%28HER-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2588%2592Activity%2520Relationships%2520of%25206%252C7-Disubstituted%25204-Anilinoquinoline-3-carbonitriles.%2520The%2520Design%2520of%2520an%2520Orally%2520Active%252C%2520Irreversible%2520Inhibitor%2520of%2520the%2520Tyrosine%2520Kinase%2520Activity%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528EGFR%2529%2520and%2520the%2520Human%2520Epidermal%2520Growth%2520Factor%2520Receptor-2%2520%2528HER-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D1%26spage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm040159cb00010_1"><span><span class="NLM_string-ref">Wissner, A.; Floyd, M. B.; Rabindran, S. K.; Nilakantan, R.; Greenberger, L. M.; Shen, R.; Wang, Y.-F.; Tsou, H.-R. Syntheses and EGFR and HER-2 kinase inhibitory activities of 4-anilinoquinoline-3-carbonitriles:  analogues of three important 4-anilinoquinazolines currently undergoing clinical evaluation as therapeutic antitumor agents. <i>  Bioorg. Med. Chem. Lett.</i><b>2002</b>, <i>12,</i> 2893−2897.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2897&author=A.+Wissner&author=M.+B.+Floyd&author=S.+K.+Rabindran&author=R.+Nilakantan&author=L.+M.+Greenberger&author=R.+Shen&author=Y.-F.+Wang&author=H.-R+Tsou&title=Syntheses+and+EGFR+and+HER-2+kinase+inhibitory+activities+of+4-anilinoquinoline-3-carbonitriles%3A%E2%80%89+analogues+of+three+important+4-anilinoquinazolines+currently+undergoing+clinical+evaluation+as+therapeutic+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DSyntheses%2520and%2520EGFR%2520and%2520HER-2%2520kinase%2520inhibitory%2520activities%2520of%25204-anilinoquinoline-3-carbonitriles%253A%25E2%2580%2589%2520analogues%2520of%2520three%2520important%25204-anilinoquinazolines%2520currently%2520undergoing%2520clinical%2520evaluation%2520as%2520therapeutic%2520antitumor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00011"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00011_1"><span><span class="NLM_string-ref">Prigent, S. A.; Lemoine, N. R. The type 1 (EGFR-related) family of growth factor receptors and their ligands. <i>  Prog. Growth Factor Res. </i><b>1992</b>, <i>4</i>, 1−24.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1992&pages=24&author=S.+A.+Prigent&author=N.+R+Lemoine&title=The+type+1+%28EGFR-related%29+family+of+growth+factor+receptors+and+their+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrigent%26aufirst%3DS.%2BA.%26atitle%3DThe%2520type%25201%2520%2528EGFR-related%2529%2520family%2520of%2520growth%2520factor%2520receptors%2520and%2520their%2520ligands%26jtitle%3DProg.%2520Growth%2520Factor%2520Res.%26date%3D1992%26volume%3D4%26spage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00012"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00012_1"><span><span class="NLM_string-ref">Stamos, J.; Sliwkowski, M. X.; Eigenbrot, C. Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor. <i>  J. Biol. Chem</i>. <b>2002</b>, <i>277</i>, 46265−46272.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46272&author=J.+Stamos&author=M.+X.+Sliwkowski&author=C+Eigenbrot&title=Structure+of+the+Epidermal+Growth+Factor+Receptor+Kinase+Domain+Alone+and+in+Complex+with+a+4-Anilinoquinazoline+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStamos%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520Kinase%2520Domain%2520Alone%2520and%2520in%2520Complex%2520with%2520a%25204-Anilinoquinazoline%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00013"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00013_1"><span><span class="NLM_string-ref">Cockerill, S.; Stubberfield, C.; Stables, J.; Carter, M.; Guntrip, S.; Smith, K.; McKeown, S.; Shaw, R.; Topley, P.; Thomsen, L.; Affleck, K.; Jowett, A.; Hayes, D.; Willson, M.; Woollard, P.; Spalding, D. Indazolylamino Quinazolines and Pyridopyrimidines as Inhibitors of the EGFr and C-erbB-2. <i>  Bioorg. Med. Chem. Lett. </i><b>2001</b>, <i>11</i>, 1401−1405.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1405&author=S.+Cockerill&author=C.+Stubberfield&author=J.+Stables&author=M.+Carter&author=S.+Guntrip&author=K.+Smith&author=S.+McKeown&author=R.+Shaw&author=P.+Topley&author=L.+Thomsen&author=K.+Affleck&author=A.+Jowett&author=D.+Hayes&author=M.+Willson&author=P.+Woollard&author=D+Spalding&title=Indazolylamino+Quinazolines+and+Pyridopyrimidines+as+Inhibitors+of+the+EGFr+and+C-erbB-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCockerill%26aufirst%3DS.%26atitle%3DIndazolylamino%2520Quinazolines%2520and%2520Pyridopyrimidines%2520as%2520Inhibitors%2520of%2520the%2520EGFr%2520and%2520C-erbB-2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00014"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00014_1"><span><span class="NLM_string-ref">Bhattacharya, S. K.; Cox, E. D.; Kath, J. C.; Mathiowetz, A. M.; Morris, J.; Moyer, J. D.; Pustilnik, L. R.; Rafidi, K.; Richter, D. T.; Su, C.; Wessel, M. D. Achieving selectivity between highly homologous tyrosine kinases:  a novel selective erbB2 inhibitor. <i>  Biochem. Biophys. Res. Commun</i>. <b>2003</b>, <i>307</i>, 267−273.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2003&pages=273&author=S.+K.+Bhattacharya&author=E.+D.+Cox&author=J.+C.+Kath&author=A.+M.+Mathiowetz&author=J.+Morris&author=J.+D.+Moyer&author=L.+R.+Pustilnik&author=K.+Rafidi&author=D.+T.+Richter&author=C.+Su&author=M.+D+Wessel&title=Achieving+selectivity+between+highly+homologous+tyrosine+kinases%3A%E2%80%89+a+novel+selective+erbB2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26atitle%3DAchieving%2520selectivity%2520between%2520highly%2520homologous%2520tyrosine%2520kinases%253A%25E2%2580%2589%2520a%2520novel%2520selective%2520erbB2%2520inhibitor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D307%26spage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00015"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00015_1"><span><span class="NLM_string-ref">Barbacci, E. G.; Pustilnik, L. R.; Rossi, A. M. K.; Emerson, E.; Miller, P. E.; Boscoe, B. P.; Cox, E. D.; Iwata, K. K.; Jani, J. P.; Provoncha, K.; Kath, J. C.; Liu, Z.; Moyer, J. D. The Biological and Biochemical Effects of CP-654577, a Selective erbB2 Kinase Inhibitor, on Human Breast Cancer Cells. <i>  Cancer Res. </i><b>2003</b>, <i>63</i>, 4450−4459.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=4459&author=E.+G.+Barbacci&author=L.+R.+Pustilnik&author=A.+M.+K.+Rossi&author=E.+Emerson&author=P.+E.+Miller&author=B.+P.+Boscoe&author=E.+D.+Cox&author=K.+K.+Iwata&author=J.+P.+Jani&author=K.+Provoncha&author=J.+C.+Kath&author=Z.+Liu&author=J.+D+Moyer&title=The+Biological+and+Biochemical+Effects+of+CP-654577%2C+a+Selective+erbB2+Kinase+Inhibitor%2C+on+Human+Breast+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarbacci%26aufirst%3DE.%2BG.%26atitle%3DThe%2520Biological%2520and%2520Biochemical%2520Effects%2520of%2520CP-654577%252C%2520a%2520Selective%2520erbB2%2520Kinase%2520Inhibitor%252C%2520on%2520Human%2520Breast%2520Cancer%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D4459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00016"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00016_1"><span><span class="NLM_string-ref">Gaul, M. D.; Guo, Y.; Affleck, K.; Cockerill, G. S.; Gilmer, T. M.; Griffin, R. J.; Guntrip, S.; Keith, B. R.; Knight, W. B.; Mullin, R. J.; Murray, D. M.; Rusnak, D. W.; Smith, K.; Tadepalli, S.; Wood, E. R.; Lackey, K. Discovery and Biological Evaluation of Potent Dual ErbB-2/EGFR Tyrosine Kinase Inhibitors:  6-Thiazolylquinazolines. <i>  Bioorg. Med. Chem. </i><i>Lett</i>. <b>2003</b>, <i>13</i>, 637−640.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=640&author=M.+D.+Gaul&author=Y.+Guo&author=K.+Affleck&author=G.+S.+Cockerill&author=T.+M.+Gilmer&author=R.+J.+Griffin&author=S.+Guntrip&author=B.+R.+Keith&author=W.+B.+Knight&author=R.+J.+Mullin&author=D.+M.+Murray&author=D.+W.+Rusnak&author=K.+Smith&author=S.+Tadepalli&author=E.+R.+Wood&author=K+Lackey&title=Discovery+and+Biological+Evaluation+of+Potent+Dual+ErbB-2%2FEGFR+Tyrosine+Kinase+Inhibitors%3A%E2%80%89+6-Thiazolylquinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGaul%26aufirst%3DM.%2BD.%26atitle%3DDiscovery%2520and%2520Biological%2520Evaluation%2520of%2520Potent%2520Dual%2520ErbB-2%252FEGFR%2520Tyrosine%2520Kinase%2520Inhibitors%253A%25E2%2580%2589%25206-Thiazolylquinazolines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00017"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00017_1"><span><span class="NLM_string-ref">Zhang, Y.-M.; Cockerill, S.; Guntrip, S. B.; Rusnak, D.; Smith, K.; Vanderwall, D.; Wood, E.; Lackey, K. Synthesis and SAR of potent EGFR/erbB2 dual inhibitors. <i>  Bioog. Med. Chem. Lett</i>. <b>2004</b>, <i>14</i>, 111−114.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=114&author=Y.-M.+Zhang&author=S.+Cockerill&author=S.+B.+Guntrip&author=D.+Rusnak&author=K.+Smith&author=D.+Vanderwall&author=E.+Wood&author=K+Lackey&title=Synthesis+and+SAR+of+potent+EGFR%2FerbB2+dual+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.-M.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520potent%2520EGFR%252FerbB2%2520dual%2520inhibitors%26jtitle%3DBioog.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00018"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00018_1"><span><span class="NLM_string-ref">Bredereck, H.; Simchen, G.; Wahl, R. Orthoamide, VIII. Über die Umsetung aktivierter Methylgruppen an substituierten Toluolen und Heterocyclen mit Aminal-<i>tert</i>-butylester zu Enaminen (Orthoamides. VIII. Conversion of activated methyl groups on substituted toluenes and heterocycles to enamines by reaction with aminal <i>tert</i>-butyl ester). <i>  Chem. Ber</i>. <b>1968</b>, <i>101</i>, 4048−4056.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1968&pages=4056&author=H.+Bredereck&author=G.+Simchen&author=R.+Wahl&author=VIII+Orthoamide&title=%C3%9Cber+die+Umsetung+aktivierter+Methylgruppen+an+substituierten+Toluolen+und+Heterocyclen+mit+Aminal-tert-butylester+zu+Enaminen+%28Orthoamides.+VIII.+Conversion+of+activated+methyl+groups+on+substituted+toluenes+and+heterocycles+to+enamines+by+reaction+with+aminal+tert-butyl+ester%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBredereck%26aufirst%3DH.%26atitle%3D%25C3%259Cber%2520die%2520Umsetung%2520aktivierter%2520Methylgruppen%2520an%2520substituierten%2520Toluolen%2520und%2520Heterocyclen%2520mit%2520Aminal-tert-butylester%2520zu%2520Enaminen%2520%2528Orthoamides.%2520VIII.%2520Conversion%2520of%2520activated%2520methyl%2520groups%2520on%2520substituted%2520toluenes%2520and%2520heterocycles%2520to%2520enamines%2520by%2520reaction%2520with%2520aminal%2520tert-butyl%2520ester%2529%26jtitle%3DChem.%2520Ber.%26date%3D1968%26volume%3D101%26spage%3D4056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00019"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00019_1"><span><span class="NLM_string-ref">Biere, H.; Russe, R. Eine einfache methode zur nitrilbildung unter kettenverlängerung von aktiven alkylgruppen (A simple method for nitrile formation with chain elongation of active alkyl groups). <i>  Tetrahedron Lett</i>. <b>1979</b>, <i>20</i> (16), 1361−1362.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1979&pages=1362&issue=16&author=H.+Biere&author=R+Russe&title=Eine+einfache+methode+zur+nitrilbildung+unter+kettenverl%C3%A4ngerung+von+aktiven+alkylgruppen+%28A+simple+method+for+nitrile+formation+with+chain+elongation+of+active+alkyl+groups%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiere%26aufirst%3DH.%26atitle%3DEine%2520einfache%2520methode%2520zur%2520nitrilbildung%2520unter%2520kettenverl%25C3%25A4ngerung%2520von%2520aktiven%2520alkylgruppen%2520%2528A%2520simple%2520method%2520for%2520nitrile%2520formation%2520with%2520chain%2520elongation%2520of%2520active%2520alkyl%2520groups%2529%26jtitle%3DTetrahedron%2520Lett.%26date%3D1979%26volume%3D20%26issue%3D16%26spage%3D1362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm040159cb00020_1"><span><span class="NLM_string-ref">Orsini, F.; Pelizzoni, F.; Ricca, G. Zinc(0)-mediated formation of carbon−carbon bond from γ-bromo crotonate. <i>  Synth.</i><i> Comm</i>. <b>1982</b>, <i>12</i> (14), 1147−1154.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1982&pages=1154&issue=14&author=F.+Orsini&author=F.+Pelizzoni&author=G.+Ricca&author=+Zinc&title=formation+of+carbon%E2%88%92carbon+bond+from+%CE%B3-bromo+crotonate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrsini%26aufirst%3DF.%26atitle%3Dformation%2520of%2520carbon%25E2%2588%2592carbon%2520bond%2520from%2520%25CE%25B3-bromo%2520crotonate%26jtitle%3DSynth.%2520Comm.%26date%3D1982%26volume%3D12%26issue%3D14%26spage%3D1154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00021"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00021" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00021_1"><span><span class="NLM_string-ref">Anthony, N. J.; Gomez, R. P.; Schaber, M. D.; Mosser, S. D.; Hamilton, K. A.; O'Neil, T. J.; Koblan, K. S.; Graham, S. L.; Hartman, G. D.; Shah, D.; Rands, E.; Kohl, N. E.; Gibbs, J. B.; Oliff, A. I. Design and in Vivo Analysis of Potent Non-Thiol Inhibitors of Farnesyl Protein Transferase. <i>  J. </i><i>Med. Chem.</i><b>1999</b>, <i>42</i> (17), 3356−3368.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3368&issue=17&author=N.+J.+Anthony&author=R.+P.+Gomez&author=M.+D.+Schaber&author=S.+D.+Mosser&author=K.+A.+Hamilton&author=T.+J.+O%27Neil&author=K.+S.+Koblan&author=S.+L.+Graham&author=G.+D.+Hartman&author=D.+Shah&author=E.+Rands&author=N.+E.+Kohl&author=J.+B.+Gibbs&author=A.+I+Oliff&title=Design+and+in+Vivo+Analysis+of+Potent+Non-Thiol+Inhibitors+of+Farnesyl+Protein+Transferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnthony%26aufirst%3DN.%2BJ.%26atitle%3DDesign%2520and%2520in%2520Vivo%2520Analysis%2520of%2520Potent%2520Non-Thiol%2520Inhibitors%2520of%2520Farnesyl%2520Protein%2520Transferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26issue%3D17%26spage%3D3368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00022"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00022" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00022_1"><span><span class="NLM_string-ref">Takacs, J. M.; Helle, M. A.; Seely, F. L. An improved procedure for the two carbon homologation of esters to α,β-unsaturated esters. <i>  Tetrahedron Lett. </i><b>1986</b>, <i>27 </i>(11), 1257−1260.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1986&pages=1260&issue=11&author=J.+M.+Takacs&author=M.+A.+Helle&author=F.+L+Seely&title=An+improved+procedure+for+the+two+carbon+homologation+of+esters+to+%CE%B1%2C%CE%B2-unsaturated+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakacs%26aufirst%3DJ.%2BM.%26atitle%3DAn%2520improved%2520procedure%2520for%2520the%2520two%2520carbon%2520homologation%2520of%2520esters%2520to%2520%25CE%25B1%252C%25CE%25B2-unsaturated%2520esters%26jtitle%3DTetrahedron%2520Lett.%26date%3D1986%26volume%3D27%26issue%3D11%26spage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00023"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00023" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00023_1"><span><span class="NLM_string-ref">Wulff, G.; Wolf, G. Zur Chemie von Haftgruppen, VI. Über die Eignung verschiedener Aldehyde und Ketone als Haftgruppen fur Monoalkohole (Chemistry of binding sites. VI. On the suitability of various aldehydes and ketones as binding sites for monoalcohols). <i>  Chem. Ber</i>. <b>1986</b>, <i>119</i> (6), 1876−1889.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1986&pages=1889&issue=6&author=G.+Wulff&author=G+Wolf&title=Zur+Chemie+von+Haftgruppen%2C+VI.+%C3%9Cber+die+Eignung+verschiedener+Aldehyde+und+Ketone+als+Haftgruppen+fur+Monoalkohole+%28Chemistry+of+binding+sites.+VI.+On+the+suitability+of+various+aldehydes+and+ketones+as+binding+sites+for+monoalcohols%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWulff%26aufirst%3DG.%26atitle%3DZur%2520Chemie%2520von%2520Haftgruppen%252C%2520VI.%2520%25C3%259Cber%2520die%2520Eignung%2520verschiedener%2520Aldehyde%2520und%2520Ketone%2520als%2520Haftgruppen%2520fur%2520Monoalkohole%2520%2528Chemistry%2520of%2520binding%2520sites.%2520VI.%2520On%2520the%2520suitability%2520of%2520various%2520aldehydes%2520and%2520ketones%2520as%2520binding%2520sites%2520for%2520monoalcohols%2529%26jtitle%3DChem.%2520Ber.%26date%3D1986%26volume%3D119%26issue%3D6%26spage%3D1889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00024"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00024" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00024_1"><span><span class="NLM_string-ref">Tsou, H.-R.; Mamuya, N.; Johnson, B. D.; Reich, M. F.; Gruber, B. C.; Ye, F.; Nilakantan, R.; Shen, R.; Discafani, C.; DeBlanc, R.; Davis, R.; Koehn, F. E.; Greenberger, L. M.; Wang, Y.-F.; Wissner, A. 6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity. <i>  J. Med. Chem. </i><b>2001</b>, <i>44</i>, 2719−2734.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2734&author=H.-R.+Tsou&author=N.+Mamuya&author=B.+D.+Johnson&author=M.+F.+Reich&author=B.+C.+Gruber&author=F.+Ye&author=R.+Nilakantan&author=R.+Shen&author=C.+Discafani&author=R.+DeBlanc&author=R.+Davis&author=F.+E.+Koehn&author=L.+M.+Greenberger&author=Y.-F.+Wang&author=A.+Wissner&author=+Substituted&title=Inhibitors+of+the+Epidermal+Growth+Factor+Receptor+%28EGFR%29+and+Human+Epidermal+Growth+Factor+Receptor+%28HER-2%29+Tyrosine+Kinases+with+Enhanced+Antitumor+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26atitle%3DInhibitors%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528EGFR%2529%2520and%2520Human%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520%2528HER-2%2529%2520Tyrosine%2520Kinases%2520with%2520Enhanced%2520Antitumor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00025"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00025" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00025_1"><span><span class="NLM_string-ref">Quanta and CHARMm are products of Accelrys Inc., 9685 Scranton Road San Diego, CA 92121-3752.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Quanta+and+CHARMm+are+products+of+Accelrys+Inc.%2C+9685+Scranton+Road+San+Diego%2C+CA+92121-3752.+Quanta+and+CHARMm+are+products+of+Accelrys+Inc.%2C+9685+Scranton+Road+San+Diego%2C+CA+92121-3752."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dother%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00026"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00026" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00026_1"><span><span class="NLM_string-ref">Wissner, A.; Hamann, P. R.; Nilakantan, R.; Greenberger, L. M.; Ye, F.; Rapuano, T. A.; Loganzo, F. Syntheses and EGFR kinase inhibitory activity of 6-substituted-4-anilino [1,7] and [1,8] naphthyridine-3-carbonitriles. <i>  Bioorg. Med. Chem. Lett. </i><b>2004</b>, <i>14</i> (6), 1411−1416.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1416&issue=6&author=A.+Wissner&author=P.+R.+Hamann&author=R.+Nilakantan&author=L.+M.+Greenberger&author=F.+Ye&author=T.+A.+Rapuano&author=F+Loganzo&title=Syntheses+and+EGFR+kinase+inhibitory+activity+of+6-substituted-4-anilino+%5B1%2C7%5D+and+%5B1%2C8%5D+naphthyridine-3-carbonitriles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DSyntheses%2520and%2520EGFR%2520kinase%2520inhibitory%2520activity%2520of%25206-substituted-4-anilino%2520%255B1%252C7%255D%2520and%2520%255B1%252C8%255D%2520naphthyridine-3-carbonitriles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D6%26spage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00027"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00027" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00027_1"><span><span class="NLM_string-ref">Akula, N.; Bhalla, J.; Sridhar, J.; Pattabiraman, N. Binding modes of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles to EGFR. <i>  Bioorg. Med. </i><i>Chem. Lett. </i><b>2004</b>, <i>14</i>, 3397−3400.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3400&author=N.+Akula&author=J.+Bhalla&author=J.+Sridhar&author=N+Pattabiraman&title=Binding+modes+of+6%2C7-disubstituted+4-anilinoquinoline-3-carbonitriles+to+EGFR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkula%26aufirst%3DN.%26atitle%3DBinding%2520modes%2520of%25206%252C7-disubstituted%25204-anilinoquinoline-3-carbonitriles%2520to%2520EGFR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00028"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00028" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00028_1"><span><span class="NLM_string-ref">Torrance, C. J.; Jackson, P. E.; Montgomery, E.; Kinzler, K. W.; Vogelstein, B.; Wissner, A.; Nunes, M.; Frost, P.; Discafani, C. M. Combinatorial chemoprevention of intestinal neoplasia. <i>  Nat. Med</i>. <b>2000</b>, <i>6</i>, 1024−1028.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1028&author=C.+J.+Torrance&author=P.+E.+Jackson&author=E.+Montgomery&author=K.+W.+Kinzler&author=B.+Vogelstein&author=A.+Wissner&author=M.+Nunes&author=P.+Frost&author=C.+M+Discafani&title=Combinatorial+chemoprevention+of+intestinal+neoplasia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorrance%26aufirst%3DC.%2BJ.%26atitle%3DCombinatorial%2520chemoprevention%2520of%2520intestinal%2520neoplasia%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26spage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00029"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00029" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00029_1"><span><span class="NLM_string-ref">Rabindran, S. K.; Discafani, C. M.; Rosfjord, E. C.; Baxter, M.; Floyd, M. B.; Golas, J.; Hallett, W. A.; Johnson, S. D.; Nilakantan, R.; Overbeek, E.; Reich, M. F.; Shen, R.; Shi, A.; Tsou, H.-R.; Wang, Y.-F.; Wissner, A. Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase. Cancer Research. <i>  Cancer Res</i>. <b>2004</b>, <i>64</i>, 3958−3965.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=3965&author=S.+K.+Rabindran&author=C.+M.+Discafani&author=E.+C.+Rosfjord&author=M.+Baxter&author=M.+B.+Floyd&author=J.+Golas&author=W.+A.+Hallett&author=S.+D.+Johnson&author=R.+Nilakantan&author=E.+Overbeek&author=M.+F.+Reich&author=R.+Shen&author=A.+Shi&author=H.-R.+Tsou&author=Y.-F.+Wang&author=A+Wissner&title=Antitumor+activity+of+HKI-272%2C+an+orally+active%2C+irreversible+inhibitor+of+the+HER-2+tyrosine+kinase.+Cancer+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26atitle%3DAntitumor%2520activity%2520of%2520HKI-272%252C%2520an%2520orally%2520active%252C%2520irreversible%2520inhibitor%2520of%2520the%2520HER-2%2520tyrosine%2520kinase.%2520Cancer%2520Research%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D3965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00030"><div class="reference"><div class="NLM_citation" id="rightTab-jm040159cb00030_1"><span><span class="NLM_string-ref">Jochims, J. C.; Abu-Taha, A. Über 5- und 4-Hydroxythiazolidin-2-thione (Studies on 5- and 4-hydroxythiazolidine-2-thiones). <i>  Chem Ber</i>. <b>1976</b>, <i>109</i> (1), 139−153.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Jochims%2C+J.+C.%3B+Abu-Taha%2C+A.+%C3%9Cber+5-+und+4-Hydroxythiazolidin-2-thione+%28Studies+on+5-+and+4-hydroxythiazolidine-2-thiones%29.+Chem+Ber.+1976%2C+109+%281%29%2C+139%E2%88%92153.+Jochims%2C+J.+C.%3B+Abu-Taha%2C+A.+%C3%9Cber+5-+und+4-Hydroxythiazolidin-2-thione+%28Studies+on+5-+and+4-hydroxythiazolidine-2-thiones%29.+Chem+Ber.+1976%2C+109+%281%29%2C+139%E2%88%92153."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJochims%26aufirst%3DJ.%2BC.%26jtitle%3DChem%2520Ber.%26date%3D1976%26volume%3D109%26issue%3D1%26spage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00031"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00031" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00031_1"><span><span class="NLM_string-ref">Alcaldi, E.; Alemany, M.; Gisbert, M. A direct synthetic approach to novel quadrupolar [14] azolophanes. <i>  Tetrahedron</i><b>1996</b>, <i>52</i>, 15171−15188.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1996&pages=15188&author=E.+Alcaldi&author=M.+Alemany&author=M+Gisbert&title=A+direct+synthetic+approach+to+novel+quadrupolar+%5B14%5D+azolophanes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlcaldi%26aufirst%3DE.%26atitle%3DA%2520direct%2520synthetic%2520approach%2520to%2520novel%2520quadrupolar%2520%255B14%255D%2520azolophanes%26jtitle%3DTetrahedron%26date%3D1996%26volume%3D52%26spage%3D15188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00032"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00032" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00032_1"><span><span class="NLM_string-ref">Shkodinskaya, E. N.; Kurdyukova, E. M.; Berlin, A. Y. Halogen substitution in the ring of sarcolysin derivatives. <i>  J. Gen. Chem. USSR (Engl. Transl.)</i><b>1961</b>, <i>31</i>, 3537−3540.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1961&pages=3540&author=E.+N.+Shkodinskaya&author=E.+M.+Kurdyukova&author=A.+Y+Berlin&title=Halogen+substitution+in+the+ring+of+sarcolysin+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShkodinskaya%26aufirst%3DE.%2BN.%26atitle%3DHalogen%2520substitution%2520in%2520the%2520ring%2520of%2520sarcolysin%2520derivatives%26jtitle%3DJ.%2520Gen.%2520Chem.%2520USSR%2520%2528Engl.%2520Transl.%2529%26date%3D1961%26volume%3D31%26spage%3D3540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00033"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00033" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00033_1"><span><span class="NLM_string-ref">Gall, R.; Erlenmeyer, H. Über einige Derivate heterocyclischer Carbonsäuren IV. Metallionen und biologische Wirkung, 36. Mitteilung (Metal ions and biological action. XXXVI. Some derivatives of heterocyclic carboxylic acids. IV). <i>  Helv. Chim Acta</i><b>1955</b>, <i>38</i> (6), 1421−1423.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1955&pages=1423&issue=6&author=R.+Gall&author=H+Erlenmeyer&title=%C3%9Cber+einige+Derivate+heterocyclischer+Carbons%C3%A4uren+IV.+Metallionen+und+biologische+Wirkung%2C+36.+Mitteilung+%28Metal+ions+and+biological+action.+XXXVI.+Some+derivatives+of+heterocyclic+carboxylic+acids.+IV%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGall%26aufirst%3DR.%26atitle%3D%25C3%259Cber%2520einige%2520Derivate%2520heterocyclischer%2520Carbons%25C3%25A4uren%2520IV.%2520Metallionen%2520und%2520biologische%2520Wirkung%252C%252036.%2520Mitteilung%2520%2528Metal%2520ions%2520and%2520biological%2520action.%2520XXXVI.%2520Some%2520derivatives%2520of%2520heterocyclic%2520carboxylic%2520acids.%2520IV%2529%26jtitle%3DHelv.%2520Chim%2520Acta%26date%3D1955%26volume%3D38%26issue%3D6%26spage%3D1423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00034"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00034" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00034_1"><span><span class="NLM_string-ref">Boger, D. L.; Zarrinmayeh, H. Regiocontrolled Nucleophilic Addition to Selectively Activated <i>p</i>-Quinone Diimines:  Alternative Preparation of a Key Intermediate Employed in the Preparation of the CC1065 Left-Hand Subunit. <i>  J. Org. Chem</i>. <b>1990</b>, <i>55</i>, 1379−1390.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=1390&author=D.+L.+Boger&author=H+Zarrinmayeh&title=Regiocontrolled+Nucleophilic+Addition+to+Selectively+Activated+p-Quinone+Diimines%3A%E2%80%89+Alternative+Preparation+of+a+Key+Intermediate+Employed+in+the+Preparation+of+the+CC1065+Left-Hand+Subunit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DRegiocontrolled%2520Nucleophilic%2520Addition%2520to%2520Selectively%2520Activated%2520p-Quinone%2520Diimines%253A%25E2%2580%2589%2520Alternative%2520Preparation%2520of%2520a%2520Key%2520Intermediate%2520Employed%2520in%2520the%2520Preparation%2520of%2520the%2520CC1065%2520Left-Hand%2520Subunit%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1990%26volume%3D55%26spage%3D1390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm040159cb00035"><div class="reference"><strong class="refLabel"><a href="#jm040159cb00035" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-jm040159cb00035_1"><span><span class="NLM_string-ref">Krawczul, H. The Mannich Reacion of Malonic Acid. An Efficient Route to Some α-Functionalized Acrylates. <i>  Synth. Commun. </i><b>1995</b>, <i>25</i>, 641−650.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=650&author=H+Krawczul&title=The+Mannich+Reacion+of+Malonic+Acid.+An+Efficient+Route+to+Some+%CE%B1-Functionalized+Acrylates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm040159cb00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrawczul%26aufirst%3DH%26atitle%3DThe%2520Mannich%2520Reacion%2520of%2520Malonic%2520Acid.%2520An%2520Efficient%2520Route%2520to%2520Some%2520%25CE%25B1-Functionalized%2520Acrylates%26jtitle%3DSynth.%2520Commun.%26date%3D1995%26volume%3D25%26spage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="NLM_notes" id="rightTab-"><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40"><a href="/doi/suppl/10.1021%2Fjm040159c">Supporting Information Available</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48744" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48744" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Experimental procedures for compounds <b>2d</b>,<b>k</b>, <b>7a</b>,<b>c</b>,<b>e</b>,<b>g</b>,<b>j</b><b>−</b><b>l</b>,<b>n</b>,<b>o</b>,<b>r</b><b>−</b><b>u</b>,<b> 8a</b>,<b>c</b>,<b>k</b>,<b>m</b>,<b> 17a</b>, and <b>25j</b>,<b>l</b>,<b>p</b>,<b>r</b>,<b>s</b> and elementary analysis data for compounds <b>7a</b><b>−</b><b>v</b>,<b> 8a</b><b>−</b><b>u</b>,<b> 21a</b><b>−</b><b>d</b>, <b>25a</b><b>−</b><b>w</b>,<b> 31</b>,<b> 32</b>,<b> 36</b><b>−</b><b>38</b>,<b> 75</b><b>−</b><b>77</b>, and <b>82</b><b>−</b><b>86</b>. This material is available free of charge via the Internet at <a class="ext-link" href="http://pubs.acs.org" target="_blank">http://pubs.acs.org</a>. </div></div></div><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm040159c/suppl_file/jm040159c_s.pdf">jm040159c_s.pdf (624.63 kb)</a></li></ul></div></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm040159c&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm040159c%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2005.48.issue-4%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm040159c" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                480KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a6acdb84e234a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
